,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes,cluster,ordered_cluster,sample
0,KEGG_2021_Human,ECM-receptor interaction,4/88,1.2121132386078124e-08,3.878762363545e-07,0,0,316.015873015873,5760.4370140542815,COL1A1;FN1;ITGAV;ITGA5,1,1,A1
1,KEGG_2021_Human,Focal adhesion,4/201,3.384308864397607e-07,3.9063960352438384e-06,0,0,133.98307952622673,1996.2066589227811,COL1A1;FN1;ITGAV;ITGA5,1,1,A1
2,KEGG_2021_Human,Proteoglycans in cancer,4/205,3.662246283041099e-07,3.9063960352438384e-06,0,0,131.29021558872304,1945.72348340374,COL1A1;FN1;ITGAV;ITGA5,1,1,A1
3,KEGG_2021_Human,Human papillomavirus infection,4/331,2.479170607875335e-06,1.983336486300268e-05,0,0,80.18756371049949,1035.0279136973668,COL1A1;FN1;ITGAV;ITGA5,1,1,A1
4,KEGG_2021_Human,PI3K-Akt signaling pathway,4/354,3.238246432286954e-06,2.0724777166636503e-05,0,0,74.83047619047619,945.893032859476,COL1A1;FN1;ITGAV;ITGA5,1,1,A1
5,KEGG_2021_Human,Regulation of actin cytoskeleton,3/218,4.328503234742615e-05,0.00023085350585293947,0,0,68.99302325581395,693.2214520048454,FN1;ITGAV;ITGA5,1,1,A1
6,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,2/77,0.0003034160628500144,0.0012136642514,0,0,106.22933333333332,860.5006812675136,ITGAV;ITGA5,1,1,A1
7,KEGG_2021_Human,Bacterial invasion of epithelial cells,2/77,0.0003034160628500144,0.0012136642514,0,0,106.22933333333332,860.5006812675136,FN1;ITGA5,1,1,A1
8,KEGG_2021_Human,Hypertrophic cardiomyopathy,2/90,0.0004144053627379791,0.0013093377956954,0,0,90.47727272727272,704.6972511803252,ITGAV;ITGA5,1,1,A1
9,KEGG_2021_Human,Small cell lung cancer,2/92,0.0004329893407438501,0.0013093377956954,0,0,88.45777777777778,685.0875715434879,FN1;ITGAV,1,1,A1
10,KEGG_2021_Human,Dilated cardiomyopathy,2/96,0.0004713603714468496,0.0013093377956954,0,0,84.67659574468085,648.6132088589799,ITGAV;ITGA5,1,1,A1
11,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,2/100,0.0005113327792346296,0.0013093377956954,0,0,81.20408163265306,615.4043164173056,COL1A1;FN1,1,1,A1
12,KEGG_2021_Human,Amoebiasis,2/102,0.0005319184795012633,0.0013093377956954,0,0,79.572,599.894924456191,COL1A1;FN1,1,1,A1
13,KEGG_2021_Human,Yersinia infection,2/137,0.000956414098463136,0.0021860893679157,0,0,58.83851851851852,409.0641844315812,FN1;ITGA5,1,1,A1
14,KEGG_2021_Human,Phagosome,2/152,0.0011752198301649,0.0025071356376852,0,0,52.91466666666667,356.97821887556444,ITGAV;ITGA5,1,1,A1
15,KEGG_2021_Human,Pathways in cancer,2/531,0.0135233413849574,0.0270466827699148,0,0,14.71758034026465,63.33472414513937,FN1;ITGAV,1,1,A1
16,KEGG_2021_Human,Cholesterol metabolism,1/50,0.0173717414502839,0.0326997486122992,0,0,67.83673469387755,274.9362107684438,APOE,1,1,A1
17,KEGG_2021_Human,Pertussis,1/76,0.0263023993869505,0.0467598211323565,0,0,44.26222222222222,161.0301743357976,ITGA5,1,1,A1
0,KEGG_2021_Human,Human papillomavirus infection,9/331,2.0383691104637823e-10,3.0779373568003126e-08,0,0,32.31055900621118,720.9681494947951,NOTCH2;ITGB5;EGF;FN1;HLA-B;GNAS;ITGA6;HLA-A;TNFRSF1A,2,2,A1
1,KEGG_2021_Human,Pathways in cancer,10/531,5.798525938562907e-10,4.3778870836149946e-08,0,0,23.336132437619963,496.318633216856,NOTCH2;EGF;TGFB3;CDH1;ERBB2;FN1;GNAS;ITGA6;MET;HSP90B1,2,2,A1
2,KEGG_2021_Human,Focal adhesion,6/201,1.8616606676837615e-07,9.370358694008266e-06,0,0,30.42923076923077,471.5504308960576,ITGB5;EGF;ERBB2;FN1;ITGA6;MET,2,2,A1
3,KEGG_2021_Human,PI3K-Akt signaling pathway,7/354,2.525520110046307e-07,9.53383841542481e-06,0,0,20.838616714697405,316.57294296627936,ITGB5;EGF;ERBB2;FN1;ITGA6;MET;HSP90B1,2,2,A1
4,KEGG_2021_Human,Gastric cancer,5/149,1.2438865154236069e-06,3.756537276579293e-05,0,0,32.78769841269841,445.8231812205297,EGF;TGFB3;CDH1;ERBB2;MET,2,2,A1
5,KEGG_2021_Human,Proteoglycans in cancer,5/205,5.948015058478435e-06,0.0001375911379955953,0,0,23.54047619047619,283.24967330495394,ITGB5;ERBB2;FN1;TIMP3;MET,2,2,A1
6,KEGG_2021_Human,Dilated cardiomyopathy,4/96,6.87126839580342e-06,0.0001375911379955953,0,0,39.29249011857708,467.1154816483118,ITGB5;TGFB3;GNAS;ITGA6,2,2,A1
7,KEGG_2021_Human,Regulation of actin cytoskeleton,5/218,8.020606975010073e-06,0.0001375911379955953,0,0,22.089201877934272,259.1835719567965,ITGB5;EGF;FN1;ITGA6;ITGAE,2,2,A1
8,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,5/219,8.20079630437323e-06,0.0001375911379955953,0,0,21.98486871384068,257.47093784027845,TGFB3;CANX;HLA-B;HLA-A;TNFRSF1A,2,2,A1
9,KEGG_2021_Human,Bladder cancer,3/41,2.0118464723773454e-05,0.0003037888173289792,0,0,68.43020594965675,739.9955237677673,EGF;CDH1;ERBB2,2,2,A1
10,KEGG_2021_Human,MAPK signaling pathway,5/294,3.387322953862e-05,0.0004649870600301473,0,0,16.217663536002636,166.9265545780892,EGF;TGFB3;ERBB2;MET;TNFRSF1A,2,2,A1
11,KEGG_2021_Human,Cell adhesion molecules,4/148,3.791777032373706e-05,0.000477131943240358,0,0,25.03787878787879,254.88787654016517,CDH1;HLA-B;ITGA6;HLA-A,2,2,A1
12,KEGG_2021_Human,Phagosome,4/152,4.2083394059137904e-05,0.0004888148079176787,0,0,24.35626535626536,245.4102549550317,ITGB5;CANX;HLA-B;HLA-A,2,2,A1
13,KEGG_2021_Human,Endometrial cancer,3/58,5.738724601054727e-05,0.0006189624391137599,0,0,47.238735177865614,461.3187716653817,EGF;CDH1;ERBB2,2,2,A1
14,KEGG_2021_Human,Adherens junction,3/71,0.00010511515842229564,0.000973425239886121,0,0,38.18286445012788,349.7723757477323,CDH1;ERBB2;MET,2,2,A1
15,KEGG_2021_Human,Melanoma,3/72,0.00010959092104678184,0.000973425239886121,0,0,37.62759924385633,343.11689727530154,EGF;CDH1;MET,2,2,A1
16,KEGG_2021_Human,Non-small cell lung cancer,3/72,0.00010959092104678184,0.000973425239886121,0,0,37.62759924385633,343.11689727530154,EGF;ERBB2;MET,2,2,A1
17,KEGG_2021_Human,Thyroid hormone synthesis,3/75,0.00012375963688097377,0.0009999937537905571,0,0,36.05434782608695,324.38707087904345,CANX;GNAS;HSP90B1,2,2,A1
18,KEGG_2021_Human,Pancreatic cancer,3/76,0.000128734691875851,0.0009999937537905571,0,0,35.55866587254318,318.52588541165494,EGF;TGFB3;ERBB2,2,2,A1
19,KEGG_2021_Human,Bacterial invasion of epithelial cells,3/77,0.0001338383109174152,0.0009999937537905571,0,0,35.07638072855464,312.8419646622961,CDH1;FN1;MET,2,2,A1
20,KEGG_2021_Human,Antigen processing and presentation,3/78,0.00013907197900398478,0.0009999937537905571,0,0,34.60695652173913,307.3277323038212,CANX;HLA-B;HLA-A,2,2,A1
21,KEGG_2021_Human,Rap1 signaling pathway,4/210,0.0001473060985704607,0.0010110554947336,0,0,17.44748455428067,153.9391184132572,EGF;CDH1;GNAS;MET,2,2,A1
22,KEGG_2021_Human,Human cytomegalovirus infection,4/225,0.00019194192446510345,0.0012513118285958,0,0,16.25092554504319,139.0805838706191,HLA-B;GNAS;HLA-A;TNFRSF1A,2,2,A1
23,KEGG_2021_Human,ECM-receptor interaction,3/88,0.00019888399924702983,0.0012513118285958,0,0,30.520204603580563,260.11725862710136,ITGB5;FN1;ITGA6,2,2,A1
24,KEGG_2021_Human,Hypertrophic cardiomyopathy,3/90,0.000212552623441213,0.0012838178455849,0,0,29.81559220389805,252.13021730456023,ITGB5;TGFB3;ITGA6,2,2,A1
25,KEGG_2021_Human,Chemical carcinogenesis,4/239,0.00024174588093043607,0.0013736902325617,0,0,15.271953578336555,127.17907893451589,NOTCH2;EGF;GNAS;HSP90B1,2,2,A1
26,KEGG_2021_Human,Calcium signaling pathway,4/240,0.0002456267303256178,0.0013736902325617,0,0,15.206471494607088,126.3915915736462,EGF;ERBB2;GNAS;MET,2,2,A1
27,KEGG_2021_Human,Prostate cancer,3/97,0.0002651547273213109,0.001429941565197,0,0,27.585568917668827,227.17259510257435,EGF;ERBB2;HSP90B1,2,2,A1
28,KEGG_2021_Human,Amoebiasis,3/102,0.00030745685299363466,0.0015475328267346,0,0,26.18577075098814,211.7689314177997,TGFB3;FN1;GNAS,2,2,A1
29,KEGG_2021_Human,Chagas disease,3/102,0.00030745685299363466,0.0015475328267346,0,0,26.18577075098814,211.7689314177997,TGFB3;GNAS;TNFRSF1A,2,2,A1
30,KEGG_2021_Human,Toxoplasmosis,3/112,0.0004046284662695075,0.0019709322066676,0,0,23.77143996808935,185.71535601511485,TGFB3;ITGA6;TNFRSF1A,2,2,A1
31,KEGG_2021_Human,MicroRNAs in cancer,4/310,0.0006464862946111971,0.0030506072026965,0,0,11.68627450980392,85.82351571308347,NOTCH2;ERBB2;TIMP3;MET,2,2,A1
32,KEGG_2021_Human,Breast cancer,3/147,0.0008934628042226501,0.0040882691950793,0,0,17.96195652173913,126.10022470604812,NOTCH2;EGF;ERBB2,2,2,A1
33,KEGG_2021_Human,Cellular senescence,3/156,0.0010608453942312,0.0047114016037918,0,0,16.89769820971867,115.7270823381469,TGFB3;HLA-B;HLA-A,2,2,A1
34,KEGG_2021_Human,Allograft rejection,2/38,0.0011099934165052,0.0047888287397798,0,0,46.15277777777778,313.9958634744484,HLA-B;HLA-A,2,2,A1
35,KEGG_2021_Human,Graft-versus-host disease,2/42,0.001355132075043,0.0056840262036526,0,0,41.52916666666667,274.25265129441186,HLA-B;HLA-A,2,2,A1
36,KEGG_2021_Human,Type I diabetes mellitus,2/43,0.0014201022558982,0.0057955524497469,0,0,40.51422764227642,265.65286017600937,HLA-B;HLA-A,2,2,A1
37,KEGG_2021_Human,Malaria,2/50,0.0019157650058532,0.0075623898052079,0,0,34.59375,216.47517339281177,TGFB3;MET,2,2,A1
38,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,3/193,0.0019532000159146,0.0075623898052079,0,0,13.581693363844394,84.7264905237309,HLA-B;HLA-A;TNFRSF1A,2,2,A1
39,KEGG_2021_Human,Autoimmune thyroid disease,2/53,0.0021498891156678,0.008115831411646,0,0,32.55392156862745,199.9572224537016,HLA-B;HLA-A,2,2,A1
40,KEGG_2021_Human,Regulation of lipolysis in adipocytes,2/55,0.0023131325887415,0.0085190980707311,0,0,31.32232704402516,190.09998180598296,GNAS;ADORA1,2,2,A1
41,KEGG_2021_Human,Human immunodeficiency virus 1 infection,3/212,0.0025503488299533,0.0091691112695942,0,0,12.335136259621386,73.65957619463337,HLA-B;HLA-A;TNFRSF1A,2,2,A1
42,KEGG_2021_Human,Viral myocarditis,2/60,0.0027460963421768,0.009643268550435,0,0,28.614942528735632,168.75876647047502,HLA-B;HLA-A,2,2,A1
43,KEGG_2021_Human,Renal cell carcinoma,2/69,0.0036137240645745,0.0119420020195689,0,0,24.75995024875622,139.2256073402869,TGFB3;MET,2,2,A1
44,KEGG_2021_Human,Renin secretion,2/69,0.0036137240645745,0.0119420020195689,0,0,24.75995024875622,139.2256073402869,GNAS;ADORA1,2,2,A1
45,KEGG_2021_Human,Central carbon metabolism in cancer,2/70,0.0037170469862234,0.0119420020195689,0,0,24.39460784313725,136.4835800450302,ERBB2;MET,2,2,A1
46,KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,2/70,0.0037170469862234,0.0119420020195689,0,0,24.39460784313725,136.4835800450302,ADAM10;MET,2,2,A1
47,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,2/77,0.0044785083289091,0.0140886407846934,0,0,22.11,119.58116668405684,ITGB5;ITGA6,2,2,A1
48,KEGG_2021_Human,ErbB signaling pathway,2/85,0.0054295113427952,0.0167317594441241,0,0,19.970883534136547,104.16625407098388,EGF;ERBB2,2,2,A1
49,KEGG_2021_Human,Colorectal cancer,2/86,0.0055543621266744,0.0167741736225567,0,0,19.732142857142858,102.47240569174454,EGF;TGFB3,2,2,A1
50,KEGG_2021_Human,Gap junction,2/88,0.0058080101471435,0.0171962653376211,0,0,19.271317829457363,99.21871235928316,EGF;GNAS,2,2,A1
51,KEGG_2021_Human,Morphine addiction,2/91,0.006198297963868,0.0179989037027705,0,0,18.618913857677903,94.64888639387834,GNAS;ADORA1,2,2,A1
52,KEGG_2021_Human,Small cell lung cancer,2/92,0.0063309980598904,0.0180373718310085,0,0,18.41111111111111,93.20251961184748,FN1;ITGA6,2,2,A1
53,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,2/100,0.0074389947886241,0.020801633575597,0,0,16.901360544217688,82.83389842043363,TGFB3;FN1,2,2,A1
54,KEGG_2021_Human,HIF-1 signaling pathway,2/109,0.0087825701831152,0.0241121472300072,0,0,15.472741433021806,73.26321689246383,EGF;ERBB2,2,2,A1
55,KEGG_2021_Human,Sphingolipid signaling pathway,2/119,0.0103932050776124,0.0280245351199905,0,0,14.143162393162394,64.58620844047488,ADORA1;TNFRSF1A,2,2,A1
56,KEGG_2021_Human,FoxO signaling pathway,2/131,0.012485247380843,0.0325046957673671,0,0,12.819767441860463,56.191701327620784,EGF;TGFB3,2,2,A1
57,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,2/131,0.012485247380843,0.0325046957673671,0,0,12.819767441860463,56.191701327620784,HLA-B;HLA-A,2,2,A1
58,KEGG_2021_Human,Estrogen signaling pathway,2/137,0.0135948431152079,0.0347935815321422,0,0,12.246296296296295,52.63537431715434,GNAS;HSP90B1,2,2,A1
59,KEGG_2021_Human,Fluid shear stress and atherosclerosis,2/139,0.013973961266051,0.0351678025195619,0,0,12.066301703163017,51.52986046289262,TNFRSF1A;HSP90B1,2,2,A1
60,KEGG_2021_Human,Phospholipase D signaling pathway,2/148,0.0157363858372094,0.0389540042855513,0,0,11.317351598173516,46.98715038313553,EGF;GNAS,2,2,A1
61,KEGG_2021_Human,Hepatitis C,2/157,0.0175894542914014,0.0428388322258325,0,0,10.655376344086022,43.05257655939376,EGF;TNFRSF1A,2,2,A1
62,KEGG_2021_Human,Hippo signaling pathway,2/163,0.0188741133720413,0.0452379542726704,0,0,10.255175983436851,40.71267904351928,TGFB3;CDH1,2,2,A1
63,KEGG_2021_Human,Hepatocellular carcinoma,2/168,0.0199742365776015,0.0471267144252787,0,0,9.943775100401606,38.9130944948488,TGFB3;MET,2,2,A1
64,KEGG_2021_Human,Protein processing in endoplasmic reticulum,2/171,0.0206470517624391,0.047964689478897,0,0,9.76577909270217,37.89300749341654,CANX;HSP90B1,2,2,A1
0,KEGG_2021_Human,ECM-receptor interaction,27/88,2.365230156105984e-40,4.4939372966013686e-38,0,0,100.86206896551724,9202.91019055206,ITGB1;LAMA5;ITGB5;LAMA2;SDC4;ITGB4;TNC;LAMC2;THBS1;COMP;ITGAV;CD36;ITGB6;LAMB3;ITGA3;LAMB2;ITGA2;FN1;LAMB1;HSPG2;COL1A1;COL1A2;COL6A2;COL6A1;SDC1;AGRN;CD44,3,3,A1
1,KEGG_2021_Human,PI3K-Akt signaling pathway,37/354,8.400670832048488e-37,7.980637290446064e-35,0,0,29.66336187471834,2464.056473756362,ITGB1;LAMA5;ITGB5;LAMA2;ITGB4;TNC;LAMC2;FGF2;AREG;THBS1;EGFR;IGF1R;COMP;FGF6;ERBB3;ERBB2;ITGAV;ITGB6;NGFR;HSP90AA1;LAMB3;ITGA3;LAMB2;ITGA2;FN1;VEGFB;LAMB1;VEGFA;COL1A1;EFNA1;EFNA3;COL1A2;COL6A2;COL6A1;FGFR4;FGFR3;FGFR2,3,3,A1
2,KEGG_2021_Human,Pathways in cancer,40/531,3.2846844644484336e-34,2.0803001608173412e-32,0,0,21.35190179996697,1646.2022179828336,RET;ITGB1;NOTCH3;LAMA5;NOTCH1;LAMA2;LRP5;CXCR4;LAMC2;FGF2;EGFR;IGF1R;GNAI2;FGF6;CDH1;ERBB2;ITGAV;FZD1;JAG2;HSP90AA1;TGFB1;FZD2;LAMB3;TGFB3;FZD4;WNT3A;ITGA3;LAMB2;ITGA2;WNT7B;FN1;VEGFB;LAMB1;ESR1;VEGFA;ADCY9;CALM3;FGFR4;FGFR3;FGFR2,3,3,A1
3,KEGG_2021_Human,Proteoglycans in cancer,29/205,1.2836595156052945e-32,6.0973826991251485e-31,0,0,38.20788770053476,2805.720122430232,ITGB1;SDC4;ITGB5;FGF2;THBS1;EGFR;IGF1R;ERBB3;PLAU;GPC1;ERBB2;GPC3;ITGAV;FZD1;TGFB1;FZD2;LUM;FZD4;WNT3A;ITGA2;WNT7B;FN1;ESR1;HSPG2;VEGFA;COL1A1;COL1A2;SDC1;CD44,3,3,A1
4,KEGG_2021_Human,Focal adhesion,26/201,3.433914216152509e-28,1.3048874021379535e-26,0,0,33.27831168831169,2104.4765644439985,ITGB1;LAMA5;ITGB5;LAMA2;ITGB4;TNC;LAMC2;THBS1;EGFR;IGF1R;COMP;ERBB2;ITGAV;ITGB6;LAMB3;ITGA3;LAMB2;ITGA2;FN1;VEGFB;LAMB1;VEGFA;COL1A1;COL1A2;COL6A2;COL6A1,3,3,A1
5,KEGG_2021_Human,Human papillomavirus infection,30/331,8.104008380395129e-28,2.5662693204584576e-26,0,0,23.238016136687232,1449.5879997359682,ITGB1;NOTCH3;LAMA5;NOTCH1;ITGB5;LAMA2;ITGB4;TNC;LAMC2;THBS1;EGFR;COMP;ITGAV;ITGB6;FZD1;FZD2;LAMB3;FZD4;WNT3A;ITGA3;LAMB2;ITGA2;WNT7B;FN1;LAMB1;VEGFA;COL1A1;COL1A2;COL6A2;COL6A1,3,3,A1
6,KEGG_2021_Human,Rap1 signaling pathway,20/210,4.2945495837363227e-19,1.1656634584427161e-17,0,0,22.05599104143337,932.7869021621424,FARP2;ITGB1;NGFR;ITGB2;VEGFB;FGF2;THBS1;EGFR;IGF1R;VEGFA;GNAI2;EFNA1;FGF6;EFNA3;ADCY9;CDH1;CALM3;FGFR4;FGFR3;FGFR2,3,3,A1
7,KEGG_2021_Human,Axon guidance,17/182,3.2558075052296e-16,7.732542824920301e-15,0,0,20.947016557325835,746.9899060200094,EPHB6;ITGB1;BMPR2;SEMA4D;SEMA4C;CXCR4;SEMA3F;NTN1;GNAI2;EFNA1;EFNB1;EFNA3;PLXNB2;PLXNA1;NEO1;EPHB4;EPHB3,3,3,A1
8,KEGG_2021_Human,Amoebiasis,14/102,6.574463940922056e-16,1.3879423875279896e-14,0,0,31.49681818181818,1101.0710754205115,LAMA5;TGFB1;LAMA2;LAMB3;TGFB3;LAMB2;ITGB2;FN1;LAMC2;LAMB1;COL1A1;COL3A1;COL1A2;CD14,3,3,A1
9,KEGG_2021_Human,Breast cancer,15/147,5.333467298829187e-15,1.0133587867775457e-13,0,0,22.67447199265381,745.1914167252887,FZD1;JAG2;NOTCH3;FZD2;NOTCH1;FZD4;WNT3A;WNT7B;LRP5;ESR1;FGF2;EGFR;IGF1R;FGF6;ERBB2,3,3,A1
10,KEGG_2021_Human,MAPK signaling pathway,18/294,6.879192224032372e-14,1.1882241114237733e-12,0,0,13.322010869565217,403.7593764928241,NGFR;TGFB1;TGFB3;VEGFB;FGF2;AREG;EGFR;IGF1R;VEGFA;EFNA1;FGF6;EFNA3;ERBB3;ERBB2;CD14;FGFR4;FGFR3;FGFR2,3,3,A1
11,KEGG_2021_Human,Regulation of actin cytoskeleton,16/218,1.1472761374107022e-13,1.8165205509002784e-12,0,0,15.90947666195191,474.0421975335727,ITGB1;ITGB5;ITGA3;ITGB4;ITGA2;ITGB2;FN1;CXCR4;FGF2;EGFR;FGF6;ITGAV;ITGB6;FGFR4;FGFR3;FGFR2,3,3,A1
12,KEGG_2021_Human,Gastric cancer,14/149,1.4403560373730204e-13,2.105135746929799e-12,0,0,20.48251851851852,605.6417705342077,FZD1;TGFB1;FZD2;TGFB3;FZD4;WNT3A;WNT7B;LRP5;FGF2;EGFR;FGF6;CDH1;ERBB2;FGFR2,3,3,A1
13,KEGG_2021_Human,Small cell lung cancer,11/92,4.60427976621964e-12,6.248665397012366e-11,0,0,26.11230972072396,681.6366432513104,ITGB1;LAMA5;LAMA2;LAMB3;ITGA3;LAMB2;ITGA2;FN1;LAMC2;ITGAV;LAMB1,3,3,A1
14,KEGG_2021_Human,Dilated cardiomyopathy,11/96,7.412236254828956e-12,9.388832589450012e-11,0,0,24.87846944603084,637.5826517952116,ITGB1;ADCY9;TGFB1;ITGB5;LAMA2;ITGB4;ITGA3;TGFB3;ITGA2;ITGAV;ITGB6,3,3,A1
15,KEGG_2021_Human,Toxoplasmosis,11/112,4.0888105403928215e-11,4.855462516716474e-10,0,0,20.920407574738057,500.41995495707545,ITGB1;LAMA5;TGFB1;LAMA2;LAMB3;TGFB3;LAMB2;LAMC2;LAMB1;CCR5;GNAI2,3,3,A1
16,KEGG_2021_Human,Hypertrophic cardiomyopathy,10/90,9.460348630942712e-11,1.0007802238809318e-09,0,0,23.80528846153846,549.4576422487248,ITGB1;TGFB1;ITGB5;LAMA2;ITGB4;ITGA3;TGFB3;ITGA2;ITGAV;ITGB6,3,3,A1
17,KEGG_2021_Human,Calcium signaling pathway,14/240,9.481075805187776e-11,1.0007802238809318e-09,0,0,12.178761061946902,281.07531003764524,RET;VEGFB;CXCR4;FGF2;EGFR;VEGFA;FGF6;ADCY9;ERBB3;ERBB2;CALM3;FGFR4;FGFR3;FGFR2,3,3,A1
18,KEGG_2021_Human,MicroRNAs in cancer,15/310,2.6780928319177206e-10,2.678092831917721e-09,0,0,10.062146892655369,221.77722406314265,NOTCH3;NOTCH1;BMPR2;WNT3A;TNC;THBS1;EGFR;VEGFA;EFNA1;EFNA3;ERBB3;PLAU;ERBB2;FGFR3;CD44,3,3,A1
19,KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,11/143,5.808649572463215e-10,5.518217093840055e-09,0,0,15.982200647249192,339.88551509749766,FZD1;FZD2;BMPR2;FZD4;WNT3A;WNT7B;FGFR4;FGFR3;FGF2;FGFR2;IGF1R,3,3,A1
20,KEGG_2021_Human,Ras signaling pathway,13/232,7.573533881830733e-10,6.8522449407039965e-09,0,0,11.55888602558886,242.75037483776867,NGFR;VEGFB;FGF2;EGFR;IGF1R;VEGFA;EFNA1;FGF6;EFNA3;CALM3;FGFR4;FGFR3;FGFR2,3,3,A1
21,KEGG_2021_Human,Hippo signaling pathway,11/163,2.342897301084117e-09,2.0234113054817376e-08,0,0,13.8652273888605,275.5281003282162,FZD1;TGFB1;FZD2;BMPR2;TGFB3;CDH1;FZD4;WNT3A;WNT7B;ITGB2;AREG,3,3,A1
22,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,8/77,1.3184011697480376e-08,1.0480573293873697e-07,0,0,21.67569045665846,393.28938449212393,ITGB1;ITGB5;LAMA2;ITGB4;ITGA3;ITGA2;ITGAV;ITGB6,3,3,A1
23,KEGG_2021_Human,Malaria,7/50,1.3238618897524672e-08,1.0480573293873697e-07,0,0,30.189306672462507,547.6378753375301,COMP;TGFB1;TGFB3;ITGB2;SDC1;CD36;THBS1,3,3,A1
24,KEGG_2021_Human,Phagosome,10/152,1.6524325048728086e-08,1.2558487037033345e-07,0,0,13.369447453954496,239.55953904256089,COMP;ITGB1;ITGB5;ITGA2;ITGB2;ITGAV;CD14;CALR;CD36;THBS1,3,3,A1
25,KEGG_2021_Human,Hepatocellular carcinoma,10/168,4.291212428425714e-08,3.135886005388022e-07,0,0,12.005842259006815,203.6684459359261,FZD1;TGFB1;FZD2;TGFB3;FZD4;WNT3A;WNT7B;LRP5;EGFR;IGF1R,3,3,A1
26,KEGG_2021_Human,Relaxin signaling pathway,9/129,5.341015563475525e-08,3.75849243355685e-07,0,0,14.118571428571428,236.41921898530137,COL1A1;COL3A1;TGFB1;COL1A2;ADCY9;VEGFB;EGFR;VEGFA;GNAI2,3,3,A1
27,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,8/100,1.0460817081461458e-07,7.098411590991702e-07,0,0,16.237899917965546,260.992482666396,COL1A1;COL3A1;TGFB1;COL1A2;TGFB3;FN1;VEGFB;VEGFA,3,3,A1
28,KEGG_2021_Human,Melanogenesis,8/101,1.1307225495920214e-07,7.268697704456762e-07,0,0,16.062487319943195,256.92332037492514,FZD1;ADCY9;FZD2;FZD4;WNT3A;WNT7B;CALM3;GNAI2,3,3,A1
29,KEGG_2021_Human,Bladder cancer,6/41,1.1476891112300153e-07,7.268697704456762e-07,0,0,31.50952380952381,503.53306752503454,CDH1;ERBB2;THBS1;FGFR3;EGFR;VEGFA,3,3,A1
30,KEGG_2021_Human,Protein digestion and absorption,8/103,1.3177897565969114e-07,8.076775927529457e-07,0,0,15.7227408142999,249.0818571482648,COL1A1;COL18A1;COL3A1;COL16A1;COL1A2;COL6A2;COL7A1;COL6A1,3,3,A1
31,KEGG_2021_Human,Fluid shear stress and atherosclerosis,8/139,1.316738631139965e-06,7.818135622393543e-06,0,0,11.381247299438282,154.10610160617594,HSP90AA1;BMPR2;SDC4;GPC1;SDC1;CALM3;ITGAV;VEGFA,3,3,A1
32,KEGG_2021_Human,Cell adhesion molecules,8/148,2.111400884600672e-06,1.215655054770084e-05,0,0,10.644743935309974,139.1072052435649,ITGB1;PTPRC;SDC4;CDH1;ITGB2;SDC1;ITGAV;NEO1,3,3,A1
33,KEGG_2021_Human,Cushing syndrome,8/155,2.9829521941522123e-06,1.6669438732027066e-05,0,0,10.134257476575536,128.9340745658401,FZD1;ADCY9;FZD2;FZD4;WNT3A;WNT7B;EGFR;GNAI2,3,3,A1
34,KEGG_2021_Human,Adherens junction,6/71,3.181887306618778e-06,1.7273102521644798e-05,0,0,16.94102564102564,214.44011319611903,FARP2;CDH1;ERBB2;SORBS1;EGFR;IGF1R,3,3,A1
35,KEGG_2021_Human,Human cytomegalovirus infection,9/225,5.730820439133267e-06,3.024599676209224e-05,0,0,7.805555555555555,94.21033808567506,ADCY9;CXCR4;CALM3;ITGAV;CALR;CCR5;EGFR;VEGFA;GNAI2,3,3,A1
36,KEGG_2021_Human,Platelet activation,7/124,7.056452246089787e-06,3.62358358582989e-05,0,0,11.0538381659877,131.11585469707975,COL1A1;ITGB1;COL3A1;COL1A2;ADCY9;ITGA2;GNAI2,3,3,A1
37,KEGG_2021_Human,Alzheimer disease,11/369,8.568079535776992e-06,4.284039767888496e-05,0,0,5.825459673482671,67.96835816216623,FZD1;APP;FZD2;FZD4;WNT3A;WNT7B;LRP5;LPL;CALM3;APOE;RTN4,3,3,A1
38,KEGG_2021_Human,Prostate cancer,6/97,1.9469606239825243e-05,9.485192783504603e-05,0,0,12.084859584859585,131.0803142748467,HSP90AA1;PLAU;ERBB2;FGFR2;EGFR;IGF1R,3,3,A1
39,KEGG_2021_Human,mTOR signaling pathway,7/154,2.8920886136987164e-05,0.00013737420915068904,0,0,8.784601691143747,91.80740247512485,FZD1;FZD2;FZD4;WNT3A;WNT7B;LRP5;IGF1R,3,3,A1
40,KEGG_2021_Human,Basal cell carcinoma,5/63,2.974752228128836e-05,0.00013785437154743388,0,0,15.681746282821893,163.44715181212086,FZD1;FZD2;FZD4;WNT3A;WNT7B,3,3,A1
41,KEGG_2021_Human,Central carbon metabolism in cancer,5/70,4.962475035308435e-05,0.000224492918263953,0,0,13.988002822865209,138.63538762221086,RET;ERBB2;FGFR3;EGFR;FGFR2,3,3,A1
42,KEGG_2021_Human,Melanoma,5/72,5.685126528036064e-05,0.0002512032651922912,0,0,13.569081199507051,132.63874680551413,FGF6;CDH1;FGF2;EGFR;IGF1R,3,3,A1
43,KEGG_2021_Human,Chemical carcinogenesis,8/239,6.85213053593735e-05,0.00029588745496093107,0,0,6.421628685779629,61.57292508879136,FGF6;HSP90AA1;ADCY9;ESR1;FGF2;EGFR;VEGFA;GNAI2,3,3,A1
44,KEGG_2021_Human,Pancreatic cancer,5/76,7.372194992909264e-05,0.0003045037062288609,0,0,12.802041607442822,121.81411400397138,TGFB1;TGFB3;ERBB2;EGFR;VEGFA,3,3,A1
45,KEGG_2021_Human,Pertussis,5/76,7.372194992909264e-05,0.0003045037062288609,0,0,12.802041607442822,121.81411400397138,ITGB1;ITGB2;CALM3;CD14;GNAI2,3,3,A1
46,KEGG_2021_Human,Estrogen signaling pathway,6/137,0.000134658341940333,0.000544363509971559,0,0,8.377862595419847,74.6699606272732,HSP90AA1;ADCY9;CALM3;ESR1;EGFR;GNAI2,3,3,A1
47,KEGG_2021_Human,TGF-beta signaling pathway,5/94,0.00020192617971508543,0.0007992911280388799,0,0,10.20358725904546,86.80812441305903,BMPR2;TGFB1;TGFB3;NEO1;THBS1,3,3,A1
48,KEGG_2021_Human,Hematopoietic cell lineage,5/99,0.00025723894141643143,0.0009974571197779994,0,0,9.65840327932852,79.83158225725104,ITGA3;ITGA2;CD14;CD36;CD44,3,3,A1
49,KEGG_2021_Human,Wnt signaling pathway,6/166,0.00038031866103809344,0.0014452109119447,0,0,6.849305555555556,53.93486396007378,FZD1;FZD2;FZD4;WNT3A;WNT7B;LRP5,3,3,A1
50,KEGG_2021_Human,HIF-1 signaling pathway,5/109,0.0004016525818146624,0.0014963527557801,0,0,8.72529992942837,68.23117418763226,ERBB2;TIMP1;EGFR;IGF1R;VEGFA,3,3,A1
51,KEGG_2021_Human,Endocytosis,7/252,0.0006076687226645263,0.0022203280251203,0,0,5.244592790387183,38.84082846552721,CXCR4;FGFR4;CCR5;FGFR3;EGFR;FGFR2;IGF1R,3,3,A1
52,KEGG_2021_Human,FoxO signaling pathway,5/131,0.000926656265151934,0.0033219752901673,0,0,7.193825542449396,50.2411586594647,TGFB1;TGFB3;S1PR4;EGFR;IGF1R,3,3,A1
53,KEGG_2021_Human,Leishmaniasis,4/77,0.0009836104688365915,0.0034608516496102,0,0,9.869489414694891,68.33911412842441,ITGB1;TGFB1;TGFB3;ITGB2,3,3,A1
54,KEGG_2021_Human,Diabetic cardiomyopathy,6/203,0.0010915486112565,0.0037708042934318,0,0,5.552453468697124,37.86860909336672,COL1A1;COL3A1;TGFB1;COL1A2;TGFB3;CD36,3,3,A1
55,KEGG_2021_Human,Apelin signaling pathway,5/137,0.0011322305555667,0.0038414965278157,0,0,6.864748401445649,46.56747144468928,NOTCH3;ADCY9;CDH1;CALM3;GNAI2,3,3,A1
56,KEGG_2021_Human,ErbB signaling pathway,4/85,0.0014212484977278,0.004737494992426,0,0,8.891133557800224,58.29222383031368,ERBB3;ERBB2;AREG;EGFR,3,3,A1
57,KEGG_2021_Human,Colorectal cancer,4/86,0.0014840985329868,0.0048617020908189,0,0,8.782261640798227,57.19841110157101,TGFB1;TGFB3;AREG;EGFR,3,3,A1
58,KEGG_2021_Human,Pathways of neurodegeneration,9/475,0.0015979988615629,0.0051460980287621,0,0,3.572041692213366,23.00038768684658,FZD1;APP;FZD2;FZD4;WNT3A;WNT7B;LRP5;CALM3;SPTBN2,3,3,A1
59,KEGG_2021_Human,Rheumatoid arthritis,4/93,0.0019792837419804,0.0062677318496047,0,0,8.088661899897854,50.35208409150037,TGFB1;TGFB3;ITGB2;VEGFA,3,3,A1
60,KEGG_2021_Human,Progesterone-mediated oocyte maturation,4/100,0.0025784986150308,0.0080313891287847,0,0,7.496212121212121,44.681532028702,HSP90AA1;ADCY9;IGF1R;GNAI2,3,3,A1
61,KEGG_2021_Human,Chagas disease,4/102,0.0027702339227821,0.0084894265375583,0,0,7.3424860853432286,43.23860470831561,TGFB1;TGFB3;CALR;GNAI2,3,3,A1
62,KEGG_2021_Human,Cholesterol metabolism,3/50,0.00290902931217,0.0087732630049572,0,0,11.40828062104658,66.623626679358,LPL;CD36;APOE,3,3,A1
63,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",4/106,0.0031825907702725,0.0094483163492464,0,0,7.0531194295900175,40.55585783546377,ADCY9;LRP5;EGFR;GNAI2,3,3,A1
64,KEGG_2021_Human,Tuberculosis,5/180,0.0037212103324598,0.0108773840487288,0,0,5.166710353866317,28.901060284734083,TGFB1;TGFB3;ITGB2;CALM3;CD14,3,3,A1
65,KEGG_2021_Human,Leukocyte transendothelial migration,4/114,0.0041291935186761,0.0118870722507342,0,0,6.537520661157025,35.88885173922555,ITGB1;ITGB2;CXCR4;GNAI2,3,3,A1
66,KEGG_2021_Human,Endometrial cancer,3/58,0.0044311763034006,0.0125660223529272,0,0,9.744963144963146,52.80883426780957,CDH1;ERBB2;EGFR,3,3,A1
67,KEGG_2021_Human,Notch signaling pathway,3/59,0.0046493902936446,0.0129909434675365,0,0,9.57046332046332,51.40314212868042,JAG2;NOTCH3;NOTCH1,3,3,A1
68,KEGG_2021_Human,Thyroid hormone signaling pathway,4/121,0.0050999200711744,0.0140432581670019,0,0,6.144211344211344,32.43240643629125,NOTCH3;NOTCH1;ITGAV;ESR1,3,3,A1
69,KEGG_2021_Human,Cytokine-cytokine receptor interaction,6/295,0.0069144396992149,0.0187677648978691,0,0,3.76720492118416,18.738617284249614,NGFR;TGFB1;BMPR2;TGFB3;CXCR4;CCR5,3,3,A1
70,KEGG_2021_Human,Renal cell carcinoma,3/69,0.0071916637098911,0.0192452972518214,0,0,8.116298116298116,40.0525736866796,TGFB1;TGFB3;VEGFA,3,3,A1
71,KEGG_2021_Human,Human immunodeficiency virus 1 infection,5/212,0.007373241600636,0.0194571653350117,0,0,4.360900589460622,21.41157635070611,CXCR4;CALM3;CALR;CCR5;GNAI2,3,3,A1
72,KEGG_2021_Human,Non-small cell lung cancer,3/72,0.0080861386557385,0.0210461143094563,0,0,7.762240501370936,37.39540058005268,RET;ERBB2;EGFR,3,3,A1
73,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,5/219,0.0084202370941446,0.0216195276741551,0,0,4.216753836920175,20.143927673304432,TGFB1;ADCY9;TGFB3;ITGB2;CALR,3,3,A1
74,KEGG_2021_Human,PPAR signaling pathway,3/74,0.0087172375821013,0.0220836685413234,0,0,7.542824514655501,35.77148986016245,LPL;CD36;SORBS1,3,3,A1
75,KEGG_2021_Human,Glioma,3/75,0.0090433244098513,0.0226083110246283,0,0,7.437687687687688,34.99973838850623,CALM3;EGFR;IGF1R,3,3,A1
76,KEGG_2021_Human,Gastric acid secretion,3/76,0.0093764788006697,0.0231367658717825,0,0,7.335431321732692,34.253170523185986,ADCY9;CALM3;GNAI2,3,3,A1
77,KEGG_2021_Human,Bacterial invasion of epithelial cells,3/77,0.0097167311818113,0.023668960571079,0,0,7.235938641344047,33.530659596019085,ITGB1;CDH1;FN1,3,3,A1
78,KEGG_2021_Human,Oxytocin signaling pathway,4/154,0.0117304136258344,0.028212387201374,0,0,4.784484848484849,21.26976400502633,ADCY9;CALM3;EGFR;GNAI2,3,3,A1
79,KEGG_2021_Human,Gap junction,3/88,0.0139354773376647,0.0330967586769537,0,0,6.296025437201908,26.904914825284497,ADCY9;EGFR;GNAI2,3,3,A1
80,KEGG_2021_Human,Th1 and Th2 cell differentiation,3/92,0.0156893377901251,0.0368021503718984,0,0,6.011843303978136,24.97784976438408,JAG2;NOTCH3;NOTCH1,3,3,A1
81,KEGG_2021_Human,Salivary secretion,3/93,0.016146340646965,0.0369615026858237,0,0,5.944744744744745,24.52838444170469,ADCY9;TRPV6;CALM3,3,3,A1
82,KEGG_2021_Human,GnRH signaling pathway,3/93,0.016146340646965,0.0369615026858237,0,0,5.944744744744745,24.52838444170469,ADCY9;CALM3;EGFR,3,3,A1
83,KEGG_2021_Human,Circadian entrainment,3/97,0.0180488521745689,0.0408247846805725,0,0,5.690626797009776,22.846006822945427,ADCY9;CALM3;GNAI2,3,3,A1
84,KEGG_2021_Human,Thyroid cancer,2/37,0.0188355239206211,0.0421029358225649,0,0,10.128061224489796,40.22876676285182,RET;CDH1,3,3,A1
0,KEGG_2021_Human,Human papillomavirus infection,20/331,3.281769949652717e-18,6.235362904340161e-16,0,0,20.33710196037756,818.7340764391582,PDGFRB;NOTCH3;ITGA4;LAMB3;ITGA3;LAMB2;ITGB4;ITGA1;HLA-B;HLA-C;LAMB1;HLA-A;HLA-F;TNFRSF1A;HLA-E;COL6A2;GNAS;ITGAV;ITGA5;IFNAR1,1,1,B1
1,KEGG_2021_Human,ECM-receptor interaction,13/88,3.2094877487467587e-17,3.0490133613094208e-15,0,0,49.84714975845411,1893.0868405267752,ITGA4;LAMB3;SDC4;ITGA3;LAMB2;ITGB4;ITGA1;LAMB1;HSPG2;COL6A2;SDC1;ITGAV;ITGA5,1,1,B1
2,KEGG_2021_Human,PI3K-Akt signaling pathway,18/354,3.9504864253459296e-15,2.501974736052422e-13,0,0,16.391183035714285,543.6125638468809,PDGFRB;CSF1R;ITGA4;LAMB3;ITGA3;LAMB2;ITGB4;ITGA1;LAMB1;COL6A2;CD19;ERBB2;ITGAV;ITGA5;TLR4;MET;FGFR1;IFNAR1,1,1,B1
3,KEGG_2021_Human,Human immunodeficiency virus 1 infection,15/212,7.759093967232886e-15,3.685569634435621e-13,0,0,22.411925145844386,728.161449390089,HLA-B;HLA-C;TRAF2;HLA-A;TNFRSF1B;HLA-F;CD3D;TNFRSF1A;HLA-E;GNAI2;CD4;CALM3;CALR;TLR4;B2M,1,1,B1
4,KEGG_2021_Human,Pathways in cancer,20/531,2.8651114221204945e-14,1.0887423404057875e-12,0,0,12.251120510068809,382.0338462759152,PDGFRB;CSF1R;NOTCH3;LAMB3;ITGA3;LAMB2;MMP2;GSTP1;LAMB1;TRAF2;MMP9;GNAI2;EDNRA;ERBB2;GNAS;CALM3;ITGAV;MET;FGFR1;IFNAR1,1,1,B1
5,KEGG_2021_Human,Phagosome,13/152,4.764874629923135e-14,1.508876966142326e-12,0,0,26.80919612136378,822.3699483184997,ITGB2;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E;C3;MRC2;ITGAV;ITGA5;CALR;CD14;TLR4,1,1,B1
6,KEGG_2021_Human,Human cytomegalovirus infection,14/225,3.87596437693357e-13,1.052047473739112e-11,0,0,19.22902146640647,549.5425837716385,HLA-B;HLA-C;TRAF2;HLA-A;HLA-F;TNFRSF1A;HLA-E;GNAI2;CCL5;GNAS;CALM3;ITGAV;CALR;B2M,1,1,B1
7,KEGG_2021_Human,Cell adhesion molecules,12/148,9.117026490921109e-13,2.165293791593763e-11,0,0,24.935294117647057,691.2926914135654,CD4;ITGA4;SDC4;ITGB2;PECAM1;HLA-B;HLA-C;SDC1;ITGAV;HLA-A;HLA-F;HLA-E,1,1,B1
8,KEGG_2021_Human,Focal adhesion,13/201,1.7543423405210594e-12,3.703611607766681e-11,0,0,19.77258711069997,535.2227183658702,PDGFRB;ITGA4;LAMB3;ITGA3;LAMB2;ITGB4;ITGA1;LAMB1;COL6A2;ERBB2;ITGAV;ITGA5;MET,1,1,B1
9,KEGG_2021_Human,Proteoglycans in cancer,13/205,2.2552230787479888e-12,4.284923849621178e-11,0,0,19.35673309178744,519.1044590097221,SDC4;MMP2;MMP9;HSPG2;DCN;GPC1;ERBB2;SDC1;ITGAV;ITGA5;TLR4;MET;FGFR1,1,1,B1
10,KEGG_2021_Human,Antigen processing and presentation,9/78,3.022403318425252e-11,5.220514822734525e-10,0,0,35.465753424657535,859.0650879179275,CD4;HLA-B;HLA-C;KLRD1;HLA-A;CALR;HLA-F;B2M;HLA-E,1,1,B1
11,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,12/219,9.277980739674498e-11,1.4690136171151291e-09,0,0,16.323809523809523,377.0929299674317,CD4;ITGB2;HLA-B;HLA-C;CALR;HLA-A;LTBR;HLA-F;CD3D;B2M;TNFRSF1A;HLA-E,1,1,B1
12,KEGG_2021_Human,Fluid shear stress and atherosclerosis,10/139,2.6492384010837446e-10,3.633401176846341e-09,0,0,21.30598621877692,469.8306324611397,SDC4;MMP2;GPC1;GSTP1;PECAM1;SDC1;CALM3;ITGAV;MMP9;TNFRSF1A,1,1,B1
13,KEGG_2021_Human,Hematopoietic cell lineage,9/99,2.677242972413093e-10,3.633401176846341e-09,0,0,27.16164383561644,598.67151400756,CSF1R;CD4;ITGA4;ITGA3;CD19;ITGA1;ITGA5;CD14;CD3D,1,1,B1
14,KEGG_2021_Human,Epstein-Barr virus infection,11/202,6.35895179944699e-10,8.05467227929952e-09,0,0,16.0015485583659,338.84859029367414,CD19;HLA-B;HLA-C;TRAF2;CALR;HLA-A;HLA-F;CD3D;B2M;HLA-E;IFNAR1,1,1,B1
15,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,10/193,6.492360059720591e-09,7.709677570918201e-08,0,0,14.977990285367335,282.37465468105927,C3;HLA-B;HLA-C;CALM3;TRAF2;HLA-A;HLA-F;TNFRSF1A;HLA-E;IFNAR1,1,1,B1
16,KEGG_2021_Human,Chagas disease,8/102,9.041551437930493e-09,1.0105263371804665e-07,0,0,22.79930994824612,422.2759385742722,C3;CCL5;GNAS;CALR;TLR4;CD3D;TNFRSF1A;GNAI2,1,1,B1
17,KEGG_2021_Human,Graft-versus-host disease,6/42,1.838615367734373e-08,1.9407606659418384e-07,0,0,43.60087719298246,776.6043478995174,HLA-B;HLA-C;KLRD1;HLA-A;HLA-F;HLA-E,1,1,B1
18,KEGG_2021_Human,Regulation of actin cytoskeleton,10/218,2.078073579648797e-08,2.0780735796487974e-07,0,0,13.161057692307692,232.8091008426844,PDGFRB;ITGA4;ITGA3;ITGB4;ITGA1;ITGB2;ITGAX;ITGAV;ITGA5;FGFR1,1,1,B1
19,KEGG_2021_Human,Pertussis,7/76,2.610901134865352e-08,2.4803560781220845e-07,0,0,26.84888888888889,468.8080547420072,C3;ITGB2;CALM3;ITGA5;CD14;TLR4;GNAI2,1,1,B1
20,KEGG_2021_Human,Herpes simplex virus 1 infection,13/498,1.1272038541354586e-07,1.019851106122558e-06,0,0,7.54905124757209,120.77240592496253,HLA-B;HLA-C;TRAF2;HLA-A;HLA-F;TNFRSF1A;HLA-E;C3;CCL5;ITGA5;CALR;B2M;IFNAR1,1,1,B1
21,KEGG_2021_Human,Dilated cardiomyopathy,7/96,1.3329815225249552e-07,1.1512113149079158e-06,0,0,20.79445692883895,329.1903408339818,ITGA4;ITGA3;ITGB4;ITGA1;GNAS;ITGAV;ITGA5,1,1,B1
22,KEGG_2021_Human,Viral myocarditis,6/60,1.6547692614395626e-07,1.366983302928334e-06,0,0,29.04093567251462,453.4577754162731,ITGB2;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,1,1,B1
23,KEGG_2021_Human,Amoebiasis,7/102,2.0249556629181521e-07,1.6030898998102038e-06,0,0,19.47522807017544,300.1628844335013,LAMB3;LAMB2;ITGB2;GNAS;LAMB1;CD14;TLR4,1,1,B1
24,KEGG_2021_Human,Cytokine-cytokine receptor interaction,10/295,3.50931340187685e-07,2.667078185426406e-06,0,0,9.567738791423002,142.20219448223455,CSF1R;CD4;IL34;CCL5;LEPR;LTBR;LTB;TNFRSF1B;TNFRSF1A;IFNAR1,1,1,B1
25,KEGG_2021_Human,Renin secretion,6/69,3.847861938452009e-07,2.811899108868776e-06,0,0,24.88095238095238,367.50604779691054,EDNRA;ADORA1;GNAS;CALM3;AQP1;GNAI2,1,1,B1
26,KEGG_2021_Human,Allograft rejection,5/38,4.621223645769627e-07,3.2519721951712192e-06,0,0,39.12829594647776,570.7815177031545,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,1,1,B1
27,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,6/77,7.414593117483738e-07,4.876157499711109e-06,0,0,22.068569310600445,311.49003360963474,ITGA4;ITGB4;ITGA3;ITGA1;ITGAV;ITGA5,1,1,B1
28,KEGG_2021_Human,Tuberculosis,8/180,7.442556183769586e-07,4.876157499711109e-06,0,0,12.411062225015714,175.13102571559648,C3;MRC2;ITGB2;ITGAX;CALM3;CD14;TLR4;TNFRSF1A,1,1,B1
29,KEGG_2021_Human,Type I diabetes mellitus,5/43,8.721369712824574e-07,5.523534151455563e-06,0,0,33.97129186602871,473.9783127862164,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,1,1,B1
30,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,7/131,1.1125902204133445e-06,6.819101350920498e-06,0,0,14.898709677419356,204.24372516533168,ITGB2;HLA-B;HLA-C;KLRD1;HLA-A;HLA-E;IFNAR1,1,1,B1
31,KEGG_2021_Human,Viral carcinogenesis,8/203,1.83844464404098e-06,1.0489363079522826e-05,0,0,10.934442134442136,144.4067012115619,C3;HLA-B;HLA-C;TRAF2;HLA-A;LTBR;HLA-F;HLA-E,1,1,B1
32,KEGG_2021_Human,Hypertrophic cardiomyopathy,6/90,1.8663984527328043e-06,1.0489363079522826e-05,0,0,18.64097744360902,245.90245292679552,ITGA4;ITGA3;ITGB4;ITGA1;ITGAV;ITGA5,1,1,B1
33,KEGG_2021_Human,Malaria,5/50,1.8770439194935584e-06,1.0489363079522826e-05,0,0,28.67676767676768,378.1264788776512,ITGB2;PECAM1;SDC1;MET;TLR4,1,1,B1
34,KEGG_2021_Human,Small cell lung cancer,6/92,2.1236781656309955e-06,1.1528538613425405e-05,0,0,18.20563035495716,237.80851572579584,LAMB3;ITGA3;LAMB2;LAMB1;TRAF2;ITGAV,1,1,B1
35,KEGG_2021_Human,Rap1 signaling pathway,8/210,2.367357467708706e-06,1.2494386635129282e-05,0,0,10.551779502274552,136.68496829675752,PDGFRB;CSF1R;ITGB2;GNAS;CALM3;MET;FGFR1;GNAI2,1,1,B1
36,KEGG_2021_Human,Autoimmune thyroid disease,5/53,2.5179692516621475e-06,1.2930112373400215e-05,0,0,26.880411255411257,346.5438165018873,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,1,1,B1
37,KEGG_2021_Human,Lipid and atherosclerosis,8/215,2.819939661027265e-06,1.4099698305136326e-05,0,0,10.294294294294296,131.5486771774895,ABCA1;CCL5;CALM3;TRAF2;CD14;MMP9;TLR4;TNFRSF1A,1,1,B1
38,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,6/100,3.4589501088805235e-06,1.6851295402238446e-05,0,0,16.6494960806271,209.3598452134237,CSF1R;IL34;CCL5;LTBR;TNFRSF1B;TNFRSF1A,1,1,B1
39,KEGG_2021_Human,NF-kappa B signaling pathway,6/104,4.346006316608613e-06,2.064353000389091e-05,0,0,15.966702470461868,197.1289518318426,TRAF2;LTBR;LTB;CD14;TLR4;TNFRSF1A,1,1,B1
40,KEGG_2021_Human,Toxoplasmosis,6/112,6.67614544141649e-06,3.093823497241788e-05,0,0,14.75571002979146,175.8433503110621,LAMB3;LAMB2;LAMB1;TLR4;TNFRSF1A;GNAI2,1,1,B1
41,KEGG_2021_Human,Leukocyte transendothelial migration,6/114,7.393936163487401e-06,3.344875883482396e-05,0,0,14.480994152046785,171.09077855114225,ITGA4;MMP2;ITGB2;PECAM1;MMP9;GNAI2,1,1,B1
42,KEGG_2021_Human,MAPK signaling pathway,8/294,2.753978625918204e-05,0.00012168742765685088,0,0,7.420903420903421,77.91858669743861,PDGFRB;CSF1R;ERBB2;TRAF2;CD14;MET;TNFRSF1A;FGFR1,1,1,B1
43,KEGG_2021_Human,Cellular senescence,6/156,4.39254891027478e-05,0.00018967824839822916,0,0,10.40421052631579,104.38560848262227,HLA-B;HLA-C;CALM3;HLA-A;HLA-F;HLA-E,1,1,B1
44,KEGG_2021_Human,Prostate cancer,5/97,4.911635516521887e-05,0.00020738016625314632,0,0,13.993506493506494,138.83403456760328,PDGFRB;GSTP1;ERBB2;MMP9;FGFR1,1,1,B1
45,KEGG_2021_Human,Calcium signaling pathway,7/240,5.8085373653025455e-05,0.00023991784769727904,0,0,7.885264663805437,76.90969116817145,PDGFRB;EDNRA;ERBB2;GNAS;CALM3;MET;FGFR1,1,1,B1
46,KEGG_2021_Human,Shigellosis,7/246,6.784790180533492e-05,0.00027427875197901354,0,0,7.684965132496513,73.76215584240508,C3;CCL5;TRAF2;ITGA5;CD14;TLR4;TNFRSF1A,1,1,B1
47,KEGG_2021_Human,Legionellosis,4/57,8.787064541542115e-05,0.00034782130476937543,0,0,19.22109337203677,179.5181840583238,C3;ITGB2;CD14;TLR4,1,1,B1
48,KEGG_2021_Human,TNF signaling pathway,5/112,9.745544128641473e-05,0.0003778884458044652,0,0,12.022696929238986,111.04301501777036,CCL5;TRAF2;TNFRSF1B;MMP9;TNFRSF1A,1,1,B1
49,KEGG_2021_Human,Axon guidance,6/182,0.00010323410956042775,0.0003922896163296255,0,0,8.855562200956937,81.28087720269397,EFNB3;PLXNB2;SEMA4G;MET;GNAI2;EPHB3,1,1,B1
50,KEGG_2021_Human,Sphingolipid signaling pathway,5/119,0.00012974173916398726,0.0004833515772775996,0,0,11.28047391205286,100.95984337164516,ADORA1;TRAF2;S1PR4;TNFRSF1A;GNAI2,1,1,B1
51,KEGG_2021_Human,Osteoclast differentiation,5/127,0.00017604520889229907,0.0006432421094141697,0,0,10.536512667660208,91.0857257397009,CSF1R;TREM2;TRAF2;TNFRSF1A;IFNAR1,1,1,B1
52,KEGG_2021_Human,Adipocytokine signaling pathway,4/69,0.00018526915385817745,0.000664172438359504,0,0,15.663116370808678,134.60413732290218,LEPR;TRAF2;TNFRSF1B;TNFRSF1A,1,1,B1
53,KEGG_2021_Human,Central carbon metabolism in cancer,4/70,0.0001958881627646176,0.0006892361282458766,0,0,15.425019425019425,131.69830157645,PDGFRB;ERBB2;MET;FGFR1,1,1,B1
54,KEGG_2021_Human,Yersinia infection,5/137,0.00025055332663892943,0.0008500916439535105,0,0,9.733372687918145,80.7075571070701,CD4;ITGA4;TRAF2;ITGA5;TLR4,1,1,B1
55,KEGG_2021_Human,Estrogen signaling pathway,5/137,0.00025055332663892943,0.0008500916439535105,0,0,9.733372687918145,80.7075571070701,MMP2;GNAS;CALM3;MMP9;GNAI2,1,1,B1
56,KEGG_2021_Human,Leishmaniasis,4/77,0.0002829013383169194,0.000943004461056398,0,0,13.940990516332985,113.90364107139888,C3;ITGA4;ITGB2;TLR4,1,1,B1
57,KEGG_2021_Human,Primary immunodeficiency,3/38,0.0005052501161127792,0.0016551296907142,0,0,21.572875226039784,163.74798116273308,CD4;CD19;CD3D,1,1,B1
58,KEGG_2021_Human,Rheumatoid arthritis,4/93,0.0005808176926855404,0.0018704298578008,0,0,11.425525785076347,85.13243391240118,CCL5;ITGB2;LTB;TLR4,1,1,B1
59,KEGG_2021_Human,Bladder cancer,3/41,0.0006328256629161943,0.0020039479325679,0,0,19.866755496335777,146.32492393593395,MMP2;ERBB2;MMP9,1,1,B1
60,KEGG_2021_Human,Toll-like receptor signaling pathway,4/104,0.0008840554226261597,0.0027536152508027,0,0,10.163076923076924,71.45650036630886,CCL5;CD14;TLR4;IFNAR1,1,1,B1
61,KEGG_2021_Human,Regulation of lipolysis in adipocytes,3/55,0.0014945093736871,0.0045799480806542,0,0,14.507789678675756,94.3870602268694,ADORA1;GNAS;GNAI2,1,1,B1
62,KEGG_2021_Human,MicroRNAs in cancer,6/310,0.0017240248564267,0.0051994400431919,0,0,5.093663434903047,32.41145765633625,PDGFRB;NOTCH3;ERBB2;ITGA5;MMP9;MET,1,1,B1
63,KEGG_2021_Human,cAMP signaling pathway,5/216,0.00195054635265,0.0057270536038789,0,0,6.064811965285899,37.84227829352654,EDNRA;ADORA1;GNAS;CALM3;GNAI2,1,1,B1
64,KEGG_2021_Human,Relaxin signaling pathway,4/129,0.0019592551802743,0.0057270536038789,0,0,8.120205128205129,50.63102902428599,MMP2;GNAS;MMP9;GNAI2,1,1,B1
65,KEGG_2021_Human,Measles,4/139,0.0025696058677404,0.0073973502253133,0,0,7.514909781576448,44.81894260852076,RACK1;TLR4;CD3D;IFNAR1,1,1,B1
66,KEGG_2021_Human,Ras signaling pathway,5/232,0.0026587747050314,0.0075398088650145,0,0,5.632759311173408,33.401642545758186,PDGFRB;CSF1R;CALM3;MET;FGFR1,1,1,B1
67,KEGG_2021_Human,Adherens junction,3/71,0.0031063813632483,0.0086795949855468,0,0,11.085256887565151,64.00956314063401,ERBB2;MET;FGFR1,1,1,B1
68,KEGG_2021_Human,Melanoma,3/72,0.0032319448516046,0.0088995582870273,0,0,10.924050632911392,62.645838570578775,PDGFRB;MET;FGFR1,1,1,B1
69,KEGG_2021_Human,Gastric acid secretion,3/76,0.0037651896765836,0.0101324341396202,0,0,10.323391711461763,57.62472904142722,GNAS;CALM3;GNAI2,1,1,B1
70,KEGG_2021_Human,Endocytosis,5/252,0.0037863306521738,0.0101324341396202,0,0,5.171407539828593,28.837619260483876,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,1,1,B1
71,KEGG_2021_Human,Necroptosis,4/159,0.0041593582881688,0.0109760843715565,0,0,6.538626964433416,35.84733233905477,TRAF2;TLR4;TNFRSF1A;IFNAR1,1,1,B1
72,KEGG_2021_Human,Hepatitis B,4/162,0.0044442249485147,0.0115671608249013,0,0,6.413502109704641,34.736488104693706,MMP9;TLR4;HSPG2;IFNAR1,1,1,B1
73,KEGG_2021_Human,cGMP-PKG signaling pathway,4/167,0.0049477783505998,0.012703755224513,0,0,6.215195847097688,32.99533501715472,EDNRA;ADORA1;CALM3;GNAI2,1,1,B1
74,KEGG_2021_Human,Complement and coagulation cascades,3/85,0.0051523591931129,0.0130526432892194,0,0,9.186168570546466,48.39549714802046,C3;ITGB2;ITGAX,1,1,B1
75,KEGG_2021_Human,Influenza A,4/172,0.0054883470958552,0.0137208677396381,0,0,6.028693528693529,31.38012235913518,CCL5;TLR4;TNFRSF1A;IFNAR1,1,1,B1
76,KEGG_2021_Human,Gap junction,3/88,0.0056743659883988,0.0140016823090362,0,0,8.860610573343262,45.82527423682534,PDGFRB;GNAS;GNAI2,1,1,B1
77,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,3/89,0.0058551548847948,0.0142625567706542,0,0,8.757138651751545,45.015483012331856,CD4;TLR4;CD3D,1,1,B1
78,KEGG_2021_Human,Morphine addiction,3/91,0.0062270163638868,0.0149763684701075,0,0,8.557249712313004,43.46105594718224,ADORA1;GNAS;GNAI2,1,1,B1
79,KEGG_2021_Human,Th1 and Th2 cell differentiation,3/92,0.0064181221981945,0.015243040220712,0,0,8.460674157303371,42.71481080345924,NOTCH3;CD4;CD3D,1,1,B1
80,KEGG_2021_Human,NOD-like receptor signaling pathway,4/181,0.0065583875430787,0.0153221089243178,0,0,5.719542228016804,28.752198878903528,CCL5;TRAF2;TLR4;IFNAR1,1,1,B1
81,KEGG_2021_Human,GnRH signaling pathway,3/93,0.0066126996410213,0.0153221089243178,0,0,8.366244725738397,41.98820191134031,MMP2;GNAS;CALM3,1,1,B1
82,KEGG_2021_Human,Circadian entrainment,3/97,0.0074260339956616,0.0169993549298279,0,0,8.00861836789658,39.2643605807317,GNAS;CALM3;GNAI2,1,1,B1
83,KEGG_2021_Human,Transcriptional misregulation in cancer,4/192,0.0080438201979947,0.0181943552097499,0,0,5.381887615930169,25.956042929511295,CSF1R;CD14;MMP9;MET,1,1,B1
84,KEGG_2021_Human,Melanogenesis,3/101,0.0082961049231821,0.0185442345341717,0,0,7.680185998450013,36.80321445295475,GNAS;CALM3;GNAI2,1,1,B1
85,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",3/106,0.0094647763713581,0.0209105524483492,0,0,7.305518004178444,34.04501516932229,GNAS;FGFR1;GNAI2,1,1,B1
86,KEGG_2021_Human,HIF-1 signaling pathway,3/109,0.0102097968772576,0.0222972575480339,0,0,7.097683305469309,32.538672872725364,ERBB2;LTBR;TLR4,1,1,B1
87,KEGG_2021_Human,Neuroactive ligand-receptor interaction,5/341,0.0131071870064483,0.0282996083093772,0,0,3.784400123685838,16.403840237315176,C3;EDNRA;ADORA1;LEPR;S1PR4,1,1,B1
88,KEGG_2021_Human,Coronavirus disease,4/232,0.0152552562962814,0.0325674010819492,0,0,4.428699955015745,18.5245041707928,C3;TLR4;TNFRSF1A;IFNAR1,1,1,B1
89,KEGG_2021_Human,Intestinal immune network for IgA production,2/48,0.0165796974560578,0.0350015835183444,0,0,10.8,44.27542487122337,ITGA4;LTBR,1,1,B1
90,KEGG_2021_Human,Dopaminergic synapse,3/132,0.0170418132441655,0.0355168307329104,0,0,5.825434206652929,23.721665303114147,GNAS;CALM3;GNAI2,1,1,B1
91,KEGG_2021_Human,Cocaine addiction,2/49,0.0172397609490781,0.0355168307329104,0,0,10.56968085106383,42.91857890457539,GNAS;GNAI2,1,1,B1
92,KEGG_2021_Human,Vascular smooth muscle contraction,3/133,0.0173845539903193,0.0355168307329104,0,0,5.78033106134372,23.42290243302603,EDNRA;GNAS;CALM3,1,1,B1
93,KEGG_2021_Human,Cholesterol metabolism,2/50,0.0179108739546233,0.0362028303338132,0,0,10.348958333333334,41.62710426921145,ABCA1;APOE,1,1,B1
94,KEGG_2021_Human,Apelin signaling pathway,3/137,0.0187940380668521,0.0375880761337042,0,0,5.6066502928396,22.282036965286498,NOTCH3;CALM3;GNAI2,1,1,B1
95,KEGG_2021_Human,Salmonella infection,4/249,0.0192541159905429,0.0381071045646161,0,0,4.117844060701204,16.265609318642536,TRAF2;CD14;TLR4;TNFRSF1A,1,1,B1
96,KEGG_2021_Human,Breast cancer,3/147,0.0225882100533993,0.044244947527277,0,0,5.214662447257384,19.765276849450697,NOTCH3;ERBB2;FGFR1,1,1,B1
97,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,3/150,0.0238019464385845,0.046146630850317,0,0,5.107465771118574,19.091645346669925,GNAS;CALM3;GNAI2,1,1,B1
98,KEGG_2021_Human,Long-term depression,2/60,0.0252081674438557,0.0483793112558848,0,0,8.560344827586206,31.50709587444893,GNAS;GNAI2,1,1,B1
99,KEGG_2021_Human,Oxytocin signaling pathway,3/154,0.0254744655404005,0.0484014845267611,0,0,4.971162712716908,18.244558286066297,GNAS;CALM3;GNAI2,1,1,B1
100,KEGG_2021_Human,Non-alcoholic fatty liver disease,3/155,0.0259022690709769,0.0487270408265903,0,0,4.938207861425716,18.04137060032608,LEPR;TRAF2;TNFRSF1A,1,1,B1
101,KEGG_2021_Human,Hepatitis C,3/157,0.0267694753147153,0.0498647089195678,0,0,4.873582114088443,17.64477003323369,TRAF2;TNFRSF1A;IFNAR1,1,1,B1
0,KEGG_2021_Human,PI3K-Akt signaling pathway,18/354,2.0368853042226965e-19,3.2793853397985416e-17,0,0,32.8359375,1413.1830611102066,ITGB5;ITGA3;FLT4;FN1;TNC;IL2RG;EREG;VEGFA;COL1A1;COL1A2;ERBB3;COL4A1;IL2RA;ERBB2;ITGA6;ITGAV;ITGB7;ITGA5,2,2,B1
1,KEGG_2021_Human,ECM-receptor interaction,12/88,2.5572664840613682e-18,2.058599519669401e-16,0,0,82.57894736842105,3345.0743710075985,COL1A1;COL1A2;ITGB5;ITGA3;COL4A1;FN1;TNC;ITGA6;ITGAV;ITGB7;ITGA5;CD44,2,2,B1
2,KEGG_2021_Human,Focal adhesion,14/201,4.6324542017977177e-17,2.486083754964776e-15,0,0,41.09952465834819,1545.7884592807386,ITGB5;ITGA3;FLT4;FN1;TNC;VEGFA;COL1A1;COL1A2;COL4A1;ERBB2;ITGA6;ITGAV;ITGB7;ITGA5,2,2,B1
3,KEGG_2021_Human,Human papillomavirus infection,16/331,6.527267565562577e-17,2.6272251951389377e-15,0,0,29.33333333333333,1093.193439607413,ITGB5;ITGA3;FN1;TNC;HLA-B;HLA-C;HLA-A;VEGFA;COL1A1;COL1A2;COL4A1;GNAS;ITGA6;ITGAV;ITGB7;ITGA5,2,2,B1
4,KEGG_2021_Human,Proteoglycans in cancer,12/205,8.39275641943302e-14,2.7024675670574325e-12,0,0,32.326697572947914,973.3187927409118,COL1A1;COL1A2;ERBB3;ITGB5;PLAU;GPC1;ERBB2;FN1;ITGAV;ITGA5;CD44;VEGFA,2,2,B1
5,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,9/100,2.8587106271515404e-12,7.670873516189967e-11,0,0,47.90431519699813,1273.327855976749,CXCL10;CXCL11;CXCL9;IL2RA;CCL5;CXCR3;CCL19;CXCL13;IL2RG,2,2,B1
6,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,11/219,5.417786203568434e-12,1.2460908268207398e-10,0,0,26.770463510848128,694.4615308108714,IL2RA;ITGB2;HLA-B;HLA-C;CD3G;HLA-A;IL2RG;ITGAL;ADCY7;B2M;ICAM1,2,2,B1
7,KEGG_2021_Human,Epstein-Barr virus infection,10/202,6.385223973711247e-11,1.2850263247093882e-09,0,0,25.7265625,603.9168910818081,CXCL10;HLA-B;HLA-C;CD3G;CD247;HLA-A;ITGAL;B2M;CD44;ICAM1,2,2,B1
8,KEGG_2021_Human,Dilated cardiomyopathy,8/96,9.521348736599894e-11,1.6218441230882602e-09,0,0,42.99134199134199,992.0208962568568,ITGB5;ITGA3;GNAS;ITGA6;ITGAV;ITGB7;ITGA5;ADCY7,2,2,B1
9,KEGG_2021_Human,Cell adhesion molecules,9/148,1.007356598191466e-10,1.6218441230882602e-09,0,0,31.28601509036673,720.1578034836931,ITGB2;HLA-B;HLA-C;ITGA6;ITGAV;ITGB7;HLA-A;ITGAL;ICAM1,2,2,B1
10,KEGG_2021_Human,Phagosome,9/152,1.2796482685892783e-10,1.8133163078345543e-09,0,0,30.404741599863552,692.5976868330727,MRC2;FCGR2A;ITGB5;ITGB2;HLA-B;HLA-C;ITGAV;ITGA5;HLA-A,2,2,B1
11,KEGG_2021_Human,Regulation of actin cytoskeleton,10/218,1.3515401052183014e-10,1.8133163078345543e-09,0,0,23.728365384615383,539.2177584006803,ITGB5;ITGA3;ITGB2;FN1;ITGAX;ITGA6;ITGAV;ITGB7;ITGA5;ITGAL,2,2,B1
12,KEGG_2021_Human,Human cytomegalovirus infection,10/225,1.8424382646465896e-10,2.281788927754622e-09,0,0,22.94767441860465,514.3666397035543,CCL5;HLA-B;GNAS;HLA-C;ITGAV;HLA-A;ADCY7;B2M;VEGFA;GNAI2,2,2,B1
13,KEGG_2021_Human,Pathways in cancer,13/531,4.0677603679270887e-10,4.6779244231161525e-09,0,0,13.180423666910151,284.9971160332773,ITGA3;FLT4;FN1;IL2RG;ADCY7;VEGFA;GNAI2;COL4A1;IL2RA;ERBB2;GNAS;ITGA6;ITGAV,2,2,B1
14,KEGG_2021_Human,Chemokine signaling pathway,9/192,1.0236896900580911e-09,1.098760267329018e-08,0,0,23.710915633746502,490.8124537287019,CXCL10;CXCL11;CXCL9;CCL5;CXCR3;CCL19;CXCL13;ADCY7;GNAI2,2,2,B1
15,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,7/100,5.288018692788343e-09,5.3210688096182714e-08,0,0,34.758439609902474,662.4201620161346,COL1A1;COL1A2;COL4A1;SERPINE1;FN1;VEGFA;ICAM1,2,2,B1
16,KEGG_2021_Human,Viral myocarditis,6/60,8.087040431801317e-09,7.658902997176543e-08,0,0,50.24242424242424,936.1672417991872,ITGB2;HLA-B;HLA-C;HLA-A;ITGAL;ICAM1,2,2,B1
17,KEGG_2021_Human,Relaxin signaling pathway,7/129,3.126094204242394e-08,2.796117593794586e-07,0,0,26.45749142203584,457.2091676514456,COL1A1;COL1A2;COL4A1;GNAS;ADCY7;VEGFA;GNAI2,2,2,B1
18,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,7/131,3.4773769170775415e-08,2.946619387628864e-07,0,0,26.02813203300825,447.0176156978487,ITGB2;HLA-B;HLA-C;CD247;HLA-A;ITGAL;ICAM1,2,2,B1
19,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,6/77,3.7089737795302146e-08,2.9857238925218224e-07,0,0,38.17989756722151,653.2552035411935,ITGB5;ITGA3;ITGA6;ITGAV;ITGB7;ITGA5,2,2,B1
20,KEGG_2021_Human,Cytokine-cytokine receptor interaction,9/295,4.313987970112193e-08,3.307390777086015e-07,0,0,15.0926147023708,255.95290564857876,CXCL10;CXCL11;CXCL9;IL2RA;CCL5;CXCR3;CCL19;CXCL13;IL2RG,2,2,B1
21,KEGG_2021_Human,Hypertrophic cardiomyopathy,6/90,9.50378659173445e-08,6.95504382395112e-07,0,0,32.25,521.4499415660819,ITGB5;ITGA3;ITGA6;ITGAV;ITGB7;ITGA5,2,2,B1
22,KEGG_2021_Human,Hematopoietic cell lineage,6/99,1.6815980520974084e-07,1.177118636468186e-06,0,0,29.1158357771261,454.15902867743614,ITGA3;IL2RA;ITGA6;CD3G;ITGA5;CD44,2,2,B1
23,KEGG_2021_Human,Amoebiasis,6/102,2.00937711227083e-07,1.2940388603024146e-06,0,0,28.201704545454547,434.87792312348313,COL1A1;COL1A2;COL4A1;ITGB2;FN1;GNAS,2,2,B1
24,KEGG_2021_Human,Chagas disease,6/102,2.00937711227083e-07,1.2940388603024146e-06,0,0,28.201704545454547,434.87792312348313,CCL5;SERPINE1;GNAS;CD3G;CD247;GNAI2,2,2,B1
25,KEGG_2021_Human,Platelet activation,6/124,6.392463415054622e-07,3.958410037783824e-06,0,0,22.918335901386747,326.8836736814432,COL1A1;COL1A2;FCGR2A;GNAS;ADCY7;GNAI2,2,2,B1
26,KEGG_2021_Human,Rap1 signaling pathway,7/210,8.670715515635852e-07,5.17031554821249e-06,0,0,15.83560545308741,221.03566655923052,FLT4;ITGB2;GNAS;ITGAL;ADCY7;VEGFA;GNAI2,2,2,B1
27,KEGG_2021_Human,Human immunodeficiency virus 1 infection,7/212,9.239512475240164e-07,5.312719673263094e-06,0,0,15.67952353942144,217.86081014428268,HLA-B;HLA-C;CD3G;CD247;HLA-A;B2M;GNAI2,2,2,B1
28,KEGG_2021_Human,Small cell lung cancer,5/92,3.320217744689286e-06,1.843293299637845e-05,0,0,25.367816091954023,320.02718140805626,ITGA3;COL4A1;FN1;ITGA6;ITGAV,2,2,B1
29,KEGG_2021_Human,Rheumatoid arthritis,5/93,3.502294834838377e-06,1.879564894696596e-05,0,0,25.078282828282827,315.0356995323513,CCL5;ITGB2;ITGAL;VEGFA;ICAM1,2,2,B1
30,KEGG_2021_Human,MicroRNAs in cancer,7/310,1.1330530696877688e-05,5.88456594257196e-05,0,0,10.555606723463043,120.20735116559368,ERBB3;PLAU;ERBB2;TNC;ITGA5;CD44;VEGFA,2,2,B1
31,KEGG_2021_Human,Calcium signaling pathway,6/240,2.865769737998871e-05,0.0001441840399430682,0,0,11.48951048951049,120.18129632859907,ERBB3;FLT4;ERBB2;GNAS;ADCY7;VEGFA,2,2,B1
32,KEGG_2021_Human,Antigen processing and presentation,4/78,4.301512988997168e-05,0.00020986169431168,0,0,23.356051703877792,234.82077797050783,HLA-B;HLA-C;HLA-A;B2M,2,2,B1
33,KEGG_2021_Human,Complement and coagulation cascades,4/85,6.027933795542898e-05,0.0002854403944360019,0,0,21.33011272141707,207.25449175404967,PLAU;SERPINE1;ITGB2;ITGAX,2,2,B1
34,KEGG_2021_Human,Th1 and Th2 cell differentiation,4/92,8.212184135698631e-05,0.000377760470242137,0,0,19.62648221343873,184.6323345485555,IL2RA;CD3G;CD247;IL2RG,2,2,B1
35,KEGG_2021_Human,Staphylococcus aureus infection,4/95,9.305240181747405e-05,0.00041615101923925886,0,0,18.976588628762546,176.14729500931637,FCGR2A;ITGB2;ITGAL;ICAM1,2,2,B1
36,KEGG_2021_Human,Allograft rejection,3/38,0.00011660554961914327,0.0005014077249251536,0,0,36.319148936170215,328.93213337279053,HLA-B;HLA-C;HLA-A,2,2,B1
37,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,5/193,0.000118344680417117,0.0005014077249251536,0,0,11.67966903073286,105.60650652212236,HLA-B;HLA-C;HLA-A;VEGFA;ICAM1,2,2,B1
38,KEGG_2021_Human,Toll-like receptor signaling pathway,4/104,0.00013219781074871336,0.0005457396802703296,0,0,17.26086956521739,154.16047142432132,CXCL10;CXCL11;CXCL9;CCL5,2,2,B1
39,KEGG_2021_Human,Th17 cell differentiation,4/107,0.0001475549898184028,0.0005939088340190713,0,0,16.755593077247784,147.80627472507544,IL2RA;CD3G;CD247;IL2RG,2,2,B1
40,KEGG_2021_Human,Graft-versus-host disease,3/42,0.00015756854407171077,0.0006187447706230592,0,0,32.58756137479542,285.32528155294955,HLA-B;HLA-C;HLA-A,2,2,B1
41,KEGG_2021_Human,Type I diabetes mellitus,3/43,0.0001690886138794749,0.0006481730198713205,0,0,31.77127659574468,275.93632160450045,HLA-B;HLA-C;HLA-A,2,2,B1
42,KEGG_2021_Human,Leukocyte transendothelial migration,4/114,0.00018836016135612493,0.0007052554878682817,0,0,15.683794466403162,134.5223310441862,ITGB2;ITGAL;ICAM1;GNAI2,2,2,B1
43,KEGG_2021_Human,Malaria,3/50,0.00026526273964070014,0.0009706204791398346,0,0,27.02987777274785,222.5853605029436,ITGB2;ITGAL;ICAM1,2,2,B1
44,KEGG_2021_Human,Autoimmune thyroid disease,3/53,0.000315376219123607,0.00112834602842,0,0,25.404255319148938,204.8026101434528,HLA-B;HLA-C;HLA-A,2,2,B1
45,KEGG_2021_Human,Regulation of lipolysis in adipocytes,3/55,0.00035195400119539483,0.0012318390041838,0,0,24.424713584288053,194.22556836269925,GNAS;ADCY7;GNAI2,2,2,B1
46,KEGG_2021_Human,Fluid shear stress and atherosclerosis,4/139,0.0004015254683124459,0.0013656567452206,0,0,12.76328502415459,99.81194689133622,GPC1;ITGAV;VEGFA;ICAM1,2,2,B1
47,KEGG_2021_Human,Endocytosis,5/252,0.0004071523215564764,0.0013656567452206,0,0,8.863247863247864,69.1893773167397,IL2RA;HLA-B;HLA-C;HLA-A;IL2RG,2,2,B1
48,KEGG_2021_Human,Cellular senescence,4/156,0.0006204461969792592,0.0020386089329318,0,0,11.326086956521738,83.64396387173055,SERPINE1;HLA-B;HLA-C;HLA-A,2,2,B1
49,KEGG_2021_Human,MAPK signaling pathway,5/294,0.0008182334000673111,0.0026347115482167,0,0,7.559015763168012,53.73222745258755,ERBB3;FLT4;ERBB2;EREG;VEGFA,2,2,B1
50,KEGG_2021_Human,Gastric acid secretion,3/76,0.0009089746531003116,0.0028143253682528,0,0,17.38006412124745,121.71594945135638,GNAS;ADCY7;GNAI2,2,2,B1
51,KEGG_2021_Human,Pertussis,3/76,0.0009089746531003116,0.0028143253682528,0,0,17.38006412124745,121.71594945135638,ITGB2;ITGA5;GNAI2,2,2,B1
52,KEGG_2021_Human,Tuberculosis,4/180,0.0010579811014412,0.0032138671194725,0,0,9.769762845849804,66.93648290024086,MRC2;FCGR2A;ITGB2;ITGAX,2,2,B1
53,KEGG_2021_Human,ErbB signaling pathway,3/85,0.0012570974643791,0.0037480128104637,0,0,15.465490399584846,103.29323424451243,ERBB3;ERBB2;EREG,2,2,B1
54,KEGG_2021_Human,Gap junction,3/88,0.0013893445250705,0.0040669903370245,0,0,14.917396745932416,98.14040765115747,GNAS;ADCY7;GNAI2,2,2,B1
55,KEGG_2021_Human,Herpes simplex virus 1 infection,6/498,0.0014521020034628,0.0041747932599558,0,0,5.393015521064301,35.241971043897124,CCL5;HLA-B;HLA-C;ITGA5;HLA-A;B2M,2,2,B1
56,KEGG_2021_Human,Morphine addiction,3/91,0.0015300336428855,0.0043216739737645,0,0,14.406673114119922,93.39076222450518,GNAS;ADCY7;GNAI2,2,2,B1
57,KEGG_2021_Human,Salivary secretion,3/93,0.0016286129467617,0.0045208049039422,0,0,14.085106382978724,90.42675735150269,GNAS;LYZ;ADCY7,2,2,B1
58,KEGG_2021_Human,Circadian entrainment,3/97,0.001837512611877,0.0050142293307153,0,0,13.483023992756904,84.93418557118899,GNAS;ADCY7;GNAI2,2,2,B1
59,KEGG_2021_Human,Melanogenesis,3/101,0.0020624307603271,0.0055341892068779,0,0,12.930091185410337,79.95800312185176,GNAS;ADCY7;GNAI2,2,2,B1
60,KEGG_2021_Human,Protein digestion and absorption,3/103,0.002181029234164,0.0057564869950887,0,0,12.670212765957446,77.64253659479164,COL1A1;COL1A2;COL4A1,2,2,B1
61,KEGG_2021_Human,NF-kappa B signaling pathway,3/104,0.0022418858798504,0.0058216713976761,0,0,12.544133136717926,76.5247046664134,PLAU;CCL19;ICAM1,2,2,B1
62,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",3/106,0.0023667454978385,0.0060483496055872,0,0,12.299318322660609,74.36462396066707,GNAS;ADCY7;GNAI2,2,2,B1
63,KEGG_2021_Human,HIF-1 signaling pathway,3/109,0.0025619933727431,0.0064450145783069,0,0,11.94941790445604,71.30181411758254,SERPINE1;ERBB2;VEGFA,2,2,B1
64,KEGG_2021_Human,TNF signaling pathway,3/112,0.0027669362290613,0.0068534881981365,0,0,11.618778059730626,68.43477270112554,CXCL10;CCL5;ICAM1,2,2,B1
65,KEGG_2021_Human,Glutamatergic synapse,3/114,0.00290902931217,0.0070962684736268,0,0,11.40828062104658,66.623626679358,GNAS;ADCY7;GNAI2,2,2,B1
66,KEGG_2021_Human,Chemical carcinogenesis,4/239,0.002977022490462,0.0071537406114087,0,0,7.295097132284921,42.434351832265,GNAS;ADCY7;VEGFA;GNAI2,2,2,B1
67,KEGG_2021_Human,"Growth hormone synthesis, secretion and action",3/119,0.0032837193495461,0.0077746884599548,0,0,10.913793103448276,62.413565909911824,GNAS;ADCY7;GNAI2,2,2,B1
68,KEGG_2021_Human,Primary immunodeficiency,2/38,0.0040654672914765,0.0094860903467785,0,0,23.04861111111111,126.88782669928548,CD79A;IL2RG,2,2,B1
69,KEGG_2021_Human,Bladder cancer,2/41,0.0047194951697385,0.0107447635728708,0,0,21.272435897435894,113.93630347986566,ERBB2;VEGFA,2,2,B1
70,KEGG_2021_Human,Apelin signaling pathway,3/137,0.0048718493218606,0.0107447635728708,0,0,9.439187043505877,50.25689061605164,SERPINE1;ADCY7;GNAI2,2,2,B1
71,KEGG_2021_Human,Yersinia infection,3/137,0.0048718493218606,0.0107447635728708,0,0,9.439187043505877,50.25689061605164,FCGR2A;FN1;ITGA5,2,2,B1
72,KEGG_2021_Human,Estrogen signaling pathway,3/137,0.0048718493218606,0.0107447635728708,0,0,9.439187043505877,50.25689061605164,GNAS;ADCY7;GNAI2,2,2,B1
73,KEGG_2021_Human,Measles,3/139,0.0050722381718543,0.0110355452117371,0,0,9.299436795994994,49.137973919606814,IL2RA;CD3G;IL2RG,2,2,B1
74,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,3/150,0.0062631723305451,0.0134449432695702,0,0,8.598784194528875,43.62222089301041,GNAS;ADCY7;GNAI2,2,2,B1
75,KEGG_2021_Human,Cocaine addiction,2/49,0.0066828970303688,0.014080526493232,0,0,17.64450354609929,88.36726791367238,GNAS;GNAI2,2,2,B1
76,KEGG_2021_Human,Oxytocin signaling pathway,3/154,0.0067341648445892,0.014080526493232,0,0,8.369310976468931,41.85125407551329,GNAS;ADCY7;GNAI2,2,2,B1
77,KEGG_2021_Human,Cushing syndrome,3/155,0.0068551228506196,0.014149676653202,0,0,8.313829787234043,41.42581056937343,GNAS;ADCY7;GNAI2,2,2,B1
78,KEGG_2021_Human,Ovarian steroidogenesis,2/51,0.0072225026271421,0.0147192775059478,0,0,16.922619047619047,83.43788300609687,GNAS;ADCY7,2,2,B1
79,KEGG_2021_Human,Influenza A,3/172,0.0091115611350234,0.0183370167842347,0,0,7.471106634772756,35.10083699792174,CXCL10;CCL5;ICAM1,2,2,B1
80,KEGG_2021_Human,Long-term depression,2/60,0.0098843204040546,0.0196466121611457,0,0,14.290229885057473,65.97521300057967,GNAS;GNAI2,2,2,B1
81,KEGG_2021_Human,Cytosolic DNA-sensing pathway,2/63,0.0108545013893802,0.0213118868742709,0,0,13.585382513661202,61.44906812714711,CXCL10;CCL5,2,2,B1
82,KEGG_2021_Human,Cortisol synthesis and secretion,2/65,0.0115237618661231,0.0223533212101907,0,0,13.15277777777778,58.70537343689256,GNAS;ADCY7,2,2,B1
83,KEGG_2021_Human,Neutrophil extracellular trap formation,3/189,0.0117556913396771,0.0225317417343812,0,0,6.782429649965683,30.13716854116709,FCGR2A;ITGB2;ITGAL,2,2,B1
84,KEGG_2021_Human,Renin secretion,2/69,0.0129153730394233,0.0244632359923194,0,0,12.36504975124378,53.77976800231812,GNAS;GNAI2,2,2,B1
85,KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,2/70,0.013274200561286,0.0248505382600819,0,0,12.182598039215684,52.65237170003471,CCL5;ADAM10,2,2,B1
86,KEGG_2021_Human,Viral carcinogenesis,3/203,0.0142323787832344,0.0263380802770201,0,0,6.303191489361702,26.80265596371328,HLA-B;HLA-C;HLA-A,2,2,B1
87,KEGG_2021_Human,Thyroid hormone synthesis,2/75,0.0151327357621299,0.0276860279284422,0,0,11.345319634703197,47.54704276850611,GNAS;ADCY7,2,2,B1
88,KEGG_2021_Human,Pancreatic cancer,2/76,0.0155171628224907,0.0280703731957416,0,0,11.19144144144144,46.62140287744705,ERBB2;VEGFA,2,2,B1
89,KEGG_2021_Human,Bacterial invasion of epithelial cells,2/77,0.0159057771109684,0.0281409902732518,0,0,11.041666666666666,45.72434655376785,FN1;ITGA5,2,2,B1
90,KEGG_2021_Human,Leishmaniasis,2/77,0.0159057771109684,0.0281409902732518,0,0,11.041666666666666,45.72434655376785,FCGR2A;ITGB2,2,2,B1
91,KEGG_2021_Human,cAMP signaling pathway,3/216,0.0167785010572714,0.029362376850225,0,0,5.914593946658676,24.176830822166,GNAS;ADCY7;GNAI2,2,2,B1
92,KEGG_2021_Human,Insulin secretion,2/86,0.0195880530452788,0.0339105004332246,0,0,9.854166666666666,38.754815869716495,GNAS;ADCY7,2,2,B1
93,KEGG_2021_Human,GABAergic synapse,2/89,0.0208876608034354,0.03539908830898,0,0,9.512931034482758,36.80169347929862,ADCY7;GNAI2,2,2,B1
94,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,2/89,0.0208876608034354,0.03539908830898,0,0,9.512931034482758,36.80169347929862,CD3G;CD247,2,2,B1
95,KEGG_2021_Human,Bile secretion,2/90,0.0213286953840061,0.0357699995502603,0,0,9.40435606060606,36.18515879365064,GNAS;ADCY7,2,2,B1
96,KEGG_2021_Human,GnRH signaling pathway,2/93,0.0226749954090764,0.0376358171222814,0,0,9.092948717948715,34.43038199107018,GNAS;ADCY7,2,2,B1
97,KEGG_2021_Human,Shigellosis,3/246,0.0235721321928733,0.0387256457454348,0,0,5.1765169424743895,19.399981318373516,CCL5;ITGA5;CD44,2,2,B1
98,KEGG_2021_Human,Prostate cancer,2/97,0.024523395696302,0.03984332280373,0,0,8.708333333333334,32.29161197321332,PLAU;ERBB2,2,2,B1
99,KEGG_2021_Human,Aldosterone synthesis and secretion,2/98,0.0249948795228368,0.03984332280373,0,0,8.6171875,31.78953106624349,GNAS;ADCY7,2,2,B1
100,KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,2/98,0.0249948795228368,0.03984332280373,0,0,8.6171875,31.78953106624349,GNAS;ADCY7,2,2,B1
101,KEGG_2021_Human,Progesterone-mediated oocyte maturation,2/100,0.025948961945953,0.040958655620573,0,0,8.44047619047619,30.82144266223132,ADCY7;GNAI2,2,2,B1
102,KEGG_2021_Human,Pancreatic secretion,2/102,0.0269177264019109,0.0420752810748317,0,0,8.270833333333334,29.898816321570965,GNAS;ADCY7,2,2,B1
103,KEGG_2021_Human,T cell receptor signaling pathway,2/104,0.0279010087799889,0.0431929078228674,0,0,8.107843137254902,29.01872002714532,CD3G;CD247,2,2,B1
104,KEGG_2021_Human,Toxoplasmosis,2/112,0.031976077624072,0.0489035232645501,0,0,7.515151515151516,25.872917364872013,ITGA6;GNAI2,2,2,B1
105,KEGG_2021_Human,Serotonergic synapse,2/113,0.032501099312465,0.0489035232645501,0,0,7.447072072072072,25.517253680402074,GNAS;GNAI2,2,2,B1
106,KEGG_2021_Human,Cholinergic synapse,2/113,0.032501099312465,0.0489035232645501,0,0,7.447072072072072,25.517253680402074,ADCY7;GNAI2,2,2,B1
0,KEGG_2021_Human,Pathways in cancer,49/531,8.237722982372118e-40,1.7216841033157728e-37,0,0,19.302396062159303,1737.1129520432935,RET;FLT4;FASLG;FGF1;FGF2;IGF1R;EDNRA;CDH1;ITGAV;HRAS;PDGFRB;HSP90AA1;ITGA3;TRAF2;AR;ADCY9;COL4A2;COL4A1;COL4A5;ITGA6;NOTCH2;NOTCH3;LAMA5;NOTCH1;LRP5;PDGFB;CXCR4;IL2RG;ADCY7;HSP90B1;GNAI2;RXRA;ERBB2;FADD;TGFB1;TGFB3;WNT7B;FZD6;FN1;VEGFB;ESR1;VEGFA;GNAS;FAS;CALM3;CALM1;FGFR4;CALM2;FGFR3,3,3,B1
1,KEGG_2021_Human,PI3K-Akt signaling pathway,42/354,1.7002441565382615e-38,1.7767551435824836e-36,0,0,24.128263937896964,2098.37386921964,LAMA5;ITGB5;FLT4;TNC;PDGFB;FASLG;IL2RG;FGF1;EFNA4;FGF2;AREG;THBS1;HSP90B1;IGF1R;RXRA;ERBB3;PDGFC;ERBB2;ITGAV;ITGB7;HRAS;PDGFRB;HSP90AA1;ITGA3;ITGA1;OSM;FN1;VEGFB;OSMR;VEGFA;COL1A1;EFNA1;COL1A2;COL4A2;COL4A1;COL6A1;COL4A5;ITGA6;FGFR4;FGFR3;EPHA2;ITGA9,3,3,B1
2,KEGG_2021_Human,Human papillomavirus infection,34/331,6.515407037383581e-29,4.5390669027105616e-27,0,0,19.130564908342688,1241.5889289573372,NOTCH2;NOTCH3;LAMA5;NOTCH1;ITGB5;TRADD;TNC;FASLG;PSEN1;THBS1;ITGAV;ITGB7;FADD;HRAS;PDGFRB;ITGA3;WNT7B;FZD6;ITGA1;HLA-B;FN1;TNFRSF1A;VEGFA;COL1A1;COL1A2;PKM;COL4A2;COL4A1;COL6A1;GNAS;FAS;COL4A5;ITGA6;ITGA9,3,3,B1
3,KEGG_2021_Human,Focal adhesion,28/201,1.34556310123161e-27,7.030567203935163e-26,0,0,25.890690351990227,1601.934293788913,LAMA5;ITGB5;FLT4;TNC;PDGFB;THBS1;IGF1R;PDGFC;ERBB2;ITGAV;ITGB7;HRAS;PDGFRB;ITGA3;ITGA1;FN1;VEGFB;VEGFA;COL1A1;COL1A2;COL4A2;COL4A1;COL6A1;COL4A5;ITGA6;TLN1;VCL;ITGA9,3,3,B1
4,KEGG_2021_Human,Rap1 signaling pathway,27/210,1.1549598628398956e-25,4.827732226670764e-24,0,0,23.399524061343204,1343.613815870075,FLT4;ITGB2;PDGFB;FGF1;ADCY7;EFNA4;FGF2;THBS1;IGF1R;GNAI2;CDH1;PDGFC;HRAS;PDGFRB;FARP2;VEGFB;VEGFA;EFNA1;ADCY9;GNAS;CALM3;TLN1;CALM1;FGFR4;CALM2;FGFR3;EPHA2,3,3,B1
5,KEGG_2021_Human,Proteoglycans in cancer,26/205,1.4131024194112668e-24,4.9223067609492464e-23,0,0,22.85675977653631,1255.207640296357,SDC4;ITGB5;SDC2;FASLG;FGF2;THBS1;IGF1R;ERBB3;PLAU;GPC1;ERBB2;GPC3;TIMP3;ITGAV;HRAS;TGFB1;WNT7B;FZD6;FN1;ESR1;VEGFA;COL1A1;COL1A2;FAS;SDC1;CD44,3,3,B1
6,KEGG_2021_Human,ECM-receptor interaction,20/88,1.9649026343747852e-24,5.866637865490431e-23,0,0,44.41176470588236,2424.287214762559,LAMA5;ITGB5;SDC4;ITGA3;ITGA1;TNC;FN1;THBS1;COL1A1;COL1A2;COL4A2;COL4A1;COL6A1;COL4A5;SDC1;ITGAV;ITGB7;ITGA6;CD44;ITGA9,3,3,B1
7,KEGG_2021_Human,MAPK signaling pathway,25/294,2.447245676927575e-19,6.39342933097329e-18,0,0,14.442084144686374,618.9032920705484,TRADD;FLT4;PDGFB;FASLG;FGF1;EFNA4;FGF2;AREG;IGF1R;ERBB3;PDGFC;ERBB2;HRAS;PDGFRB;TGFB1;TGFB3;VEGFB;TRAF2;TNFRSF1A;VEGFA;EFNA1;FAS;FGFR4;FGFR3;EPHA2,3,3,B1
8,KEGG_2021_Human,Axon guidance,21/182,4.0084622697089777e-19,9.308540159657517e-18,0,0,19.753846153846155,836.7869299959034,SEMA4A;NRP1;SEMA3C;SEMA4C;SEMA3B;CXCR4;SEMA3F;NTN1;EFNA4;GNAI2;EFNB2;EFNA1;PLXNB2;PLXNA1;EPHA1;EPHB2;HRAS;NEO1;EPHB4;EPHA2;PLXNA3,3,3,B1
9,KEGG_2021_Human,Calcium signaling pathway,22/240,8.224258926437969e-18,1.718870115625535e-16,0,0,15.357442571652088,604.1532440668108,PDGFRB;RET;FLT4;PDGFB;VEGFB;HTR2C;CXCR4;FGF1;ADCY7;FGF2;VEGFA;EDNRA;ADCY9;ERBB3;PDGFC;ERBB2;GNAS;CALM3;CALM1;FGFR4;CALM2;FGFR3,3,3,B1
10,KEGG_2021_Human,Regulation of actin cytoskeleton,21/218,1.7380147098008318e-17,3.302227948621581e-16,0,0,16.114486528699725,621.8774223274451,PDGFRB;ITGB5;ITGA3;ITGA1;ITGB2;PDGFB;FN1;CXCR4;ITGAE;FGF1;FGF2;PDGFC;ITGAX;ITGA6;ITGAV;ITGB7;FGFR4;FGFR3;HRAS;VCL;ITGA9,3,3,B1
11,KEGG_2021_Human,Cell adhesion molecules,17/148,1.224788661193248e-15,2.1331735849115735e-14,0,0,19.0957046826934,655.6702704171269,SDC4;SDC2;ITGB2;HLA-B;PTPRM;PTPRF;ICAM1;VCAN;CDH1;PECAM1;SDC1;ITGAV;ITGB7;MADCAM1;ITGA6;NEO1;ITGA9,3,3,B1
12,KEGG_2021_Human,Human cytomegalovirus infection,19/225,7.465725999831853e-15,1.2002590261268132e-13,0,0,13.725250073551043,446.4611617418295,TRADD;HLA-B;CXCR4;TRAF2;FASLG;ADCY7;TNFRSF1A;VEGFA;GNAI2;ADCY9;GNAS;FAS;CALM3;ITGAV;CALR;FADD;CALM1;CALM2;HRAS,3,3,B1
13,KEGG_2021_Human,Fluid shear stress and atherosclerosis,16/139,8.484752197539298e-15,1.2666522923469384e-13,0,0,19.007286961758503,615.8457095729723,ACVR1;HSP90AA1;SDC4;SDC2;PDGFB;ICAM1;HSP90B1;TNFRSF1A;VEGFA;GPC1;PECAM1;SDC1;CALM3;ITGAV;CALM1;CALM2,3,3,B1
14,KEGG_2021_Human,Ras signaling pathway,19/232,1.3096386513351324e-14,1.8247631875269517e-13,0,0,13.269455114525536,424.177241300921,PDGFRB;FLT4;PDGFB;VEGFB;FASLG;FGF1;EFNA4;FGF2;IGF1R;VEGFA;EFNA1;PDGFC;CALM3;CALM1;FGFR4;CALM2;FGFR3;HRAS;EPHA2,3,3,B1
15,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,13/100,6.205663954428493e-13,8.10614854047222e-12,0,0,21.398134266200238,601.4618348532671,TGFB1;TGFB3;SERPINE1;FN1;VEGFB;ICAM1;VEGFA;COL1A1;COL1A2;COL4A2;COL4A1;COL4A5;HRAS,3,3,B1
16,KEGG_2021_Human,Dilated cardiomyopathy,12/96,7.988639338569669e-12,9.821327186829769e-11,0,0,20.313463514902363,519.0699467291402,ADCY9;TGFB1;ITGB5;ITGA3;TGFB3;ITGA1;GNAS;ITGAV;ITGB7;ITGA6;ADCY7;ITGA9,3,3,B1
17,KEGG_2021_Human,Cytokine-cytokine receptor interaction,18/295,1.0109619618467516e-11,1.1738391668109503e-10,0,0,9.562606878206346,242.1016219742907,ACVR1;CXCL9;TGFB1;IL20;TGFB3;GDF15;OSM;IL20RA;CXCR4;INHBB;FASLG;CXCL13;IL2RG;OSMR;TNFRSF1A;CXCL10;CXCR3;FAS,3,3,B1
18,KEGG_2021_Human,Amoebiasis,12/102,1.6622368128248334e-11,1.7815708718823243e-10,0,0,18.95347721822542,470.4304570590223,COL1A1;LAMA5;TGFB1;COL1A2;COL4A2;COL4A1;TGFB3;ITGB2;FN1;GNAS;COL4A5;VCL,3,3,B1
19,KEGG_2021_Human,Relaxin signaling pathway,13/129,1.7048525089783008e-11,1.7815708718823243e-10,0,0,16.025049975012493,397.34043179885214,TGFB1;VEGFB;ADCY7;GNAI2;VEGFA;COL1A1;ADCY9;COL1A2;COL4A2;COL4A1;GNAS;COL4A5;HRAS,3,3,B1
20,KEGG_2021_Human,Breast cancer,13/147,8.975456653327073e-11,8.932716383549324e-10,0,0,13.859777200951765,320.6312848000511,NOTCH2;NOTCH3;NOTCH1;FLT4;WNT7B;FZD6;LRP5;FGF1;FGF2;ESR1;IGF1R;ERBB2;HRAS,3,3,B1
21,KEGG_2021_Human,MicroRNAs in cancer,17/310,2.0807942335511539e-10,1.976754521873596e-09,0,0,8.467525851968825,188.76741129089908,PDGFRB;NOTCH2;NOTCH3;NOTCH1;TNC;PDGFB;EFNA4;THBS1;VEGFA;EFNA1;ERBB3;PLAU;ERBB2;TIMP3;FGFR3;HRAS;CD44,3,3,B1
22,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,14/193,2.350769320158569e-10,2.136133860491917e-09,0,0,11.229458059780614,248.96953062613903,TRADD;HLA-B;PDGFB;TRAF2;FGF2;ICAM1;TNFRSF1A;VEGFA;FAS;CALM3;FADD;CALM1;CALM2;HRAS,3,3,B1
23,KEGG_2021_Human,Human immunodeficiency virus 1 infection,14/212,8.094952326987814e-10,7.0493543180852225e-09,0,0,10.142077711420775,212.3204438314571,TRADD;HLA-B;CXCR4;TRAF2;FASLG;TNFRSF1A;GNAI2;FAS;CALM3;CALR;FADD;CALM1;CALM2;HRAS,3,3,B1
24,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,14/219,1.2370285465398232e-09,1.0341558649072922e-08,0,0,9.79227345558127,200.84495022840144,NRP1;TGFB1;TGFB3;ITGB2;HLA-B;IL2RG;ADCY7;ICAM1;TNFRSF1A;ADCY9;CANX;CALR;TLN1;HRAS,3,3,B1
25,KEGG_2021_Human,Small cell lung cancer,10/92,1.8928066591366768e-09,1.5215253529214058e-08,0,0,17.096523092890504,343.38717289572213,LAMA5;RXRA;COL4A2;ITGA3;COL4A1;FN1;COL4A5;ITGAV;TRAF2;ITGA6,3,3,B1
26,KEGG_2021_Human,Prostate cancer,10/97,3.196959986289332e-09,2.4746838412387792e-08,0,0,16.10988831825222,315.1265803165908,PDGFRB;AR;HSP90AA1;PLAU;PDGFC;ERBB2;PDGFB;HRAS;IGF1R;HSP90B1,3,3,B1
27,KEGG_2021_Human,Malaria,8/50,3.596036525791925e-09,2.68418440675183e-08,0,0,26.382950382950384,512.9751429681239,TGFB1;TGFB3;SDC2;ITGB2;PECAM1;SDC1;THBS1;ICAM1,3,3,B1
28,KEGG_2021_Human,Melanogenesis,10/101,4.75994289734509e-09,3.4304416053280134e-08,0,0,15.398643909282208,295.08467773568736,ADCY9;WNT7B;FZD6;GNAS;CALM3;CALM1;CALM2;HRAS;ADCY7;GNAI2,3,3,B1
29,KEGG_2021_Human,Chagas disease,10/102,5.243530142185018e-09,3.652992665722229e-08,0,0,15.23049645390071,290.38877093838295,TGFB1;TGFB3;SERPINE1;GNAS;FAS;FASLG;FADD;CALR;TNFRSF1A;GNAI2,3,3,B1
30,KEGG_2021_Human,Estrogen signaling pathway,11/137,7.377423410882122e-09,4.973811267336658e-08,0,0,12.298922902494333,230.2953806245636,HSP90AA1;ADCY9;GNAS;CALM3;CALM1;ESR1;CALM2;HRAS;ADCY7;HSP90B1;GNAI2,3,3,B1
31,KEGG_2021_Human,Lipid and atherosclerosis,13/215,9.681348068009178e-09,6.323130456918496e-08,0,0,9.16239776151528,169.07431853664514,ABCA1;HSP90AA1;TRAF2;FASLG;HSP90B1;ICAM1;TNFRSF1A;RXRA;FAS;CALM3;CALM1;CALM2;HRAS,3,3,B1
32,KEGG_2021_Human,Gastric cancer,11/149,1.7792922809817543e-08,1.1268851112884446e-07,0,0,11.222619047619048,200.26163340582517,TGFB1;RXRA;CDH1;TGFB3;WNT7B;FZD6;ERBB2;LRP5;FGF1;FGF2;HRAS,3,3,B1
33,KEGG_2021_Human,Alzheimer disease,16/369,2.0837424622190347e-08,1.280888748834642e-07,0,0,6.545713985940615,115.77086994834691,APP;WNT7B;FZD6;LRP5;ADAM10;TRAF2;PSEN1;TNFRSF1A;NCSTN;FAS;CALM3;APOE;FADD;CALM1;CALM2;HRAS,3,3,B1
34,KEGG_2021_Human,Gap junction,9/88,2.15648802122012e-08,1.2877314183857288e-07,0,0,15.861116063469424,279.98358919419263,PDGFRB;ADCY9;PDGFC;PDGFB;GNAS;HTR2C;HRAS;ADCY7;GNAI2,3,3,B1
35,KEGG_2021_Human,Hypertrophic cardiomyopathy,9/90,2.631754698660621e-08,1.5278798111668608e-07,0,0,15.4679186228482,269.9620467478919,TGFB1;ITGB5;ITGA3;TGFB3;ITGA1;ITGAV;ITGB7;ITGA6;ITGA9,3,3,B1
36,KEGG_2021_Human,Chemical carcinogenesis,13/239,3.409259188216005e-08,1.9257707306409325e-07,0,0,8.179395921508272,140.63805257731022,NOTCH2;HSP90AA1;ADCY7;ESR1;FGF2;HSP90B1;VEGFA;GNAI2;AR;ADCY9;RXRA;GNAS;HRAS,3,3,B1
37,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,9/100,6.649005852925815e-08,3.6569532191091984e-07,0,0,13.76118247949234,227.4202382409763,CXCL10;CXCL9;IL20;CXCR3;IL20RA;CXCR4;CXCL13;IL2RG;TNFRSF1A,3,3,B1
38,KEGG_2021_Human,Melanoma,8/72,6.969580445945147e-08,3.734980290262912e-07,0,0,17.29458041958042,284.99956492695134,PDGFRB;CDH1;PDGFC;PDGFB;FGF1;FGF2;HRAS;IGF1R,3,3,B1
39,KEGG_2021_Human,Apelin signaling pathway,10/137,9.014872470665346e-08,4.710270865922643e-07,0,0,11.013570112246608,178.65998708635618,NOTCH3;ADCY9;CDH1;SERPINE1;CALM3;CALM1;CALM2;HRAS;ADCY7;GNAI2,3,3,B1
40,KEGG_2021_Human,Bladder cancer,6/41,6.060567633300533e-07,3.089411305755638e-06,0,0,23.425418719211823,335.36513897305383,CDH1;ERBB2;THBS1;HRAS;FGFR3;VEGFA,3,3,B1
41,KEGG_2021_Human,Renin secretion,7/69,8.867758423962483e-07,4.412765501447998e-06,0,0,15.514000896057349,216.19805273147307,EDNRA;EDN2;GNAS;CALM3;CALM1;CALM2;GNAI2,3,3,B1
42,KEGG_2021_Human,Adherens junction,7/71,1.0793946407845162e-06,5.246359998231718e-06,0,0,15.027669270833334,206.4668040374413,FARP2;CDH1;ERBB2;PTPRM;PTPRF;VCL;IGF1R,3,3,B1
43,KEGG_2021_Human,Tuberculosis,10/180,1.1379327729608825e-06,5.405180671564192e-06,0,0,8.209845640383813,112.3623882109911,TGFB1;TGFB3;TRADD;ITGB2;ITGAX;CALM3;FADD;CALM1;CALM2;TNFRSF1A,3,3,B1
44,KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,9/143,1.4150168617777652e-06,6.571967202478954e-06,0,0,9.32494219045617,125.59176335503882,ACVR1;WNT7B;FZD6;INHBB;FGFR4;FGF2;FGFR3;HRAS;IGF1R,3,3,B1
45,KEGG_2021_Human,Glioma,7/75,1.5709076891891485e-06,7.13738493566374e-06,0,0,14.140829248366012,188.97601936650332,PDGFRB;PDGFB;CALM3;CALM1;HRAS;CALM2;IGF1R,3,3,B1
46,KEGG_2021_Human,Gastric acid secretion,7/76,1.719417556945446e-06,7.64592062556592e-06,0,0,13.935185185185183,184.96902829653249,ADCY9;GNAS;CALM3;CALM1;ADCY7;CALM2;GNAI2,3,3,B1
47,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,7/77,1.879491656373933e-06,8.183619920461501e-06,0,0,13.735416666666667,181.09472758924244,ITGB5;ITGA3;ITGA1;ITGAV;ITGB7;ITGA6;ITGA9,3,3,B1
48,KEGG_2021_Human,Hepatitis C,9/157,3.0698469615714027e-06,1.3093837040171902e-05,0,0,8.436857632280168,107.09648238316495,CXCL10;RXRA;TRADD;FAS;TRAF2;FASLG;FADD;HRAS;TNFRSF1A,3,3,B1
49,KEGG_2021_Human,Pathways of neurodegeneration,15/475,3.2519972926757797e-06,1.3593348683384756e-05,0,0,4.648897058823529,58.74458454363758,APP;WNT7B;FZD6;LRP5;TRAF2;FASLG;PSEN1;TNFRSF1A;FAS;CALM3;FADD;CALM1;CALM2;HRAS;SPTBN2,3,3,B1
50,KEGG_2021_Human,Hippo signaling pathway,9/163,4.1769880538818856e-06,1.7117460848261058e-05,0,0,8.10567953173587,100.39629929914445,TGFB1;TGFB3;CDH1;WNT7B;SERPINE1;FZD6;ITGB2;FGF1;AREG,3,3,B1
51,KEGG_2021_Human,GnRH signaling pathway,7/93,6.695167195122774e-06,2.6909421995781915e-05,0,0,11.17094638242894,133.09204716720734,ADCY9;GNAS;CALM3;CALM1;HRAS;ADCY7;CALM2,3,3,B1
52,KEGG_2021_Human,TGF-beta signaling pathway,7/94,7.188518221615676e-06,2.83471756286354e-05,0,0,11.04198595146871,130.7705211525703,ACVR1;TGFB1;TGFB3;INHBB;NEO1;LTBP1;THBS1,3,3,B1
53,KEGG_2021_Human,Vascular smooth muscle contraction,8/133,7.743340089660674e-06,2.996959405072372e-05,0,0,8.827524475524475,103.8882880341818,EDNRA;ADCY9;EDN2;GNAS;CALM3;CALM1;CALM2;ADCY7,3,3,B1
54,KEGG_2021_Human,Circadian entrainment,7/97,8.853192402477297e-06,3.3642131129413725e-05,0,0,10.67229938271605,124.16934784330262,ADCY9;GNAS;CALM3;CALM1;CALM2;ADCY7;GNAI2,3,3,B1
55,KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,7/98,9.474464323489638e-06,3.536005435016669e-05,0,0,10.55448717948718,122.0828069359672,ADCY9;GNAS;HTR2C;CALM3;CALM1;CALM2;ADCY7,3,3,B1
56,KEGG_2021_Human,Protein digestion and absorption,7/103,1.3149472151468678e-05,4.821473122205182e-05,0,0,10.002242476851851,112.41649289367334,COL1A1;COL18A1;COL1A2;COL4A2;COL4A1;COL6A1;COL4A5,3,3,B1
57,KEGG_2021_Human,Central carbon metabolism in cancer,6/70,1.4761802174524742e-05,5.3193390594408126e-05,0,0,12.792025862068966,142.2916858252701,RET;PDGFRB;PKM;ERBB2;HRAS;FGFR3,3,3,B1
58,KEGG_2021_Human,Chemokine signaling pathway,9/192,1.5683619831146243e-05,5.555722957134856e-05,0,0,6.811129069498961,75.35079696212098,CXCL10;CXCL9;ADCY9;CXCR3;CXCR4;CXCL13;ADCY7;HRAS;GNAI2,3,3,B1
59,KEGG_2021_Human,Oxytocin signaling pathway,8/154,2.2561423343070854e-05,7.784917937532652e-05,0,0,7.549765303189961,80.7769701818531,ADCY9;GNAS;CALM3;CALM1;CALM2;ADCY7;HRAS;GNAI2,3,3,B1
60,KEGG_2021_Human,TNF signaling pathway,7/112,2.272153082246372e-05,7.784917937532652e-05,0,0,9.14074074074074,97.73460610645678,CXCL10;TRADD;FAS;TRAF2;FADD;ICAM1;TNFRSF1A,3,3,B1
61,KEGG_2021_Human,Epstein-Barr virus infection,9/202,2.346060787572657e-05,7.908495235527182e-05,0,0,6.454936875136832,68.81083935139642,CXCL10;TRADD;HLA-B;FAS;TRAF2;CALR;FADD;CD44;ICAM1,3,3,B1
62,KEGG_2021_Human,Cellular senescence,8/156,2.475931249031393e-05,8.213803667421606e-05,0,0,7.446985446985447,78.98502785685255,TGFB1;TGFB3;SERPINE1;HLA-B;CALM3;CALM1;CALM2;HRAS,3,3,B1
63,KEGG_2021_Human,Necroptosis,8/159,2.8391038042105226e-05,9.271448360624987e-05,0,0,7.297920622423933,76.40512036623035,HSP90AA1;TRADD;FAS;TRAF2;FASLG;HMGB1;FADD;TNFRSF1A,3,3,B1
64,KEGG_2021_Human,JAK-STAT signaling pathway,8/162,3.2458688293413035e-05,0.000104367166974205,0,0,7.154663518299882,73.94732819857362,PDGFRB;IL20;OSM;PDGFB;IL20RA;IL2RG;OSMR;HRAS,3,3,B1
65,KEGG_2021_Human,Thyroid hormone signaling pathway,7/121,3.742520583863437e-05,0.00011851315182234218,0,0,8.41526559454191,85.77820021340747,NOTCH2;NOTCH3;NOTCH1;RXRA;ITGAV;ESR1;HRAS,3,3,B1
66,KEGG_2021_Human,cAMP signaling pathway,9/216,3.968634867310885e-05,0.00012379771451760815,0,0,6.014084507042254,60.94975923224102,EDNRA;ADCY9;EDN2;GNAS;CALM3;CALM1;CALM2;ADCY7;GNAI2,3,3,B1
67,KEGG_2021_Human,Platelet activation,7/124,4.378583163420779e-05,0.0001345770413463151,0,0,8.198243114909781,82.27920977636461,COL1A1;ADCY9;COL1A2;GNAS;TLN1;ADCY7;GNAI2,3,3,B1
68,KEGG_2021_Human,ErbB signaling pathway,6/85,4.487136919085062e-05,0.00013591472696938812,0,0,10.35530336097774,103.67430067203424,ERBB3;NRG4;ERBB2;NRG2;AREG;HRAS,3,3,B1
69,KEGG_2021_Human,Oocyte meiosis,7/129,5.634303040068186e-05,0.00016822419076775014,0,0,7.860257285974499,76.9051660919273,AR;ADCY9;CALM3;CALM1;CALM2;ADCY7;IGF1R,3,3,B1
70,KEGG_2021_Human,Salivary secretion,6/93,7.442823128172217e-05,0.00021909155405464692,0,0,9.399286563614744,89.34656551806674,ADCY9;GNAS;CALM3;CALM1;ADCY7;CALM2,3,3,B1
71,KEGG_2021_Human,IL-17 signaling pathway,6/94,7.901278727959476e-05,0.00022935656307549032,0,0,9.292006269592475,87.77136996007849,CXCL10;HSP90AA1;TRADD;TRAF2;FADD;HSP90B1,3,3,B1
72,KEGG_2021_Human,Notch signaling pathway,5/59,8.275373381031301e-05,0.0002369250735117181,0,0,12.5539066463724,118.0022209356035,NOTCH2;NOTCH3;NCSTN;NOTCH1;PSEN1,3,3,B1
73,KEGG_2021_Human,Aldosterone synthesis and secretion,6/98,9.965269896204222e-05,0.00028145154166306515,0,0,8.886206896551725,81.8759057380678,ADCY9;GNAS;CALM3;CALM1;CALM2;ADCY7,3,3,B1
74,KEGG_2021_Human,Apoptosis,7/142,0.00010328201099265804,0.0002878125372995404,0,0,7.098662551440329,65.15186095026415,TRADD;FAS;FASLG;TRAF2;FADD;HRAS;TNFRSF1A,3,3,B1
75,KEGG_2021_Human,Phospholipase D signaling pathway,7/148,0.0001337207276838912,0.0003677320011307008,0,0,6.794523246650906,60.60549666181787,PDGFRB;ADCY9;PDGFC;PDGFB;GNAS;HRAS;ADCY7,3,3,B1
76,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,7/150,0.00014534906484644228,0.00039451889029748624,0,0,6.698815073815074,59.193224395065336,ADCY9;GNAS;CALM3;CALM1;CALM2;ADCY7;GNAI2,3,3,B1
77,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",6/106,0.00015371201493831916,0.000411869373360368,0,0,8.172,71.75367182803208,ADCY9;RXRA;GNAS;LRP5;ADCY7;GNAI2,3,3,B1
78,KEGG_2021_Human,Phagosome,7/152,0.00015778418958841976,0.00041742905853138897,0,0,6.605747126436782,57.82857545965646,ITGB5;CANX;ITGB2;HLA-B;ITGAV;CALR;THBS1,3,3,B1
79,KEGG_2021_Human,Thyroid cancer,4/37,0.00016986224410931315,0.00044376511273558057,0,0,16.339723768295197,141.83734435979983,RET;RXRA;CDH1;HRAS,3,3,B1
80,KEGG_2021_Human,Renal cell carcinoma,5/69,0.00017485773780486272,0.00045117613828662105,0,0,10.587007705479452,91.59389779193565,TGFB1;TGFB3;PDGFB;HRAS;VEGFA,3,3,B1
81,KEGG_2021_Human,Toxoplasmosis,6/112,0.0002077310064846438,0.0005294607360401287,0,0,7.707091737150293,65.35048518981401,LAMA5;TGFB1;TGFB3;ITGA6;TNFRSF1A;GNAI2,3,3,B1
82,KEGG_2021_Human,Leukocyte transendothelial migration,6/114,0.000228726804813787,0.0005759506289889334,0,0,7.563601532567049,63.40553745916706,ITGB2;PECAM1;CXCR4;VCL;ICAM1;GNAI2,3,3,B1
83,KEGG_2021_Human,Thyroid hormone synthesis,5/75,0.0002589689453446089,0.0006443393997264675,0,0,9.676614481409002,79.91724695710454,ADCY9;CANX;GNAS;ADCY7;HSP90B1,3,3,B1
84,KEGG_2021_Human,Pertussis,5/76,0.0002755362097786399,0.0006774949158086557,0,0,9.53984179046884,78.19609414767926,ITGB2;CALM3;CALM1;CALM2;GNAI2,3,3,B1
85,KEGG_2021_Human,cGMP-PKG signaling pathway,7/167,0.00028115795489094803,0.0006832792159559085,0,0,5.981901041666666,48.91157574421821,EDNRA;ADCY9;CALM3;CALM1;CALM2;ADCY7;GNAI2,3,3,B1
86,KEGG_2021_Human,Neurotrophin signaling pathway,6/119,0.00028857193142870776,0.0006924389882457918,0,0,7.227097955447055,58.904940132220815,CALM3;FASLG;PSEN1;CALM1;CALM2;HRAS,3,3,B1
87,KEGG_2021_Human,Hepatocellular carcinoma,7/168,0.00029155325820875446,0.0006924389882457918,0,0,5.944444444444445,48.38948897460559,TGFB1;TGFB3;WNT7B;FZD6;LRP5;HRAS;IGF1R,3,3,B1
88,KEGG_2021_Human,Influenza A,7/172,0.00033626860299148755,0.0007896644721934933,0,0,5.799158249158249,46.37934977465407,CXCL10;TRADD;FAS;FASLG;FADD;ICAM1;TNFRSF1A,3,3,B1
89,KEGG_2021_Human,Intestinal immune network for IgA production,4/48,0.0004692530187393497,0.0010897097879613,0,0,12.247990105132962,93.87310893038192,TGFB1;CXCR4;ITGB7;MADCAM1,3,3,B1
90,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,6/131,0.0004826685219904695,0.0011085463856704,0,0,6.5293241379310345,49.85909720183229,ITGB2;HLA-B;FAS;FASLG;HRAS;ICAM1,3,3,B1
91,KEGG_2021_Human,Ovarian steroidogenesis,4/51,0.0005921948004049003,0.0013453121009198,0,0,11.464466637718916,85.200189211017,ADCY9;GNAS;ADCY7;IGF1R,3,3,B1
92,KEGG_2021_Human,Rheumatoid arthritis,5/93,0.0006995363700441967,0.0015720763584864,0,0,7.69030199252802,55.87075741168851,TGFB1;TGFB3;ITGB2;ICAM1;VEGFA,3,3,B1
93,KEGG_2021_Human,Regulation of lipolysis in adipocytes,4/55,0.0007895565674499657,0.0017555034318834,0,0,10.563158596772045,75.46361779315903,ADCY9;GNAS;ADCY7;GNAI2,3,3,B1
94,KEGG_2021_Human,Progesterone-mediated oocyte maturation,5/100,0.000971537165044435,0.0021373817630977,0,0,7.1211247296323,49.39661480052165,HSP90AA1;ADCY9;ADCY7;IGF1R;GNAI2,3,3,B1
95,KEGG_2021_Human,Long-term depression,4/60,0.0010964582663114,0.0023870810172821,0,0,9.617589893100098,65.55031940345549,GNAS;HRAS;IGF1R;GNAI2,3,3,B1
96,KEGG_2021_Human,mTOR signaling pathway,6/154,0.0011254641483268,0.002424969144333,0,0,5.508201304753029,37.39826188533405,WNT7B;FZD6;LRP5;HRAS;IGF1R;TNFRSF1A,3,3,B1
97,KEGG_2021_Human,NF-kappa B signaling pathway,5/104,0.0011584926865579,0.0024319565700026,0,0,6.832018818320188,46.18878914403817,PLAU;TRADD;TRAF2;ICAM1;TNFRSF1A,3,3,B1
98,KEGG_2021_Human,Cushing syndrome,6/155,0.0011636155837333,0.0024319565700026,0,0,5.47095579726915,36.96299869564875,ADCY9;WNT7B;FZD6;GNAS;ADCY7;GNAI2,3,3,B1
99,KEGG_2021_Human,Non-alcoholic fatty liver disease,6/155,0.0011636155837333,0.0024319565700026,0,0,5.47095579726915,36.96299869564875,TGFB1;RXRA;FAS;TRAF2;FASLG;TNFRSF1A,3,3,B1
100,KEGG_2021_Human,Phototransduction,3/28,0.0012032968571451,0.0024899905261715,0,0,16.073513513513515,108.05725030431714,CALM3;CALM1;CALM2,3,3,B1
101,KEGG_2021_Human,Glucagon signaling pathway,5/107,0.0013152690015485,0.0026950119737611,0,0,6.630069836153639,43.9819875595455,PKM;GNAS;CALM3;CALM1;CALM2,3,3,B1
102,KEGG_2021_Human,Hepatitis B,6/162,0.001459165148245,0.0029608302522641,0,0,5.223607427055703,34.109586201312425,TGFB1;TGFB3;FAS;FASLG;FADD;HRAS,3,3,B1
103,KEGG_2021_Human,Long-term potentiation,4/67,0.0016546112472069,0.0033251322179447,0,0,8.545945362271892,54.72985093895191,CALM3;CALM1;HRAS;CALM2,3,3,B1
104,KEGG_2021_Human,Serotonergic synapse,5/113,0.0016751082015712,0.0033342629916989,0,0,6.259830035514967,40.012066869498256,APP;GNAS;HTR2C;HRAS;GNAI2,3,3,B1
105,KEGG_2021_Human,Adipocytokine signaling pathway,4/69,0.0018446251489143,0.0036030528609635,0,0,8.282155939298796,52.14014039277942,RXRA;TRADD;TRAF2;TNFRSF1A,3,3,B1
106,KEGG_2021_Human,Amphetamine addiction,4/69,0.0018446251489143,0.0036030528609635,0,0,8.282155939298796,52.14014039277942,GNAS;CALM3;CALM1;CALM2,3,3,B1
107,KEGG_2021_Human,RIG-I-like receptor signaling pathway,4/70,0.0019450772118137,0.0037640846043433,0,0,8.156256441970728,50.91505243037379,CXCL10;TRADD;TRAF2;FADD,3,3,B1
108,KEGG_2021_Human,"Growth hormone synthesis, secretion and action",5/119,0.0021024678510925,0.0039946889170758,0,0,5.928562845469839,36.5474761549422,ADCY9;GNAS;HRAS;ADCY7;GNAI2,3,3,B1
109,KEGG_2021_Human,Sphingolipid signaling pathway,5/119,0.0021024678510925,0.0039946889170758,0,0,5.928562845469839,36.5474761549422,TRADD;TRAF2;HRAS;TNFRSF1A;GNAI2,3,3,B1
110,KEGG_2021_Human,Non-small cell lung cancer,4/72,0.0021572226148893,0.0040617975361429,0,0,7.915566226490596,48.59313635032947,RET;RXRA;ERBB2;HRAS,3,3,B1
111,KEGG_2021_Human,Pancreatic cancer,4/76,0.0026284242230023,0.0049048273447097,0,0,7.474300831443688,44.40759246452069,TGFB1;TGFB3;ERBB2;VEGFA,3,3,B1
112,KEGG_2021_Human,African trypanosomiasis,3/37,0.0027158775559314,0.0050231717627404,0,0,11.813394276629571,69.80109576376776,FAS;FASLG;ICAM1,3,3,B1
113,KEGG_2021_Human,Salmonella infection,7/249,0.0028825400717834,0.0052383804181186,0,0,3.938504361799816,23.03664049986024,HSP90AA1;TRADD;TRAF2;FADD;HRAS;HSP90B1;TNFRSF1A,3,3,B1
114,KEGG_2021_Human,Antigen processing and presentation,4/78,0.0028885791627757,0.0052383804181186,0,0,7.271557271557271,42.51672655553919,HSP90AA1;CANX;HLA-B;CALR,3,3,B1
115,KEGG_2021_Human,Alcoholism,6/186,0.0029209287366441,0.0052383804181186,0,0,4.5216091954022986,26.38744953942255,GNAS;CALM3;CALM1;CALM2;HRAS;GNAI2,3,3,B1
116,KEGG_2021_Human,Allograft rejection,3/38,0.0029324904733008,0.0052383804181186,0,0,11.475289575289576,66.92277829459934,HLA-B;FAS;FASLG,3,3,B1
117,KEGG_2021_Human,Endocytosis,7/252,0.0030799147079709,0.0054551031692027,0,0,3.88968253968254,22.493463800715464,HLA-B;CXCR4;IL2RG;FGFR4;FGFR3;HRAS;IGF1R,3,3,B1
118,KEGG_2021_Human,FoxO signaling pathway,5/131,0.0031881026216873,0.0055992726717029,0,0,5.360676233963905,30.814932416729917,TGFB1;TGFB3;FASLG;HRAS;IGF1R,3,3,B1
119,KEGG_2021_Human,Dopaminergic synapse,5/132,0.0032938334457649,0.0057367599180405,0,0,5.318196526804012,30.39723296720538,GNAS;CALM3;CALM1;CALM2;GNAI2,3,3,B1
120,KEGG_2021_Human,Insulin signaling pathway,5/137,0.0038606936405705,0.0066333822416016,0,0,5.1154524699045245,28.42610086129979,CALM3;CALM1;CALM2;HRAS;PTPRF,3,3,B1
121,KEGG_2021_Human,Pathogenic Escherichia coli infection,6/197,0.0038727822988365,0.0066333822416016,0,0,4.258819281458747,23.652554249854195,TRADD;FAS;TRAF2;FASLG;FADD;TNFRSF1A,3,3,B1
122,KEGG_2021_Human,Graft-versus-host disease,3/42,0.0039038565345311,0.0066333822416016,0,0,10.296257796257796,57.10088722472947,HLA-B;FAS;FASLG,3,3,B1
123,KEGG_2021_Human,Complement and coagulation cascades,4/85,0.0039371888072028,0.0066360682314952,0,0,6.640799529688419,36.77202161173677,PLAU;ITGB2;SERPINE1;ITGAX,3,3,B1
124,KEGG_2021_Human,Colorectal cancer,4/86,0.0041053950226988,0.0068105556250619,0,0,6.559482329517173,36.04732888659138,TGFB1;TGFB3;AREG;HRAS,3,3,B1
125,KEGG_2021_Human,Measles,5/139,0.0041058852093674,0.0068105556250619,0,0,5.038591290124719,27.688741613440744,TRADD;FAS;FASLG;FADD;IL2RG,3,3,B1
126,KEGG_2021_Human,Type I diabetes mellitus,3/43,0.0041736633086859,0.0068684695394911,0,0,10.038344594594594,54.99969991889258,HLA-B;FAS;FASLG,3,3,B1
127,KEGG_2021_Human,Bile secretion,4/90,0.0048267756761268,0.0078812196586758,0,0,6.2531245056162,33.35151851574649,ADCY9;RXRA;GNAS;ADCY7,3,3,B1
128,KEGG_2021_Human,Morphine addiction,4/91,0.0050195685429834,0.0081324792673141,0,0,6.180936742513097,32.72442131303909,ADCY9;GNAS;ADCY7;GNAI2,3,3,B1
129,KEGG_2021_Human,Th1 and Th2 cell differentiation,4/92,0.0052174618915784,0.0083880733487683,0,0,6.1103896103896105,32.11464489509395,NOTCH2;NOTCH3;NOTCH1;IL2RG,3,3,B1
130,KEGG_2021_Human,Choline metabolism in cancer,4/98,0.0065152257485182,0.0103945204690099,0,0,5.718627876682588,28.785362015061622,PDGFRB;PDGFC;PDGFB;HRAS,3,3,B1
131,KEGG_2021_Human,Hematopoietic cell lineage,4/99,0.0067504555608172,0.0106882213046273,0,0,5.658145363408521,28.280232574964607,ITGA3;ITGA1;ITGA6;CD44,3,3,B1
132,KEGG_2021_Human,Longevity regulating pathway,4/102,0.0074897161825982,0.0116111630065811,0,0,5.484103845619881,26.840434716346227,ADCY9;HRAS;ADCY7;IGF1R,3,3,B1
133,KEGG_2021_Human,Autoimmune thyroid disease,3/53,0.0075000335209973,0.0116111630065811,0,0,8.026621621621622,39.27303785435883,HLA-B;FAS;FASLG,3,3,B1
134,KEGG_2021_Human,Endocrine and other factor-regulated calcium reabsorption,3/53,0.0075000335209973,0.0116111630065811,0,0,8.026621621621622,39.27303785435883,ADCY9;GNAS;ESR1,3,3,B1
135,KEGG_2021_Human,C-type lectin receptor signaling pathway,4/104,0.0080110665878854,0.0123111243887356,0,0,5.373877551020408,25.939338128092672,CALM3;CALM1;CALM2;HRAS,3,3,B1
136,KEGG_2021_Human,Th17 cell differentiation,4/107,0.0088368929272737,0.0134810994291986,0,0,5.216564295621161,24.668193274714785,HSP90AA1;TGFB1;RXRA;IL2RG,3,3,B1
137,KEGG_2021_Human,HIF-1 signaling pathway,4/109,0.0094172271912107,0.0142623223403119,0,0,5.116682863621639,23.87042353292704,SERPINE1;ERBB2;IGF1R;VEGFA,3,3,B1
138,KEGG_2021_Human,Endometrial cancer,3/58,0.0096124935060732,0.0144533175738798,0,0,7.295085995085995,33.88342478652476,CDH1;ERBB2;HRAS,3,3,B1
139,KEGG_2021_Human,Protein processing in endoplasmic reticulum,5/171,0.009691437557376,0.0144679317820828,0,0,4.060694834131045,18.827462395095694,HSP90AA1;CANX;TRAF2;CALR;HSP90B1,3,3,B1
140,KEGG_2021_Human,Viral myocarditis,3/60,0.0105447208022081,0.0156301180685212,0,0,7.038406827880512,32.0397424665505,ITGB2;HLA-B;ICAM1,3,3,B1
141,KEGG_2021_Human,Cholinergic synapse,4/113,0.0106511006296789,0.0156766199408655,0,0,4.927916120576671,22.38304861786273,ADCY9;HRAS;ADCY7;GNAI2,3,3,B1
142,KEGG_2021_Human,Glutamatergic synapse,4/114,0.010975088464695,0.0160405139099389,0,0,4.88286951144094,22.0321286271,ADCY9;GNAS;ADCY7;GNAI2,3,3,B1
143,KEGG_2021_Human,Shigellosis,6/246,0.011064212105271,0.0160584745139003,0,0,3.3808620689655173,15.227536350156718,TRADD;TRAF2;TLN1;VCL;CD44;TNFRSF1A,3,3,B1
144,KEGG_2021_Human,Cortisol synthesis and secretion,3/65,0.0130978397534146,0.0187496473182442,0,0,6.469158674803836,28.04579514067651,ADCY9;GNAS;ADCY7,3,3,B1
145,KEGG_2021_Human,Inflammatory bowel disease,3/65,0.0130978397534146,0.0187496473182442,0,0,6.469158674803836,28.04579514067651,TGFB1;TGFB3;IL2RG,3,3,B1
146,KEGG_2021_Human,p53 signaling pathway,3/73,0.0178560174248671,0.0253871268149471,0,0,5.727509652509653,23.055601646563527,SERPINE1;FAS;THBS1,3,3,B1
147,KEGG_2021_Human,Viral carcinogenesis,5/203,0.0190787912598233,0.0269423471169126,0,0,3.3988861214888613,13.456795041587378,PKM;TRADD;HLA-B;TRAF2;HRAS,3,3,B1
148,KEGG_2021_Human,Chronic myeloid leukemia,3/76,0.0198566778335914,0.0278526554847021,0,0,5.491299518696779,21.521582968903243,TGFB1;TGFB3;HRAS,3,3,B1
149,KEGG_2021_Human,Bacterial invasion of epithelial cells,3/77,0.0205499338297078,0.028443285896748,0,0,5.4168188458729,21.04378630651759,CDH1;FN1;VCL,3,3,B1
150,KEGG_2021_Human,Leishmaniasis,3/77,0.0205499338297078,0.028443285896748,0,0,5.4168188458729,21.04378630651759,TGFB1;TGFB3;ITGB2,3,3,B1
151,KEGG_2021_Human,Insulin secretion,3/86,0.0273832893130804,0.0376520228054856,0,0,4.827254965809183,17.367605712089812,ADCY9;GNAS;ADCY7,3,3,B1
152,KEGG_2021_Human,GABAergic synapse,3/89,0.0298982154288771,0.0408413531021916,0,0,4.658155248271528,16.34992222189889,ADCY9;ADCY7;GNAI2,3,3,B1
153,KEGG_2021_Human,Herpes simplex virus 1 infection,8/498,0.035529254194204,0.0482182735492769,0,0,2.210246895961182,7.376475470998217,TRADD;HLA-B;FAS;TRAF2;FASLG;CALR;FADD;TNFRSF1A,3,3,B1
154,KEGG_2021_Human,Phosphatidylinositol signaling system,3/97,0.0371790782140454,0.0499453731111616,0,0,4.259991374353077,14.023930325637837,CALM3;CALM1;CALM2,3,3,B1
155,KEGG_2021_Human,Wnt signaling pathway,4/166,0.037279800025556,0.0499453731111616,0,0,3.306794322667338,10.877050646262978,WNT7B;FZD6;LRP5;PSEN1,3,3,B1
0,KEGG_2021_Human,Human immunodeficiency virus 1 infection,13/212,2.3923396001219183e-14,3.755973172191412e-12,0,0,29.31384193695752,919.3969788229804,HLA-B;HLA-C;CXCR4;TRAF2;HLA-A;HLA-F;CD3D;TNFRSF1A;HLA-E;GNAI2;CD4;CALR;B2M,4,4,B1
1,KEGG_2021_Human,Cell adhesion molecules,11/148,3.44609685925343e-13,1.864215794467846e-11,0,0,34.57092986353538,992.059985919857,CD4;ITGA4;SDC4;CDH1;HLA-B;HLA-C;SDC1;HLA-A;HLA-F;PTPRF;HLA-E,4,4,B1
2,KEGG_2021_Human,Human papillomavirus infection,14/331,3.5621957856073494e-13,1.864215794467846e-11,0,0,20.15728853348984,577.7729784737633,LAMA5;ITGA4;ITGA3;LAMB2;ITGB4;HLA-B;HLA-C;HLA-A;HLA-F;TNFRSF1A;HLA-E;COL1A1;ITGA5;IFNAR1,4,4,B1
3,KEGG_2021_Human,Antigen processing and presentation,9/78,1.0028825825603605e-12,3.936314136549414e-11,0,0,54.005434782608695,1492.0698576716406,CD4;HLA-B;HLA-C;KLRD1;CALR;HLA-A;HLA-F;B2M;HLA-E,4,4,B1
4,KEGG_2021_Human,Human cytomegalovirus infection,12/225,1.386592218861983e-12,4.353899567226626e-11,0,0,24.70109546165884,674.4429595696848,CCL5;HLA-B;HLA-C;CXCR4;TRAF2;CALR;HLA-A;HLA-F;B2M;TNFRSF1A;HLA-E;GNAI2,4,4,B1
5,KEGG_2021_Human,ECM-receptor interaction,9/88,3.0747742062373867e-12,8.045659172987829e-11,0,0,47.14556962025316,1249.724842245456,COL1A1;LAMA5;ITGA4;SDC4;ITGA3;LAMB2;ITGB4;SDC1;ITGA5,4,4,B1
6,KEGG_2021_Human,Epstein-Barr virus infection,11/202,1.0436974058647796e-11,2.340864181725291e-10,0,0,24.72934213521512,625.2978959333121,CD19;HLA-B;HLA-C;TRAF2;CALR;HLA-A;HLA-F;CD3D;B2M;HLA-E;IFNAR1,4,4,B1
7,KEGG_2021_Human,Pathways in cancer,14/531,1.9685794094698726e-10,3.863337091084625e-09,0,0,12.233547748639287,273.401916023736,CSF1R;LAMA5;ITGA3;LAMB2;GSTP1;CXCR4;TRAF2;MMP9;HSP90B1;GNAI2;AR;CDH1;ERBB2;IFNAR1,4,4,B1
8,KEGG_2021_Human,PI3K-Akt signaling pathway,12/354,2.7162629357349225e-10,4.738369787893142e-09,0,0,15.283430799220271,336.64192384262225,COL1A1;CSF1R;LAMA5;ITGA4;ITGA3;LAMB2;ITGB4;CD19;ERBB2;ITGA5;HSP90B1;IFNAR1,4,4,B1
9,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,8/100,3.9665672491709613e-10,6.227510581198409e-09,0,0,35.22803904170364,762.614823617327,CSF1R;IL34;CCL5;CXCR4;CCR7;CCL19;CXCL14;TNFRSF1A,4,4,B1
10,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,10/219,5.559080735216686e-10,7.934324322082e-09,0,0,20.08958566629339,428.1174714256176,CD4;HLA-B;HLA-C;CALR;HLA-A;HLA-F;CD3D;B2M;TNFRSF1A;HLA-E,4,4,B1
11,KEGG_2021_Human,Herpes simplex virus 1 infection,13/498,1.0906554852428694e-09,1.4269409265260878e-08,0,0,11.853514526710404,244.61489794691835,HLA-B;HLA-C;TRAF2;HLA-A;HLA-F;TNFRSF1A;HLA-E;C3;CCL5;ITGA5;CALR;B2M;IFNAR1,4,4,B1
12,KEGG_2021_Human,Graft-versus-host disease,6/42,1.980395575125643e-09,2.3917085022671223e-08,0,0,65.05555555555556,1303.7113313642426,HLA-B;HLA-C;KLRD1;HLA-A;HLA-F;HLA-E,4,4,B1
13,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,9/193,3.631277418376069e-09,4.0722182477503056e-08,0,0,20.13485054347826,391.2942693848198,C3;HLA-B;HLA-C;TRAF2;HLA-A;HLA-F;TNFRSF1A;HLA-E;IFNAR1,4,4,B1
14,KEGG_2021_Human,Cytokine-cytokine receptor interaction,10/295,9.80150039391807e-09,1.0258903745634249e-07,0,0,14.675625233296008,270.6292478146425,CSF1R;CD4;IL34;CCL5;CXCR4;CCR7;CCL19;CXCL14;TNFRSF1A;IFNAR1,4,4,B1
15,KEGG_2021_Human,Phagosome,8/152,1.1149319207590896e-08,1.094026947244857e-07,0,0,22.447845804988663,411.0624247202816,C3;HLA-B;HLA-C;ITGA5;CALR;HLA-A;HLA-F;HLA-E,4,4,B1
16,KEGG_2021_Human,Hematopoietic cell lineage,7/99,1.2679113340543214e-08,1.1709534085089909e-07,0,0,30.20804347826087,549.2822135066664,CSF1R;CD4;ITGA4;ITGA3;CD19;ITGA5;CD3D,4,4,B1
17,KEGG_2021_Human,Allograft rejection,5/38,7.339655858626458e-08,6.401810943357522e-07,0,0,58.01282051282051,952.9991572624742,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,4,4,B1
18,KEGG_2021_Human,Focal adhesion,8/201,9.809017647099136e-08,8.105346161024024e-07,0,0,16.707201015121075,269.61042834951246,COL1A1;LAMA5;ITGA4;ITGA3;LAMB2;ITGB4;ERBB2;ITGA5,4,4,B1
19,KEGG_2021_Human,Type I diabetes mellitus,5/43,1.3923982753215965e-07,1.0930326461274533e-06,0,0,50.366902834008094,795.1457206265724,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,4,4,B1
20,KEGG_2021_Human,Autoimmune thyroid disease,5/53,4.062049058653992e-07,3.0368652486127464e-06,0,0,39.85376602564103,586.5042855701355,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,4,4,B1
21,KEGG_2021_Human,Chagas disease,6/102,4.458392069700592e-07,3.181670704286332e-06,0,0,24.32230392156863,355.6725286827171,C3;CCL5;CALR;CD3D;TNFRSF1A;GNAI2,4,4,B1
22,KEGG_2021_Human,Viral myocarditis,5/60,7.614453088321698e-07,5.1976918907239415e-06,0,0,34.76923076923077,489.8305741808636,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,4,4,B1
23,KEGG_2021_Human,Viral carcinogenesis,7/203,1.721381246007569e-06,1.1260702317632848e-05,0,0,14.105,187.20696982333072,C3;HLA-B;HLA-C;TRAF2;HLA-A;HLA-F;HLA-E,4,4,B1
24,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,6/131,1.942067214370145e-06,1.2196182106244512e-05,0,0,18.65223529411765,245.30967687218757,HLA-B;HLA-C;KLRD1;HLA-A;HLA-E;IFNAR1,4,4,B1
25,KEGG_2021_Human,Fluid shear stress and atherosclerosis,6/139,2.742005720134401e-06,1.655749607927311e-05,0,0,17.523219814241486,224.41673758950932,SDC4;GSTP1;SDC1;MMP9;TNFRSF1A;HSP90B1,4,4,B1
26,KEGG_2021_Human,Prostate cancer,5/97,8.293245768679125e-06,4.8223688358615655e-05,0,0,20.74728260869565,242.74464093193143,AR;GSTP1;ERBB2;MMP9;HSP90B1,4,4,B1
27,KEGG_2021_Human,Chemokine signaling pathway,6/192,1.748585020033805e-05,9.804566005189548e-05,0,0,12.49652118912081,136.8883747441226,CCL5;CXCR4;CCR7;CCL19;CXCL14;GNAI2,4,4,B1
28,KEGG_2021_Human,Sphingolipid signaling pathway,5/119,2.2409816194422888e-05,0.00012132210836291012,0,0,16.724865047233468,179.0565970655011,ADORA1;TRAF2;S1PR4;TNFRSF1A;GNAI2,4,4,B1
29,KEGG_2021_Human,Proteoglycans in cancer,6/205,2.5307516350563588e-05,0.00013244266890128278,0,0,11.6724800472953,123.54630423523749,COL1A1;SDC4;ERBB2;SDC1;ITGA5;MMP9,4,4,B1
30,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,4/77,6.870947146661275e-05,0.000347980226459942,0,0,20.542775911088132,196.9153155528977,ITGA4;ITGA3;ITGB4;ITGA5,4,4,B1
31,KEGG_2021_Human,Endocytosis,6/252,7.989699054923414e-05,0.000388873458247118,0,0,9.419894787183166,88.87456307694941,HLA-B;HLA-C;CXCR4;HLA-A;HLA-F;HLA-E,4,4,B1
32,KEGG_2021_Human,Cellular senescence,5/156,8.173773326213307e-05,0.000388873458247118,0,0,12.603158430973,118.62086175812276,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,4,4,B1
33,KEGG_2021_Human,Hypertrophic cardiomyopathy,4/90,0.0001262171296346121,0.0005828261574304147,0,0,17.426064063185606,156.44261007150965,ITGA4;ITGA3;ITGB4;ITGA5,4,4,B1
34,KEGG_2021_Human,Small cell lung cancer,4/92,0.00013743901716261857,0.000616512162700889,0,0,17.028301886792452,151.4212839873825,LAMA5;ITGA3;LAMB2;TRAF2,4,4,B1
35,KEGG_2021_Human,Dilated cardiomyopathy,4/96,0.00016202550494050927,0.0007066112298794432,0,0,16.284659557013946,142.1285481391349,ITGA4;ITGA3;ITGB4;ITGA5,4,4,B1
36,KEGG_2021_Human,Primary immunodeficiency,3/38,0.00017248657101679831,0.0007319024770172252,0,0,31.6,273.8200410889594,CD4;CD19;CD3D,4,4,B1
37,KEGG_2021_Human,Bladder cancer,3/41,0.00021664292641719905,0.0008950773538815855,0,0,29.100877192982452,245.53166885504453,CDH1;ERBB2;MMP9,4,4,B1
38,KEGG_2021_Human,TNF signaling pathway,4/112,0.00029286203425116594,0.0011494834844358,0,0,13.86093640810622,112.76993024473433,CCL5;TRAF2;MMP9;TNFRSF1A,4,4,B1
39,KEGG_2021_Human,Toxoplasmosis,4/112,0.00029286203425116594,0.0011494834844358,0,0,13.86093640810622,112.76993024473433,LAMA5;LAMB2;TNFRSF1A;GNAI2,4,4,B1
40,KEGG_2021_Human,Leukocyte transendothelial migration,4/114,0.00031332400896440395,0.0011998016928636,0,0,13.60754716981132,109.78940175830172,ITGA4;CXCR4;MMP9;GNAI2,4,4,B1
41,KEGG_2021_Human,Lipid and atherosclerosis,5/215,0.0003642518624178151,0.0013616081523713,0,0,9.03525641025641,71.53813344443999,CCL5;TRAF2;MMP9;TNFRSF1A;HSP90B1,4,4,B1
42,KEGG_2021_Human,Regulation of actin cytoskeleton,5/218,0.00038811574180807137,0.0014170737549736,0,0,8.906644998194293,69.95463312790258,ITGA4;ITGA3;ITGB4;CXCR4;ITGA5,4,4,B1
43,KEGG_2021_Human,Osteoclast differentiation,4/127,0.0004721306350136534,0.0016846479476623,0,0,12.161374443933118,93.13490471546332,CSF1R;TRAF2;TNFRSF1A;IFNAR1,4,4,B1
44,KEGG_2021_Human,Yersinia infection,4/137,0.0006281970139287871,0.0021917095819293,0,0,11.241310824230387,82.87832583762037,CD4;ITGA4;TRAF2;ITGA5,4,4,B1
45,KEGG_2021_Human,Shigellosis,5/246,0.0006720663937624979,0.0022937918221893,0,0,7.860676667730609,57.42344905913458,C3;CCL5;TRAF2;ITGA5;TNFRSF1A,4,4,B1
46,KEGG_2021_Human,Adherens junction,3/71,0.0010933717221235,0.0036523268164552,0,0,16.237745098039216,110.71688689066416,CDH1;ERBB2;PTPRF,4,4,B1
47,KEGG_2021_Human,Pertussis,3/76,0.0013313658795046,0.0043546758975464,0,0,15.121765601217655,100.12952530280404,C3;ITGA5;GNAI2,4,4,B1
48,KEGG_2021_Human,Axon guidance,4/182,0.0017993787912729,0.0057653565353031,0,0,8.380326478694085,52.96629300468801,PLXNB2;CXCR4;SEMA4G;GNAI2,4,4,B1
49,KEGG_2021_Human,IL-17 signaling pathway,3/94,0.0024483316682373,0.0076877614382654,0,0,12.11965811965812,72.86760756625405,TRAF2;MMP9;HSP90B1,4,4,B1
50,KEGG_2021_Human,Rap1 signaling pathway,4/210,0.0030206092458905,0.009298738266761,0,0,7.230994687671735,41.95637683737292,CSF1R;CDH1;FPR1;GNAI2,4,4,B1
51,KEGG_2021_Human,Amoebiasis,3/102,0.0030861435444888,0.0093177795477835,0,0,11.135802469135802,64.37421452181565,COL1A1;LAMA5;LAMB2,4,4,B1
52,KEGG_2021_Human,Protein digestion and absorption,3/103,0.0031723538439294,0.0093973500659797,0,0,11.023888888888887,63.42353522113061,COL1A1;COL18A1;SLC1A5,4,4,B1
53,KEGG_2021_Human,NF-kappa B signaling pathway,3/104,0.0032600326825281,0.0094782431695726,0,0,10.914191419141916,62.49485715816841,TRAF2;CCL19;TNFRSF1A,4,4,B1
54,KEGG_2021_Human,Chemical carcinogenesis,4/239,0.0047853178756763,0.0136599073905669,0,0,6.329345644319551,33.8126481788613,AR;GSTP1;HSP90B1;GNAI2,4,4,B1
55,KEGG_2021_Human,Relaxin signaling pathway,3/129,0.0059510482754035,0.0166841889149705,0,0,8.737654320987655,44.773382495331255,COL1A1;MMP9;GNAI2,4,4,B1
56,KEGG_2021_Human,Estrogen signaling pathway,3/137,0.0070247674488225,0.0193489208678093,0,0,8.212686567164178,40.7210719480047,MMP9;HSP90B1;GNAI2,4,4,B1
57,KEGG_2021_Human,Measles,3/139,0.0073099811164653,0.0197873626773286,0,0,8.09109477124183,39.79616766905161,RACK1;CD3D;IFNAR1,4,4,B1
58,KEGG_2021_Human,Intestinal immune network for IgA production,2/48,0.0082761018636345,0.0220228473320444,0,0,15.728853754940712,75.41015236871628,ITGA4;CXCR4,4,4,B1
59,KEGG_2021_Human,MAPK signaling pathway,4/294,0.0098127361131834,0.0256766594961633,0,0,5.114638906961614,23.65046947275912,CSF1R;ERBB2;TRAF2;TNFRSF1A,4,4,B1
60,KEGG_2021_Human,Hepatitis C,3/157,0.0101869121539278,0.0262187739043717,0,0,7.138888888888889,32.743595464550545,TRAF2;TNFRSF1A;IFNAR1,4,4,B1
61,KEGG_2021_Human,Necroptosis,3/159,0.0105416198947698,0.0266941019915947,0,0,7.046652421652421,32.07935000897507,TRAF2;TNFRSF1A;IFNAR1,4,4,B1
62,KEGG_2021_Human,Regulation of lipolysis in adipocytes,2/55,0.0107576625735069,0.0268087781593745,0,0,13.646655231560892,61.84851083908173,ADORA1;GNAI2,4,4,B1
63,KEGG_2021_Human,Endometrial cancer,2/58,0.0119096416355857,0.0292158396372963,0,0,12.913636363636364,57.21266475287484,CDH1;ERBB2,4,4,B1
64,KEGG_2021_Human,Protein processing in endoplasmic reticulum,3/171,0.0128201920589798,0.0309656946655359,0,0,6.539351851851852,28.490215546495563,TRAF2;CALR;HSP90B1,4,4,B1
65,KEGG_2021_Human,Influenza A,3/172,0.0130217996092933,0.0309760990705918,0,0,6.500328731097962,28.2187748785102,CCL5;TNFRSF1A;IFNAR1,4,4,B1
66,KEGG_2021_Human,NOD-like receptor signaling pathway,3/181,0.0149182747914348,0.0349577483918697,0,0,6.168851435705368,25.941058637425662,CCL5;TRAF2;IFNAR1,4,4,B1
67,KEGG_2021_Human,Neuroactive ligand-receptor interaction,4/341,0.0161466824916581,0.0371615339720497,0,0,4.390795588152959,18.116601165492742,C3;FPR1;ADORA1;S1PR4,4,4,B1
68,KEGG_2021_Human,Adipocytokine signaling pathway,2/69,0.0165688368028247,0.0371615339720497,0,0,10.787516960651288,44.23131845610424,TRAF2;TNFRSF1A,4,4,B1
69,KEGG_2021_Human,Renin secretion,2/69,0.0165688368028247,0.0371615339720497,0,0,10.787516960651288,44.23131845610424,ADORA1;GNAI2,4,4,B1
70,KEGG_2021_Human,Central carbon metabolism in cancer,2/70,0.0170252954843732,0.0376474843809379,0,0,10.628342245989304,43.2898232833362,ERBB2;SLC1A5,4,4,B1
71,KEGG_2021_Human,Bacterial invasion of epithelial cells,2/77,0.0203681165677928,0.043805401385527,0,0,9.632969696969695,37.50870823084154,CDH1;ITGA5,4,4,B1
72,KEGG_2021_Human,Leishmaniasis,2/77,0.0203681165677928,0.043805401385527,0,0,9.632969696969695,37.50870823084154,C3;ITGA4,4,4,B1
0,KEGG_2021_Human,Cell adhesion molecules,12/148,1.5654139511127546e-16,2.1759253920467292e-14,0,0,58.3,2121.7242125743264,PTPRC;ITGB2;HLA-B;PECAM1;HLA-C;SDC1;ITGB8;HLA-A;HLA-F;ITGAL;HLA-E;ICAM1,1,1,C1
1,KEGG_2021_Human,Epstein-Barr virus infection,12/202,6.874873520061697e-15,4.2749141457568054e-13,0,0,41.61684210526316,1357.1628072456988,HLA-B;HLA-C;HLA-A;CALR;CD247;HLA-F;ITGAL;CD3D;B2M;HLA-E;TLR2;ICAM1,1,1,C1
2,KEGG_2021_Human,Phagosome,11/152,1.1835854431772542e-14,4.2749141457568054e-13,0,0,49.87119652253489,1599.2517240336006,C3;ITGB2;HLA-B;HLA-C;HLA-A;CALR;CD14;CD36;HLA-F;HLA-E;TLR2,1,1,C1
3,KEGG_2021_Human,Human immunodeficiency virus 1 infection,12/212,1.2301911210810948e-14,4.2749141457568054e-13,0,0,39.516,1265.65882393179,HLA-B;HLA-C;HLA-A;CALR;CD247;HLA-F;CCR5;CD3D;B2M;HLA-E;TLR2;GNAI2,1,1,C1
4,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,12/219,1.817653314377241e-14,5.053076213968729e-13,0,0,38.16618357487923,1207.5263339131586,MMP7;ITGB2;HLA-B;HLA-C;HLA-A;CALR;HLA-F;ITGAL;CD3D;B2M;HLA-E;ICAM1,1,1,C1
5,KEGG_2021_Human,Viral myocarditis,8/60,4.4007964032834733e-13,1.019517833427338e-11,0,0,90.07239819004523,2562.723721847758,ITGB2;HLA-B;HLA-C;HLA-A;HLA-F;ITGAL;HLA-E;ICAM1,1,1,C1
6,KEGG_2021_Human,Antigen processing and presentation,8/78,3.924551633066906e-12,7.793038242804284e-11,0,0,66.85042016806723,1755.7439931701376,HLA-B;HLA-C;KLRD1;HLA-A;CALR;HLA-F;B2M;HLA-E,1,1,C1
7,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,9/131,6.2389008878027426e-12,1.0840090292557266e-10,0,0,44.34277198211625,1144.053143459391,ITGB2;HLA-B;HLA-C;KLRD1;HLA-A;CD247;ITGAL;HLA-E;ICAM1,1,1,C1
8,KEGG_2021_Human,Malaria,7/50,9.940683639001056e-12,1.47299875228372e-10,0,0,92.6279069767442,2346.671086832658,ITGB2;PECAM1;SDC1;CD36;ITGAL;TLR2;ICAM1,1,1,C1
9,KEGG_2021_Human,ECM-receptor interaction,8/88,1.0597113325782158e-11,1.47299875228372e-10,0,0,58.46470588235294,1477.4288116958217,COL1A1;COL1A2;COL6A2;ITGA1;FN1;SDC1;ITGB8;CD36,1,1,C1
10,KEGG_2021_Human,Human cytomegalovirus infection,10/225,2.8545826491524577e-11,3.6071544384744696e-10,0,0,28.69622093023256,696.7301937399226,CCL5;HLA-B;HLA-C;HLA-A;CALR;HLA-F;CCR5;B2M;HLA-E;GNAI2,1,1,C1
11,KEGG_2021_Human,Human papillomavirus infection,11/331,5.855535302105025e-11,6.782661724938321e-10,0,0,21.77600806451613,513.0655843998607,COL1A1;COL1A2;COL6A2;ITGA1;FN1;HLA-B;HLA-C;ITGB8;HLA-A;HLA-F;HLA-E,1,1,C1
12,KEGG_2021_Human,Graft-versus-host disease,6/42,2.9298571531629e-10,3.132693417612639e-09,0,0,92.23148148148148,2024.563774256265,HLA-B;HLA-C;KLRD1;HLA-A;HLA-F;HLA-E,1,1,C1
13,KEGG_2021_Human,Chagas disease,7/102,1.6970539308872579e-09,1.684932117095206e-08,0,0,41.81684210526316,844.4648683106772,C3;CCL5;CALR;CD247;CD3D;TLR2;GNAI2,1,1,C1
14,KEGG_2021_Human,Leukocyte transendothelial migration,7/114,3.7122615824303404e-09,3.440029066385449e-08,0,0,37.10467289719626,720.26197952019,MMP2;ITGB2;PECAM1;ITGAL;MMP9;GNAI2;ICAM1,1,1,C1
15,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,8/193,5.795179095317467e-09,5.0345618390570495e-08,0,0,25.14848966613673,476.9722769517862,C3;HLA-B;HLA-C;HLA-A;HLA-F;CCR5;HLA-E;ICAM1,1,1,C1
16,KEGG_2021_Human,Proteoglycans in cancer,8/205,9.300446033331773e-09,7.604482344900684e-08,0,0,23.60226933412959,436.4815693236062,COL1A1;COL1A2;MMP2;ERBB2;FN1;SDC1;MMP9;TLR2,1,1,C1
17,KEGG_2021_Human,Allograft rejection,5/38,1.522220965062119e-08,1.1754928563535254e-07,0,0,81.5929565929566,1468.7148567279053,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,1,1,C1
18,KEGG_2021_Human,Type I diabetes mellitus,5/43,2.8968290670549333e-08,2.1192591595822934e-07,0,0,70.83926031294452,1229.5615771136167,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,1,1,C1
19,KEGG_2021_Human,Herpes simplex virus 1 infection,10/498,6.025517356823206e-08,4.187734562992129e-07,0,0,12.46798155737705,207.27617121941748,C3;CCL5;HLA-B;HLA-C;HLA-A;CALR;HLA-F;B2M;HLA-E;TLR2,1,1,C1
20,KEGG_2021_Human,Amoebiasis,6/102,6.855282015562502e-08,4.537543810300893e-07,0,0,34.482638888888886,568.8139315536824,COL1A1;COL1A2;ITGB2;FN1;CD14;TLR2,1,1,C1
21,KEGG_2021_Human,Autoimmune thyroid disease,5/53,8.503893985777178e-08,5.372914836468307e-07,0,0,56.052927927927925,912.550442839142,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,1,1,C1
22,KEGG_2021_Human,Focal adhesion,7/201,1.867715463962721e-07,1.1287497803948618e-06,0,0,20.37525773195876,315.6816033850298,COL1A1;COL1A2;COL6A2;ITGA1;ERBB2;FN1;ITGB8,1,1,C1
23,KEGG_2021_Human,Viral carcinogenesis,7/203,1.9977050093864227e-07,1.1570041512696362e-06,0,0,20.16530612244898,311.0719607091727,C3;HLA-B;HLA-C;HLA-A;HLA-F;CCR5;HLA-E,1,1,C1
24,KEGG_2021_Human,PI3K-Akt signaling pathway,8/354,6.214651954172854e-07,3.4553464865201067e-06,0,0,13.336960217613056,190.60097819093403,COL1A1;COL1A2;COL6A2;ITGA1;ERBB2;FN1;ITGB8;TLR2,1,1,C1
25,KEGG_2021_Human,Rheumatoid arthritis,5/93,1.4479680162737348e-06,7.741059779309582e-06,0,0,30.512899262899264,410.2565903458998,CCL5;ITGB2;ITGAL;TLR2;ICAM1,1,1,C1
26,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,5/100,2.075056133137789e-06,1.0682696389116766e-05,0,0,28.25462304409673,369.7265014059194,COL1A1;COL1A2;MMP2;FN1;ICAM1,1,1,C1
27,KEGG_2021_Human,Lipid and atherosclerosis,6/215,5.46571978121552e-06,2.713339462817705e-05,0,0,15.748803827751196,190.8284880797743,CCL5;CD14;CD36;MMP9;TLR2;ICAM1,1,1,C1
28,KEGG_2021_Human,Regulation of actin cytoskeleton,6/218,5.917843943732666e-06,2.835562502099391e-05,0,0,15.523584905660377,186.86574900546483,ITGA1;ITGB2;FN1;ITGAX;ITGB8;ITGAL,1,1,C1
29,KEGG_2021_Human,Legionellosis,4/57,6.119919069279261e-06,2.835562502099391e-05,0,0,39.53326713008938,474.5558239322869,C3;ITGB2;CD14;TLR2,1,1,C1
30,KEGG_2021_Human,Relaxin signaling pathway,5/129,7.254116428023449e-06,3.252652204823417e-05,0,0,21.615082824760243,255.7916249536488,COL1A1;COL1A2;MMP2;MMP9;GNAI2,1,1,C1
31,KEGG_2021_Human,Fluid shear stress and atherosclerosis,5/139,1.0434926904951404e-05,4.532671374338267e-05,0,0,19.9919322307382,229.31450029165015,MMP2;PECAM1;SDC1;MMP9;ICAM1,1,1,C1
32,KEGG_2021_Human,Endocytosis,6/252,1.3522883882102645e-05,5.696002604885659e-05,0,0,13.3550135501355,149.72475573782503,HLA-B;HLA-C;HLA-A;HLA-F;CCR5;HLA-E,1,1,C1
33,KEGG_2021_Human,Cellular senescence,5/156,1.8244311217847195e-05,7.458703703766941e-05,0,0,17.7259710041167,193.4197198540773,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,1,1,C1
34,KEGG_2021_Human,Pertussis,4/76,1.931187145270856e-05,7.669571805504256e-05,0,0,29.07309941520468,315.58240479061874,C3;ITGB2;CD14;GNAI2,1,1,C1
35,KEGG_2021_Human,Tuberculosis,5/180,3.627205657101047e-05,0.00014005044064917932,0,0,15.276447876447875,156.1934746262965,C3;ITGB2;ITGAX;CD14;TLR2,1,1,C1
36,KEGG_2021_Human,Staphylococcus aureus infection,4/95,4.655752051743995e-05,0.00017490527978173385,0,0,22.980913823019087,229.2305249991365,C3;ITGB2;ITGAL;ICAM1,1,1,C1
37,KEGG_2021_Human,Hematopoietic cell lineage,4/99,5.471861850606781e-05,0.00020015494664061648,0,0,22.00886426592798,215.9797314532316,ITGA1;CD14;CD36;CD3D,1,1,C1
38,KEGG_2021_Human,Diabetic cardiomyopathy,5/203,6.427817595807034e-05,0.0002290940117479943,0,0,13.486213486213488,130.17284888448603,COL1A1;COL1A2;MMP2;CD36;MMP9,1,1,C1
39,KEGG_2021_Human,Primary immunodeficiency,3/38,6.901721319653771e-05,0.00023983481585796853,0,0,43.786813186813184,419.5282273663024,CD79A;PTPRC;CD3D,1,1,C1
40,KEGG_2021_Human,Bladder cancer,3/41,8.683120085209544e-05,0.0002943789492302748,0,0,40.32388663967611,377.0906221007877,MMP2;ERBB2;MMP9,1,1,C1
41,KEGG_2021_Human,Leishmaniasis,3/77,0.0005653645324446717,0.0018710873811859,0,0,20.66943866943867,154.56688593756198,C3;ITGB2;TLR2,1,1,C1
42,KEGG_2021_Human,Neutrophil extracellular trap formation,4/189,0.0006530472872176161,0.0021110133237964,0,0,11.250640113798008,82.51063093527793,C3;ITGB2;ITGAL;TLR2,1,1,C1
43,KEGG_2021_Human,Chemokine signaling pathway,4/192,0.0006927035757170843,0.0021883135687426,0,0,11.06942889137738,80.52908112490005,CCL5;CXCR3;CCR5;GNAI2,1,1,C1
44,KEGG_2021_Human,Complement and coagulation cascades,3/85,0.0007545323809738631,0.002330666687897,0,0,18.645403377110693,134.04949356274375,C3;ITGB2;ITGAX,1,1,C1
45,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,3/89,0.0008625091398184474,0.002606277618147,0,0,17.77459749552773,125.411602100639,CD247;CD3D;TLR2,1,1,C1
46,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,3/100,0.0012085906045389,0.0035743424261896,0,0,15.750198255352895,105.81456304852416,CCL5;CXCR3;CCR5,1,1,C1
47,KEGG_2021_Human,Protein digestion and absorption,3/103,0.001316076151094,0.0037618888513925,0,0,15.275384615384615,101.32316258533392,COL1A1;COL1A2;COL6A2,1,1,C1
48,KEGG_2021_Human,T cell receptor signaling pathway,3/104,0.0013531974285584,0.0037618888513925,0,0,15.123381568926124,99.8942457490359,PTPRC;CD247;CD3D,1,1,C1
49,KEGG_2021_Human,Toll-like receptor signaling pathway,3/104,0.0013531974285584,0.0037618888513925,0,0,15.123381568926124,99.8942457490359,CCL5;CD14;TLR2,1,1,C1
50,KEGG_2021_Human,TNF signaling pathway,3/112,0.0016740597162256,0.0044748903952955,0,0,14.007762879322511,89.54467512114829,CCL5;MMP9;ICAM1,1,1,C1
51,KEGG_2021_Human,Toxoplasmosis,3/112,0.0016740597162256,0.0044748903952955,0,0,14.007762879322511,89.54467512114829,CCR5;TLR2;GNAI2,1,1,C1
52,KEGG_2021_Human,Platelet activation,3/124,0.0022384574231419,0.0058706713550327,0,0,12.61093452002543,76.9515226837369,COL1A1;COL1A2;GNAI2,1,1,C1
53,KEGG_2021_Human,Estrogen signaling pathway,3/137,0.0029693104605084,0.0076432250742717,0,0,11.380022962112514,66.22519605871695,MMP2;MMP9;GNAI2,1,1,C1
54,KEGG_2021_Human,Pathways in cancer,5/531,0.0048979631759571,0.0123784887537824,0,0,4.992292672901038,26.553684414972373,MMP2;ERBB2;FN1;MMP9;GNAI2,1,1,C1
55,KEGG_2021_Human,Rap1 signaling pathway,3/210,0.0096956031172184,0.0240658720230956,0,0,7.339650687476775,34.02722818634839,ITGB2;ITGAL;GNAI2,1,1,C1
56,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,2/77,0.0114028352733629,0.0278069140876745,0,0,13.255333333333333,59.30294627765024,ITGA1;ITGB8,1,1,C1
57,KEGG_2021_Human,Shigellosis,3/246,0.0148277973694112,0.0355355833508305,0,0,6.240899018676797,26.281996347237115,C3;CCL5;CD14,1,1,C1
58,KEGG_2021_Human,Salmonella infection,3/249,0.0153128541334361,0.0355428565538842,0,0,6.163852407754847,25.759125462810783,PTPRC;CD14;TLR2,1,1,C1
59,KEGG_2021_Human,Hypertrophic cardiomyopathy,2/90,0.0153422402390867,0.0355428565538842,0,0,11.289772727272728,47.15902283177912,ITGA1;ITGB8,1,1,C1
60,KEGG_2021_Human,Th1 and Th2 cell differentiation,2/92,0.0159933759805166,0.0364439223162592,0,0,11.037777777777778,45.64762012704363,CD247;CD3D,1,1,C1
61,KEGG_2021_Human,Dilated cardiomyopathy,2/96,0.0173306971443836,0.0388543048882148,0,0,10.565957446808511,42.8478731064877,ITGA1;ITGB8,1,1,C1
62,KEGG_2021_Human,Prostate cancer,2/97,0.0176722531744932,0.0389911617659454,0,0,10.454210526315787,42.19067930712156,ERBB2;MMP9,1,1,C1
63,KEGG_2021_Human,NF-kappa B signaling pathway,2/104,0.0201426246241397,0.0437472628555534,0,0,9.733333333333333,38.00785959042778,CD14;ICAM1,1,1,C1
64,KEGG_2021_Human,Th17 cell differentiation,2/107,0.0212432299314208,0.0454278301610384,0,0,9.453809523809523,36.41339910186105,CD247;CD3D,1,1,C1
0,KEGG_2021_Human,Pathways in cancer,21/531,7.854422827752151e-20,1.2252899611293353e-17,0,0,25.01084558823529,1100.2427309356794,NOTCH2;HSP90AA1;TGFB3;ITGA3;ITGA2;FN1;PDGFB;TGFBR1;EGFR;LRP6;HSP90B1;GNAI2;AR;CDH1;ERBB2;ITGA6;CALM3;ITGAV;CALM1;FGFR4;CALM2,2,2,C1
1,KEGG_2021_Human,PI3K-Akt signaling pathway,17/354,2.0276957974389966e-17,1.5816027220024173e-15,0,0,27.478569073524564,1056.19503744367,HSP90AA1;ITGA3;ITGA2;INSR;FN1;TNC;PDGFB;EGFR;HSP90B1;COL1A1;COL1A2;ERBB3;ERBB2;ITGA6;ITGAV;ITGB6;FGFR4,2,2,C1
2,KEGG_2021_Human,ECM-receptor interaction,11/88,4.1070526438060775e-16,2.1356673747791604e-14,0,0,67.58503401360544,2394.4469096610287,COL1A1;COL1A2;SDC4;ITGA3;ITGA2;FN1;TNC;SDC1;ITGA6;ITGAV;ITGB6,2,2,C1
3,KEGG_2021_Human,Focal adhesion,12/201,1.418794725591988e-13,5.533299429808753e-12,0,0,30.59698025551684,905.174898053024,COL1A1;COL1A2;ITGA3;ITGA2;ERBB2;FN1;TNC;PDGFB;ITGA6;ITGAV;ITGB6;EGFR,2,2,C1
4,KEGG_2021_Human,Fluid shear stress and atherosclerosis,9/139,9.95683092925664e-11,3.106531249928072e-09,0,0,31.180594405594405,718.0946137934785,HSP90AA1;SDC4;PDGFB;SDC1;CALM3;ITGAV;CALM1;CALM2;HSP90B1,2,2,C1
5,KEGG_2021_Human,Proteoglycans in cancer,10/205,1.3647107628862802e-10,3.548247983504328e-09,0,0,23.556350626118068,535.0803471599609,COL1A1;COL1A2;SDC4;ERBB3;ITGA2;ERBB2;FN1;SDC1;ITGAV;EGFR,2,2,C1
6,KEGG_2021_Human,Regulation of actin cytoskeleton,10/218,2.49354871532982e-10,5.557051422735027e-09,0,0,22.06954382826476,488.0049321865691,ITGA3;ITGA2;FN1;PDGFB;ITGA6;ITGAV;ITGAE;ITGB6;FGFR4;EGFR,2,2,C1
7,KEGG_2021_Human,Human papillomavirus infection,11/331,8.865756634223875e-10,1.7288225436736555e-08,0,0,16.06376488095238,334.8275674501631,COL1A1;NOTCH2;COL1A2;ITGA3;ITGA2;FN1;TNC;ITGA6;ITGAV;ITGB6;EGFR,2,2,C1
8,KEGG_2021_Human,Rap1 signaling pathway,9/210,3.881237474904385e-09,6.727478289834267e-08,0,0,20.09430122116689,389.1685782395588,CDH1;INSR;PDGFB;CALM3;CALM1;FGFR4;CALM2;EGFR;GNAI2,2,2,C1
9,KEGG_2021_Human,Calcium signaling pathway,9/240,1.2430358890144477e-08,1.939135986862538e-07,0,0,17.458087367178276,317.7917301765735,RYR1;ERBB3;ERBB2;PDGFB;CALM3;CALM1;FGFR4;CALM2;EGFR,2,2,C1
10,KEGG_2021_Human,Adherens junction,6/71,3.2464033009313696e-08,4.603990135866305e-07,0,0,39.0481178396072,673.3118907553765,CDH1;INSR;ERBB2;TGFBR1;PTPRF;EGFR,2,2,C1
11,KEGG_2021_Human,Apelin signaling pathway,7/137,7.188604109053185e-08,8.62632493086382e-07,0,0,23.19715719063545,381.5511035885799,RYR1;CDH1;CALM3;CALM1;CALM2;TGFBR1;GNAI2,2,2,C1
12,KEGG_2021_Human,Estrogen signaling pathway,7/137,7.188604109053185e-08,8.62632493086382e-07,0,0,23.19715719063545,381.5511035885799,HSP90AA1;CALM3;CALM1;CALM2;EGFR;HSP90B1;GNAI2,2,2,C1
13,KEGG_2021_Human,Hypertrophic cardiomyopathy,6/90,1.3582725708739304e-07,1.513503721830951e-06,0,0,30.18693009118541,477.3121743414264,TGFB3;ITGA3;ITGA2;ITGA6;ITGAV;ITGB6,2,2,C1
14,KEGG_2021_Human,Dilated cardiomyopathy,6/96,1.99809655019583e-07,2.072410685445842e-06,0,0,28.16595744680851,434.48526124373166,TGFB3;ITGA3;ITGA2;ITGA6;ITGAV;ITGB6,2,2,C1
15,KEGG_2021_Human,Prostate cancer,6/97,2.1255494209700945e-07,2.072410685445842e-06,0,0,27.855038578442837,427.96663251548847,AR;HSP90AA1;ERBB2;PDGFB;EGFR;HSP90B1,2,2,C1
16,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,6/100,2.548631234370334e-07,2.3387439562457183e-06,0,0,26.961973743775463,409.35122345586257,COL1A1;COL3A1;COL1A2;TGFB3;FN1;TGFBR1,2,2,C1
17,KEGG_2021_Human,MAPK signaling pathway,8/294,9.897890601957042e-07,8.578171855029436e-06,0,0,12.22128982128982,168.96879089914225,ERBB3;TGFB3;INSR;ERBB2;PDGFB;FGFR4;TGFBR1;EGFR,2,2,C1
18,KEGG_2021_Human,Relaxin signaling pathway,6/129,1.1470704667933942e-06,9.41805225367208e-06,0,0,20.574987026466008,281.4308303528383,COL1A1;COL3A1;COL1A2;TGFBR1;EGFR;GNAI2,2,2,C1
19,KEGG_2021_Human,Glioma,5/75,1.6151950718255592e-06,1.2598521560239362e-05,0,0,29.578869047619047,394.4654191644695,PDGFB;CALM3;CALM1;CALM2;EGFR,2,2,C1
20,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,5/77,1.841627196348052e-06,1.3680659172871246e-05,0,0,28.75434027777778,379.6970674149244,ITGA3;ITGA2;ITGA6;ITGAV;ITGB6,2,2,C1
21,KEGG_2021_Human,Human cytomegalovirus infection,7/225,2.0627719935544664e-06,1.4626928681568036e-05,0,0,13.771739130434783,180.29216991513184,CALM3;ITGAV;CALR;CALM1;CALM2;EGFR;GNAI2,2,2,C1
22,KEGG_2021_Human,Ras signaling pathway,7/232,2.5275300269846726e-06,1.658834194596496e-05,0,0,13.33855072463768,171.9108165508856,INSR;PDGFB;CALM3;CALM1;FGFR4;CALM2;EGFR,2,2,C1
23,KEGG_2021_Human,Cell adhesion molecules,6/148,2.55648886944006e-06,1.658834194596496e-05,0,0,17.80491459394666,229.2716734332288,SDC4;CDH1;SDC1;ITGA6;ITGAV;PTPRF,2,2,C1
24,KEGG_2021_Human,Gastric cancer,6/149,2.658388132366179e-06,1.658834194596496e-05,0,0,17.67951197738432,226.9658723950605,TGFB3;CDH1;ERBB2;TGFBR1;EGFR;LRP6,2,2,C1
25,KEGG_2021_Human,Oxytocin signaling pathway,6/154,3.218853318905027e-06,1.931311991343016e-05,0,0,17.07791834387579,215.97564455371744,RYR1;CALM3;CALM1;CALM2;EGFR;GNAI2,2,2,C1
26,KEGG_2021_Human,Small cell lung cancer,5/92,4.44837716542134e-06,2.570173473354552e-05,0,0,23.778735632183903,293.02467461099025,ITGA3;ITGA2;FN1;ITGA6;ITGAV,2,2,C1
27,KEGG_2021_Human,Salivary secretion,5/93,4.691737095231542e-06,2.6139678102004305e-05,0,0,23.50733901515152,288.4281776110344,TRPV6;CALM3;AQP5;CALM1;CALM2,2,2,C1
28,KEGG_2021_Human,Alzheimer disease,8/369,5.344440651044837e-06,2.874940488148257e-05,0,0,9.64530624807633,117.0887483119306,APP;NCSTN;INSR;CALM3;CALM1;DKK1;CALM2;LRP6,2,2,C1
29,KEGG_2021_Human,Circadian entrainment,5/97,5.771565441660068e-06,3.0012140296632357e-05,0,0,22.480751811594203,271.17557959561594,RYR1;CALM3;CALM1;CALM2;GNAI2,2,2,C1
30,KEGG_2021_Human,Amoebiasis,5/102,7.3851344183574385e-06,3.716390223431485e-05,0,0,21.316580756013742,251.8776015851397,COL1A1;COL3A1;COL1A2;TGFB3;FN1,2,2,C1
31,KEGG_2021_Human,Axon guidance,6/182,8.416638794399708e-06,4.1031114122698576e-05,0,0,14.340667311411991,167.57499976950658,EFNB2;SEMA4C;PLXNB2;SLIT2;GNAI2;EPHB3,2,2,C1
32,KEGG_2021_Human,Diabetic cardiomyopathy,6/203,1.5670079081102348e-05,7.407673747430202e-05,0,0,12.798358354033914,141.59793265060142,COL1A1;COL3A1;COL1A2;TGFB3;INSR;TGFBR1,2,2,C1
33,KEGG_2021_Human,Platelet activation,5/124,1.9104410128591345e-05,8.765552882530146e-05,0,0,17.356442577030812,188.5880123799976,COL1A1;COL3A1;COL1A2;ITGA2;GNAI2,2,2,C1
34,KEGG_2021_Human,FoxO signaling pathway,5/131,2.4901416888020396e-05,0.0001109891724151766,0,0,16.38640873015873,173.70553256605524,TGFB3;INSR;S1PR1;TGFBR1;EGFR,2,2,C1
35,KEGG_2021_Human,Insulin signaling pathway,5/137,3.0885144724181695e-05,0.00013383562713812066,0,0,15.63683712121212,162.39223195904628,INSR;CALM3;CALM1;CALM2;PTPRF,2,2,C1
36,KEGG_2021_Human,Renin secretion,4/69,3.3438834445678734e-05,0.00014098535604124005,0,0,24.969544740973312,257.3309500523308,CALM3;CALM1;CALM2;GNAI2,2,2,C1
37,KEGG_2021_Human,Chemical carcinogenesis,6/239,3.925306482662913e-05,0.00016114416086721433,0,0,10.80120536937266,109.58342419802476,NOTCH2;AR;HSP90AA1;EGFR;HSP90B1;GNAI2,2,2,C1
38,KEGG_2021_Human,Gastric acid secretion,4/76,4.895046393575769e-05,0.00018625054570678532,0,0,22.534013605442176,223.64336339204715,CALM3;CALM1;CALM2;GNAI2,2,2,C1
39,KEGG_2021_Human,Pancreatic cancer,4/76,4.895046393575769e-05,0.00018625054570678532,0,0,22.534013605442176,223.64336339204715,TGFB3;ERBB2;TGFBR1;EGFR,2,2,C1
40,KEGG_2021_Human,Pertussis,4/76,4.895046393575769e-05,0.00018625054570678532,0,0,22.534013605442176,223.64336339204715,CALM3;CALM1;CALM2;GNAI2,2,2,C1
41,KEGG_2021_Human,Phototransduction,3/28,5.492744715462998e-05,0.00020401623228862565,0,0,47.8128,469.0195366273563,CALM3;CALM1;CALM2,2,2,C1
42,KEGG_2021_Human,Cellular senescence,5/156,5.744202040280975e-05,0.00020839430657763536,0,0,13.65618101545254,133.34898134948045,TGFB3;CALM3;CALM1;CALM2;TGFBR1,2,2,C1
43,KEGG_2021_Human,cGMP-PKG signaling pathway,5/167,7.93446813068308e-05,0.0002813129609969455,0,0,12.721836419753089,120.11587922114774,INSR;CALM3;CALM1;CALM2;GNAI2,2,2,C1
44,KEGG_2021_Human,GnRH signaling pathway,4/93,0.00010775717292106576,0.0003735581994596946,0,0,18.2141710616831,166.39793233311173,CALM3;CALM1;CALM2;EGFR,2,2,C1
45,KEGG_2021_Human,Melanogenesis,4/101,0.00014834889670889214,0.0005030962584040689,0,0,16.705238796549548,147.27244386239468,CALM3;CALM1;CALM2;GNAI2,2,2,C1
46,KEGG_2021_Human,Chagas disease,4/102,0.00015410255873147402,0.0005114893438746797,0,0,16.533944189920867,145.13317992873723,TGFB3;CALR;TGFBR1;GNAI2,2,2,C1
47,KEGG_2021_Human,MicroRNAs in cancer,6/310,0.00016436990788598282,0.0005342022006294442,0,0,8.248740201567749,71.87449974026775,NOTCH2;ERBB3;ERBB2;TNC;PDGFB;EGFR,2,2,C1
48,KEGG_2021_Human,Bladder cancer,3/41,0.0001744367577627291,0.0005553496777752191,0,0,31.435263157894735,272.0391422190547,CDH1;ERBB2;EGFR,2,2,C1
49,KEGG_2021_Human,Human immunodeficiency virus 1 infection,5/212,0.0002422254037758987,0.0007477000291752709,0,0,9.933574879227054,82.70338668244017,CALM3;CALR;CALM1;CALM2;GNAI2,2,2,C1
50,KEGG_2021_Human,Pathways of neurodegeneration,7/475,0.000244440394153454,0.0007477000291752709,0,0,6.333751393534002,52.674890895260006,RYR1;APP;CALM3;CALM1;DKK1;CALM2;LRP6,2,2,C1
51,KEGG_2021_Human,Lipid and atherosclerosis,5/215,0.00025847795670123696,0.0007754338701037109,0,0,9.790178571428571,80.8737295106514,HSP90AA1;CALM3;CALM1;CALM2;HSP90B1,2,2,C1
52,KEGG_2021_Human,Oocyte meiosis,4/129,0.00037873005392741,0.0011147526115599,0,0,12.944979591836734,101.98944068340344,AR;CALM3;CALM1;CALM2,2,2,C1
53,KEGG_2021_Human,Dopaminergic synapse,4/132,0.00041322983932781454,0.0011937750913914,0,0,12.63966836734694,98.4820596084877,CALM3;CALM1;CALM2;GNAI2,2,2,C1
54,KEGG_2021_Human,Endometrial cancer,3/58,0.0004891263826698153,0.0013873402853907,0,0,21.70036363636364,165.4194773782111,CDH1;ERBB2;EGFR,2,2,C1
55,KEGG_2021_Human,Breast cancer,4/147,0.0006201648148609925,0.0017276019842556,0,0,11.30526616240902,83.49532909421418,NOTCH2;ERBB2;EGFR;LRP6,2,2,C1
56,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,4/150,0.0006689947152869721,0.0018309329049959,0,0,11.071288789488396,80.92818048684136,CALM3;CALM1;CALM2;GNAI2,2,2,C1
57,KEGG_2021_Human,Long-term potentiation,3/67,0.0007467319771045088,0.0020084515246259,0,0,18.6403125,134.2066009029362,CALM3;CALM1;CALM2,2,2,C1
58,KEGG_2021_Human,Amphetamine addiction,3/69,0.000813662973934021,0.002151380066673,0,0,18.073636363636364,128.57520412659468,CALM3;CALM1;CALM2,2,2,C1
59,KEGG_2021_Human,Melanoma,3/72,0.0009210215770968808,0.0023946561004518,0,0,17.285217391304347,120.82413789232052,CDH1;PDGFB;EGFR,2,2,C1
60,KEGG_2021_Human,Hepatocellular carcinoma,4/168,0.001020820727299,0.0026106234993221,0,0,9.847187655550025,67.8190421217337,TGFB3;TGFBR1;EGFR;LRP6,2,2,C1
61,KEGG_2021_Human,Tuberculosis,4/180,0.0013173510666612,0.0033146252645025,0,0,9.170222634508349,60.81812997388213,TGFB3;CALM3;CALM1;CALM2,2,2,C1
62,KEGG_2021_Human,Alcoholism,4/186,0.0014861547980413,0.0036289060737366,0,0,8.865216416236825,57.7264166848302,CALM3;CALM1;CALM2;GNAI2,2,2,C1
63,KEGG_2021_Human,ErbB signaling pathway,3/85,0.0014887819789688,0.0036289060737366,0,0,14.535365853658536,94.62228040462342,ERBB3;ERBB2;EGFR,2,2,C1
64,KEGG_2021_Human,Colorectal cancer,3/86,0.0015397218329483,0.0036953323990761,0,0,14.359518072289156,92.99444332020654,TGFB3;TGFBR1;EGFR,2,2,C1
65,KEGG_2021_Human,Gap junction,3/88,0.0016448557298592,0.0038878408160309,0,0,14.020235294117647,89.87114672298931,PDGFB;EGFR;GNAI2,2,2,C1
66,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,4/193,0.0017015324138556,0.0039617769636041,0,0,8.533851635892452,54.41376680073388,PDGFB;CALM3;CALM1;CALM2,2,2,C1
67,KEGG_2021_Human,Phosphatidylinositol signaling system,3/97,0.0021732810137107,0.0049857623255716,0,0,12.672127659574468,77.69936953463504,CALM3;CALM1;CALM2,2,2,C1
68,KEGG_2021_Human,Aldosterone synthesis and secretion,3/98,0.0022377421660764,0.0049869682558275,0,0,12.538105263157895,76.51112782343627,CALM3;CALM1;CALM2,2,2,C1
69,KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,3/98,0.0022377421660764,0.0049869682558275,0,0,12.538105263157895,76.51112782343627,CALM3;CALM1;CALM2,2,2,C1
70,KEGG_2021_Human,Hematopoietic cell lineage,3/99,0.0023033809474062,0.0050609496872588,0,0,12.406875,75.35163247123117,ITGA3;ITGA2;ITGA6,2,2,C1
71,KEGG_2021_Human,cAMP signaling pathway,4/216,0.0025612823121288,0.0055088515710336,0,0,7.599152868694648,45.34602400276742,CALM3;CALM1;CALM2;GNAI2,2,2,C1
72,KEGG_2021_Human,Protein digestion and absorption,3/103,0.0025778600300349,0.0055088515710336,0,0,11.9082,70.98234699692145,COL1A1;COL3A1;COL1A2,2,2,C1
73,KEGG_2021_Human,C-type lectin receptor signaling pathway,3/104,0.0026494970110091,0.0055854261313164,0,0,11.78970297029703,69.95285223079561,CALM3;CALM1;CALM2,2,2,C1
74,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",3/106,0.0027964412342004,0.0058165977671369,0,0,11.559611650485436,67.96366926109907,EGFR;LRP6;GNAI2,2,2,C1
75,KEGG_2021_Human,Glucagon signaling pathway,3/107,0.0028717623388725,0.0058946700640014,0,0,11.447884615384616,67.00251544220828,CALM3;CALM1;CALM2,2,2,C1
76,KEGG_2021_Human,HIF-1 signaling pathway,3/109,0.0030261366122618,0.0061308741754915,0,0,11.230754716981131,65.14363917463193,INSR;ERBB2;EGFR,2,2,C1
77,KEGG_2021_Human,Toxoplasmosis,3/112,0.0032671281304917,0.0065342562609835,0,0,10.92,62.50437568845662,TGFB3;ITGA6;GNAI2,2,2,C1
78,KEGG_2021_Human,Neurotrophin signaling pathway,3/119,0.003874347549083,0.0076506103500881,0,0,10.257413793103447,56.96329614458424,CALM3;CALM1;CALM2,2,2,C1
79,KEGG_2021_Human,Parkinson disease,4/249,0.004258212994533,0.0083035153393393,0,0,6.564598084131612,35.83552184427418,CALM3;CALM1;CALM2;GNAI2,2,2,C1
80,KEGG_2021_Human,Vascular smooth muscle contraction,3/133,0.0052843835705361,0.0101773313210326,0,0,9.146307692307692,47.95408486507544,CALM3;CALM1;CALM2,2,2,C1
81,KEGG_2021_Human,Phospholipase D signaling pathway,3/148,0.0070982889687846,0.0135040619406146,0,0,8.193931034482759,40.54276377350281,INSR;PDGFB;EGFR,2,2,C1
82,KEGG_2021_Human,Phagosome,3/152,0.0076368864580781,0.0143536661139781,0,0,7.97234899328859,38.86333015649471,ITGA2;ITGAV;CALR,2,2,C1
83,KEGG_2021_Human,Malaria,2/50,0.0077812124839393,0.0144508231844587,0,0,16.25735294117647,78.94640668269977,TGFB3;SDC1,2,2,C1
84,KEGG_2021_Human,Hippo signaling pathway,3/163,0.0092404288338618,0.0169589046833229,0,0,7.420125,34.757104540775615,TGFB3;CDH1;TGFBR1,2,2,C1
85,KEGG_2021_Human,Regulation of lipolysis in adipocytes,2/55,0.009353537479896,0.0169668819402765,0,0,14.719940806511284,68.77157326825663,INSR;GNAI2,2,2,C1
86,KEGG_2021_Human,Protein processing in endoplasmic reticulum,3/171,0.0105213537111099,0.0188658756199213,0,0,7.063928571428572,32.17159178832658,HSP90AA1;CALR;HSP90B1,2,2,C1
87,KEGG_2021_Human,Notch signaling pathway,2/59,0.010704648823228,0.0189764229139042,0,0,13.68421052631579,62.08631906453382,NOTCH2;NCSTN,2,2,C1
88,KEGG_2021_Human,Long-term depression,2/60,0.0110551402595005,0.0193775492188998,0,0,13.447599729546992,60.57955112322511,RYR1;GNAI2,2,2,C1
89,KEGG_2021_Human,Renal cell carcinoma,2/69,0.0144325201711685,0.0250163682966922,0,0,11.63593795727246,49.316261583476326,TGFB3;PDGFB,2,2,C1
90,KEGG_2021_Human,Central carbon metabolism in cancer,2/70,0.0148320510028186,0.0254263731476891,0,0,11.464244521337948,48.27553049864857,ERBB2;EGFR,2,2,C1
91,KEGG_2021_Human,Non-small cell lung cancer,2/72,0.0156453450710385,0.0265290633813262,0,0,11.135574229691876,46.2970612598155,ERBB2;EGFR,2,2,C1
92,KEGG_2021_Human,Chronic myeloid leukemia,2/76,0.0173281106466688,0.029066508181509,0,0,10.531531531531533,42.70983840250568,TGFB3;TGFBR1,2,2,C1
93,KEGG_2021_Human,Bacterial invasion of epithelial cells,2/77,0.0177603501826593,0.0294746237073921,0,0,10.390588235294118,41.88224615368415,CDH1;FN1,2,2,C1
94,KEGG_2021_Human,Antigen processing and presentation,2/78,0.0181971560803858,0.0298816457741072,0,0,10.253353973168217,41.079959713205824,HSP90AA1;CALR,2,2,C1
95,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,3/219,0.0203079432116227,0.0330004077188869,0,0,5.480833333333333,21.357399902824188,TGFB3;CALR;TGFBR1,2,2,C1
96,KEGG_2021_Human,TGF-beta signaling pathway,2/94,0.0257859520097423,0.0410470256481612,0,0,8.463341858482524,30.958273416173974,TGFB3;TGFBR1,2,2,C1
97,KEGG_2021_Human,IL-17 signaling pathway,2/94,0.0257859520097423,0.0410470256481612,0,0,8.463341858482524,30.958273416173974,HSP90AA1;HSP90B1,2,2,C1
98,KEGG_2021_Human,Choline metabolism in cancer,2/98,0.0278524987743966,0.043888785947534,0,0,8.10906862745098,29.037217248436296,PDGFB;EGFR,2,2,C1
99,KEGG_2021_Human,Salmonella infection,3/249,0.0282962283936942,0.0441421162941631,0,0,4.805121951219512,17.13038831964417,HSP90AA1;HSP90B1;S100A10,2,2,C1
100,KEGG_2021_Human,Progesterone-mediated oocyte maturation,2/100,0.0289100845392208,0.0446201403499712,0,0,7.942777110844338,28.14574537420548,HSP90AA1;GNAI2,2,2,C1
101,KEGG_2021_Human,Endocytosis,3/252,0.0291747071519043,0.0446201403499712,0,0,4.7465060240963854,16.77630311376778,FGFR4;TGFBR1;EGFR,2,2,C1
102,KEGG_2021_Human,Th17 cell differentiation,2/107,0.0327359896743093,0.0495807222251675,0,0,7.4106442577030815,25.339069213964127,HSP90AA1;TGFBR1,2,2,C1
103,KEGG_2021_Human,Insulin resistance,2/108,0.033298022190603,0.0499470332859045,0,0,7.340362560118387,24.973801939175644,INSR;PTPRF,2,2,C1
0,KEGG_2021_Human,Cell adhesion molecules,9/148,8.149797881407464e-15,6.519838305125973e-13,0,0,116.78809679529104,3788.697336394037,PTPRC;ITGA4;ITGB2;HLA-B;SDC1;ITGAV;ITGB7;HLA-A;HLA-F,1,1,D1
1,KEGG_2021_Human,ECM-receptor interaction,7/88,1.851613212424374e-12,7.406452849697495e-11,0,0,132.28205128205127,3573.594833401612,COL1A1;ITGA4;FN1;SDC1;ITGAV;ITGB7;CD44,1,1,D1
2,KEGG_2021_Human,Epstein-Barr virus infection,8/202,1.069603922328483e-11,2.852277126209288e-10,0,0,67.99312714776632,1717.5844212797592,HLA-B;HLA-A;VIM;CALR;HLA-F;CD3D;B2M;CD44,1,1,D1
3,KEGG_2021_Human,Phagosome,7/152,9.091770008863584e-11,1.818354001772717e-09,0,0,73.657824933687,1703.0474621475869,C3;ITGB2;HLA-B;ITGAV;HLA-A;CALR;HLA-F,1,1,D1
4,KEGG_2021_Human,Human papillomavirus infection,8/331,5.480451972801475e-10,8.768723156482362e-09,0,0,40.57172342621259,865.1783438202083,COL1A1;ITGA4;FN1;HLA-B;ITGAV;ITGB7;HLA-A;HLA-F,1,1,D1
5,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,7/219,1.1776680639400083e-09,1.5702240852533448e-08,0,0,50.20899854862119,1032.2834321784396,ITGB2;HLA-B;HLA-A;CALR;HLA-F;CD3D;B2M,1,1,D1
6,KEGG_2021_Human,Human cytomegalovirus infection,7/225,1.4217777825629394e-09,1.6248888943576452e-08,0,0,48.812279463655614,994.3724094424748,CCL5;HLA-B;ITGAV;HLA-A;CALR;HLA-F;B2M,1,1,D1
7,KEGG_2021_Human,Antigen processing and presentation,5/78,1.172977585089853e-08,1.172977585089853e-07,0,0,90.89954337899545,1659.9288588530228,HLA-B;HLA-A;CALR;HLA-F;B2M,1,1,D1
8,KEGG_2021_Human,Human immunodeficiency virus 1 infection,6/212,4.5248497883959566e-08,4.022088700796406e-07,0,0,41.13869625520111,695.7004566316618,HLA-B;HLA-A;CALR;HLA-F;CD3D;B2M,1,1,D1
9,KEGG_2021_Human,Regulation of actin cytoskeleton,6/218,5.3409064439823267e-08,4.272725155185861e-07,0,0,39.9622641509434,669.1795168121265,ITGA4;ITGB2;FN1;ITGAX;ITGAV;ITGB7,1,1,D1
10,KEGG_2021_Human,Herpes simplex virus 1 infection,7/498,3.329736887227633e-07,2.279780821199964e-06,0,0,21.37286542378192,318.780612871424,C3;CCL5;HLA-B;HLA-A;CALR;HLA-F;B2M,1,1,D1
11,KEGG_2021_Human,Viral myocarditis,4/60,3.419671231799946e-07,2.279780821199964e-06,0,0,88.94642857142857,1324.2834590055554,ITGB2;HLA-B;HLA-A;HLA-F,1,1,D1
12,KEGG_2021_Human,Focal adhesion,5/201,1.337589882385776e-06,8.231322353143237e-06,0,0,33.64625850340136,455.0535725896941,COL1A1;ITGA4;FN1;ITGAV;ITGB7,1,1,D1
13,KEGG_2021_Human,Proteoglycans in cancer,5/205,1.473834779767606e-06,8.421913027243463e-06,0,0,32.96666666666667,442.6646262909155,COL1A1;FN1;SDC1;ITGAV;CD44,1,1,D1
14,KEGG_2021_Human,Chagas disease,4/102,2.901041852278447e-06,1.5472223212151714e-05,0,0,50.71938775510204,646.6945421627448,C3;CCL5;CALR;CD3D,1,1,D1
15,KEGG_2021_Human,Allograft rejection,3/38,7.054141025398755e-06,3.5270705126993774e-05,0,0,100.56302521008404,1192.8681197467536,HLA-B;HLA-A;HLA-F,1,1,D1
16,KEGG_2021_Human,Graft-versus-host disease,3/42,9.575094300590784e-06,4.50592672968978e-05,0,0,90.23076923076924,1042.737914575217,HLA-B;HLA-A;HLA-F,1,1,D1
17,KEGG_2021_Human,Type I diabetes mellitus,3/43,1.0286672165207128e-05,4.571854295647613e-05,0,0,87.97058823529412,1010.312424773928,HLA-B;HLA-A;HLA-F,1,1,D1
18,KEGG_2021_Human,Autoimmune thyroid disease,3/53,1.940242439066148e-05,8.169441848699569e-05,0,0,70.34117647058824,763.2096802766982,HLA-B;HLA-A;HLA-F,1,1,D1
19,KEGG_2021_Human,PI3K-Akt signaling pathway,5/354,2.1037334863140287e-05,8.414933945256115e-05,0,0,18.74976122254059,201.9201507072224,COL1A1;ITGA4;FN1;ITGAV;ITGB7,1,1,D1
20,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,4/193,3.6082402498459696e-05,0.0001374567714227036,0,0,26.178571428571427,267.7990702843502,C3;HLA-B;HLA-A;HLA-F,1,1,D1
21,KEGG_2021_Human,Viral carcinogenesis,4/203,4.394763690537216e-05,0.00015980958874680783,0,0,24.850502512562816,249.3129572845683,C3;HLA-B;HLA-A;HLA-F,1,1,D1
22,KEGG_2021_Human,Leishmaniasis,3/77,5.9666458152070285e-05,0.0001988881938402343,0,0,47.47058823529412,461.7340948301653,C3;ITGA4;ITGB2,1,1,D1
23,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,3/77,5.9666458152070285e-05,0.0001988881938402343,0,0,47.47058823529412,461.7340948301653,ITGA4;ITGAV;ITGB7,1,1,D1
24,KEGG_2021_Human,Complement and coagulation cascades,3/85,8.015427688190231e-05,0.0002564936860220874,0,0,42.82209469153515,403.8790406182925,C3;ITGB2;ITGAX,1,1,D1
25,KEGG_2021_Human,Hypertrophic cardiomyopathy,3/90,9.503457079054536e-05,0.0002924140639709088,0,0,40.35091277890466,373.7006911121373,ITGA4;ITGAV;ITGB7,1,1,D1
26,KEGG_2021_Human,Dilated cardiomyopathy,3/96,0.00011514055840279767,0.0003411572100823635,0,0,37.73624288425047,342.2434558750413,ITGA4;ITGAV;ITGB7,1,1,D1
27,KEGG_2021_Human,Hematopoietic cell lineage,3/99,0.0001261560956566538,0.0003604459875904395,0,0,36.5514705882353,328.1587580174437,ITGA4;CD3D;CD44,1,1,D1
28,KEGG_2021_Human,Amoebiasis,3/102,0.00013783717764729214,0.0003802404900614956,0,0,35.43850267379679,315.0283525400414,COL1A1;ITGB2;FN1,1,1,D1
29,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,3/131,0.00028855049794020246,0.0007694679945072065,0,0,27.36948529411765,223.07883396526145,ITGB2;HLA-B;HLA-A,1,1,D1
30,KEGG_2021_Human,Cellular senescence,3/156,0.000481365021138088,0.0012422323126144,0,0,22.868512110726645,174.68992718194062,HLA-B;HLA-A;HLA-F,1,1,D1
31,KEGG_2021_Human,Primary immunodeficiency,2/38,0.0006535983868982156,0.0016339959672455,0,0,61.55555555555556,451.387965030658,PTPRC;CD3D,1,1,D1
32,KEGG_2021_Human,Tuberculosis,3/180,0.0007301301231801276,0.0017700124198306,0,0,19.743768693918245,142.59517954248318,C3;ITGB2;ITGAX,1,1,D1
33,KEGG_2021_Human,Intestinal immune network for IgA production,2/48,0.0010424693212675,0.0024528689912178,0,0,48.14975845410628,330.6040915341501,ITGA4;ITGB7,1,1,D1
34,KEGG_2021_Human,Malaria,2/50,0.0011307590059983,0.0025845920137104,0,0,46.138888888888886,313.0461870363529,ITGB2;SDC1,1,1,D1
35,KEGG_2021_Human,Legionellosis,2/57,0.0014670547641947,0.0032601216982105,0,0,40.25252525252525,262.627538609776,C3;ITGB2,1,1,D1
36,KEGG_2021_Human,Shigellosis,3/246,0.0017950683835049,0.0038812289373079,0,0,14.333333333333334,90.62554097587316,C3;CCL5;CD44,1,1,D1
37,KEGG_2021_Human,Endocytosis,3/252,0.0019228441068388,0.0040480928565029,0,0,13.983699503897943,87.45335588117806,HLA-B;HLA-A;HLA-F,1,1,D1
38,KEGG_2021_Human,Pertussis,2/76,0.0025901140533562,0.005313054468423,0,0,29.88888888888889,178.0198173382836,C3;ITGB2,1,1,D1
39,KEGG_2021_Human,Small cell lung cancer,2/92,0.0037680465442261,0.0075093822705099,0,0,24.55555555555556,137.04943154835937,FN1;ITGAV,1,1,D1
40,KEGG_2021_Human,Rheumatoid arthritis,2/93,0.0038485584136363,0.0075093822705099,0,0,24.284493284493283,135.02315810678772,CCL5;ITGB2,1,1,D1
41,KEGG_2021_Human,Staphylococcus aureus infection,2/95,0.0040119852700405,0.0076418767048391,0,0,23.759856630824373,131.11803417110073,C3;ITGB2,1,1,D1
42,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,2/100,0.004434499847536,0.0082502322744856,0,0,22.54195011337869,122.13995997533476,COL1A1;FN1,1,1,D1
43,KEGG_2021_Human,T cell receptor signaling pathway,2/104,0.0047867577714046,0.0087031959480083,0,0,21.65359477124183,115.67138059180392,PTPRC;CD3D,1,1,D1
44,KEGG_2021_Human,Leukocyte transendothelial migration,2/114,0.0057221397634708,0.010172692912837,0,0,19.71031746031746,101.77249874583728,ITGA4;ITGB2,1,1,D1
45,KEGG_2021_Human,Yersinia infection,2/137,0.0081633472444682,0.0141971256425534,0,0,16.333333333333332,78.53231621226735,ITGA4;FN1,1,1,D1
46,KEGG_2021_Human,Fluid shear stress and atherosclerosis,2/139,0.0083942929149811,0.0142881581531593,0,0,16.093268450932683,76.9290936521396,SDC1;ITGAV,1,1,D1
47,KEGG_2021_Human,Neutrophil extracellular trap formation,2/189,0.0150924344910985,0.0251540574851642,0,0,11.760546642899584,49.31857782921134,C3;ITGB2,1,1,D1
0,KEGG_2021_Human,PI3K-Akt signaling pathway,16/354,1.16890321248324e-22,4.7227518737283066e-21,0,0,103.28468113083498,5215.959661286612,ITGB1;HSP90AA1;FN1;TNC;THBS2;THBS1;VEGFA;HSP90B1;COL1A1;COMP;COL1A2;ERBB3;ERBB2;ITGA6;ITGAV;ITGB6,2,2,D1
1,KEGG_2021_Human,ECM-receptor interaction,12/88,1.1956333857540018e-22,4.7227518737283066e-21,0,0,241.68825910931173,12199.98730720534,COL1A1;ITGB1;COMP;COL1A2;FN1;TNC;ITGA6;ITGAV;ITGB6;CD36;THBS2;THBS1,2,2,D1
2,KEGG_2021_Human,Focal adhesion,13/201,3.369818245182476e-20,8.873854712313854e-19,0,0,114.02083333333331,5112.334208614134,ITGB1;FN1;TNC;THBS2;THBS1;VEGFA;COL1A1;COMP;COL1A2;ERBB2;ITGA6;ITGAV;ITGB6,2,2,D1
3,KEGG_2021_Human,Human papillomavirus infection,12/331,1.4839092338461417e-15,2.93072073684613e-14,0,0,56.87774294670847,1942.0391390520865,COL1A1;ITGB1;COMP;COL1A2;FN1;TNC;ITGA6;ITGAV;ITGB6;THBS2;THBS1;VEGFA,2,2,D1
4,KEGG_2021_Human,Proteoglycans in cancer,10/205,2.9345419947085855e-14,4.636576351639564e-13,0,0,67.62393162393163,2107.137358721581,COL1A1;ITGB1;COL1A2;ERBB3;GPC1;ERBB2;FN1;ITGAV;THBS1;VEGFA,2,2,D1
5,KEGG_2021_Human,Pathways in cancer,9/531,8.569508822204385e-09,1.128318661590244e-07,0,0,20.96228448275862,389.37559598882257,ITGB1;HSP90AA1;CDH1;ERBB2;FN1;ITGA6;ITGAV;VEGFA;HSP90B1,2,2,D1
6,KEGG_2021_Human,Phagosome,6/152,2.7429006681248567e-08,3.095559325455196e-07,0,0,42.88896899783706,746.768349471025,ITGB1;COMP;ITGAV;CD36;THBS2;THBS1,2,2,D1
7,KEGG_2021_Human,Bladder cancer,4/41,1.8630950015221925e-07,1.8398063140031647e-06,0,0,102.64092664092664,1590.5090771112336,CDH1;ERBB2;THBS1;VEGFA,2,2,D1
8,KEGG_2021_Human,Malaria,4/50,4.205009693617207e-07,3.6910640643973264e-06,0,0,82.52173913043478,1211.569241792194,COMP;CD36;THBS2;THBS1,2,2,D1
9,KEGG_2021_Human,Fluid shear stress and atherosclerosis,5/139,7.165768410577245e-07,5.660957044356023e-06,0,0,37.01679104477612,523.7424457694602,HSP90AA1;GPC1;ITGAV;VEGFA;HSP90B1,2,2,D1
10,KEGG_2021_Human,Cell adhesion molecules,5/148,9.776244361598689e-07,7.021120950602693e-06,0,0,34.67132867132867,479.786708903718,ITGB1;CDH1;ITGA6;ITGAV;PTPRF,2,2,D1
11,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,4/77,2.4155132216897017e-06,1.5902128709457203e-05,0,0,51.92954990215264,671.6359632230644,ITGB1;ITGA6;ITGAV;ITGB6,2,2,D1
12,KEGG_2021_Human,Hypertrophic cardiomyopathy,4/90,4.511303107426435e-06,2.741484196051449e-05,0,0,44.05094130675526,542.2197110881452,ITGB1;ITGA6;ITGAV;ITGB6,2,2,D1
13,KEGG_2021_Human,Small cell lung cancer,4/92,4.924921170579454e-06,2.7790626605412637e-05,0,0,43.04545454545455,526.0672076409821,ITGB1;FN1;ITGA6;ITGAV,2,2,D1
14,KEGG_2021_Human,IL-17 signaling pathway,4/94,5.365961214971553e-06,2.8260729065516844e-05,0,0,42.08465608465608,510.7156098397375,HSP90AA1;S100A9;S100A8;HSP90B1,2,2,D1
15,KEGG_2021_Human,Dilated cardiomyopathy,4/96,5.8355673666745e-06,2.8813113872955343e-05,0,0,41.165631469979296,496.10921566723687,ITGB1;ITGA6;ITGAV;ITGB6,2,2,D1
16,KEGG_2021_Human,Regulation of actin cytoskeleton,5/218,6.535935816096733e-06,3.013039713572355e-05,0,0,23.19483568075117,276.90447182557085,ITGB1;FN1;ITGA6;ITGAV;ITGB6,2,2,D1
17,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,4/100,6.865153777759796e-06,3.013039713572355e-05,0,0,39.44246031746032,468.9334664055757,COL1A1;COL1A2;FN1;VEGFA,2,2,D1
18,KEGG_2021_Human,MicroRNAs in cancer,5/310,3.567372063488338e-05,0.0001483275752713572,0,0,16.12295081967213,165.11669128977732,ERBB3;ERBB2;TNC;THBS1;VEGFA,2,2,D1
19,KEGG_2021_Human,Adherens junction,3/71,9.32234562086695e-05,0.00036823265202424457,0,0,39.92045454545455,370.48222519399377,CDH1;ERBB2;PTPRF,2,2,D1
20,KEGG_2021_Human,Bacterial invasion of epithelial cells,3/77,0.00011872375145321811,0.0004466274459430587,0,0,36.67260442260442,331.47307958978314,ITGB1;CDH1;FN1,2,2,D1
21,KEGG_2021_Human,Rap1 signaling pathway,4/210,0.00012567242912732806,0.0004512782682299507,0,0,18.2792417938049,164.1810753169122,ITGB1;CDH1;THBS1;VEGFA,2,2,D1
22,KEGG_2021_Human,Prostate cancer,3/97,0.0002353859754423274,0.0008084996547801681,0,0,28.84090909090909,240.94514370450875,HSP90AA1;ERBB2;HSP90B1,2,2,D1
23,KEGG_2021_Human,Amoebiasis,3/102,0.0002729897357288534,0.0008985912134408091,0,0,27.37741046831956,224.6611208844998,COL1A1;COL1A2;FN1,2,2,D1
24,KEGG_2021_Human,Platelet activation,3/124,0.0004842171900831711,0.0015301263206628,0,0,22.374906085649886,170.7871437987668,COL1A1;ITGB1;COL1A2,2,2,D1
25,KEGG_2021_Human,Relaxin signaling pathway,3/129,0.0005434610443625707,0.0016512854809478,0,0,21.48160173160173,161.48906943463453,COL1A1;COL1A2;VEGFA,2,2,D1
26,KEGG_2021_Human,Axon guidance,3/182,0.0014710842949236,0.0043042836777394,0,0,15.080751650584054,98.35297554164488,ITGB1;SEMA4C;PLXNB2,2,2,D1
27,KEGG_2021_Human,Diabetic cardiomyopathy,3/203,0.0020098091655677,0.0056705330028519,0,0,13.482954545454543,83.72531187958572,COL1A1;COL1A2;CD36,2,2,D1
28,KEGG_2021_Human,Lipid and atherosclerosis,3/215,0.0023662281470012,0.0062554606298227,0,0,12.71204974271012,76.86287601708993,HSP90AA1;CD36;HSP90B1,2,2,D1
29,KEGG_2021_Human,Endometrial cancer,2/58,0.0023754913784137,0.0062554606298227,0,0,30.930124223602483,186.8968520281422,CDH1;ERBB2,2,2,D1
30,KEGG_2021_Human,Chemical carcinogenesis,3/239,0.0031913737998027,0.0079718785117726,0,0,11.405431432973806,65.55047937712337,HSP90AA1;VEGFA;HSP90B1,2,2,D1
31,KEGG_2021_Human,Calcium signaling pathway,3/240,0.0032291153465408,0.0079718785117726,0,0,11.356731875719218,65.13707018664526,ERBB3;ERBB2;VEGFA,2,2,D1
32,KEGG_2021_Human,Pancreatic cancer,2/76,0.0040397406896228,0.009670894378188,0,0,23.38542890716804,128.890540062766,ERBB2;VEGFA,2,2,D1
33,KEGG_2021_Human,ErbB signaling pathway,2/85,0.0050256606650963,0.0116772703689003,0,0,20.840230487166057,110.31147379580284,ERBB3;ERBB2,2,2,D1
34,KEGG_2021_Human,MAPK signaling pathway,3/294,0.0056915018482802,0.0128465327432611,0,0,9.223992502343018,47.67679830132992,ERBB3;ERBB2;VEGFA,2,2,D1
35,KEGG_2021_Human,TGF-beta signaling pathway,2/94,0.0061111598513641,0.013410600784938,0,0,18.793005671077506,95.79995291250644,THBS1;FBN1,2,2,D1
36,KEGG_2021_Human,Hematopoietic cell lineage,2/99,0.0067564423254116,0.0144259173975005,0,0,17.81981174361273,89.05021124053485,ITGA6;CD36,2,2,D1
37,KEGG_2021_Human,Protein digestion and absorption,2/103,0.0072940666337881,0.0151639806334016,0,0,17.110632802410677,84.19618904330586,COL1A1;COL1A2,2,2,D1
38,KEGG_2021_Human,Insulin resistance,2/108,0.0079925381793877,0.0160680646710752,0,0,16.299425758818703,78.7139513198353,CD36;PTPRF,2,2,D1
39,KEGG_2021_Human,HIF-1 signaling pathway,2/109,0.0081357289473798,0.0160680646710752,0,0,16.146281999187323,77.68767334306337,ERBB2;VEGFA,2,2,D1
40,KEGG_2021_Human,Toxoplasmosis,2/112,0.0085722422040996,0.0165172471737529,0,0,15.703557312252965,74.73677741296086,ITGB1;ITGA6,2,2,D1
41,KEGG_2021_Human,Yersinia infection,2/137,0.0126051138276089,0.023158232380956,0,0,12.77938808373591,55.892605043800906,ITGB1;FN1,2,2,D1
42,KEGG_2021_Human,Estrogen signaling pathway,2/137,0.0126051138276089,0.023158232380956,0,0,12.77938808373591,55.892605043800906,HSP90AA1;HSP90B1,2,2,D1
43,KEGG_2021_Human,Gastric cancer,2/149,0.0147833232232656,0.026542784878136,0,0,11.729074238391007,49.42931612079058,CDH1;ERBB2,2,2,D1
44,KEGG_2021_Human,Tight junction,2/169,0.0187465499788547,0.0329106099628784,0,0,10.313980734183806,41.01607693200061,ITGB1;ERBB2,2,2,D1
45,KEGG_2021_Human,Protein processing in endoplasmic reticulum,2/171,0.0191650954260513,0.0329139682316968,0,0,10.190892719320813,40.30156268946794,HSP90AA1;HSP90B1,2,2,D1
0,KEGG_2021_Human,Legionellosis,2/57,0.00011882605719638104,0.0026480482854578,0,0,181.26363636363635,1638.2335266199009,C3;ITGB2,1,1,F1
1,KEGG_2021_Human,Pertussis,2/76,0.0002116527257361983,0.0026480482854578,0,0,134.59459459459458,1138.7461429354153,C3;ITGB2,1,1,F1
2,KEGG_2021_Human,Leishmaniasis,2/77,0.00021726782324248188,0.0026480482854578,0,0,132.79333333333332,1120.0294025235596,C3;ITGB2,1,1,F1
3,KEGG_2021_Human,Complement and coagulation cascades,2/85,0.00026480482854578146,0.0026480482854578,0,0,119.94578313253012,987.9355417477028,C3;ITGB2,1,1,F1
4,KEGG_2021_Human,ErbB signaling pathway,2/85,0.00026480482854578146,0.0026480482854578,0,0,119.94578313253012,987.9355417477028,NRG4;ERBB2,1,1,F1
5,KEGG_2021_Human,Staphylococcus aureus infection,2/95,0.00033074986387049546,0.0027562488655874,0,0,106.99462365591398,857.470767002487,C3;ITGB2,1,1,F1
6,KEGG_2021_Human,Phagosome,2/152,0.0008436496422942477,0.0060260688735303,0,0,66.14666666666666,468.1711089232232,C3;ITGB2,1,1,F1
7,KEGG_2021_Human,Tuberculosis,2/180,0.001179888359317,0.0072200395683723,0,0,55.662921348314605,375.2980881761809,C3;ITGB2,1,1,F1
8,KEGG_2021_Human,Neutrophil extracellular trap formation,2/189,0.001299607122307,0.0072200395683723,0,0,52.95989304812834,351.955205011133,C3;ITGB2,1,1,F1
0,KEGG_2021_Human,Pathways in cancer,13/531,1.569043538812112e-12,2.1652800835607144e-10,0,0,23.241772384629527,631.7242701147629,NOTCH2;HSP90AA1;FN1;TGFA;VEGFA;HSP90B1;AR;CDH1;ERBB2;GNAS;CALM3;ITGAV;FGFR3,2,2,F1
1,KEGG_2021_Human,PI3K-Akt signaling pathway,11/354,9.096586769382047e-12,6.276644870873612e-10,0,0,27.36126251742933,695.608711033995,COL1A1;HSP90AA1;ERBB3;ERBB2;FN1;TGFA;ITGAV;ITGB6;FGFR3;VEGFA;HSP90B1,2,2,F1
2,KEGG_2021_Human,Proteoglycans in cancer,9/205,4.3996014858236737e-11,2.0238166834788903e-09,0,0,36.31224489795918,865.9352738150596,COL1A1;ERBB3;GPC1;ERBB2;FN1;SDC1;ITGAV;CD44;VEGFA,2,2,F1
3,KEGG_2021_Human,Fluid shear stress and atherosclerosis,7/139,3.093614038886041e-09,1.0672968434156845e-07,0,0,38.955667789001126,763.2944656120262,HSP90AA1;GPC1;SDC1;CALM3;ITGAV;VEGFA;HSP90B1,2,2,F1
4,KEGG_2021_Human,ECM-receptor interaction,6/88,7.4342181430715805e-09,2.051844207487756e-07,0,0,51.9616724738676,972.5755830045564,COL1A1;FN1;SDC1;ITGAV;ITGB6;CD44,2,2,F1
5,KEGG_2021_Human,Human papillomavirus infection,8/331,6.454931628241219e-08,1.4846342744954804e-06,0,0,18.71207430340557,309.7940392208909,COL1A1;NOTCH2;PKM;FN1;GNAS;ITGAV;ITGB6;VEGFA,2,2,F1
6,KEGG_2021_Human,Prostate cancer,5/97,6.018775532874944e-07,1.16264576054327e-05,0,0,37.24512743628186,533.4698492415318,AR;HSP90AA1;ERBB2;TGFA;HSP90B1,2,2,F1
7,KEGG_2021_Human,Bladder cancer,4/41,6.739975423439246e-07,1.16264576054327e-05,0,0,71.81621621621622,1020.5112600102832,CDH1;ERBB2;FGFR3;VEGFA,2,2,F1
8,KEGG_2021_Human,Focal adhesion,6/201,1.0171074245745592e-06,1.5595647176809907e-05,0,0,21.726373626373626,299.79240538640033,COL1A1;ERBB2;FN1;ITGAV;ITGB6;VEGFA,2,2,F1
9,KEGG_2021_Human,Chemical carcinogenesis,6/239,2.779247334006929e-06,3.5717850972666353e-05,0,0,18.1480686695279,232.17423879413215,NOTCH2;AR;HSP90AA1;GNAS;VEGFA;HSP90B1,2,2,F1
10,KEGG_2021_Human,Calcium signaling pathway,6/240,2.8470750775313763e-06,3.5717850972666353e-05,0,0,18.06959706959707,230.73463100699243,ERBB3;ERBB2;GNAS;CALM3;FGFR3;VEGFA,2,2,F1
11,KEGG_2021_Human,Estrogen signaling pathway,5/137,3.32401706639395e-06,3.822619626353043e-05,0,0,25.90647857889237,326.7930395337648,HSP90AA1;GNAS;TGFA;CALM3;HSP90B1,2,2,F1
12,KEGG_2021_Human,MicroRNAs in cancer,6/310,1.232638060649033e-05,0.00013084927105351272,0,0,13.859492481203008,156.66449907475754,NOTCH2;ERBB3;ERBB2;FGFR3;CD44;VEGFA,2,2,F1
13,KEGG_2021_Human,Rap1 signaling pathway,5/210,2.6424224564903677e-05,0.0002604673564254791,0,0,16.619848612279227,175.1936363398376,CDH1;GNAS;CALM3;FGFR3;VEGFA,2,2,F1
14,KEGG_2021_Human,MAPK signaling pathway,5/294,0.00013014862257479376,0.0011973673276881,0,0,11.73905261901921,105.0273493468679,ERBB3;ERBB2;TGFA;FGFR3;VEGFA,2,2,F1
15,KEGG_2021_Human,Central carbon metabolism in cancer,3/70,0.0002273001187293863,0.0019604635240409,0,0,28.741935483870968,241.1229748561462,PKM;ERBB2;FGFR3,2,2,F1
16,KEGG_2021_Human,Axon guidance,4/182,0.00024854403573128844,0.0020175927606422,0,0,14.82247191011236,123.0248941188284,EFNB2;SEMA3F;EPHB4;PLXNA3,2,2,F1
17,KEGG_2021_Human,Pancreatic cancer,3/76,0.0002898863382919705,0.0022224619269051,0,0,26.3716305788776,214.82387360798796,ERBB2;TGFA;VEGFA,2,2,F1
18,KEGG_2021_Human,ErbB signaling pathway,3/85,0.0004030556520051702,0.0029274568408796,0,0,23.466561762391816,183.42487607303391,ERBB3;ERBB2;TGFA,2,2,F1
19,KEGG_2021_Human,Regulation of actin cytoskeleton,4/218,0.0004927200090940664,0.003399768062749,0,0,12.306542056074766,93.72132606354924,FN1;ITGAV;ITGB6;FGFR3,2,2,F1
20,KEGG_2021_Human,Human cytomegalovirus infection,4/225,0.0005549296578796657,0.0036110223196238,0,0,11.912518853695325,89.30421312308533,GNAS;CALM3;ITGAV;VEGFA,2,2,F1
21,KEGG_2021_Human,Dilated cardiomyopathy,3/96,0.0005756702248675736,0.0036110223196238,0,0,20.679500520291363,154.2685690429783,GNAS;ITGAV;ITGB6,2,2,F1
22,KEGG_2021_Human,Ras signaling pathway,4/232,0.00062254530526496,0.0037287827007646,0,0,11.542690058479533,85.20460771147164,TGFA;CALM3;FGFR3;VEGFA,2,2,F1
23,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,3/100,0.0006484839479590657,0.0037287827007646,0,0,19.822746923844363,145.51627376631131,COL1A1;FN1;VEGFA,2,2,F1
24,KEGG_2021_Human,Amoebiasis,3/102,0.0006869941894639448,0.0037922079258409,0,0,19.420332355816228,141.44186794145844,COL1A1;FN1;GNAS,2,2,F1
25,KEGG_2021_Human,Glucagon signaling pathway,3/107,0.0007895773777299936,0.0041908337741053,0,0,18.482009925558312,132.0357140094594,PKM;GNAS;CALM3,2,2,F1
26,KEGG_2021_Human,Relaxin signaling pathway,3/129,0.0013553632092342,0.0069274119583082,0,0,15.238095238095235,100.62759328722868,COL1A1;GNAS;VEGFA,2,2,F1
27,KEGG_2021_Human,Cell adhesion molecules,3/148,0.0020083403688533,0.009898248960777,0,0,13.228698553948831,82.15612575990296,CDH1;SDC1;ITGAV,2,2,F1
28,KEGG_2021_Human,Alzheimer disease,4/369,0.003414465456105,0.0162481459635342,0,0,7.160182648401826,40.6679351716946,APP;NCSTN;ADAM10;CALM3,2,2,F1
29,KEGG_2021_Human,Endometrial cancer,2/58,0.004368494923651,0.020095076648795,0,0,22.220982142857142,120.73407868148206,CDH1;ERBB2,2,2,F1
30,KEGG_2021_Human,Notch signaling pathway,2/59,0.0045169787852541,0.0201078410440346,0,0,21.830043859649123,117.88031402926508,NOTCH2;NCSTN,2,2,F1
31,KEGG_2021_Human,Lipid and atherosclerosis,3/215,0.0057349974716297,0.0241618467078072,0,0,9.017346317711503,46.54003898276535,HSP90AA1;CALM3;HSP90B1,2,2,F1
32,KEGG_2021_Human,Amphetamine addiction,2/69,0.0061280045998061,0.0241618467078072,0,0,18.5625,94.57382315557096,GNAS;CALM3,2,2,F1
33,KEGG_2021_Human,Renal cell carcinoma,2/69,0.0061280045998061,0.0241618467078072,0,0,18.5625,94.57382315557096,TGFA;VEGFA,2,2,F1
34,KEGG_2021_Human,Renin secretion,2/69,0.0061280045998061,0.0241618467078072,0,0,18.5625,94.57382315557096,GNAS;CALM3,2,2,F1
35,KEGG_2021_Human,Adherens junction,2/71,0.0064773387554686,0.0248226456780029,0,0,18.02264492753623,90.82413757847569,CDH1;ERBB2,2,2,F1
36,KEGG_2021_Human,Non-small cell lung cancer,2/72,0.0066553470296094,0.0248226456780029,0,0,17.764285714285716,89.04054540085103,ERBB2;TGFA,2,2,F1
37,KEGG_2021_Human,Thyroid hormone synthesis,2/75,0.0072026453389378,0.024900773877666,0,0,17.03167808219178,84.02249521013059,GNAS;HSP90B1,2,2,F1
38,KEGG_2021_Human,Glioma,2/75,0.0072026453389378,0.024900773877666,0,0,17.03167808219178,84.02249521013059,TGFA;CALM3,2,2,F1
39,KEGG_2021_Human,Gastric acid secretion,2/76,0.007389477349401,0.024900773877666,0,0,16.800675675675677,82.4526469576761,GNAS;CALM3,2,2,F1
40,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,2/77,0.0075784963975505,0.024900773877666,0,0,16.575833333333332,80.93051938196929,ITGAV;ITGB6,2,2,F1
41,KEGG_2021_Human,Bacterial invasion of epithelial cells,2/77,0.0075784963975505,0.024900773877666,0,0,16.575833333333332,80.93051938196929,CDH1;FN1,2,2,F1
42,KEGG_2021_Human,Hypertrophic cardiomyopathy,2/90,0.0102313661073952,0.0326479132021234,0,0,14.117897727272728,64.69240278225716,ITGAV;ITGB6,2,2,F1
43,KEGG_2021_Human,Small cell lung cancer,2/92,0.0106711538307555,0.0326479132021234,0,0,13.802777777777775,62.66752462455978,FN1;ITGAV,2,2,F1
44,KEGG_2021_Human,Salivary secretion,2/93,0.0108941545377731,0.0326479132021234,0,0,13.650412087912088,61.693432126641376,GNAS;CALM3,2,2,F1
45,KEGG_2021_Human,GnRH signaling pathway,2/93,0.0108941545377731,0.0326479132021234,0,0,13.650412087912088,61.693432126641376,GNAS;CALM3,2,2,F1
46,KEGG_2021_Human,IL-17 signaling pathway,2/94,0.0111192168152159,0.0326479132021234,0,0,13.501358695652174,60.74369859051535,HSP90AA1;HSP90B1,2,2,F1
47,KEGG_2021_Human,Circadian entrainment,2/97,0.0118067009357296,0.033230227349772,0,0,13.073026315789471,58.032314670661705,GNAS;CALM3,2,2,F1
48,KEGG_2021_Human,Aldosterone synthesis and secretion,2/98,0.0120399374455695,0.033230227349772,0,0,12.936197916666666,57.17186348229599,GNAS;CALM3,2,2,F1
49,KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,2/98,0.0120399374455695,0.033230227349772,0,0,12.936197916666666,57.17186348229599,GNAS;CALM3,2,2,F1
50,KEGG_2021_Human,Melanogenesis,2/101,0.0127517722391139,0.0345047954705435,0,0,12.54229797979798,54.71057010760131,GNAS;CALM3,2,2,F1
51,KEGG_2021_Human,HIF-1 signaling pathway,2/109,0.0147376692833557,0.0391115069442903,0,0,11.599883177570094,48.920750227803,ERBB2;VEGFA,2,2,F1
52,KEGG_2021_Human,Serotonergic synapse,2/113,0.0157775957885995,0.0410812871476743,0,0,11.179617117117116,46.38606860239311,APP;GNAS,2,2,F1
53,KEGG_2021_Human,Thyroid hormone signaling pathway,2/121,0.0179491889931118,0.0458701496490635,0,0,10.423844537815128,41.90604766134445,NOTCH2;ITGAV,2,2,F1
54,KEGG_2021_Human,Platelet activation,2/124,0.0187945087853043,0.0471571311340363,0,0,10.165983606557376,40.40155585559051,COL1A1;GNAS,2,2,F1
55,KEGG_2021_Human,Oocyte meiosis,2/129,0.0202401977431191,0.0498776301526864,0,0,9.763287401574804,38.07764747187854,AR;CALM3,2,2,F1
0,KEGG_2021_Human,Cell adhesion molecules,16/148,7.96351804913306e-20,1.2343452976156245e-17,0,0,43.6297520661157,1918.6982328209651,SELPLG;SDC4;ITGB2;HLA-B;ICAM2;HLA-C;ICAM3;HLA-A;L1CAM;ITGAL;HLA-G;ICAM1;CD4;PTPRC;PECAM1;SDC1,3,3,F1
1,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,13/100,2.490584722430479e-17,1.930203159883621e-15,0,0,51.11890606420928,1954.3488313147127,CSF1R;CCL11;CCL21;CSF1;TNFSF14;IL34;IL2RG;TNFRSF1A;CXCL12;CCL5;CXCR3;LTBR;CCL19,3,3,F1
2,KEGG_2021_Human,Cytokine-cytokine receptor interaction,17/295,2.3612858706221677e-16,1.2199976998214532e-14,0,0,22.25333066879829,800.7227968806465,CSF1R;CCL11;CCL21;CSF1;TNFSF14;IL34;IL16;IL2RG;TNFRSF1A;CD4;CXCL12;CCL5;CXCR3;LTBR;LTB;CCL19;IFNAR1,3,3,F1
3,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,13/219,7.554588805864868e-13,2.927403162272636e-11,0,0,21.459574824238366,598.9678720767237,ITGB2;HLA-B;HLA-C;HLA-A;IL2RG;ITGAL;CD3D;HLA-G;TNFRSF1A;ICAM1;CD4;LTBR;B2M,3,3,F1
4,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,10/131,3.3772249547923174e-11,1.0469397359856182e-09,0,0,26.836472022761143,647.064419615802,ITGB2;HLA-B;ICAM2;HLA-C;CD247;HLA-A;ITGAL;HLA-G;IFNAR1;ICAM1,3,3,F1
5,KEGG_2021_Human,NF-kappa B signaling pathway,9/104,1.1134959971039985e-10,2.876531325851996e-09,0,0,30.306621392190152,694.5776447677194,CXCL12;CCL21;TNFSF14;LTBR;LTB;CCL19;CD14;TNFRSF1A;ICAM1,3,3,F1
6,KEGG_2021_Human,Human papillomavirus infection,13/331,1.3550497217751006e-10,2.906224458169615e-09,0,0,13.822543916720884,314.0760195450532,NOTCH3;JAG1;ITGB5;FN1;HLA-B;HLA-C;HLA-A;HLA-G;TNFRSF1A;COL1A1;COL4A2;ITGA5;IFNAR1,3,3,F1
7,KEGG_2021_Human,Proteoglycans in cancer,11/205,1.499986817119801e-10,2.906224458169615e-09,0,0,18.64991408934708,421.868416152166,COL1A1;SDC4;ITGB5;MMP2;ERBB2;FN1;SDC1;ITGA5;MMP9;HSPG2;HBEGF,3,3,F1
8,KEGG_2021_Human,ECM-receptor interaction,8/88,8.615185863313543e-10,1.4837264542373324e-08,0,0,31.506349206349206,657.6107439981574,COL1A1;SDC4;COL4A2;ITGB5;FN1;SDC1;ITGA5;HSPG2,3,3,F1
9,KEGG_2021_Human,Viral myocarditis,7/60,1.7444807487686122e-09,2.703945160591349e-08,0,0,41.01768867924528,827.1958887345744,ITGB2;HLA-B;HLA-C;HLA-A;ITGAL;HLA-G;ICAM1,3,3,F1
10,KEGG_2021_Human,Epstein-Barr virus infection,10/202,2.388222905227622e-09,3.365223184638922e-08,0,0,16.851946721311474,334.5569173925036,HLA-B;HLA-C;CD247;HLA-A;ITGAL;CD3D;B2M;HLA-G;IFNAR1;ICAM1,3,3,F1
11,KEGG_2021_Human,Phagosome,9/152,3.32201417176283e-09,4.290934971860322e-08,0,0,20.0850439882698,392.1141790017534,C3;ITGB5;ITGB2;HLA-B;HLA-C;ITGA5;HLA-A;CD14;HLA-G,3,3,F1
12,KEGG_2021_Human,Human immunodeficiency virus 1 infection,10/212,3.806414444140169e-09,4.538417221859432e-08,0,0,16.009576367472814,310.37090390372606,CD4;HLA-B;HLA-C;CD247;HLA-A;CD3D;B2M;HLA-G;TNFRSF1A;GNAI2,3,3,F1
13,KEGG_2021_Human,Leukocyte transendothelial migration,8/114,6.857362422974304e-09,7.592079825435836e-08,0,0,23.747229709493865,446.3990694323429,CXCL12;MMP2;ITGB2;PECAM1;ITGAL;MMP9;ICAM1;GNAI2,3,3,F1
14,KEGG_2021_Human,Rheumatoid arthritis,7/93,3.9011251902027774e-08,4.031162696542871e-07,0,0,25.23637354651163,430.51778764864,CXCL12;CSF1;CCL5;ITGB2;LTB;ITGAL;ICAM1,3,3,F1
15,KEGG_2021_Human,Human cytomegalovirus infection,9/225,1.0001434444291317e-07,9.688889617907212e-07,0,0,13.247983870967742,213.53037100141185,CXCL12;CCL5;HLA-B;HLA-C;HLA-A;B2M;HLA-G;TNFRSF1A;GNAI2,3,3,F1
16,KEGG_2021_Human,Primary immunodeficiency,5/38,2.238759481046868e-07,2.0412218797780268e-06,0,0,45.67493112947658,699.3824810902067,CD79A;CD4;PTPRC;IL2RG;CD3D,3,3,F1
17,KEGG_2021_Human,Pathways in cancer,12/531,3.337762071144969e-07,2.7636641317587267e-06,0,0,7.606544528264917,113.43484002323926,CSF1R;NOTCH3;CXCL12;JAG1;COL4A2;MMP2;ERBB2;FN1;IL2RG;MMP9;IFNAR1;GNAI2,3,3,F1
18,KEGG_2021_Human,Antigen processing and presentation,6/78,3.387717322801021e-07,2.7636641317587267e-06,0,0,25.45769230769231,379.2671550357354,CD4;HLA-B;HLA-C;HLA-A;B2M;HLA-G,3,3,F1
19,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,8/193,4.1143209247529924e-07,3.188598716683568e-06,0,0,13.552295152295152,199.26782318410457,C3;HLA-B;HLA-C;HLA-A;HLA-G;TNFRSF1A;IFNAR1;ICAM1,3,3,F1
20,KEGG_2021_Human,PI3K-Akt signaling pathway,10/354,4.70769427236967e-07,3.47472672484428e-06,0,0,9.333301563095691,135.97591289063757,COL1A1;CSF1R;CSF1;COL4A2;ITGB5;ERBB2;FN1;ITGA5;IL2RG;IFNAR1,3,3,F1
21,KEGG_2021_Human,Fluid shear stress and atherosclerosis,7/139,6.175609580121601e-07,4.350997658722037e-06,0,0,16.403764204545453,234.5326227860905,SDC4;MMP2;PECAM1;SDC1;MMP9;TNFRSF1A;ICAM1,3,3,F1
22,KEGG_2021_Human,Th1 and Th2 cell differentiation,6/92,9.045176160254066e-07,5.90513705455111e-06,0,0,21.298389982110912,296.3854996095232,NOTCH3;CD4;JAG1;CD247;IL2RG;CD3D,3,3,F1
23,KEGG_2021_Human,Malaria,5/50,9.143438019950106e-07,5.90513705455111e-06,0,0,33.474747474747474,465.4683448473296,ITGB2;PECAM1;SDC1;ITGAL;ICAM1,3,3,F1
24,KEGG_2021_Human,Herpes simplex virus 1 infection,11/498,1.35833816789594e-06,8.309961689355328e-06,0,0,7.319028062970568,98.87456917945708,C3;TNFSF14;CCL5;HLA-B;HLA-C;ITGA5;HLA-A;B2M;HLA-G;TNFRSF1A;IFNAR1,3,3,F1
25,KEGG_2021_Human,Hematopoietic cell lineage,6/99,1.3939290575692808e-06,8.309961689355328e-06,0,0,19.68833746898263,265.46541713663566,CSF1R;CD4;CSF1;ITGA5;CD14;CD3D,3,3,F1
26,KEGG_2021_Human,Chagas disease,6/102,1.6611561828879429e-06,9.536266975838187e-06,0,0,19.07019230769231,253.78605634339215,C3;CCL5;CD247;CD3D;TNFRSF1A;GNAI2,3,3,F1
27,KEGG_2021_Human,TNF signaling pathway,6/112,2.870304324765261e-06,1.5889184654950554e-05,0,0,17.262409288824383,220.2872016611224,JAG1;CSF1;CCL5;MMP9;TNFRSF1A;ICAM1,3,3,F1
28,KEGG_2021_Human,Axon guidance,7/182,3.7468469770249785e-06,2.0026251084099022e-05,0,0,12.34625,154.26140435609517,EFNB1;CXCL12;EFNB3;SLIT2;L1CAM;EPHB4;GNAI2,3,3,F1
29,KEGG_2021_Human,Chemokine signaling pathway,7/192,5.330564553268075e-06,2.754125019188505e-05,0,0,11.672972972972971,141.7338612383047,CXCL12;CCL11;CCL21;CCL5;CXCR3;CCL19;GNAI2,3,3,F1
30,KEGG_2021_Human,Pertussis,5/76,7.423081149761205e-06,3.711540574880603e-05,0,0,21.18864703371745,250.2573374239351,C3;ITGB2;ITGA5;CD14;GNAI2,3,3,F1
31,KEGG_2021_Human,Allograft rejection,4/38,9.82322016568247e-06,4.758122267752446e-05,0,0,34.934152765583846,402.817386198265,HLA-B;HLA-C;HLA-A;HLA-G,3,3,F1
32,KEGG_2021_Human,Regulation of actin cytoskeleton,7/218,1.2217983838606236e-05,5.738749984799899e-05,0,0,10.221119668246445,115.62745477913514,CXCL12;ITGB5;ITGB2;FN1;ITGAX;ITGA5;ITGAL,3,3,F1
33,KEGG_2021_Human,Bladder cancer,4/41,1.3369130866008912e-05,6.094750835974651e-05,0,0,32.09681323114159,360.2084821137282,MMP2;ERBB2;MMP9;HBEGF,3,3,F1
34,KEGG_2021_Human,Graft-versus-host disease,4/42,1.4736919464200526e-05,6.526350048431662e-05,0,0,31.25058915946583,347.66763838452806,HLA-B;HLA-C;HLA-A;HLA-G,3,3,F1
35,KEGG_2021_Human,Type I diabetes mellitus,4/43,1.620497896096418e-05,6.977143719304021e-05,0,0,30.44776119402985,335.8446525394133,HLA-B;HLA-C;HLA-A;HLA-G,3,3,F1
36,KEGG_2021_Human,Staphylococcus aureus infection,5/95,2.209692164253609e-05,9.25681852592728e-05,0,0,16.699494949494948,179.01979241939915,C3;SELPLG;ITGB2;ITGAL;ICAM1,3,3,F1
37,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,5/100,2.8321318632782203e-05,0.00011552116810740108,0,0,15.81658692185008,165.62964902369305,COL1A1;COL4A2;MMP2;FN1;ICAM1,3,3,F1
38,KEGG_2021_Human,Amoebiasis,5/102,3.11608149251413e-05,0.0001238442644460744,0,0,15.48890971571384,160.71833569556358,COL1A1;COL4A2;ITGB2;FN1;CD14,3,3,F1
39,KEGG_2021_Human,Autoimmune thyroid disease,4/53,3.743600292527063e-05,0.0001450645113354237,0,0,24.22174840085288,246.88931844043904,HLA-B;HLA-C;HLA-A;HLA-G,3,3,F1
40,KEGG_2021_Human,Focal adhesion,6/201,7.955567148754858e-05,0.0003007592458675617,0,0,9.34153846153846,88.17528141441534,COL1A1;COL4A2;ITGB5;ERBB2;FN1;ITGA5,3,3,F1
41,KEGG_2021_Human,Viral carcinogenesis,6/203,8.401977543734065e-05,0.0003100729807806619,0,0,9.245763373682156,86.76648143254826,C3;HLA-B;HLA-C;HLA-A;LTBR;HLA-G,3,3,F1
42,KEGG_2021_Human,Osteoclast differentiation,5/127,8.881017322973481e-05,0.00032012969420020686,0,0,12.29942871336314,114.74148548052302,CSF1R;CSF1;TREM2;TNFRSF1A;IFNAR1,3,3,F1
43,KEGG_2021_Human,Relaxin signaling pathway,5/129,9.562137365018704e-05,0.00033684802081315887,0,0,12.099828934506354,111.98529845802632,COL1A1;COL4A2;MMP2;MMP9;GNAI2,3,3,F1
44,KEGG_2021_Human,IL-17 signaling pathway,4/94,0.00034943517952004444,0.0012036100627912,0,0,13.160199004975125,104.74455695326168,CCL11;MMP9;S100A9;S100A8,3,3,F1
45,KEGG_2021_Human,Tuberculosis,5/180,0.0004498489142027864,0.0015157952543789,0,0,8.55151515151515,65.90309621493061,C3;ITGB2;ITGAX;CD14;TNFRSF1A,3,3,F1
46,KEGG_2021_Human,T cell receptor signaling pathway,4/104,0.0005130325471433614,0.0016919158469621,0,0,11.83820895522388,89.67646036684098,CD4;PTPRC;CD247;CD3D,3,3,F1
47,KEGG_2021_Human,Th17 cell differentiation,4/107,0.000571208562637559,0.0018445276501837,0,0,11.491667874221127,85.81697351547037,CD4;CD247;IL2RG;CD3D,3,3,F1
48,KEGG_2021_Human,Rap1 signaling pathway,5/210,0.0009030247524346388,0.0028565068699463,0,0,7.288987435328899,51.094056891333366,CSF1R;CSF1;ITGB2;ITGAL;GNAI2,3,3,F1
49,KEGG_2021_Human,Lipid and atherosclerosis,5/215,0.0010031240318304,0.0031096844986743,0,0,7.113636363636363,49.1170705581442,CCL5;CD14;MMP9;TNFRSF1A;ICAM1,3,3,F1
50,KEGG_2021_Human,Legionellosis,3/57,0.0010933717221235,0.0033229924888068,0,0,16.237745098039216,110.71688689066416,C3;ITGB2;CD14,3,3,F1
51,KEGG_2021_Human,Estrogen signaling pathway,4/137,0.0014352325409916,0.0042780969971867,0,0,8.886095836606442,58.17219009147921,MMP2;MMP9;HBEGF;GNAI2,3,3,F1
52,KEGG_2021_Human,Shigellosis,5/246,0.0018184110531543,0.0053179945894137,0,0,6.1888595498554,39.05041775751716,C3;CCL5;ITGA5;CD14;TNFRSF1A,3,3,F1
53,KEGG_2021_Human,Endocytosis,5/252,0.0020199623851344,0.0057980401795526,0,0,6.036682615629984,37.45566209286248,HLA-B;HLA-C;HLA-A;IL2RG;HLA-G,3,3,F1
54,KEGG_2021_Human,Cellular senescence,4/156,0.0023066749995528,0.0065006295441944,0,0,7.767871170463472,47.166111258726666,HLA-B;HLA-C;HLA-A;HLA-G,3,3,F1
55,KEGG_2021_Human,Influenza A,4/172,0.0032791245541145,0.009076148319424,0,0,7.022388059701493,40.1693152795112,CCL5;TNFRSF1A;IFNAR1;ICAM1,3,3,F1
56,KEGG_2021_Human,Complement and coagulation cascades,3/85,0.0034383610832529,0.0093499292614771,0,0,10.678084648493543,60.57421521232011,C3;ITGB2;ITGAX,3,3,F1
57,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,3/89,0.0039136468572871,0.0102896169150476,0,0,10.17937756497948,56.42719747607681,CD4;CD247;CD3D,3,3,F1
58,KEGG_2021_Human,MAPK signaling pathway,5/294,0.0039166928902439,0.0102896169150476,0,0,5.1483695082311,28.53487729018788,CSF1R;CSF1;ERBB2;CD14;TNFRSF1A,3,3,F1
59,KEGG_2021_Human,Neutrophil extracellular trap formation,4/189,0.004584882502201,0.0118442797973526,0,0,6.371601452198467,34.311015202417764,C3;SELPLG;ITGB2;ITGAL,3,3,F1
60,KEGG_2021_Human,Protein digestion and absorption,3/103,0.0058832732554827,0.014949300895079,0,0,8.748088235294118,44.92704932462819,COL1A1;COL18A1;COL4A2,3,3,F1
61,KEGG_2021_Human,Toll-like receptor signaling pathway,3/104,0.0060427858839981,0.0151069647099952,0,0,8.661036691904485,44.24828490808913,CCL5;CD14;IFNAR1,3,3,F1
62,KEGG_2021_Human,Sphingolipid signaling pathway,3/119,0.0087497109577789,0.0215270666421546,0,0,7.535370182555781,35.708119502491336,S1PR4;TNFRSF1A;GNAI2,3,3,F1
63,KEGG_2021_Human,Coronavirus disease,4/232,0.0093479125249144,0.0226394756462773,0,0,5.158680282796544,24.104460941536686,C3;TNFRSF1A;HBEGF;IFNAR1,3,3,F1
64,KEGG_2021_Human,Intestinal immune network for IgA production,2/48,0.0126147732665187,0.0296218185456088,0,0,12.528670447385004,54.786455996885486,CXCL12;LTBR,3,3,F1
65,KEGG_2021_Human,Apelin signaling pathway,3/137,0.0128042699519728,0.0296218185456088,0,0,6.517230026338893,28.401935780117388,NOTCH3;JAG1;GNAI2,3,3,F1
66,KEGG_2021_Human,Yersinia infection,3/137,0.0128042699519728,0.0296218185456088,0,0,6.517230026338893,28.401935780117388,CD4;FN1;ITGA5,3,3,F1
67,KEGG_2021_Human,Measles,3/139,0.0133106599417918,0.0303404748673196,0,0,6.420739619377162,27.732394776538435,IL2RG;CD3D;IFNAR1,3,3,F1
68,KEGG_2021_Human,Cholesterol metabolism,2/50,0.0136373517747766,0.0306346307984112,0,0,12.005434782608695,51.56265564232933,LPL;APOE,3,3,F1
69,KEGG_2021_Human,Breast cancer,3/147,0.0154498449434806,0.0342103709462785,0,0,6.061580882352941,25.27773977548124,NOTCH3;JAG1;ERBB2,3,3,F1
70,KEGG_2021_Human,Notch signaling pathway,2/59,0.018662205384361,0.0407414342898022,0,0,10.105263157894736,40.23162849090562,NOTCH3;JAG1,3,3,F1
71,KEGG_2021_Human,Hepatitis B,3/162,0.0199555801930478,0.0429599295822557,0,0,5.485571587125416,21.47187919797854,MMP9;HSPG2;IFNAR1,3,3,F1
0,KEGG_2021_Human,ECM-receptor interaction,31/88,8.156990790527105e-52,1.3459034804369725e-49,0,0,174.12280701754386,20483.032085802024,ITGB1;LAMA5;ITGB5;SDC4;TNC;LAMC1;THBS2;THBS1;COMP;SPP1;ITGAV;CD36;ITGB6;LAMB3;LAMB2;ITGA2;ITGA1;FN1;HSPG2;COL1A1;COL1A2;COL4A1;COL6A2;COL6A1;COL4A6;COL4A5;COL6A3;SDC1;ITGA6;AGRN;CD44,1,1,G2
1,KEGG_2021_Human,Focal adhesion,32/201,4.621276827991683e-41,3.8125533830931394e-39,0,0,61.26840624696867,5690.322699825477,ITGB1;LAMA5;ITGB5;TNC;LAMC1;THBS2;THBS1;EGFR;COMP;ERBB2;SPP1;ITGAV;ITGB6;HRAS;LAMB3;EGF;LAMB2;ITGA2;ITGA1;FN1;VEGFB;PGF;VEGFA;COL1A1;COL1A2;COL4A1;COL6A2;COL6A1;COL4A6;COL4A5;COL6A3;ITGA6,1,1,G2
2,KEGG_2021_Human,PI3K-Akt signaling pathway,33/354,2.084276376799254e-34,1.14635200723959e-32,0,0,33.55856697819315,2602.583365317113,ITGB1;LAMA5;ITGB5;TNC;LAMC1;THBS2;THBS1;EGFR;COMP;ERBB3;ERBB2;SPP1;ITGAV;ITGB6;HRAS;LAMB3;EGF;LAMB2;ITGA2;ITGA1;FN1;VEGFB;PGF;VEGFA;COL1A1;COL1A2;COL4A1;COL6A2;COL6A1;COL4A6;COL4A5;COL6A3;ITGA6,1,1,G2
3,KEGG_2021_Human,Human papillomavirus infection,30/331,8.39068786469986e-31,3.461158744188693e-29,0,0,31.017244106945103,2148.0376831661,ITGB1;LAMA5;ITGB5;TNC;LAMC1;THBS2;THBS1;EGFR;COMP;SPP1;ITGAV;ITGB6;HRAS;LAMB3;EGF;LAMB2;ITGA2;ITGA1;FZD6;FN1;VEGFA;COL1A1;COL1A2;COL4A1;COL6A2;COL6A1;COL4A6;COL4A5;COL6A3;ITGA6,1,1,G2
4,KEGG_2021_Human,Proteoglycans in cancer,23/205,1.0003922002312044e-25,3.3012942607629744e-24,0,0,35.61028257456829,2049.8786817146943,ITGB1;SDC4;ITGB5;LUM;MMP2;ITGA2;SDC2;FZD6;FN1;HSPG2;THBS1;EGFR;VEGFA;COL1A1;COL1A2;ERBB3;PLAU;GPC1;ERBB2;SDC1;ITGAV;HRAS;CD44,1,1,G2
5,KEGG_2021_Human,Pathways in cancer,28/531,3.4223442754761483e-22,9.411446757559407e-21,0,0,16.617586786970485,821.3499222044858,ITGB1;LAMA5;CXCL8;LRP5;LAMC1;EGFR;CDH1;ERBB2;ITGAV;HRAS;LAMB3;EGF;MMP1;LAMB2;MMP2;ITGA2;FZD6;FN1;VEGFB;PGF;VEGFA;AR;COL4A1;COL4A6;COL4A5;ITGA6;CALM3;CALM2,1,1,G2
6,KEGG_2021_Human,Protein digestion and absorption,13/103,1.5149810128993478e-15,3.5710266732627495e-14,0,0,35.78069444444444,1220.9580002152493,COL18A1;COL16A1;COL1A1;COL3A1;COL1A2;COL5A1;COL4A1;COL6A2;COL5A2;COL6A1;COL4A6;COL4A5;COL6A3,1,1,G2
7,KEGG_2021_Human,Bladder cancer,10/41,2.859608207291293e-15,5.897941927538291e-14,0,0,77.24834823163623,2586.8997746558152,CXCL8;CDH1;EGF;MMP1;MMP2;ERBB2;THBS1;HRAS;EGFR;VEGFA,1,1,G2
8,KEGG_2021_Human,Small cell lung cancer,12/92,1.3129981614356847e-14,2.407163295965422e-13,0,0,36.71666666666667,1173.6070578240729,ITGB1;LAMA5;LAMB3;COL4A1;LAMB2;ITGA2;COL4A6;FN1;COL4A5;ITGAV;ITGA6;LAMC1,1,1,G2
9,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,12/100,3.688875302661331e-14,6.086644249391197e-13,0,0,33.36531986531987,1032.0183607976169,COL1A1;COL3A1;COL1A2;CXCL8;COL4A1;MMP2;FN1;VEGFB;COL4A6;COL4A5;HRAS;VEGFA,1,1,G2
10,KEGG_2021_Human,Amoebiasis,12/102,4.7089499185807616e-14,7.063424877871142e-13,0,0,32.620576131687244,1001.0186936532972,COL1A1;LAMA5;COL3A1;COL1A2;CXCL8;LAMB3;LAMB2;COL4A1;FN1;COL4A6;COL4A5;LAMC1,1,1,G2
11,KEGG_2021_Human,Relaxin signaling pathway,12/129,8.239166523254405e-13,1.1328853969474808e-11,0,0,25.058562836340613,697.2471692686428,COL1A1;COL3A1;COL1A2;MMP1;COL4A1;MMP2;VEGFB;COL4A6;COL4A5;HRAS;EGFR;VEGFA,1,1,G2
12,KEGG_2021_Human,Fluid shear stress and atherosclerosis,10/139,9.378806430203464e-10,1.1903869699873632e-08,0,0,18.472027645465584,383.9853983149291,SDC4;MMP2;GPC1;SDC2;SDC1;CALM3;ITGAV;CALM2;VEGFA;BMPR1A,1,1,G2
13,KEGG_2021_Human,Malaria,7/50,3.171125741288853e-09,3.737398195090434e-08,0,0,37.60086533261222,735.8180713426998,COMP;CXCL8;SDC2;SDC1;CD36;THBS2;THBS1,1,1,G2
14,KEGG_2021_Human,Rap1 signaling pathway,11/210,3.778906552979501e-09,4.15679720827745e-08,0,0,13.285206520406913,257.6510519282317,ITGB1;EGF;CDH1;VEGFB;CALM3;CALM2;THBS1;HRAS;EGFR;PGF;VEGFA,1,1,G2
15,KEGG_2021_Human,Regulation of actin cytoskeleton,11/218,5.5867164518879285e-09,5.7613013410094266e-08,0,0,12.766584187581008,242.60179224831788,ITGB1;ITGB5;EGF;ITGA2;ITGA1;FN1;ITGA6;ITGAV;ITGB6;HRAS;EGFR,1,1,G2
16,KEGG_2021_Human,Cell adhesion molecules,9/148,2.9537101189293733e-08,2.8668362919020385e-07,0,0,15.237410071942444,264.180405747538,ITGB1;VCAN;SDC4;CDH1;SDC2;SDC1;ITGA6;ITGAV;PTPRF,1,1,G2
17,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,7/77,6.89673327396286e-08,6.322005501132621e-07,0,0,23.066279069767443,380.3544738375844,ITGB1;ITGB5;ITGA2;ITGA1;ITGAV;ITGA6;ITGB6,1,1,G2
18,KEGG_2021_Human,Hypertrophic cardiomyopathy,7/90,2.0403698454706545e-07,1.7719001289613578e-06,0,0,19.44073970299804,299.4839061980427,ITGB1;ITGB5;ITGA2;ITGA1;ITGAV;ITGA6;ITGB6,1,1,G2
19,KEGG_2021_Human,Dilated cardiomyopathy,7/96,3.182340594096904e-07,2.6254309901299457e-06,0,0,18.12464071073948,271.1533010993122,ITGB1;ITGB5;ITGA2;ITGA1;ITGA6;ITGAV;ITGB6,1,1,G2
20,KEGG_2021_Human,Phagosome,8/152,5.456554404045001e-07,4.287292746035358e-06,0,0,12.916993464052288,186.2795552443129,COMP;ITGB1;ITGB5;ITGA2;ITGAV;CD36;THBS2;THBS1,1,1,G2
21,KEGG_2021_Human,ErbB signaling pathway,6/85,2.794789613475791e-06,2.0960922101068437e-05,0,0,17.309471846355304,221.34926310956968,ERBB3;EGF;ERBB2;NRG2;HRAS;EGFR,1,1,G2
22,KEGG_2021_Human,Prostate cancer,6/97,6.038660559211381e-06,4.216289634196272e-05,0,0,15.017809776430466,180.47395091584465,AR;EGF;PLAU;ERBB2;HRAS;EGFR,1,1,G2
23,KEGG_2021_Human,Gastric cancer,7/149,6.132784922467305e-06,4.216289634196272e-05,0,0,11.329430068784802,135.9742517018405,EGF;CDH1;ERBB2;FZD6;LRP5;HRAS;EGFR,1,1,G2
24,KEGG_2021_Human,Lipid and atherosclerosis,8/215,7.283151193202087e-06,4.667942571964427e-05,0,0,8.957090082409776,105.961900350816,CXCL8;MMP1;TNFSF10;TNFRSF10B;CALM3;CD36;CALM2;HRAS,1,1,G2
25,KEGG_2021_Human,Endometrial cancer,5/58,7.355545870974249e-06,4.667942571964427e-05,0,0,21.284305317324183,251.5816805376001,CDH1;EGF;ERBB2;HRAS;EGFR,1,1,G2
26,KEGG_2021_Human,Ras signaling pathway,8/232,1.2677744855135105e-05,7.747510744804785e-05,0,0,8.27016806722689,93.25162374016932,EGF;VEGFB;CALM3;CALM2;HRAS;EGFR;PGF;VEGFA,1,1,G2
27,KEGG_2021_Human,Toxoplasmosis,6/112,1.3825947892248102e-05,8.043020261659474e-05,0,0,12.882888744307092,144.1461712810855,ITGB1;LAMA5;LAMB3;LAMB2;ITGA6;LAMC1,1,1,G2
28,KEGG_2021_Human,MicroRNAs in cancer,9/310,1.413621742958332e-05,8.043020261659474e-05,0,0,6.978879924062649,77.93155005288489,ERBB3;PLAU;ERBB2;TNC;THBS1;HRAS;EGFR;CD44;VEGFA,1,1,G2
29,KEGG_2021_Human,Calcium signaling pathway,8/240,1.6198666816767306e-05,8.909266749222018e-05,0,0,7.981744421906693,88.04328327091345,ERBB3;EGF;ERBB2;VEGFB;CALM3;CALM2;EGFR;VEGFA,1,1,G2
30,KEGG_2021_Human,Axon guidance,7/182,2.2562359216297063e-05,0.0001200899764738392,0,0,9.177674418604653,98.19402709103213,ITGB1;NRP1;SEMA3C;SEMA4C;PLXNB2;SEMA3F;HRAS,1,1,G2
31,KEGG_2021_Human,Glioma,5/75,2.6035189761106467e-05,0.0001342439472057052,0,0,16.101461038961038,169.96801268830694,EGF;CALM3;HRAS;CALM2;EGFR,1,1,G2
32,KEGG_2021_Human,Alzheimer disease,9/369,5.5254865739721045e-05,0.00027627432869860524,0,0,5.817559523809524,57.03275983437078,APP;NCSTN;FZD6;LRP5;ADAM10;CALM3;APOE;CALM2;HRAS,1,1,G2
33,KEGG_2021_Human,Breast cancer,6/147,6.412547962841934e-05,0.00031119718054968207,0,0,9.667889459525556,93.34027048421922,EGF;ERBB2;FZD6;LRP5;HRAS;EGFR,1,1,G2
34,KEGG_2021_Human,MAPK signaling pathway,8/294,6.845944833164347e-05,0.0003227373992777478,0,0,6.456931303990127,61.91725107970157,ERBB3;EGF;ERBB2;VEGFB;HRAS;EGFR;PGF;VEGFA,1,1,G2
35,KEGG_2021_Human,GnRH signaling pathway,5/93,7.340560368323766e-05,0.0003364423502148392,0,0,12.79635847107438,121.8150660221898,MMP2;CALM3;HRAS;CALM2;EGFR,1,1,G2
36,KEGG_2021_Human,TGF-beta signaling pathway,5/94,7.724687130065493e-05,0.0003444792909353531,0,0,12.65194075587334,119.79495347623704,BAMBI;INHBA;THBS1;BMPR1A;FBN1,1,1,G2
37,KEGG_2021_Human,Human cytomegalovirus infection,7/225,8.666047799616145e-05,0.0003762889176149116,0,0,7.351344143375293,68.76089026241968,CXCL8;CALM3;ITGAV;CALM2;HRAS;EGFR;VEGFA,1,1,G2
38,KEGG_2021_Human,Hematopoietic cell lineage,5/99,9.883188015420392e-05,0.0004181348775754781,0,0,11.975942940038683,110.4432275995174,ITGA2;ITGA1;ITGA6;CD36;CD44,1,1,G2
39,KEGG_2021_Human,Platelet activation,5/124,0.00028400054831189656,0.0011715022617865,0,0,9.448051948051948,77.15784114404573,COL1A1;ITGB1;COL3A1;COL1A2;ITGA2,1,1,G2
40,KEGG_2021_Human,Adherens junction,4/71,0.0003354587720731066,0.0013500170095625,0,0,13.308737212812344,106.47005067487464,CDH1;ERBB2;PTPRF;EGFR,1,1,G2
41,KEGG_2021_Human,Melanoma,4/72,0.00035393653858457235,0.0013581285782896,0,0,13.112359550561798,104.1959612339233,CDH1;EGF;HRAS;EGFR,1,1,G2
42,KEGG_2021_Human,Non-small cell lung cancer,4/72,0.00035393653858457235,0.0013581285782896,0,0,13.112359550561798,104.1959612339233,EGF;ERBB2;HRAS;EGFR,1,1,G2
43,KEGG_2021_Human,Pancreatic cancer,4/76,0.0004351803642424969,0.0015777447753921,0,0,12.38139825218477,95.82892690404466,EGF;ERBB2;EGFR;VEGFA,1,1,G2
44,KEGG_2021_Human,Pertussis,4/76,0.0004351803642424969,0.0015777447753921,0,0,12.38139825218477,95.82892690404466,ITGB1;CXCL8;CALM3;CALM2,1,1,G2
45,KEGG_2021_Human,Apelin signaling pathway,5/137,0.0004494182087480584,0.0015777447753921,0,0,8.511966253443527,65.60646236624278,CDH1;SPP1;CALM3;CALM2;HRAS,1,1,G2
46,KEGG_2021_Human,Estrogen signaling pathway,5/137,0.0004494182087480584,0.0015777447753921,0,0,8.511966253443527,65.60646236624278,MMP2;CALM3;CALM2;HRAS;EGFR,1,1,G2
47,KEGG_2021_Human,Melanogenesis,4/101,0.0012678444380784,0.0043582152558946,0,0,9.178732769605004,61.226159720323686,FZD6;CALM3;CALM2;HRAS,1,1,G2
48,KEGG_2021_Human,HIF-1 signaling pathway,4/109,0.001679475079262,0.0056553752669029,0,0,8.47597645799893,54.15533589930299,EGF;ERBB2;EGFR;VEGFA,1,1,G2
49,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,5/193,0.0020790154343881,0.0068607509334808,0,0,5.959562379110252,36.80542795754828,CXCL8;CALM3;CALM2;HRAS;VEGFA,1,1,G2
50,KEGG_2021_Human,Diabetic cardiomyopathy,5/203,0.0025878683170767,0.0083725151434834,0,0,5.655704775022957,33.69058533243802,COL1A1;COL3A1;COL1A2;MMP2;CD36,1,1,G2
51,KEGG_2021_Human,FoxO signaling pathway,4/131,0.0032735891310886,0.0103873501274929,0,0,6.999911527912944,40.05257189105276,EGF;TNFSF10;HRAS;EGFR,1,1,G2
52,KEGG_2021_Human,Long-term potentiation,3/67,0.0037604919132756,0.0117071918054809,0,0,10.334895833333333,57.701847280697145,CALM3;HRAS;CALM2,1,1,G2
53,KEGG_2021_Human,Insulin signaling pathway,4/137,0.0038419701120795,0.0117393531202429,0,0,6.682098504688688,37.164294959841726,CALM3;CALM2;HRAS;PTPRF,1,1,G2
54,KEGG_2021_Human,Central carbon metabolism in cancer,3/70,0.0042542088327827,0.0125347224537348,0,0,9.870646766169154,53.89221592743272,ERBB2;HRAS;EGFR,1,1,G2
55,KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,3/70,0.0042542088327827,0.0125347224537348,0,0,9.870646766169154,53.89221592743272,CXCL8;ADAM10;EGFR,1,1,G2
56,KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,4/143,0.0044738418546377,0.0129505948423723,0,0,6.391722576994584,34.57607290675993,FZD6;INHBA;HRAS;BMPR1A,1,1,G2
57,KEGG_2021_Human,Phospholipase D signaling pathway,4/148,0.005051171003975,0.0143697106147566,0,0,6.168227215980025,32.61841934275883,CXCL8;EGF;HRAS;EGFR,1,1,G2
58,KEGG_2021_Human,Chemical carcinogenesis,5/239,0.0051782681607685,0.0144815973987594,0,0,4.776855089355089,25.14194787843941,AR;EGF;HRAS;EGFR;VEGFA,1,1,G2
59,KEGG_2021_Human,Bacterial invasion of epithelial cells,3/77,0.0055537847380088,0.0152729080295244,0,0,8.933783783783785,46.39560177649829,ITGB1;CDH1;FN1,1,1,G2
60,KEGG_2021_Human,Oxytocin signaling pathway,4/154,0.0058075251064747,0.0157088793863661,0,0,5.919700374531836,30.47817390776696,CALM3;CALM2;HRAS;EGFR,1,1,G2
61,KEGG_2021_Human,Cellular senescence,4/156,0.0060755258543908,0.0160842843121386,0,0,5.841218214074512,29.81057966071869,CXCL8;CALM3;CALM2;HRAS,1,1,G2
62,KEGG_2021_Human,Salmonella infection,5/249,0.0061412721919074,0.0160842843121386,0,0,4.578753725782415,23.31832606312945,CXCL8;TNFSF10;TNFRSF10B;HRAS;S100A10,1,1,G2
63,KEGG_2021_Human,Phototransduction,2/28,0.007474124606165,0.0188514659054926,0,0,16.805579036348266,82.28529572043183,CALM3;CALM2,1,1,G2
64,KEGG_2021_Human,Wnt signaling pathway,4/166,0.0075393878762488,0.0188514659054926,0,0,5.477874878623942,26.77373950151769,SFRP1;BAMBI;FZD6;LRP5,1,1,G2
65,KEGG_2021_Human,Colorectal cancer,3/86,0.007540586362197,0.0188514659054926,0,0,7.96144578313253,38.911210652087526,EGF;HRAS;EGFR,1,1,G2
66,KEGG_2021_Human,Hepatocellular carcinoma,4/168,0.0078576423253517,0.0193509102042244,0,0,5.410523431077007,26.22085022557302,FZD6;LRP5;HRAS;EGFR,1,1,G2
67,KEGG_2021_Human,Gap junction,3/88,0.0080319292790254,0.0194892401623411,0,0,7.773333333333333,37.5011292497025,EGF;HRAS;EGFR,1,1,G2
68,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,3/89,0.0082845209667059,0.0198108110073404,0,0,7.682558139534883,36.82531642948109,EGF;HRAS;EGFR,1,1,G2
69,KEGG_2021_Human,Salivary secretion,3/93,0.0093414547015859,0.0217090144473475,0,0,7.33962962962963,34.300241893615826,TRPV6;CALM3;CALM2,1,1,G2
70,KEGG_2021_Human,Rheumatoid arthritis,3/93,0.0093414547015859,0.0217090144473475,0,0,7.33962962962963,34.300241893615826,CXCL8;MMP1;VEGFA,1,1,G2
71,KEGG_2021_Human,IL-17 signaling pathway,3/94,0.009617416890843,0.0220399137081819,0,0,7.258608058608059,33.71027921487154,CXCL8;MMP1;S100A8,1,1,G2
72,KEGG_2021_Human,Choline metabolism in cancer,3/98,0.010768661875962,0.0243401261579965,0,0,6.951578947368421,31.49840392735093,EGF;HRAS;EGFR,1,1,G2
73,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,3/100,0.0113729262286274,0.0253585517259935,0,0,6.8075601374570445,30.474176658100003,CXCL8;TNFSF10;TNFRSF10B,1,1,G2
74,KEGG_2021_Human,Cytokine-cytokine receptor interaction,5/295,0.0122240230346545,0.02689285067624,0,0,3.8434561128526648,16.92793424088766,CXCL8;TNFSF10;TNFRSF10B;INHBA;BMPR1A,1,1,G2
75,KEGG_2021_Human,C-type lectin receptor signaling pathway,3/104,0.0126392653525305,0.0274405103048361,0,0,6.536633663366336,28.57127938463682,CALM3;CALM2;HRAS,1,1,G2
76,KEGG_2021_Human,Thyroid cancer,2/37,0.0128171709269279,0.0274653662719884,0,0,12.478492935635792,54.36841348053223,CDH1;HRAS,1,1,G2
77,KEGG_2021_Human,Pathogenic Escherichia coli infection,4/197,0.0134981081470046,0.0285536903109713,0,0,4.590790009896955,19.76429550457468,ITGB1;CXCL8;TNFSF10;TNFRSF10B,1,1,G2
78,KEGG_2021_Human,Neurotrophin signaling pathway,3/119,0.0180846447743037,0.0377717264273433,0,0,5.687068965517241,22.82045645859243,CALM3;CALM2;HRAS,1,1,G2
79,KEGG_2021_Human,Oocyte meiosis,3/129,0.022333999325314,0.0460213604049899,0,0,5.233068783068783,19.894270444518614,AR;CALM3;CALM2,1,1,G2
80,KEGG_2021_Human,Cholesterol metabolism,2/50,0.0226749954090764,0.0460213604049899,0,0,9.092948717948715,34.43038199107018,CD36;APOE,1,1,G2
81,KEGG_2021_Human,Coronavirus disease,4/232,0.023097197764536,0.0460213604049899,0,0,3.879164202641435,14.616861312301392,NRP1;CXCL8;MMP1;EGFR,1,1,G2
82,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,3/131,0.0232436744456502,0.0460213604049899,0,0,5.15078125,19.3758084372285,TNFSF10;TNFRSF10B;HRAS,1,1,G2
83,KEGG_2021_Human,Pathways of neurodegeneration,6/475,0.0234290562061767,0.0460213604049899,0,0,2.8583192412322624,10.729496767078276,APP;FZD6;LRP5;CALM3;CALM2;HRAS,1,1,G2
0,KEGG_2021_Human,PI3K-Akt signaling pathway,27/354,3.2302111290399943e-25,6.008192700014389e-23,0,0,23.426804946150774,1321.086254561595,CSF1R;CHRM1;CSF1;ITGB5;FLT4;IGF1R;CD19;ERBB2;ITGAV;ITGB7;PDGFRB;ITGA3;ITGA1;F2R;FN1;COL1A1;COL1A2;COL4A2;COL4A1;COL6A2;ITGA11;COL6A1;COL6A3;ITGA5;TLR4;TLR2;IFNAR1,2,2,G2
1,KEGG_2021_Human,ECM-receptor interaction,17/88,3.996746064740837e-23,3.716973840208979e-21,0,0,60.11071492244607,3100.1486043756145,ITGB5;ITGA3;ITGA1;FN1;HSPG2;COL1A1;COL1A2;COL4A2;COL4A1;COL6A2;COL6A1;ITGA11;COL6A3;SDC1;ITGAV;ITGB7;ITGA5,2,2,G2
2,KEGG_2021_Human,Human papillomavirus infection,23/331,1.441926099015099e-20,8.939941813893614e-19,0,0,20.045721401885785,915.803256684878,PDGFRB;ITGB5;ITGA3;NOTCH4;ITGA1;FN1;HLA-B;HLA-C;HLA-A;HLA-F;TNFRSF1A;COL1A1;COL1A2;COL4A2;COL4A1;COL6A2;ITGA11;COL6A1;COL6A3;ITGAV;ITGB7;ITGA5;IFNAR1,2,2,G2
3,KEGG_2021_Human,Focal adhesion,19/201,1.3230125837127117e-19,6.15200851426411e-18,0,0,26.73883259597545,1162.3158054765458,PDGFRB;ITGB5;ITGA3;FLT4;ITGA1;FN1;IGF1R;COL1A1;COL1A2;COL4A2;COL4A1;COL6A2;ITGA11;ERBB2;COL6A1;COL6A3;ITGAV;ITGB7;ITGA5,2,2,G2
4,KEGG_2021_Human,Human immunodeficiency virus 1 infection,17/212,2.1015060527366875e-16,7.817602516180478e-15,0,0,21.749626744563454,785.1334082626578,HLA-B;HLA-C;CXCR4;CD3G;HLA-A;TNFRSF1B;HLA-F;CD3D;TNFRSF1A;GNAI2;CALM3;RIPK1;CALR;CALM1;TLR4;B2M;TLR2,2,2,G2
5,KEGG_2021_Human,Proteoglycans in cancer,16/205,2.650091902500419e-15,8.2152848977513e-14,0,0,20.862433862433864,700.2305286931573,TGFB1;ITGB5;MMP2;FN1;MMP9;HSPG2;IGF1R;COL1A1;COL1A2;GPC1;ERBB2;SDC1;ITGAV;ITGA5;TLR4;TLR2,2,2,G2
6,KEGG_2021_Human,Pathways in cancer,22/531,5.968678229617475e-15,1.5859630724412152e-13,0,0,11.328253597408803,371.0258040142488,PDGFRB;CSF1R;TGFB1;ITGA3;MMP2;NOTCH4;FLT4;F2R;FN1;CXCR4;MMP9;TGFBR2;IGF1R;GNAI2;EDNRB;COL4A2;COL4A1;ERBB2;CALM3;ITGAV;CALM1;IFNAR1,2,2,G2
7,KEGG_2021_Human,Chagas disease,12/102,6.97340026744898e-14,1.621315562181888e-12,0,0,31.45079365079365,952.7731216244453,C3;TGFB1;CCL5;SERPINE1;CD3G;CALR;TLR4;CD3D;TGFBR2;TNFRSF1A;TLR2;GNAI2,2,2,G2
8,KEGG_2021_Human,Cell adhesion molecules,13/148,2.7860098481487773e-13,5.757753686174139e-12,0,0,22.935921463632308,663.0544572314799,SELPLG;ITGB2;HLA-B;ICAM2;HLA-C;ICAM3;HLA-A;HLA-F;PTPRC;PECAM1;SDC1;ITGAV;ITGB7,2,2,G2
9,KEGG_2021_Human,Phagosome,13/152,3.937275448542293e-13,7.323332334288665e-12,0,0,22.27138770910982,636.1402581289851,ITGB5;ITGB2;HLA-B;HLA-C;HLA-A;HLA-F;C3;ITGAV;ITGA5;CALR;CD14;TLR4;TLR2,2,2,G2
10,KEGG_2021_Human,Regulation of actin cytoskeleton,14/218,2.391418395011368e-12,4.0436711042919493e-11,0,0,16.487326637972263,441.1865903140015,PDGFRB;CHRM1;ITGB5;ITGA3;ITGA1;F2R;ITGB2;FN1;CXCR4;ITGA11;ITGAX;ITGAV;ITGB7;ITGA5,2,2,G2
11,KEGG_2021_Human,Human cytomegalovirus infection,14/225,3.672578960173568e-12,5.6924973882690297e-11,0,0,15.934689631256502,419.5624014847336,HLA-B;HLA-C;CXCR4;HLA-A;HLA-F;TNFRSF1A;GNAI2;CCL5;CALM3;RIPK1;ITGAV;CALR;CALM1;B2M,2,2,G2
12,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,10/100,4.871683987460452e-11,6.97025555128957e-10,0,0,25.59948320413437,607.8596354394149,CSF1R;CCL21;CSF1;CCL5;CXCR4;CCR7;CCL19;TNFRSF1B;CXCL14;TNFRSF1A,2,2,G2
13,KEGG_2021_Human,Amoebiasis,10/102,5.947930479800868e-11,7.90225049459258e-10,0,0,25.040444893832152,589.587107967294,COL1A1;TGFB1;COL1A2;COL4A2;COL4A1;ITGB2;FN1;CD14;TLR4;TLR2,2,2,G2
14,KEGG_2021_Human,Cytokine-cytokine receptor interaction,14/295,1.3731174914426974e-10,1.702665689388945e-09,0,0,11.922662963284438,270.7489780429486,CSF1R;TGFB1;CCL21;CSF1;CXCR4;TNFRSF1B;CXCL14;TGFBR2;TNFRSF1A;CCL5;CCR7;LTB;CCL19;IFNAR1,2,2,G2
15,KEGG_2021_Human,Epstein-Barr virus infection,12/202,2.414137303148638e-10,2.8064346149102916e-09,0,0,14.822556390977445,328.23823238061925,CD19;HLA-B;HLA-C;CD3G;RIPK1;CALR;HLA-A;HLA-F;CD3D;B2M;TLR2;IFNAR1,2,2,G2
16,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,12/219,6.116403990935383e-10,6.382583206512554e-09,0,0,13.59351276742581,288.38469577589507,TGFB1;ITGB2;HLA-B;HLA-C;CD3G;CALR;HLA-A;HLA-F;CD3D;B2M;TGFBR2;TNFRSF1A,2,2,G2
17,KEGG_2021_Human,Relaxin signaling pathway,10/129,6.17669342565731e-10,6.382583206512554e-09,0,0,19.332616767637287,409.9494501994365,COL1A1;TGFB1;COL1A2;EDNRB;COL4A2;COL4A1;MMP2;MMP9;TGFBR2;GNAI2,2,2,G2
18,KEGG_2021_Human,Hematopoietic cell lineage,9/99,1.1190532442414227e-09,1.0954942285731822e-08,0,0,22.77471264367816,469.4046562407936,CSF1R;CSF1;ITGA3;CD19;ITGA1;CD3G;ITGA5;CD14;CD3D,2,2,G2
19,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,9/100,1.2249125221180211e-09,1.13916864556976e-08,0,0,22.52330428192497,462.18713223840615,COL1A1;TGFB1;COL1A2;COL4A2;COL4A1;MMP2;SERPINE1;FN1;TGFBR2,2,2,G2
20,KEGG_2021_Human,Pertussis,8/76,3.020263113145932e-09,2.6750901859292545e-08,0,0,26.518716577540108,520.2421103297562,C3;ITGB2;CALM3;ITGA5;CD14;CALM1;TLR4;GNAI2,2,2,G2
21,KEGG_2021_Human,Hypertrophic cardiomyopathy,8/90,1.175359700929537e-08,9.937132016949725e-08,0,0,21.97560975609756,401.2549992632378,TGFB1;ITGB5;ITGA3;ITGA1;ITGA11;ITGAV;ITGB7;ITGA5,2,2,G2
22,KEGG_2021_Human,Tuberculosis,10/180,1.5685380485090958e-08,1.2684699000986604e-07,0,0,13.497948016415869,242.56537071259976,C3;TGFB1;ITGB2;ITGAX;CALM3;CD14;CALM1;TLR4;TNFRSF1A;TLR2,2,2,G2
23,KEGG_2021_Human,Dilated cardiomyopathy,8/96,1.9639129146068717e-08,1.5220325088203254e-07,0,0,20.47107438016529,363.2744018714262,TGFB1;ITGB5;ITGA3;ITGA1;ITGA11;ITGAV;ITGB7;ITGA5,2,2,G2
24,KEGG_2021_Human,Fluid shear stress and atherosclerosis,9/139,2.2640702401373376e-08,1.6844682586621793e-07,0,0,15.73527851458886,276.996235896716,MMP2;GPC1;PECAM1;SDC1;CALM3;ITGAV;CALM1;MMP9;TNFRSF1A,2,2,G2
25,KEGG_2021_Human,Protein digestion and absorption,8/103,3.4261797062685035e-08,2.451036251407468e-07,0,0,18.95598086124402,325.83880762758344,COL1A1;COL18A1;COL1A2;COL4A2;COL4A1;COL6A2;COL6A1;COL6A3,2,2,G2
26,KEGG_2021_Human,Cellular senescence,9/156,6.16094599544617e-08,4.244207241307362e-07,0,0,13.903589021815623,230.83364722107208,TGFB1;SERPINE1;HLA-B;HLA-C;CALM3;HLA-A;CALM1;HLA-F;TGFBR2,2,2,G2
27,KEGG_2021_Human,Rap1 signaling pathway,10/210,6.758494979274853e-08,4.489571664804009e-07,0,0,11.455813953488372,189.1341195728632,PDGFRB;CSF1R;CSF1;FLT4;F2R;ITGB2;CALM3;CALM1;IGF1R;GNAI2,2,2,G2
28,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,7/77,8.597656444818507e-08,5.514358961159457e-07,0,0,22.285393258426968,362.5653213089154,ITGB5;ITGA3;ITGA1;ITGA11;ITGAV;ITGB7;ITGA5,2,2,G2
29,KEGG_2021_Human,Malaria,6/50,1.3991390814586561e-07,8.674662305043668e-07,0,0,30.09090909090909,474.9019053178628,TGFB1;ITGB2;PECAM1;SDC1;TLR4;TLR2,2,2,G2
30,KEGG_2021_Human,Calcium signaling pathway,10/240,2.3473480673011654e-07,1.4084088403806992e-06,0,0,9.946410515672396,151.8300611538132,PDGFRB;CHRM1;EDNRB;TBXA2R;FLT4;ERBB2;F2R;CXCR4;CALM3;CALM1,2,2,G2
31,KEGG_2021_Human,Rheumatoid arthritis,7/93,3.182340594096904e-07,1.8497354703188253e-06,0,0,18.12464071073948,271.1533010993122,TGFB1;CSF1;CCL5;ITGB2;LTB;TLR4;TLR2,2,2,G2
32,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,9/193,3.7872767825645293e-07,2.1346469138090987e-06,0,0,11.08695652173913,163.93671071194782,C3;HLA-B;HLA-C;CALM3;HLA-A;CALM1;HLA-F;TNFRSF1A;IFNAR1,2,2,G2
33,KEGG_2021_Human,NF-kappa B signaling pathway,7/104,6.836721289716822e-07,3.740088705550968e-06,0,0,16.060349820456388,227.98931126516072,CCL21;RIPK1;LTB;CD14;CCL19;TLR4;TNFRSF1A,2,2,G2
34,KEGG_2021_Human,Lipid and atherosclerosis,9/215,9.359962540145997e-07,4.974151521334729e-06,0,0,9.891864747238031,137.31544742272598,ABCA1;CCL5;CALM3;CD14;CALM1;MMP9;TLR4;TNFRSF1A;TLR2,2,2,G2
35,KEGG_2021_Human,MAPK signaling pathway,10/294,1.4967015920423163e-06,7.732958225551969e-06,0,0,8.033082214215526,107.74168129975185,PDGFRB;CSF1R;TGFB1;CSF1;FLT4;ERBB2;CD14;TGFBR2;TNFRSF1A;IGF1R,2,2,G2
36,KEGG_2021_Human,Antigen processing and presentation,6/78,2.030080000552161e-06,1.0205267029802756e-05,0,0,18.362962962962964,240.69134999172405,HLA-B;HLA-C;HLA-A;CALR;HLA-F;B2M,2,2,G2
37,KEGG_2021_Human,Osteoclast differentiation,7/127,2.629429499511197e-06,1.287036544497586e-05,0,0,12.967041198501873,166.61018833171454,CSF1R;TGFB1;CSF1;TREM2;TGFBR2;TNFRSF1A;IFNAR1,2,2,G2
38,KEGG_2021_Human,Herpes simplex virus 1 infection,12/498,4.665401211490739e-06,2.225037500864814e-05,0,0,5.707818930041152,70.06539931877799,C3;CCL5;HLA-B;HLA-C;ITGA5;CALR;HLA-A;HLA-F;B2M;TNFRSF1A;TLR2;IFNAR1,2,2,G2
39,KEGG_2021_Human,Legionellosis,5/57,7.882805664504412e-06,3.665504633994552e-05,0,0,20.976331360946745,246.48923396706851,C3;ITGB2;CD14;TLR4;TLR2,2,2,G2
40,KEGG_2021_Human,Viral myocarditis,5/60,1.016595732127353e-05,4.611873321358235e-05,0,0,19.829170829170828,227.9653869991178,ITGB2;HLA-B;HLA-C;HLA-A;HLA-F,2,2,G2
41,KEGG_2021_Human,Toll-like receptor signaling pathway,6/104,1.0850041752092692e-05,4.805018490212478e-05,0,0,13.473469387755102,154.01983151097096,CCL5;RIPK1;CD14;TLR4;TLR2;IFNAR1,2,2,G2
42,KEGG_2021_Human,Hepatitis B,7/162,1.3082901973957864e-05,5.659115737572472e-05,0,0,10.021239579557813,112.68086590425496,TGFB1;MMP9;TLR4;HSPG2;TGFBR2;TLR2;IFNAR1,2,2,G2
43,KEGG_2021_Human,TNF signaling pathway,6/112,1.6588165623306988e-05,7.012270013488864e-05,0,0,12.451572327044024,137.05222815962827,CSF1;CCL5;RIPK1;TNFRSF1B;MMP9;TNFRSF1A,2,2,G2
44,KEGG_2021_Human,Leukocyte transendothelial migration,6/114,1.83498060745147e-05,7.58458651079941e-05,0,0,12.219753086419754,133.26730194862822,MMP2;ITGB2;PECAM1;CXCR4;MMP9;GNAI2,2,2,G2
45,KEGG_2021_Human,Allograft rejection,4/38,3.246311761891371e-05,0.00013126391037212936,0,0,25.40920716112532,262.61447101876826,HLA-B;HLA-C;HLA-A;HLA-F,2,2,G2
46,KEGG_2021_Human,Leishmaniasis,5/77,3.448642319326881e-05,0.0001364781854031489,0,0,15.134310134310134,155.50420185191487,C3;TGFB1;ITGB2;TLR4;TLR2,2,2,G2
47,KEGG_2021_Human,Chemokine signaling pathway,7/192,3.904601877814875e-05,0.0001513033227653264,0,0,8.383419374430611,85.0981588551305,CCL21;CCL5;CXCR4;CCR7;CCL19;CXCL14;GNAI2,2,2,G2
48,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,6/131,4.02787529342481e-05,0.0001528948580769418,0,0,10.5488,106.75054842921908,ITGB2;HLA-B;ICAM2;HLA-C;HLA-A;IFNAR1,2,2,G2
49,KEGG_2021_Human,Graft-versus-host disease,4/42,4.850807582792026e-05,0.00018045004207986335,0,0,22.72997711670481,225.794598036873,HLA-B;HLA-C;HLA-A;HLA-F,2,2,G2
50,KEGG_2021_Human,Type I diabetes mellitus,4/43,5.328731260591136e-05,0.00019434196362155907,0,0,22.14604236343367,217.9128998788356,HLA-B;HLA-C;HLA-A;HLA-F,2,2,G2
51,KEGG_2021_Human,Complement and coagulation cascades,5/85,5.5548578386248845e-05,0.0001969513638460473,0,0,13.615384615384617,133.4069781680664,C3;ITGB2;SERPINE1;F2R;ITGAX,2,2,G2
52,KEGG_2021_Human,Measles,6/139,5.612054991312099e-05,0.0001969513638460473,0,0,9.910275689223058,97.00186272209346,RACK1;CD3G;TLR4;CD3D;TLR2;IFNAR1,2,2,G2
53,KEGG_2021_Human,Small cell lung cancer,5/92,8.110721149131407e-05,0.00027936928402563733,0,0,12.515473032714413,117.89248542248107,COL4A2;ITGA3;COL4A1;FN1;ITGAV,2,2,G2
54,KEGG_2021_Human,Autoimmune thyroid disease,4/53,0.00012188512151674564,0.0004121933200384489,0,0,17.61756876663709,158.7771331813639,HLA-B;HLA-C;HLA-A;HLA-F,2,2,G2
55,KEGG_2021_Human,Ras signaling pathway,7/232,0.00012816773919136008,0.0004256999908855888,0,0,6.879051186017478,61.65123091102421,PDGFRB;CSF1R;CSF1;FLT4;CALM3;CALM1;IGF1R,2,2,G2
56,KEGG_2021_Human,Shigellosis,7/246,0.000183904544301448,0.0006001095656152513,0,0,6.471487001081284,55.66186617778172,C3;CCL5;RIPK1;ITGA5;CD14;TLR4;TNFRSF1A,2,2,G2
57,KEGG_2021_Human,Toxoplasmosis,5/112,0.00020517487847309323,0.0006579746102757817,0,0,10.16586217520797,86.32492195551133,TGFB1;TLR4;TNFRSF1A;TLR2;GNAI2,2,2,G2
58,KEGG_2021_Human,Endocytosis,7/252,0.00021312774798317596,0.0006718942563537411,0,0,6.31107544141252,53.35142610227867,HLA-B;HLA-C;CXCR4;HLA-A;HLA-F;TGFBR2;IGF1R,2,2,G2
59,KEGG_2021_Human,Transcriptional misregulation in cancer,6/192,0.0003278805174724948,0.0010035424472233,0,0,7.067383512544803,56.70063761811355,CSF1R;ITGB7;CD14;MMP9;TGFBR2;IGF1R,2,2,G2
60,KEGG_2021_Human,Platelet activation,5/124,0.0003291187595732503,0.0010035424472233,0,0,9.135192538553882,73.25594849986626,COL1A1;COL1A2;TBXA2R;F2R;GNAI2,2,2,G2
61,KEGG_2021_Human,Renin secretion,4/69,0.00033935720239146875,0.0010180716071744,0,0,13.270234113712377,106.008698723836,CALM3;CALM1;AQP1;GNAI2,2,2,G2
62,KEGG_2021_Human,Diabetic cardiomyopathy,6/203,0.0004410092586116909,0.0013020273349488,0,0,6.669035532994924,51.52793416901543,COL1A1;TGFB1;COL1A2;MMP2;MMP9;TGFBR2,2,2,G2
63,KEGG_2021_Human,Glioma,4/75,0.0004667637554266463,0.0013565321642086,0,0,12.14513165952235,93.14936211054014,PDGFRB;CALM3;CALM1;IGF1R,2,2,G2
64,KEGG_2021_Human,Estrogen signaling pathway,5/137,0.0005199868929912048,0.0014879624937902,0,0,8.23010323010323,62.233628814803545,MMP2;CALM3;CALM1;MMP9;GNAI2,2,2,G2
65,KEGG_2021_Human,Primary immunodeficiency,3/38,0.0008003661767667638,0.0022555774072517,0,0,18.312442396313365,130.5757939927757,PTPRC;CD19;CD3D,2,2,G2
66,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,4/89,0.0008908943790286154,0.0024732291716316,0,0,10.13759590792839,71.1992220278813,CD3G;CD3D;TLR4;TLR2,2,2,G2
67,KEGG_2021_Human,Bladder cancer,3/41,0.0010008983065077,0.0027377512501534,0,0,16.864176570458405,116.47846233095048,MMP2;ERBB2;MMP9,2,2,G2
68,KEGG_2021_Human,Prostate cancer,4/97,0.0012278762424571,0.0033099272622756,0,0,9.261804581580176,62.076960260230734,PDGFRB;ERBB2;MMP9;IGF1R,2,2,G2
69,KEGG_2021_Human,cGMP-PKG signaling pathway,5/167,0.0012671100555621,0.0033126812211661,0,0,6.695835029168363,44.66802608342118,EDNRB;CALM3;CALM1;ADRA2A;GNAI2,2,2,G2
70,KEGG_2021_Human,Salmonella infection,6/249,0.001277151781001,0.0033126812211661,0,0,5.393964334705076,35.94064701883247,PTPRC;RIPK1;CD14;TLR4;TNFRSF1A;TLR2,2,2,G2
71,KEGG_2021_Human,Neuroactive ligand-receptor interaction,7/341,0.0012823282146449,0.0033126812211661,0,0,4.608423602233735,30.68785192747214,C3;CHRM1;EDNRB;TBXA2R;F2R;S1PR4;ADRA2A,2,2,G2
72,KEGG_2021_Human,Melanogenesis,4/101,0.0014259680854265,0.0036332885464293,0,0,8.878081577767817,58.177219281646686,EDNRB;CALM3;CALM1;GNAI2,2,2,G2
73,KEGG_2021_Human,Intestinal immune network for IgA production,3/48,0.0015850525143587,0.0039840509144693,0,0,14.23584229390681,91.78043611536052,TGFB1;CXCR4;ITGB7,2,2,G2
74,KEGG_2021_Human,Th17 cell differentiation,4/107,0.0017633804211116,0.0043656226580573,0,0,8.358379062895736,52.99649150055304,TGFB1;CD3G;CD3D;TGFBR2,2,2,G2
75,KEGG_2021_Human,Cholesterol metabolism,3/50,0.001783802806518,0.0043656226580573,0,0,13.628689087165409,86.25607933742052,ABCA1;LPL;APOE,2,2,G2
76,KEGG_2021_Human,HIF-1 signaling pathway,4/109,0.0018871689630356,0.0045586159366834,0,0,8.198343685300207,51.42556577565686,SERPINE1;ERBB2;TLR4;IGF1R,2,2,G2
77,KEGG_2021_Human,Alzheimer disease,7/369,0.0020089099064012,0.0047904774691107,0,0,4.245887392141039,26.36765295107483,CHRM1;CSF1;LPL;CALM3;APOE;CALM1;TNFRSF1A,2,2,G2
78,KEGG_2021_Human,Neutrophil extracellular trap formation,5/189,0.0021816680363606,0.0051365855033301,0,0,5.8886765408504536,36.08384031833502,C3;SELPLG;ITGB2;TLR4;TLR2,2,2,G2
79,KEGG_2021_Human,Viral carcinogenesis,5/203,0.0029703185915853,0.0069059907254358,0,0,5.468420468420469,31.82120932908589,C3;HLA-B;HLA-C;HLA-A;HLA-F,2,2,G2
80,KEGG_2021_Human,FoxO signaling pathway,4/131,0.0036690070796085,0.0084251273679899,0,0,6.770626497774734,37.96855085697664,TGFB1;S1PR4;TGFBR2;IGF1R,2,2,G2
81,KEGG_2021_Human,Inflammatory bowel disease,3/65,0.0037744923935291,0.0085616534780052,0,0,10.323621227887616,57.60053490723054,TGFB1;TLR4;TLR2,2,2,G2
82,KEGG_2021_Human,cAMP signaling pathway,5/216,0.0038706449171833,0.0086739753565794,0,0,5.12811832717046,28.48328270142009,CHRM1;F2R;CALM3;CALM1;GNAI2,2,2,G2
83,KEGG_2021_Human,Apelin signaling pathway,4/137,0.0043030485325422,0.0095281788934864,0,0,6.463223275580255,35.21442958623038,SERPINE1;CALM3;CALM1;GNAI2,2,2,G2
84,KEGG_2021_Human,Adherens junction,3/71,0.0048377544480063,0.010586145027402,0,0,9.409867172675522,50.16686835892171,ERBB2;IGF1R;TGFBR2,2,2,G2
85,KEGG_2021_Human,Coronavirus disease,5/232,0.0052288616464393,0.0113089333283454,0,0,4.7627922738054895,25.021622993852727,C3;TLR4;TNFRSF1A;TLR2;IFNAR1,2,2,G2
86,KEGG_2021_Human,Breast cancer,4/147,0.0055174183500652,0.0117958599208292,0,0,6.008209182122226,31.24175778620365,NOTCH4;FLT4;ERBB2;IGF1R,2,2,G2
87,KEGG_2021_Human,Gastric acid secretion,3/76,0.0058487757270354,0.012223284103692,0,0,8.763146266018559,45.055917352368986,CALM3;CALM1;GNAI2,2,2,G2
88,KEGG_2021_Human,Pancreatic cancer,3/76,0.0058487757270354,0.012223284103692,0,0,8.763146266018559,45.055917352368986,TGFB1;ERBB2;TGFBR2,2,2,G2
89,KEGG_2021_Human,Necroptosis,4/159,0.0072535501554979,0.0149906703213623,0,0,5.5396914446002805,27.289983938110005,RIPK1;TLR4;TNFRSF1A;IFNAR1,2,2,G2
90,KEGG_2021_Human,Hippo signaling pathway,4/163,0.0079038725119349,0.0160652470027682,0,0,5.399234345091605,26.13446714254645,TGFB1;SERPINE1;ITGB2;TGFBR2,2,2,G2
91,KEGG_2021_Human,Phototransduction,2/28,0.0079462512056703,0.0160652470027682,0,0,16.266775777414075,78.65075568636239,CALM3;CALM1,2,2,G2
92,KEGG_2021_Human,Influenza A,4/172,0.009504580261005,0.0190091605220101,0,0,5.107660455486543,23.781172404267068,CCL5;TLR4;TNFRSF1A;IFNAR1,2,2,G2
93,KEGG_2021_Human,GnRH signaling pathway,3/93,0.0101835299327531,0.0201503890158731,0,0,7.101792114695341,32.57580379183859,MMP2;CALM3;CALM1,2,2,G2
94,KEGG_2021_Human,TGF-beta signaling pathway,3/94,0.0104832324988093,0.0205250657345108,0,0,7.02339595887983,32.01248569235427,TGFB1;TGFBR2;FBN1,2,2,G2
95,KEGG_2021_Human,Staphylococcus aureus infection,3/95,0.0107880197297362,0.0209017882263639,0,0,6.946704067321178,31.463839031032744,C3;SELPLG;ITGB2,2,2,G2
96,KEGG_2021_Human,NOD-like receptor signaling pathway,4/181,0.011303064618906,0.0216612349141054,0,0,4.845738147875215,21.72190019119432,CCL5;RIPK1;TLR4;IFNAR1,2,2,G2
97,KEGG_2021_Human,Circadian entrainment,3/97,0.0114129087181845,0.0216612349141054,0,0,6.798215511324639,30.408487463309,CALM3;CALM1;GNAI2,2,2,G2
98,KEGG_2021_Human,T cell receptor signaling pathway,3/104,0.0137622465847819,0.0258563420683781,0,0,6.324816352603002,27.107063574474683,PTPRC;CD3G;CD3D,2,2,G2
99,KEGG_2021_Human,Pathogenic Escherichia coli infection,4/197,0.0150144016856411,0.0279267871352926,0,0,4.4404145077720205,18.64417010457104,F2R;RIPK1;TLR4;TNFRSF1A,2,2,G2
100,KEGG_2021_Human,MicroRNAs in cancer,5/310,0.0168496066742229,0.0310299687267867,0,0,3.530715186452891,14.417421129632116,PDGFRB;NOTCH4;ERBB2;ITGA5;MMP9,2,2,G2
101,KEGG_2021_Human,Sphingolipid signaling pathway,3/119,0.0196597518135948,0.0358501356600847,0,0,5.502780867630701,21.621426369934127,S1PR4;TNFRSF1A;GNAI2,2,2,G2
102,KEGG_2021_Human,Oocyte meiosis,3/129,0.024253323369361,0.0437972635602053,0,0,5.063492063492063,18.832147909850423,CALM3;CALM1;IGF1R,2,2,G2
103,KEGG_2021_Human,Dopaminergic synapse,3/132,0.0257350126339482,0.0460260802876381,0,0,4.9449862465616405,18.098169281493263,CALM3;CALM1;GNAI2,2,2,G2
104,KEGG_2021_Human,Pathways of neurodegeneration,6/475,0.0268780286366098,0.047612507870566,0,0,2.7626154939587777,9.990850043923622,CHRM1;CSF1;CALM3;TNFRSF1B;CALM1;TNFRSF1A,2,2,G2
105,KEGG_2021_Human,Yersinia infection,3/137,0.0283105994909662,0.0496770896728275,0,0,4.759268175252768,16.964501856481633,FN1;ITGA5;TLR4,2,2,G2
0,KEGG_2021_Human,PI3K-Akt signaling pathway,42/354,1.7136673472940855e-40,3.6329747762634603e-38,0,0,27.703846153846158,2536.6962457342097,ITGB1;CSF1R;LAMA5;CSF3;ITGB5;ITGB4;LAMA1;TNC;LPAR2;TGFA;LAMC2;AREG;THBS1;HSP90B1;IGF1R;RXRA;ERBB3;CHAD;ERBB2;ITGB8;ITGAV;ITGB7;ITGB6;NGFR;HSP90AA1;LAMB3;ITGA3;LAMB2;INSR;ITGA2;FN1;EREG;VEGFA;EFNA1;COL4A1;COL6A1;COL4A5;COL9A3;ITGA6;ITGA5;FGFR3;FGFR1,3,3,G2
1,KEGG_2021_Human,ECM-receptor interaction,28/88,6.988646613817784e-40,7.40796541064685e-38,0,0,84.7834862385321,7644.004238469131,ITGB1;LAMA5;ITGB5;SDC4;ITGB4;LAMA1;TNC;LAMC2;THBS1;CHAD;ITGB8;ITGAV;ITGB7;CD36;ITGB6;LAMB3;ITGA3;LAMB2;ITGA2;FN1;COL4A1;COL6A1;COL4A5;SDC1;ITGA6;COL9A3;ITGA5;CD44,3,3,G2
2,KEGG_2021_Human,Pathways in cancer,47/531,1.64448639351385e-39,1.162103718083121e-37,0,0,20.909389348025712,1867.2793623578957,NOTCH2;RET;ITGB1;CSF1R;NOTCH3;LAMA5;NOTCH1;LAMA1;GSTP1;LRP5;LPAR2;TGFA;LAMC2;PLD1;ADCY7;HSP90B1;IGF1R;GNAI2;RXRA;CDH1;ERBB2;ITGAV;JAG2;HSP90AA1;TGFB1;LAMB3;ITGA3;LAMB2;ITGA2;FN1;TRAF2;ESR1;TGFBR1;VEGFA;AR;BMP2;CXCL12;COL4A1;GNAS;COL4A5;CALM3;ITGA6;IL6ST;CALM1;CALM2;FGFR3;FGFR1,3,3,G2
3,KEGG_2021_Human,Human papillomavirus infection,34/331,1.8618159424540293e-30,9.867624495006351e-29,0,0,21.746395998823186,1488.6712946125729,NOTCH2;ITGB1;NOTCH3;LAMA5;NOTCH1;ITGB5;ITGB4;LAMA1;TNC;LAMC2;PSEN1;THBS1;CHAD;ITGB8;ITGAV;ITGB7;ITGB6;LAMB3;ITGA3;LAMB2;ITGA2;HLA-B;FN1;HLA-A;HLA-F;VEGFA;PKM;COL4A1;COL6A1;GNAS;COL4A5;COL9A3;ITGA6;ITGA5,3,3,G2
4,KEGG_2021_Human,Focal adhesion,27/201,2.1358156379743302e-27,9.055858305011162e-26,0,0,27.77445141065831,1705.655416452012,ITGB1;LAMA5;ITGB5;ITGB4;LAMA1;TNC;LAMC2;THBS1;IGF1R;CHAD;ERBB2;ITGB8;ITGAV;ITGB7;ITGB6;LAMB3;ITGA3;LAMB2;ITGA2;FN1;VEGFA;COL4A1;COL6A1;COL4A5;COL9A3;ITGA6;ITGA5,3,3,G2
5,KEGG_2021_Human,Rap1 signaling pathway,20/210,1.879714389641828e-17,6.641657510067794e-16,0,0,17.699505173189383,681.6579760480009,FARP2;ITGB1;NGFR;CSF1R;INSR;ITGB2;LPAR2;ADCY7;THBS1;IGF1R;VEGFA;GNAI2;EFNA1;CDH1;GNAS;CALM3;CALM1;CALM2;FGFR3;FGFR1,3,3,G2
6,KEGG_2021_Human,Small cell lung cancer,15/92,6.551348514329013e-17,1.984122692911073e-15,0,0,31.593570364062167,1177.3115155215196,ITGB1;LAMA5;LAMB3;ITGA3;LAMA1;LAMB2;ITGA2;FN1;LAMC2;TRAF2;RXRA;COL4A1;COL4A5;ITGAV;ITGA6,3,3,G2
7,KEGG_2021_Human,Dilated cardiomyopathy,15/96,1.2783817279331143e-16,3.387711579022753e-15,0,0,30.027322404371585,1098.8728788770509,ITGB1;TGFB1;ITGB5;ITGB4;ITGA3;LAMA1;ITGA2;ADCY7;GNAS;ITGB8;ITGAV;ITGB7;ITGA6;ITGB6;ITGA5,3,3,G2
8,KEGG_2021_Human,Proteoglycans in cancer,19/205,2.0988077822259455e-16,4.943858331465562e-15,0,0,17.034034991798798,614.9285273939686,ITGB1;TGFB1;SDC4;ITGB5;ITGA2;FN1;ESR1;THBS1;IGF1R;VEGFA;ERBB3;GPC1;ERBB2;SDC1;TIMP3;ITGAV;ITGA5;CD44;FGFR1,3,3,G2
9,KEGG_2021_Human,Hypertrophic cardiomyopathy,13/90,4.2928135697899116e-14,9.10076476795461e-13,0,0,26.939463762044408,829.1764614467716,ITGB1;TGFB1;ITGB5;ITGB4;ITGA3;LAMA1;ITGA2;ITGB8;ITGAV;ITGB7;ITGA6;ITGB6;ITGA5,3,3,G2
10,KEGG_2021_Human,Cell adhesion molecules,15/148,9.525223066515165e-14,1.835770263728377e-12,0,0,18.23924565512141,546.8535858738953,ITGB1;SDC4;ITGB2;HLA-B;HLA-A;L1CAM;HLA-F;PTPRF;CD4;CDH1;SDC1;ITGB8;ITGA6;ITGAV;ITGB7,3,3,G2
11,KEGG_2021_Human,Regulation of actin cytoskeleton,17/218,1.5369737803048554e-13,2.6813676878358024e-12,0,0,13.857960199004976,408.8623586749428,ITGB1;ITGB5;ITGA3;ITGB4;ITGA2;ITGB2;FN1;LPAR2;CXCL12;ITGB8;ITGA6;ITGAV;ITGB7;ITGA5;ITGB6;FGFR3;FGFR1,3,3,G2
12,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,12/77,1.6442349029181809e-13,2.6813676878358024e-12,0,0,29.24012307692308,860.7219424698129,ITGB1;ITGB5;ITGB4;ITGA3;LAMA1;ITGA2;ITGB8;ITGAV;ITGB7;ITGA6;ITGB6;ITGA5,3,3,G2
13,KEGG_2021_Human,Human cytomegalovirus infection,17/225,2.57926333674343e-13,3.90574162421148e-12,0,0,13.38681891025641,388.03170346388816,HLA-B;TRAF2;HLA-A;HLA-F;ADCY7;VEGFA;GNAI2;CXCL12;CCL5;GNAS;CALM3;RIPK1;ITGAV;CALR;CALM1;CALM2;B2M,3,3,G2
14,KEGG_2021_Human,Cytokine-cytokine receptor interaction,18/295,1.8860932671832656e-12,2.665678484285682e-11,0,0,10.695264387343386,288.7348492110998,ACVR1;NGFR;CSF1R;CSF3;TGFB1;BMPR2;GDF15;BMP7;TGFBR1;CXCL10;GDF9;CD4;BMP2;CXCL12;CLCF1;CCL5;TNFSF10;IL6ST,3,3,G2
15,KEGG_2021_Human,Fluid shear stress and atherosclerosis,13/139,1.2807926741583454e-11,1.6970502932598076e-10,0,0,16.422235023041473,411.88536815751104,ACVR1;HSP90AA1;BMPR2;SDC4;GSTP1;HSP90B1;VEGFA;GPC1;SDC1;CALM3;ITGAV;CALM1;CALM2,3,3,G2
16,KEGG_2021_Human,Axon guidance,14/182,2.8836165208332792e-11,3.5960394259803245e-10,0,0,13.34349593495935,323.83851721905467,EPHB6;ITGB1;BMPR2;SEMA4D;SEMA4C;UNC5C;L1CAM;NTN1;BMP7;GNAI2;EFNA1;CXCL12;PLXNB2;PLXNA3,3,3,G2
17,KEGG_2021_Human,Phagosome,13/152,3.996698843879389e-11,4.70722308279128e-10,0,0,14.876537479693663,356.1884502883176,ITGB1;ITGB5;ITGA2;ITGB2;HLA-B;HLA-A;HLA-F;THBS1;CANX;ITGAV;ITGA5;CALR;CD36,3,3,G2
18,KEGG_2021_Human,Amoebiasis,11/102,1.0874808350686372e-10,1.2133996686029002e-09,0,0,18.968428396999823,435.17343900398936,LAMA5;TGFB1;LAMB3;COL4A1;LAMA1;LAMB2;ITGB2;FN1;GNAS;COL4A5;LAMC2,3,3,G2
19,KEGG_2021_Human,MAPK signaling pathway,16/294,1.8963027005061426e-10,2.010080862536512e-09,0,0,9.31565491408526,208.53973749008884,NGFR;CSF1R;TGFB1;INSR;TGFA;TRAF2;AREG;TGFBR1;EREG;IGF1R;VEGFA;EFNA1;ERBB3;ERBB2;FGFR3;FGFR1,3,3,G2
20,KEGG_2021_Human,Ras signaling pathway,13/232,7.385677841011436e-09,7.45601762997345e-08,0,0,9.403888643393724,176.07580738875305,NGFR;CSF1R;INSR;TGFA;PLD1;IGF1R;VEGFA;EFNA1;CALM3;CALM1;CALM2;FGFR3;FGFR1,3,3,G2
21,KEGG_2021_Human,Human immunodeficiency virus 1 infection,12/212,2.5641253522761798e-08,2.412943704724928e-07,0,0,9.43824,164.97159455864195,CD4;HLA-B;CALM3;TRAF2;RIPK1;HLA-A;CALR;CALM1;HLA-F;CALM2;B2M;GNAI2,3,3,G2
22,KEGG_2021_Human,Hematopoietic cell lineage,9/99,2.617816283427988e-08,2.412943704724928e-07,0,0,15.44765625,269.6904389288909,CSF1R;CSF3;CD4;ITGA3;ITGA2;ITGA6;CD36;ITGA5;CD44,3,3,G2
23,KEGG_2021_Human,Adherens junction,8/71,2.9194939738336923e-08,2.501422040705017e-07,0,0,19.4905869324474,338.1474637121466,FARP2;CDH1;INSR;ERBB2;PTPRF;TGFBR1;IGF1R;FGFR1,3,3,G2
24,KEGG_2021_Human,MicroRNAs in cancer,14/310,2.949790142340822e-08,2.501422040705017e-07,0,0,7.524115578993627,130.46023909656023,NOTCH2;NOTCH3;NOTCH1;BMPR2;TNC;THBS1;VEGFA;EFNA1;ERBB3;ERBB2;TIMP3;ITGA5;FGFR3;CD44,3,3,G2
25,KEGG_2021_Human,Estrogen signaling pathway,10/137,3.578825368657411e-08,2.918119146751427e-07,0,0,12.236344472688945,209.8000319683132,HSP90AA1;GNAS;TGFA;CALM3;CALM1;ESR1;CALM2;ADCY7;HSP90B1;GNAI2,3,3,G2
26,KEGG_2021_Human,Antigen processing and presentation,8/78,6.180727051449095e-08,4.853015314471142e-07,0,0,17.53532668881506,291.073180943696,HSP90AA1;CD4;CANX;HLA-B;HLA-A;CALR;HLA-F;B2M,3,3,G2
27,KEGG_2021_Human,Toxoplasmosis,9/112,7.7089794614877e-08,5.836798735126401e-07,0,0,13.489077669902912,220.92809242084363,ITGB1;LAMA5;TGFB1;LAMB3;LAMA1;LAMB2;LAMC2;ITGA6;GNAI2,3,3,G2
28,KEGG_2021_Human,TGF-beta signaling pathway,8/94,2.6769611065300535e-07,1.9569508778771425e-06,0,0,14.261402559942312,215.82370082131044,ACVR1;BMP2;BMPR2;TGFB1;LTBP1;THBS1;BMP7;TGFBR1,3,3,G2
29,KEGG_2021_Human,Lipid and atherosclerosis,11/215,2.779153659779742e-07,1.9639352529110177e-06,0,0,8.413048552754436,127.0029536413187,HSP90AA1;RXRA;CCL5;TNFSF10;CALM3;TRAF2;CD36;CALM1;CALM2;AGER;HSP90B1,3,3,G2
30,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,11/219,3.3419755209743735e-07,2.263235654589344e-06,0,0,8.249580280830282,123.01389309369398,CD4;TGFB1;CANX;ITGB2;HLA-B;HLA-A;CALR;HLA-F;ADCY7;B2M;TGFBR1,3,3,G2
31,KEGG_2021_Human,Prostate cancer,8/97,3.416204761644293e-07,2.263235654589344e-06,0,0,13.778590715094504,205.1572280530377,AR;HSP90AA1;GSTP1;ERBB2;TGFA;IGF1R;HSP90B1;FGFR1,3,3,G2
32,KEGG_2021_Human,Breast cancer,9/147,7.889229813766117e-07,4.959374731526297e-06,0,0,10.050101902173912,141.2300332105901,JAG2;NOTCH2;NOTCH3;NOTCH1;ERBB2;LRP5;ESR1;FGFR1;IGF1R,3,3,G2
33,KEGG_2021_Human,Chemical carcinogenesis,11/239,7.953714192070477e-07,4.959374731526297e-06,0,0,7.518274853801169,105.5900851724313,NOTCH2;AR;HSP90AA1;RXRA;GSTP1;GNAS;ADCY7;ESR1;HSP90B1;VEGFA;GNAI2,3,3,G2
34,KEGG_2021_Human,Calcium signaling pathway,11/240,8.287599230779551e-07,5.019917248357899e-06,0,0,7.4850627296042145,104.8158433086276,RET;ERBB3;ERBB2;GNAS;CALM3;CALM1;CALM2;ADCY7;FGFR3;FGFR1;VEGFA,3,3,G2
35,KEGG_2021_Human,Pertussis,7/76,8.945238747126221e-07,5.267751706640997e-06,0,0,15.446822742474916,215.1275024827811,ITGB1;ITGB2;CALM3;ITGA5;CALM1;CALM2;GNAI2,3,3,G2
36,KEGG_2021_Human,Malaria,6/50,1.1479715680292036e-06,6.577566822221383e-06,0,0,20.630464954892435,282.17347380198294,CSF3;TGFB1;ITGB2;SDC1;CD36;THBS1,3,3,G2
37,KEGG_2021_Human,Alzheimer disease,13/369,1.5820613679635432e-06,8.82623710548082e-06,0,0,5.744631206959043,76.72978611574437,APP;INSR;LRP5;ADAM10;TRAF2;PSEN1;DKK1;AGER;RTN4;NCSTN;CALM3;CALM1;CALM2,3,3,G2
38,KEGG_2021_Human,Relaxin signaling pathway,8/129,2.9991721353178464e-06,1.6303192120189318e-05,0,0,10.11826510346595,128.67574055264996,TGFB1;COL4A1;GNAS;COL4A5;ADCY7;TGFBR1;GNAI2;VEGFA,3,3,G2
39,KEGG_2021_Human,Notch signaling pathway,6/59,3.094778789214897e-06,1.6402327582838954e-05,0,0,17.119400835373757,217.17319459191765,NOTCH2;JAG2;NOTCH3;NCSTN;NOTCH1;PSEN1,3,3,G2
40,KEGG_2021_Human,IL-17 signaling pathway,7/94,3.781017474812912e-06,1.9550626942935058e-05,0,0,12.239787798408488,152.8200836679214,CXCL10;CSF3;HSP90AA1;TRAF2;S100A9;S100A8;HSP90B1,3,3,G2
41,KEGG_2021_Human,Apelin signaling pathway,8/137,4.697502485672003e-06,2.371120302291582e-05,0,0,9.486929872002884,116.39020537846032,NOTCH3;CDH1;CALM3;CALM1;CALM2;ADCY7;TGFBR1;GNAI2,3,3,G2
42,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,7/100,5.714942831324485e-06,2.8175997214902112e-05,0,0,11.446650124069478,138.18883959303977,TGFB1;COL4A1;FN1;COL4A5;AGER;TGFBR1;VEGFA,3,3,G2
43,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,9/193,7.453083368455259e-06,3.5910310775284427e-05,0,0,7.519998301630435,88.78773812403679,HLA-B;CALM3;TRAF2;HLA-A;IL6ST;CALM1;HLA-F;CALM2;VEGFA,3,3,G2
44,KEGG_2021_Human,Renin secretion,6/69,7.784964047998895e-06,3.667583062612813e-05,0,0,14.394765539803709,169.33018112821318,GNAS;CALM3;CALM1;CALM2;AQP1;GNAI2,3,3,G2
45,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",7/106,8.409130116788492e-06,3.875512140780784e-05,0,0,10.74965034965035,125.62248354866786,RXRA;GNAS;LRP5;PLD1;ADCY7;FGFR1;GNAI2,3,3,G2
46,KEGG_2021_Human,Bladder cancer,5/41,8.614478805121845e-06,3.885679801459215e-05,0,0,20.861742424242426,243.29102095581163,CDH1;ERBB2;THBS1;FGFR3;VEGFA,3,3,G2
47,KEGG_2021_Human,Epstein-Barr virus infection,9/202,1.0757057486741774e-05,4.7510337233109504e-05,0,0,7.166045984455959,81.9791970710364,CXCL10;HLA-B;TRAF2;RIPK1;HLA-A;CALR;HLA-F;B2M;CD44,3,3,G2
48,KEGG_2021_Human,Cellular senescence,8/156,1.2219454932940296e-05,5.286784583231312e-05,0,0,8.261051749423842,93.45299268789282,TGFB1;HLA-B;CALM3;HLA-A;CALM1;HLA-F;CALM2;TGFBR1,3,3,G2
49,KEGG_2021_Human,Gastric acid secretion,6/76,1.365141782281002e-05,5.674707016540636e-05,0,0,12.950708833151582,145.0695299894663,GNAS;CALM3;CALM1;ADCY7;CALM2;GNAI2,3,3,G2
50,KEGG_2021_Human,Pancreatic cancer,6/76,1.365141782281002e-05,5.674707016540636e-05,0,0,12.950708833151582,145.0695299894663,TGFB1;ERBB2;TGFA;PLD1;TGFBR1;VEGFA,3,3,G2
51,KEGG_2021_Human,Hippo signaling pathway,8/163,1.6811852742552585e-05,6.854063041194514e-05,0,0,7.885171292823205,86.6850502584734,BMP2;TGFB1;BMPR2;CDH1;ITGB2;BMP7;AREG;TGFBR1,3,3,G2
52,KEGG_2021_Human,ErbB signaling pathway,6/85,2.5968241690852207e-05,0.00010387296676340884,0,0,11.470093728862691,121.10854732151697,NRG3;ERBB3;ERBB2;TGFA;AREG;EREG,3,3,G2
53,KEGG_2021_Human,GnRH signaling pathway,6/93,4.3278250541134336e-05,0.00016990720582815702,0,0,10.411160831797842,104.60989007890662,GNAS;CALM3;PLD1;CALM1;ADCY7;CALM2,3,3,G2
54,KEGG_2021_Human,Circadian entrainment,6/97,5.486495542164551e-05,0.00021147946453434267,0,0,9.951514134720242,97.63068031712936,GNAS;CALM3;CALM1;CALM2;ADCY7;GNAI2,3,3,G2
55,KEGG_2021_Human,Viral myocarditis,5/60,5.656703750319805e-05,0.0002141466419763926,0,0,13.641873278236917,133.41866819740238,LAMA1;ITGB2;HLA-B;HLA-A;HLA-F,3,3,G2
56,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,6/100,6.508419032181117e-05,0.00024206751488112225,0,0,9.632450868929674,92.8551781720776,CSF1R;CXCL10;CXCL12;CCL5;TNFSF10;IL6ST,3,3,G2
57,KEGG_2021_Human,Melanogenesis,6/101,6.880916880675628e-05,0.0002515093756384885,0,0,9.53057452792286,91.34268034841575,GNAS;CALM3;CALM1;CALM2;ADCY7;GNAI2,3,3,G2
58,KEGG_2021_Human,Chagas disease,6/102,7.27023586749745e-05,0.0002612355938829592,0,0,9.430820610687023,89.86757907537377,TGFB1;CCL5;GNAS;CALR;TGFBR1;GNAI2,3,3,G2
59,KEGG_2021_Human,Protein digestion and absorption,6/103,7.676927790697962e-05,0.0002712514486046613,0,0,9.333123475249865,88.42860122391258,COL18A1;COL4A1;COL7A1;COL6A1;COL4A5;COL9A3,3,3,G2
60,KEGG_2021_Human,Th17 cell differentiation,6/107,9.48883947776853e-05,0.0003297760605388407,0,0,8.96168090091452,83.01033983749545,HSP90AA1;CD4;TGFB1;RXRA;IL6ST;TGFBR1,3,3,G2
61,KEGG_2021_Human,Central carbon metabolism in cancer,5/70,0.00011867584499213004,0.0004057948248117995,0,0,11.537296037296038,104.28694305502805,RET;PKM;ERBB2;FGFR3;FGFR1,3,3,G2
62,KEGG_2021_Human,Glioma,5/75,0.00016467008638808636,0.0005541279097503859,0,0,10.710497835497836,93.30521480739354,TGFA;CALM3;CALM1;CALM2;IGF1R,3,3,G2
63,KEGG_2021_Human,Thyroid hormone signaling pathway,6/121,0.0001866235069100155,0.0006181903666394263,0,0,7.865117822768005,67.533183760553,NOTCH2;NOTCH3;NOTCH1;RXRA;ITGAV;ESR1,3,3,G2
64,KEGG_2021_Human,Platelet activation,6/124,0.00021323605906142,0.0006954776080157083,0,0,7.663992754560745,64.78457952169295,ITGB1;FGB;ITGA2;GNAS;ADCY7;GNAI2,3,3,G2
65,KEGG_2021_Human,Oocyte meiosis,6/129,0.0002641555866654272,0.0008484997632283418,0,0,7.350586482964066,60.56127831151122,AR;CALM3;CALM1;CALM2;ADCY7;IGF1R,3,3,G2
66,KEGG_2021_Human,Colorectal cancer,5/86,0.0003128879602378826,0.00099003354582733,0,0,9.25084175084175,74.65119746828569,TGFB1;TGFA;AREG;TGFBR1;EREG,3,3,G2
67,KEGG_2021_Human,Ovarian steroidogenesis,4/51,0.0004102277528170341,0.0012789453470178,0,0,12.680211166213406,98.89040621581616,INSR;GNAS;ADCY7;IGF1R,3,3,G2
68,KEGG_2021_Human,Th1 and Th2 cell differentiation,5/92,0.00042758262039297183,0.0013137321090334,0,0,8.610240334378265,66.79275999923871,NOTCH2;JAG2;NOTCH3;CD4;NOTCH1,3,3,G2
69,KEGG_2021_Human,Rheumatoid arthritis,5/93,0.0004494182087480584,0.0013419247923181,0,0,8.511966253443527,65.60646236624278,TGFB1;CXCL12;CCL5;ITGB2;VEGFA,3,3,G2
70,KEGG_2021_Human,Salivary secretion,5/93,0.0004494182087480584,0.0013419247923181,0,0,8.511966253443527,65.60646236624278,GNAS;CALM3;CALM1;ADCY7;CALM2,3,3,G2
71,KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,6/143,0.0004587248752235203,0.0013506899103803,0,0,6.594751211901711,50.694247776142,ACVR1;BMPR2;IL6ST;FGFR3;FGFR1;IGF1R,3,3,G2
72,KEGG_2021_Human,Regulation of lipolysis in adipocytes,4/55,0.0005481516602630812,0.0015918924928188,0,0,11.683325961963734,87.72961045631041,INSR;GNAS;ADCY7;GNAI2,3,3,G2
73,KEGG_2021_Human,Gastric cancer,6/149,0.0005702100904158435,0.0015940622237296,0,0,6.316126621470133,47.17834370857258,TGFB1;RXRA;CDH1;ERBB2;LRP5;TGFBR1,3,3,G2
74,KEGG_2021_Human,Aldosterone synthesis and secretion,5/98,0.0005714562688842293,0.0015940622237296,0,0,8.052297165200391,60.12910058384696,GNAS;CALM3;CALM1;CALM2;ADCY7,3,3,G2
75,KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,5/98,0.0005714562688842293,0.0015940622237296,0,0,8.052297165200391,60.12910058384696,GNAS;CALM3;CALM1;CALM2;ADCY7,3,3,G2
76,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,6/150,0.0005906738075787,0.0016262707429439,0,0,6.271946564885496,46.62719758820295,GNAS;CALM3;CALM1;CALM2;ADCY7;GNAI2,3,3,G2
77,KEGG_2021_Human,Oxytocin signaling pathway,6/154,0.0006782956772090886,0.0018435728662605,0,0,6.101196616463792,44.5138867310453,GNAS;CALM3;CALM1;CALM2;ADCY7;GNAI2,3,3,G2
78,KEGG_2021_Human,cAMP signaling pathway,7/216,0.0007307299764639053,0.0019609462659537,0,0,5.0635995583364,36.56661486197232,GNAS;CALM3;CALM1;PLD1;CALM2;ADCY7;GNAI2,3,3,G2
79,KEGG_2021_Human,Glucagon signaling pathway,5/107,0.0008517538379079429,0.002257147670456,0,0,7.338458110516934,51.86978498386728,PKM;GNAS;CALM3;CALM1;CALM2,3,3,G2
80,KEGG_2021_Human,Phototransduction,3/28,0.0009086467222529108,0.0023781864829335,0,0,17.765373134328357,124.4207533401805,CALM3;CALM1;CALM2,3,3,G2
81,KEGG_2021_Human,cGMP-PKG signaling pathway,6/167,0.0010341667043019,0.0026736992842927,0,0,5.604855151486416,38.528667126415975,INSR;CALM3;CALM1;CALM2;ADCY7;GNAI2,3,3,G2
82,KEGG_2021_Human,Hepatocellular carcinoma,6/168,0.0010665302666253,0.0027241495966816,0,0,5.569974554707379,38.1172555197972,TGFB1;GSTP1;LRP5;TGFA;TGFBR1;IGF1R,3,3,G2
83,KEGG_2021_Human,Amphetamine addiction,4/69,0.0012905069068752,0.0032569936221136,0,0,9.16043956043956,60.94184118303395,GNAS;CALM3;CALM1;CALM2,3,3,G2
84,KEGG_2021_Human,Neurotrophin signaling pathway,5/119,0.0013708168177081,0.0034189784159309,0,0,6.562001594896332,43.25900136785636,NGFR;CALM3;PSEN1;CALM1;CALM2,3,3,G2
85,KEGG_2021_Human,Non-small cell lung cancer,4/72,0.0015116759296353,0.003726456942822,0,0,8.754975674480319,56.85950781773877,RET;RXRA;ERBB2;TGFA,3,3,G2
86,KEGG_2021_Human,Thyroid hormone synthesis,4/75,0.001757965652873,0.0042837783725181,0,0,8.383776342264111,53.1833069841588,CANX;GNAS;ADCY7;HSP90B1,3,3,G2
87,KEGG_2021_Human,Endocytosis,7/252,0.0017804760182157,0.0042893285893379,0,0,4.311648351648351,27.296504707907197,HLA-B;HLA-A;HLA-F;PLD1;FGFR3;TGFBR1;IGF1R,3,3,G2
88,KEGG_2021_Human,Bacterial invasion of epithelial cells,4/77,0.0019368198911982,0.0046135485048767,0,0,8.153259861983727,50.93103264594957,ITGB1;CDH1;FN1;ITGA5,3,3,G2
89,KEGG_2021_Human,Thyroid cancer,3/37,0.0020604136077316,0.0048534187204344,0,0,13.05684811237928,80.754627931084,RET;RXRA;CDH1,3,3,G2
90,KEGG_2021_Human,FoxO signaling pathway,5/131,0.0020927590041494,0.0048754385591173,0,0,5.933441558441558,36.60501478640387,TGFB1;INSR;TNFSF10;TGFBR1;IGF1R,3,3,G2
91,KEGG_2021_Human,Dopaminergic synapse,5/132,0.0021633793138631,0.004985178418902,0,0,5.886423287998091,36.11958647546277,GNAS;CALM3;CALM1;CALM2;GNAI2,3,3,G2
92,KEGG_2021_Human,Allograft rejection,3/38,0.0022258949896533,0.0050422681422154,0,0,12.68315565031983,77.4635932754753,HLA-B;HLA-A;HLA-F,3,3,G2
93,KEGG_2021_Human,Vascular smooth muscle contraction,5/133,0.0022357226668313,0.0050422681422154,0,0,5.840139678030303,35.64348653358879,GNAS;CALM3;CALM1;CALM2;ADCY7,3,3,G2
94,KEGG_2021_Human,Insulin signaling pathway,5/137,0.0025428191008918,0.0056153921811362,0,0,5.6620179063360885,33.827623675392765,INSR;CALM3;CALM1;CALM2;PTPRF,3,3,G2
95,KEGG_2021_Human,Yersinia infection,5/137,0.0025428191008918,0.0056153921811362,0,0,5.6620179063360885,33.827623675392765,ITGB1;CD4;FN1;TRAF2;ITGA5,3,3,G2
96,KEGG_2021_Human,Viral carcinogenesis,6/203,0.0027775733745437,0.0060705727361161,0,0,4.572247839733405,26.913062904231868,PKM;HLA-B;TRAF2;HLA-A;IL6ST;HLA-F,3,3,G2
97,KEGG_2021_Human,Graft-versus-host disease,3/42,0.0029693104605084,0.0064234063023244,0,0,11.380022962112514,66.22519605871695,HLA-B;HLA-A;HLA-F,3,3,G2
98,KEGG_2021_Human,Type I diabetes mellitus,3/43,0.0031761585884371,0.0068014709166533,0,0,11.094962686567165,63.81914407439845,HLA-B;HLA-A;HLA-F,3,3,G2
99,KEGG_2021_Human,Bile secretion,4/90,0.0034155983339853,0.0072410684680489,0,0,6.916244098618639,39.28013467233808,RXRA;GNAS;ADCY7;AQP1,3,3,G2
100,KEGG_2021_Human,Phospholipase D signaling pathway,5/148,0.0035444243390197,0.0074397817809126,0,0,5.223564314473405,29.473332303748904,INSR;GNAS;LPAR2;PLD1;ADCY7,3,3,G2
101,KEGG_2021_Human,Intestinal immune network for IgA production,3/48,0.004342084904701,0.0090247254882021,0,0,9.859701492537312,53.63086674116421,TGFB1;CXCL12;ITGB7,3,3,G2
102,KEGG_2021_Human,Necroptosis,5/159,0.0048023477431862,0.0098844438985968,0,0,4.847746950019677,25.88042603617916,HSP90AA1;TNFSF10;TRAF2;RIPK1;HMGB1,3,3,G2
103,KEGG_2021_Human,Progesterone-mediated oocyte maturation,4/100,0.0049739964840798,0.0101393005252397,0,0,6.192669172932331,32.84301689755327,HSP90AA1;ADCY7;IGF1R;GNAI2,3,3,G2
104,KEGG_2021_Human,Pathways of neurodegeneration,9/475,0.005492055733622,0.0110887220526464,0,0,2.926720091201717,15.23197611392075,APP;LRP5;CALM3;TRAF2;PSEN1;CALM1;DKK1;CALM2;AGER,3,3,G2
105,KEGG_2021_Human,Autoimmune thyroid disease,3/53,0.0057367882591747,0.0114735765183494,0,0,8.871492537313433,45.784493378546806,HLA-B;HLA-A;HLA-F,3,3,G2
106,KEGG_2021_Human,Protein processing in endoplasmic reticulum,5/171,0.0065052128180164,0.0128888328730793,0,0,4.494569185834246,22.63083655985634,HSP90AA1;CANX;TRAF2;CALR;HSP90B1,3,3,G2
107,KEGG_2021_Human,HIF-1 signaling pathway,4/109,0.006732404804928,0.0132154612837475,0,0,5.659291084854995,28.3011123021668,INSR;ERBB2;IGF1R;VEGFA,3,3,G2
108,KEGG_2021_Human,Shigellosis,6/246,0.0070296618626318,0.0136723698612656,0,0,3.744847328244275,18.56551755427284,ITGB1;CCL5;TRAF2;RIPK1;ITGA5;CD44,3,3,G2
109,KEGG_2021_Human,TNF signaling pathway,4/112,0.0073992100181858,0.0142602956714127,0,0,5.501253132832081,26.991249561653778,CXCL10;CCL5;RIPK1;TRAF2,3,3,G2
110,KEGG_2021_Human,Glutamatergic synapse,4/114,0.0078671093135089,0.0148913140577132,0,0,5.400683526999316,26.166660510550408,GNAS;PLD1;ADCY7;GNAI2,3,3,G2
111,KEGG_2021_Human,Leukocyte transendothelial migration,4/114,0.0078671093135089,0.0148913140577132,0,0,5.400683526999316,26.166660510550408,ITGB1;CXCL12;ITGB2;GNAI2,3,3,G2
112,KEGG_2021_Human,Tuberculosis,5/180,0.0080327718960752,0.0150527622115029,0,0,4.261471861471861,20.55830172471736,TGFB1;ITGB2;CALM3;CALM1;CALM2,3,3,G2
113,KEGG_2021_Human,Long-term depression,3/60,0.0080944098684496,0.0150527622115029,0,0,7.779261586802828,37.46944818368691,GNAS;IGF1R;GNAI2,3,3,G2
114,KEGG_2021_Human,Sphingolipid signaling pathway,4/119,0.0091208803837818,0.0167694915187461,0,0,5.164563582870219,24.25893097364017,TRAF2;S1PR3;PLD1;GNAI2,3,3,G2
115,KEGG_2021_Human,Alcoholism,5/186,0.0091797088347768,0.0167694915187461,0,0,4.118951950443663,19.32101419513385,GNAS;CALM3;CALM1;CALM2;GNAI2,3,3,G2
116,KEGG_2021_Human,Cytosolic DNA-sensing pathway,3/63,0.0092548608853457,0.0167694915187461,0,0,7.389179104477612,34.60061710207232,CXCL10;CCL5;RIPK1,3,3,G2
117,KEGG_2021_Human,Chemokine signaling pathway,5/192,0.0104350671188402,0.0185902036066733,0,0,3.985577702155242,18.18453029015568,CXCL10;CXCL12;CCL5;ADCY7;GNAI2,3,3,G2
118,KEGG_2021_Human,Transcriptional misregulation in cancer,5/192,0.0104350671188402,0.0185902036066733,0,0,3.985577702155242,18.18453029015568,NGFR;CSF1R;RXRA;ITGB7;IGF1R,3,3,G2
119,KEGG_2021_Human,Long-term potentiation,3/67,0.0109459885918683,0.0193379131789673,0,0,6.925956156716418,31.269183771576184,CALM3;CALM1;CALM2,3,3,G2
120,KEGG_2021_Human,Osteoclast differentiation,4/127,0.0113860479298772,0.0199491087697022,0,0,4.826700898587934,21.60125569490247,CSF1R;TGFB1;TRAF2;TGFBR1,3,3,G2
121,KEGG_2021_Human,Pathogenic Escherichia coli infection,5/197,0.0115673345961301,0.0201006142162262,0,0,3.880800189393939,17.30670062957459,ITGB1;TNFSF10;LPAR2;TRAF2;RIPK1,3,3,G2
122,KEGG_2021_Human,Adipocytokine signaling pathway,3/69,0.0118540703388016,0.0202666363856931,0,0,6.715400271370421,29.78336417542189,RXRA;TRAF2;CD36,3,3,G2
123,KEGG_2021_Human,Renal cell carcinoma,3/69,0.0118540703388016,0.0202666363856931,0,0,6.715400271370421,29.78336417542189,TGFB1;TGFA;VEGFA,3,3,G2
124,KEGG_2021_Human,RIG-I-like receptor signaling pathway,3/70,0.0123238869154662,0.0209013122086307,0,0,6.614836266429049,29.080248200040216,CXCL10;TRAF2;RIPK1,3,3,G2
125,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,4/131,0.0126428542169427,0.0212721039205703,0,0,4.673731573027056,20.427306160362267,ITGB2;TNFSF10;HLA-B;HLA-A,3,3,G2
126,KEGG_2021_Human,Diabetic cardiomyopathy,5/203,0.0130332410145753,0.0217562763392912,0,0,3.762052341597796,16.328255891809246,TGFB1;INSR;CD36;AGER;TGFBR1,3,3,G2
127,KEGG_2021_Human,Melanoma,3/72,0.0132952535326412,0.022020263663437,0,0,6.422452952628164,27.747232955177974,CDH1;IGF1R;FGFR1,3,3,G2
128,KEGG_2021_Human,Leishmaniasis,3/77,0.0159102153758867,0.0261470206177364,0,0,5.986990722065349,24.790894658798603,ITGB1;TGFB1;ITGB2,3,3,G2
129,KEGG_2021_Human,Apoptosis,4/142,0.0165452711544262,0.026981519113372,0,0,4.298790454396862,17.63215514129564,NGFR;TNFSF10;TRAF2;RIPK1,3,3,G2
130,KEGG_2021_Human,Herpes simplex virus 1 infection,8/498,0.0214831007177299,0.0347665446729674,0,0,2.451890523651321,9.41645776647253,CCL5;HLA-B;TRAF2;HLA-A;ITGA5;CALR;HLA-F;B2M,3,3,G2
131,KEGG_2021_Human,Non-alcoholic fatty liver disease,4/155,0.0220381353850573,0.0353945810729709,0,0,3.9261066573719066,14.978021907981317,TGFB1;RXRA;INSR;TRAF2,3,3,G2
132,KEGG_2021_Human,Gap junction,3/88,0.0226120800364624,0.0360433155468423,0,0,5.209306409130816,19.739473709454856,GNAS;ADCY7;GNAI2,3,3,G2
133,KEGG_2021_Human,Hepatitis C,4/157,0.0229706949458785,0.0363416964815391,0,0,3.874391862007961,14.620157201312086,CXCL10;RXRA;TRAF2;RIPK1,3,3,G2
134,KEGG_2021_Human,Morphine addiction,3/91,0.0246676833648348,0.0387373990618148,0,0,5.030953188602442,18.625903079979206,GNAS;ADCY7;GNAI2,3,3,G2
135,KEGG_2021_Human,Parkinson disease,5/249,0.0285612746705861,0.0441970089793011,0,0,3.0456718827620466,10.82950620745035,GNAS;CALM3;CALM1;CALM2;GNAI2,3,3,G2
136,KEGG_2021_Human,Salmonella infection,5/249,0.0285612746705861,0.0441970089793011,0,0,3.0456718827620466,10.82950620745035,HSP90AA1;TNFSF10;TRAF2;RIPK1;HSP90B1,3,3,G2
137,KEGG_2021_Human,Phosphatidylinositol signaling system,3/97,0.0290716409922685,0.0446607818142096,0,0,4.708399491902191,16.6582802828451,CALM3;CALM1;CALM2,3,3,G2
0,KEGG_2021_Human,Pathways in cancer,33/531,6.981956179098303e-26,1.3195897178495793e-23,0,0,16.688468158347675,966.6608818170764,NOTCH2;CSF1R;NOTCH3;NOTCH1;NOTCH4;GSTP1;LAMA4;LRP5;PDGFB;CXCR4;LAMC2;LAMC1;FGF2;EGFR;LRP6;GNAI2;ERBB2;ITGAV;PDGFRB;PDGFRA;TGFB1;LAMB3;EGF;LAMB2;MMP2;LAMB1;MMP9;CXCL12;GNAS;CALM3;ITGA6;CALM1;CALM2,1,1,H1
1,KEGG_2021_Human,ECM-receptor interaction,17/88,4.722729878996096e-22,4.462979735651311e-20,0,0,51.02574587308799,2505.5929753526734,ITGB5;VWF;SDC4;LAMB3;ITGB4;LAMB2;LAMA4;LAMC2;LAMB1;LAMC1;THBS1;COL1A1;COL1A2;SDC1;ITGAV;ITGA6;CD44,1,1,H1
2,KEGG_2021_Human,Human papillomavirus infection,25/331,1.2143810575480765e-21,7.650600662552881e-20,0,0,18.823529411764707,906.5421632665528,NOTCH2;NOTCH3;NOTCH1;ITGB5;ITGB4;NOTCH4;LAMA4;LAMC2;LAMC1;THBS1;EGFR;ITGAV;PDGFRB;LAMB3;VWF;EGF;LAMB2;HLA-B;HLA-C;LAMB1;COL1A1;COL1A2;PKM;GNAS;ITGA6,1,1,H1
3,KEGG_2021_Human,PI3K-Akt signaling pathway,25/354,6.296932495586405e-21,2.975300604164576e-19,0,0,17.487037368138743,813.3959792450689,CSF1R;CSF1;ITGB5;ITGB4;LAMA4;PDGFB;LAMC2;LAMC1;FGF2;THBS1;EGFR;ERBB2;ITGAV;PDGFRB;PDGFRA;LAMB3;VWF;EGF;LAMB2;INSR;LAMB1;COL1A1;COL1A2;ITGA6;TLR2,1,1,H1
4,KEGG_2021_Human,Focal adhesion,20/201,8.4393907994081e-20,3.190089722176262e-18,0,0,24.19766728054021,1062.7323097437138,PDGFRB;PDGFRA;LAMB3;VWF;ITGB5;EGF;LAMB2;ITGB4;LAMA4;PDGFB;LAMB1;LAMC2;LAMC1;THBS1;EGFR;COL1A1;COL1A2;ERBB2;ITGA6;ITGAV,1,1,H1
5,KEGG_2021_Human,Proteoglycans in cancer,18/205,6.396310781647197e-17,2.014837896218867e-15,0,0,20.61462450592885,768.6827609308634,TGFB1;SDC4;ITGB5;SDC2;MMP2;FGF2;MMP9;THBS1;EGFR;DCN;COL1A1;COL1A2;ERBB2;SDC1;TIMP3;ITGAV;CD44;TLR2,1,1,H1
6,KEGG_2021_Human,Rap1 signaling pathway,17/210,1.950695118745415e-15,5.2668768206126204e-14,0,0,18.65557969803332,631.875502632075,PDGFRB;PDGFRA;CSF1R;CSF1;EGF;INSR;ITGB2;PDGFB;FPR1;FGF2;THBS1;EGFR;GNAI2;GNAS;CALM3;CALM1;CALM2,1,1,H1
7,KEGG_2021_Human,Amoebiasis,12/102,3.703868827093367e-13,8.750390104008079e-12,0,0,26.93877551020408,771.1016605047961,COL1A1;TGFB1;COL1A2;LAMB3;LAMB2;LAMA4;ITGB2;GNAS;LAMC2;LAMB1;LAMC1;TLR2,1,1,H1
8,KEGG_2021_Human,Fluid shear stress and atherosclerosis,12/139,1.5442033530144925e-11,3.2428270413304337e-10,0,0,19.054796721838343,474.3487352602096,SDC4;SDC2;MMP2;GSTP1;PDGFB;PECAM1;SDC1;CALM3;ITGAV;CALM1;CALM2;MMP9,1,1,H1
9,KEGG_2021_Human,Human cytomegalovirus infection,14/225,2.4546327920126414e-11,4.6392559769038927e-10,0,0,13.60120458135861,332.2836688139658,PDGFRA;HLA-B;HLA-C;CXCR4;EGFR;GNAI2;CXCL12;CXCR2;GNAS;CALM3;ITGAV;CALR;CALM1;CALM2,1,1,H1
10,KEGG_2021_Human,Regulation of actin cytoskeleton,13/218,2.2394151104839048e-10,3.847722326195074e-09,0,0,12.869248177017854,285.9500127838817,PDGFRB;PDGFRA;ITGB5;EGF;ITGB4;ITGB2;PDGFB;CXCR4;FGF2;EGFR;CXCL12;ITGA6;ITGAV,1,1,H1
11,KEGG_2021_Human,Cell adhesion molecules,11/148,5.702610248323328e-10,8.60599172883113e-09,0,0,16.020275750202757,340.99039860725645,CD4;SDC4;SDC2;ITGB2;HLA-B;PECAM1;HLA-C;SDC1;ITGA6;ITGAV;JAM3,1,1,H1
12,KEGG_2021_Human,Toxoplasmosis,10/112,5.919465210307127e-10,8.60599172883113e-09,0,0,19.4,412.2035335317041,TGFB1;LAMB3;LAMB2;LAMA4;LAMB1;ITGA6;LAMC2;LAMC1;TLR2;GNAI2,1,1,H1
13,KEGG_2021_Human,MicroRNAs in cancer,14/310,1.6653100538926064e-09,2.2481685727550193e-08,0,0,9.65357545045045,195.1301775336114,PDGFRB;NOTCH2;PDGFRA;NOTCH3;NOTCH1;NOTCH4;PDGFB;MMP9;THBS1;EGFR;ERBB2;TIMP3;VIM;CD44,1,1,H1
14,KEGG_2021_Human,Renin secretion,8/69,4.094421327748034e-09,4.892528196128236e-08,0,0,25.495339119254258,492.4078126842041,ADCYAP1;ADORA1;GNAS;CALM3;CALM1;CALM2;AQP1;GNAI2,1,1,H1
15,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,9/100,4.141822811537131e-09,4.892528196128236e-08,0,0,19.38755304101839,374.2210663367914,CSF1R;CXCL12;CSF1;IL34;CXCR2;CXCR4;CCL19;CCL28;CCR10,1,1,H1
16,KEGG_2021_Human,Ras signaling pathway,12/232,5.7698915203236406e-09,6.414761749065695e-08,0,0,10.948051948051948,207.69125176303325,PDGFRB;PDGFRA;CSF1R;CSF1;EGF;INSR;PDGFB;CALM3;CALM1;CALM2;FGF2;EGFR,1,1,H1
17,KEGG_2021_Human,Glioma,8/75,8.039407241027178e-09,8.000831224198015e-08,0,0,23.20515071700322,432.5187269521061,PDGFRB;PDGFRA;EGF;PDGFB;CALM3;CALM1;CALM2;EGFR,1,1,H1
18,KEGG_2021_Human,Calcium signaling pathway,12/240,8.438905443458106e-09,8.000831224198015e-08,0,0,10.559613319011817,196.30757508125453,PDGFRB;PDGFRA;EGF;ERBB2;GNAS;PDGFB;CXCR4;CALM3;CALM1;CALM2;FGF2;EGFR,1,1,H1
19,KEGG_2021_Human,Breast cancer,10/147,8.466488067934408e-09,8.000831224198015e-08,0,0,14.418248175182482,267.9941422347593,NOTCH2;NOTCH3;NOTCH1;EGF;NOTCH4;ERBB2;LRP5;FGF2;EGFR;LRP6,1,1,H1
20,KEGG_2021_Human,Malaria,7/50,1.031586914579862e-08,9.28428223121876e-08,0,0,31.368028900428996,576.8449532438276,TGFB1;SDC2;ITGB2;PECAM1;SDC1;THBS1;TLR2,1,1,H1
21,KEGG_2021_Human,Phagosome,10/152,1.1685050340969172e-08,1.0038520520196244e-07,0,0,13.907042253521126,254.01150874265667,MRC2;ITGB5;CANX;ITGB2;HLA-B;HLA-C;ITGAV;CALR;THBS1;TLR2,1,1,H1
22,KEGG_2021_Human,Small cell lung cancer,8/92,4.1061058866986256e-08,3.37414788080887e-07,0,0,18.49299719887955,314.53269921046166,LAMB3;LAMB2;LAMA4;LAMC2;ITGAV;ITGA6;LAMB1;LAMC1,1,1,H1
23,KEGG_2021_Human,Prostate cancer,8/97,6.232220525529211e-08,4.907873663854254e-07,0,0,17.44965851509143,289.5063779143601,PDGFRB;PDGFRA;EGF;GSTP1;ERBB2;PDGFB;MMP9;EGFR,1,1,H1
24,KEGG_2021_Human,Axon guidance,10/182,6.494186774466362e-08,4.909605201496569e-07,0,0,11.463953488372091,189.7258314643944,EFNB2;EFNB1;CXCL12;EFNB3;PLXNA1;CXCR4;SEMA3F;EPHB4;GNAI2;EPHB3,1,1,H1
25,KEGG_2021_Human,Bladder cancer,6/41,9.272845289534341e-08,6.740645229699962e-07,0,0,32.72802197802198,529.984185009625,EGF;MMP2;ERBB2;THBS1;MMP9;EGFR,1,1,H1
26,KEGG_2021_Human,Leukocyte transendothelial migration,8/114,2.1970558193651995e-07,1.5379390735556395e-06,0,0,14.638549759526452,224.42327627562372,CXCL12;MMP2;ITGB2;PECAM1;CXCR4;MMP9;JAM3;GNAI2,1,1,H1
27,KEGG_2021_Human,Human immunodeficiency virus 1 infection,10/212,2.700496930993328e-07,1.8228354284204965e-06,0,0,9.746534653465346,147.4130213144903,CD4;HLA-B;HLA-C;CXCR4;CALM3;CALR;CALM1;CALM2;TLR2;GNAI2,1,1,H1
28,KEGG_2021_Human,Gap junction,7/88,5.524200217067485e-07,3.5813441811418056e-06,0,0,16.620280474649405,239.48090953130304,PDGFRB;PDGFRA;EGF;PDGFB;GNAS;EGFR;GNAI2,1,1,H1
29,KEGG_2021_Human,Relaxin signaling pathway,8/129,5.684673303399692e-07,3.5813441811418056e-06,0,0,12.814130610922057,184.27132423039288,COL1A1;TGFB1;COL1A2;MMP2;GNAS;MMP9;EGFR;GNAI2,1,1,H1
30,KEGG_2021_Human,MAPK signaling pathway,11/294,6.744703889608046e-07,4.112093661728777e-06,0,0,7.698076168040832,109.38456670631984,PDGFRB;PDGFRA;CSF1R;TGFB1;CSF1;EGF;INSR;ERBB2;PDGFB;FGF2;EGFR,1,1,H1
31,KEGG_2021_Human,Cytokine-cytokine receptor interaction,11/295,6.974042230592278e-07,4.1190436924435644e-06,0,0,7.670579029733959,108.73736623269345,CSF1R;CD4;TGFB1;CXCL12;CSF1;IL34;CXCR2;CXCR4;CCL19;CCL28;CCR10,1,1,H1
32,KEGG_2021_Human,Estrogen signaling pathway,8/137,8.989040822109277e-07,5.018996766608251e-06,0,0,12.014591883264934,167.26822352926075,MMP2;GNAS;CALM3;CALM1;CALM2;MMP9;EGFR;GNAI2,1,1,H1
33,KEGG_2021_Human,Alzheimer disease,12/369,9.02888307220532e-07,5.018996766608251e-06,0,0,6.699708454810495,93.24431115031074,APP;NCSTN;CSF1;INSR;LRP5;ADAM10;CALM3;APOE;CALM1;CALM2;AGER;LRP6,1,1,H1
34,KEGG_2021_Human,Phospholipase D signaling pathway,8/148,1.6114422783694067e-06,8.701788303194797e-06,0,0,11.064425770308125,147.581525971644,PDGFRB;PDGFRA;EGF;INSR;CXCR2;GNAS;PDGFB;EGFR,1,1,H1
35,KEGG_2021_Human,Melanoma,6/72,2.806442365703953e-06,1.4733822419945752e-05,0,0,17.32867132867133,221.5226804356304,PDGFRB;PDGFRA;EGF;PDGFB;FGF2;EGFR,1,1,H1
36,KEGG_2021_Human,Intestinal immune network for IgA production,5/48,6.513203049509968e-06,3.3270145306956326e-05,0,0,21.97895902547065,262.4656778947968,TGFB1;CXCL12;CXCR4;CCL28;CCR10,1,1,H1
37,KEGG_2021_Human,GnRH signaling pathway,6/93,1.2470427728786217e-05,6.202396949317355e-05,0,0,13.131962864721483,148.2881010056838,MMP2;GNAS;CALM3;CALM1;CALM2;EGFR,1,1,H1
38,KEGG_2021_Human,Dilated cardiomyopathy,6/96,1.4965645751170311e-05,7.252582171720997e-05,0,0,12.692307692307692,141.00840684819448,TGFB1;ITGB5;ITGB4;GNAS;ITGAV;ITGA6,1,1,H1
39,KEGG_2021_Human,Circadian entrainment,6/97,1.5881623265639958e-05,7.504066993014879e-05,0,0,12.552197802197805,138.70615245584332,ADCYAP1;GNAS;CALM3;CALM1;CALM2;GNAI2,1,1,H1
40,KEGG_2021_Human,Notch signaling pathway,5/59,1.815005609260955e-05,8.343005254132313e-05,0,0,17.49206349206349,190.95800430548292,NOTCH2;NOTCH3;NCSTN;NOTCH1;NOTCH4,1,1,H1
41,KEGG_2021_Human,Gastric cancer,7/149,1.8540011675849583e-05,8.343005254132313e-05,0,0,9.451387939286205,102.97834743083123,TGFB1;EGF;ERBB2;LRP5;FGF2;EGFR;LRP6,1,1,H1
42,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,8/219,2.8599465798968588e-05,0.0001257046287443038,0,0,7.314933556360933,76.52973108258331,CD4;TGFB1;MMP7;CANX;ITGB2;HLA-B;HLA-C;CALR,1,1,H1
43,KEGG_2021_Human,Central carbon metabolism in cancer,5/70,4.182218042305525e-05,0.0001796452749990328,0,0,14.523809523809524,146.4302636546068,PDGFRB;PDGFRA;PKM;ERBB2;EGFR,1,1,H1
44,KEGG_2021_Human,Tuberculosis,7/180,6.209259894314569e-05,0.0002500914060592813,0,0,7.745608620012346,75.03081031987975,MRC2;TGFB1;ITGB2;CALM3;CALM1;CALM2;TLR2,1,1,H1
45,KEGG_2021_Human,Gastric acid secretion,5/76,6.219204277664668e-05,0.0002500914060592813,0,0,13.292421193829645,128.7408676109938,GNAS;CALM3;CALM1;CALM2;GNAI2,1,1,H1
46,KEGG_2021_Human,Pertussis,5/76,6.219204277664668e-05,0.0002500914060592813,0,0,13.292421193829645,128.7408676109938,ITGB2;CALM3;CALM1;CALM2;GNAI2,1,1,H1
47,KEGG_2021_Human,Antigen processing and presentation,5/78,7.044980998052925e-05,0.00027739612679833394,0,0,12.926940639269406,123.58943816299583,CD4;CANX;HLA-B;HLA-C;CALR,1,1,H1
48,KEGG_2021_Human,Chemokine signaling pathway,7/192,9.31284438301326e-05,0.0003592097119162257,0,0,7.238782471792181,67.18698319916376,CXCL12;CXCR2;CXCR4;CCL19;CCL28;CCR10;GNAI2,1,1,H1
49,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,7/193,9.62004569906604e-05,0.00036363772742469626,0,0,7.199498903852176,66.5887157625649,HLA-B;PDGFB;HLA-C;CALM3;CALM1;CALM2;FGF2,1,1,H1
50,KEGG_2021_Human,ErbB signaling pathway,5/85,0.00010617472866173096,0.00039347105327582657,0,0,11.791666666666666,107.89875482368232,NRG4;EGF;ERBB2;NRG1;EGFR,1,1,H1
51,KEGG_2021_Human,Diabetic cardiomyopathy,7/203,0.00013171554236006476,0.00047873533665485074,0,0,6.82871012482663,61.01360952766172,COL1A1;TGFB1;COL1A2;INSR;MMP2;AGER;MMP9,1,1,H1
52,KEGG_2021_Human,Hypertrophic cardiomyopathy,5/90,0.00013919562758791734,0.0004963768606437053,0,0,11.095238095238097,98.52161150592028,TGFB1;ITGB5;ITGB4;ITGAV;ITGA6,1,1,H1
53,KEGG_2021_Human,Rheumatoid arthritis,5/93,0.00016246788871798708,0.0005686376105129547,0,0,10.715367965367966,93.49190892633176,TGFB1;CXCL12;CSF1;ITGB2;TLR2,1,1,H1
54,KEGG_2021_Human,cAMP signaling pathway,7/216,0.00019309717333821052,0.0006635521047440327,0,0,6.399730570910949,54.73252460161682,ADCYAP1;ADORA1;GNAS;CALM3;CALM1;CALM2;GNAI2,1,1,H1
55,KEGG_2021_Human,Choline metabolism in cancer,5/98,0.00020772902046670304,0.0006946313079203684,0,0,10.136712749615976,85.95198629072142,PDGFRB;PDGFRA;EGF;PDGFB;EGFR,1,1,H1
56,KEGG_2021_Human,Oxytocin signaling pathway,6/154,0.00020949198175376188,0.0006946313079203684,0,0,7.695686070686071,65.18881067223408,GNAS;CALM3;CALM1;CALM2;EGFR;GNAI2,1,1,H1
57,KEGG_2021_Human,Hematopoietic cell lineage,5/99,0.00021782905942503464,0.0007098222798505439,0,0,10.02836879432624,84.55719933656911,CSF1R;CD4;CSF1;ITGA6;CD44,1,1,H1
58,KEGG_2021_Human,Cellular senescence,6/156,0.00022464567956703837,0.0007191413268092424,0,0,7.592307692307692,63.78287180357964,TGFB1;HLA-B;HLA-C;CALM3;CALM1;CALM2,1,1,H1
59,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,5/100,0.000228298833907696,0.0007191413268092424,0,0,9.922305764411028,83.19709621314455,COL1A1;TGFB1;COL1A2;MMP2;AGER,1,1,H1
60,KEGG_2021_Human,Regulation of lipolysis in adipocytes,4/55,0.0002380365961439089,0.000729013568463322,0,0,14.679245283018869,122.47020773140906,INSR;ADORA1;GNAS;GNAI2,1,1,H1
61,KEGG_2021_Human,Melanogenesis,5/101,0.00023914730817315325,0.000729013568463322,0,0,9.81845238095238,81.87048617083943,GNAS;CALM3;CALM1;CALM2;GNAI2,1,1,H1
62,KEGG_2021_Human,Chagas disease,5/102,0.0002503835416361404,0.0007511506249084211,0,0,9.71674030436917,80.57623074982425,TGFB1;GNAS;CALR;TLR2;GNAI2,1,1,H1
63,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",5/106,0.00029939052638433805,0.0008841376482287482,0,0,9.330033003300333,75.70166470765447,GNAS;LRP5;EGFR;GNAI2;LRP6,1,1,H1
64,KEGG_2021_Human,Glucagon signaling pathway,5/107,0.0003127047033020723,0.000909249060370641,0,0,9.238095238095235,74.55374966755207,PKM;GNAS;CALM3;CALM1;CALM2,1,1,H1
65,KEGG_2021_Human,cGMP-PKG signaling pathway,6/167,0.0003241219662164887,0.000928167448710854,0,0,7.069636884854276,56.80022465671699,INSR;ADORA1;CALM3;CALM1;CALM2;GNAI2,1,1,H1
66,KEGG_2021_Human,Chemical carcinogenesis,7/239,0.0003570710922644677,0.001007260245343,0,0,5.758536993639103,45.70882306648439,NOTCH2;EGF;GSTP1;GNAS;FGF2;EGFR;GNAI2,1,1,H1
67,KEGG_2021_Human,Phototransduction,3/28,0.0004797457979083837,0.0013334111147747,0,0,22.2785046728972,170.25799550591918,CALM3;CALM1;CALM2,1,1,H1
68,KEGG_2021_Human,Thyroid hormone signaling pathway,5/121,0.0005502553421529749,0.0015072211545929,0,0,8.117405582922824,60.92216897499654,NOTCH2;NOTCH3;NOTCH1;NOTCH4;ITGAV,1,1,H1
69,KEGG_2021_Human,Amphetamine addiction,4/69,0.0005687986093414018,0.0015357562452217,0,0,11.50943396226415,85.99830784660682,GNAS;CALM3;CALM1;CALM2,1,1,H1
70,KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,4/70,0.0006007367451765133,0.001599144293498,0,0,11.334476843910808,84.0718242928172,CXCR2;ADAM10;EGFR;JAM3,1,1,H1
71,KEGG_2021_Human,Platelet activation,5/124,0.0006151531140032346,0.0016147769242584,0,0,7.91156462585034,58.49525557957321,COL1A1;COL1A2;VWF;GNAS;GNAI2,1,1,H1
72,KEGG_2021_Human,Dopaminergic synapse,5/132,0.0008163047549137769,0.0020933796317656,0,0,7.410198725159355,52.6918690168897,GNAS;CALM3;CALM1;CALM2;GNAI2,1,1,H1
73,KEGG_2021_Human,Pancreatic cancer,4/76,0.0008196301203738561,0.0020933796317656,0,0,10.38679245283019,73.81537536599376,TGFB1;EGF;ERBB2;EGFR,1,1,H1
74,KEGG_2021_Human,Vascular smooth muscle contraction,5/133,0.0008445232579324602,0.0021281986099898,0,0,7.351934523809524,52.02771648859984,RAMP3;GNAS;CALM3;CALM1;CALM2,1,1,H1
75,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,4/77,0.0008609129760536215,0.0021409546378175,0,0,10.243990695270096,72.29713982938937,ITGB5;ITGB4;ITGAV;ITGA6,1,1,H1
76,KEGG_2021_Human,Epstein-Barr virus infection,6/202,0.0008834993896912484,0.0021685894110603,0,0,5.796899529042387,40.76159441708033,HLA-B;HLA-C;VIM;CALR;CD44;TLR2,1,1,H1
77,KEGG_2021_Human,Apelin signaling pathway,5/137,0.0009647254851113302,0.0023376040600774,0,0,7.127705627705628,49.49241412816405,NOTCH3;CALM3;CALM1;CALM2;GNAI2,1,1,H1
78,KEGG_2021_Human,Lipid and atherosclerosis,6/215,0.0012184063776733,0.0029149215870919,0,0,5.432738314317262,36.45482323236784,CALM3;CALM1;CALM2;AGER;MMP9;TLR2,1,1,H1
79,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,5/150,0.0014441760417829,0.0034118658987121,0,0,6.48440065681445,42.409383087684624,GNAS;CALM3;CALM1;CALM2;GNAI2,1,1,H1
80,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,4/89,0.0014769155895367,0.0034461363755858,0,0,8.79245283018868,57.30744401859203,CD4;EGF;EGFR;TLR2,1,1,H1
81,KEGG_2021_Human,Th1 and Th2 cell differentiation,4/92,0.0016690107958431,0.0038468663465166,0,0,8.491423670668954,54.307105288431686,NOTCH2;NOTCH3;CD4;NOTCH1,1,1,H1
82,KEGG_2021_Human,Salivary secretion,4/93,0.0017367208724649,0.0039547017457333,0,0,8.39559041763833,53.3603283667338,GNAS;CALM3;CALM1;CALM2,1,1,H1
83,KEGG_2021_Human,JAK-STAT signaling pathway,5/162,0.0020248467606594,0.0045559052114836,0,0,5.985138004246284,37.1213895497771,PDGFRB;PDGFRA;EGF;PDGFB;EGFR,1,1,H1
84,KEGG_2021_Human,Aldosterone synthesis and secretion,4/98,0.002104078403358,0.0046240792817985,0,0,7.947009233239663,48.98439316013528,GNAS;CALM3;CALM1;CALM2,1,1,H1
85,KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,4/98,0.002104078403358,0.0046240792817985,0,0,7.947009233239663,48.98439316013528,GNAS;CALM3;CALM1;CALM2,1,1,H1
86,KEGG_2021_Human,Hepatocellular carcinoma,5/168,0.0023718252237865,0.0051525858309845,0,0,5.763073327490505,34.83256547045246,TGFB1;GSTP1;LRP5;EGFR;LRP6,1,1,H1
87,KEGG_2021_Human,Endocytosis,6/252,0.0027119657527395,0.005824562809861,0,0,4.606941838649155,27.227401902769675,PDGFRA;CXCR2;HLA-B;HLA-C;CXCR4;EGFR,1,1,H1
88,KEGG_2021_Human,HIF-1 signaling pathway,4/109,0.0030945743034342,0.0065716240825738,0,0,7.110512129380054,41.08528515846881,EGF;INSR;ERBB2;EGFR,1,1,H1
89,KEGG_2021_Human,Alcoholism,5/186,0.0036721624573484,0.0077115411604316,0,0,5.185214417258616,29.073365351667697,GNAS;CALM3;CALM1;CALM2;GNAI2,1,1,H1
90,KEGG_2021_Human,Neutrophil extracellular trap formation,5/189,0.0039303267027592,0.0081629862288077,0,0,5.099896480331263,28.24849350419042,VWF;ITGB2;FPR1;AGER;TLR2,1,1,H1
91,KEGG_2021_Human,Endometrial cancer,3/58,0.0040096608096258,0.008237237967601,0,0,10.111299915038233,55.80475591701284,EGF;ERBB2;EGFR,1,1,H1
92,KEGG_2021_Human,Viral myocarditis,3/60,0.0044116539054523,0.0089656192272096,0,0,9.755533694048204,52.90919186046535,ITGB2;HLA-B;HLA-C,1,1,H1
93,KEGG_2021_Human,Pathways of neurodegeneration,8/475,0.0047344174479247,0.0095192010389125,0,0,3.2620397195280684,17.461361294284675,APP;CSF1;LRP5;CALM3;CALM1;CALM2;AGER;LRP6,1,1,H1
94,KEGG_2021_Human,Osteoclast differentiation,4/127,0.0053321449104017,0.0106081619796413,0,0,6.064427059364934,31.74122153545412,CSF1R;TGFB1;CSF1;SIRPA,1,1,H1
95,KEGG_2021_Human,FoxO signaling pathway,4/131,0.0059451713884539,0.0117042278210263,0,0,5.872232952013074,30.09622692373667,TGFB1;EGF;INSR;EGFR,1,1,H1
96,KEGG_2021_Human,Long-term potentiation,3/67,0.0060069317388336,0.0117042278210263,0,0,8.685455607476635,44.42472606708996,CALM3;CALM1;CALM2,1,1,H1
97,KEGG_2021_Human,Insulin signaling pathway,4/137,0.0069500536884441,0.0134036749705709,0,0,5.605617818130232,27.854347980487173,INSR;CALM3;CALM1;CALM2,1,1,H1
98,KEGG_2021_Human,Adherens junction,3/71,0.0070542372718105,0.0134671802461837,0,0,8.172897196261681,40.48956912552897,INSR;ERBB2;EGFR,1,1,H1
99,KEGG_2021_Human,Non-small cell lung cancer,3/72,0.0073318833153032,0.013857259465923,0,0,8.054043071921983,39.58983286424559,EGF;ERBB2;EGFR,1,1,H1
100,KEGG_2021_Human,Leishmaniasis,3/77,0.008816762255149,0.0164986937249819,0,0,7.507956554685527,35.52089751747039,TGFB1;ITGB2;TLR2,1,1,H1
101,KEGG_2021_Human,Complement and coagulation cascades,3/85,0.0115347871749658,0.021373282118319,0,0,6.772737633918395,30.222582046871768,VWF;ITGB2;TFPI,1,1,H1
102,KEGG_2021_Human,Colorectal cancer,3/86,0.0119046913015935,0.021844530640788,0,0,6.690800585519649,29.645751313053328,TGFB1;EGF;EGFR,1,1,H1
103,KEGG_2021_Human,Parkinson disease,5/249,0.0122138806074645,0.0221963791808731,0,0,3.834113973458236,16.88997070259072,GNAS;CALM3;CALM1;CALM2;GNAI2,1,1,H1
104,KEGG_2021_Human,Wnt signaling pathway,4/166,0.0133837610939828,0.0240907699691691,0,0,4.59538784067086,19.823185029237827,MMP7;LRP5;RSPO3;LRP6,1,1,H1
105,KEGG_2021_Human,Morphine addiction,3/91,0.0138561628799725,0.0247057998520264,0,0,6.309048428207307,26.99657703589845,ADORA1;GNAS;GNAI2,1,1,H1
106,KEGG_2021_Human,TGF-beta signaling pathway,3/94,0.0151092038696316,0.0266882199192559,0,0,6.1001335113484645,25.574512017464105,TGFB1;THBS1;DCN,1,1,H1
107,KEGG_2021_Human,Phosphatidylinositol signaling system,3/97,0.0164243206274072,0.0287425610979626,0,0,5.90455358918274,24.26176391955712,CALM3;CALM1;CALM2,1,1,H1
108,KEGG_2021_Human,Allograft rejection,2/38,0.0185248472315401,0.0321210653831292,0,0,10.212962962962964,40.73585663844716,HLA-B;HLA-C,1,1,H1
109,KEGG_2021_Human,C-type lectin receptor signaling pathway,3/104,0.0197358422258483,0.0339097652789576,0,0,5.493383917831036,21.56328368475938,CALM3;CALM1;CALM2,1,1,H1
110,KEGG_2021_Human,Graft-versus-host disease,2/42,0.0223684665325919,0.0380868484203592,0,0,9.189814814814817,34.92224336189293,HLA-B;HLA-C,1,1,H1
111,KEGG_2021_Human,Type I diabetes mellitus,2/43,0.0233765774126228,0.0394479743838011,0,0,8.965221318879856,33.67355706170915,HLA-B;HLA-C,1,1,H1
112,KEGG_2021_Human,Serotonergic synapse,3/113,0.0244957473190857,0.040970763215108,0,0,5.041631265930332,18.70069978930709,APP;GNAS;GNAI2,1,1,H1
113,KEGG_2021_Human,Type II diabetes mellitus,2/46,0.0265104993556734,0.0439516173528269,0,0,8.352693602693602,30.322068782022388,PKM;INSR,1,1,H1
114,KEGG_2021_Human,Neurotrophin signaling pathway,3/119,0.0279832043351068,0.0459897879942191,0,0,4.779407025459233,17.091880228757773,CALM3;CALM1;CALM2,1,1,H1
115,KEGG_2021_Human,Cocaine addiction,2/49,0.0298040535312284,0.0485600527362255,0,0,7.818360914105595,27.46676871436148,GNAS;GNAI2,1,1,H1
0,KEGG_2021_Human,ECM-receptor interaction,7/88,4.693380061611769e-11,3.3825546546299076e-09,0,0,74.73054213633924,1777.262902174573,SDC4;FN1;TNC;SDC1;ITGB7;ITGA5;ITGB6,2,2,H1
1,KEGG_2021_Human,PI3K-Akt signaling pathway,10/354,5.831990783844669e-11,3.3825546546299076e-09,0,0,28.52616279069768,672.2212400355796,HSP90AA1;ERBB3;ERBB2;FN1;TNC;TGFA;ITGB7;ITGA5;ITGB6;HSP90B1,2,2,H1
2,KEGG_2021_Human,Pathways in cancer,11/531,1.4421154974147611e-10,5.576179923337076e-09,0,0,21.65485829959514,490.6934544528378,ALK;AR;HSP90AA1;TGFB1;CXCL8;TGFB3;CDH1;ERBB2;FN1;TGFA;HSP90B1,2,2,H1
3,KEGG_2021_Human,Cell adhesion molecules,7/148,1.859474050613742e-09,5.3924747467798526e-08,0,0,42.80080172679617,860.4233254408111,SDC4;CDH1;HLA-B;SDC1;ITGB7;PTPRF;HLA-E,2,2,H1
4,KEGG_2021_Human,Proteoglycans in cancer,7/205,1.7880586258683607e-08,4.148296012014597e-07,0,0,30.391743522178302,542.175036637107,TGFB1;SDC4;ERBB3;ERBB2;FN1;SDC1;ITGA5,2,2,H1
5,KEGG_2021_Human,Hypertrophic cardiomyopathy,5/90,2.150206883634499e-07,4.157066641693364e-06,0,0,46.78823529411765,718.3178603231958,TGFB1;TGFB3;ITGB7;ITGA5;ITGB6,2,2,H1
6,KEGG_2021_Human,Dilated cardiomyopathy,5/96,2.971826097569592e-07,4.538604714073583e-06,0,0,43.69010989010989,656.6151243617619,TGFB1;TGFB3;ITGB7;ITGA5;ITGB6,2,2,H1
7,KEGG_2021_Human,Prostate cancer,5/97,3.130072216602471e-07,4.538604714073583e-06,0,0,43.21304347826087,647.2034622987994,AR;HSP90AA1;ERBB2;TGFA;HSP90B1,2,2,H1
8,KEGG_2021_Human,Focal adhesion,6/201,4.6432860783143786e-07,5.43372458492187e-06,0,0,25.352564102564106,369.70816035634016,ERBB2;FN1;TNC;ITGB7;ITGA5;ITGB6,2,2,H1
9,KEGG_2021_Human,Human papillomavirus infection,7/331,4.684245331829199e-07,5.43372458492187e-06,0,0,18.45437466451959,268.9520416971749,FN1;HLA-B;TNC;ITGB7;ITGA5;ITGB6;HLA-E,2,2,H1
10,KEGG_2021_Human,Malaria,4/50,9.026389057144724e-07,9.5187375511708e-06,0,0,66.63545150501672,927.4284322473036,TGFB1;CXCL8;TGFB3;SDC1,2,2,H1
11,KEGG_2021_Human,Cellular senescence,5/156,3.2957200223887285e-06,3.185862688309104e-05,0,0,26.250331125827813,331.3549344859936,TGFB1;CXCL8;TGFB3;HLA-B;HLA-E,2,2,H1
12,KEGG_2021_Human,Pancreatic cancer,4/76,4.894372873939752e-06,4.367286564438548e-05,0,0,42.51709401709402,519.874553049576,TGFB1;TGFB3;ERBB2;TGFA,2,2,H1
13,KEGG_2021_Human,Antigen processing and presentation,4/78,5.430308250947791e-06,4.4993982650710274e-05,0,0,41.36382536382536,501.4749430885794,HSP90AA1;HLA-B;KLRD1;HLA-E,2,2,H1
14,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,4/100,1.4590163823584494e-05,0.0001076687218210694,0,0,31.84935897435897,354.6478025742392,TGFB1;CXCL8;TGFB3;FN1,2,2,H1
15,KEGG_2021_Human,Amoebiasis,4/102,1.5779036818604998e-05,0.0001076687218210694,0,0,31.19623233908948,344.9313840349303,TGFB1;CXCL8;TGFB3;FN1,2,2,H1
16,KEGG_2021_Human,Chagas disease,4/102,1.5779036818604998e-05,0.0001076687218210694,0,0,31.19623233908948,344.9313840349303,C3;TGFB1;CXCL8;TGFB3,2,2,H1
17,KEGG_2021_Human,Regulation of actin cytoskeleton,5/218,1.677012545857298e-05,0.000108074141844137,0,0,18.55117370892019,203.98706434344248,FN1;ITGAX;ITGB7;ITGA5;ITGB6,2,2,H1
18,KEGG_2021_Human,Bladder cancer,3/41,3.123742232540663e-05,0.0001907126836709037,0,0,58.280701754385966,604.5978075814852,CXCL8;CDH1;ERBB2,2,2,H1
19,KEGG_2021_Human,Graft-versus-host disease,3/42,3.360629519553546e-05,0.0001949165121341057,0,0,56.78347578347579,584.9150656046422,HLA-B;KLRD1;HLA-E,2,2,H1
20,KEGG_2021_Human,Fluid shear stress and atherosclerosis,4/139,5.320637647806756e-05,0.0002939018891169446,0,0,22.603988603988604,222.4533633875737,HSP90AA1;SDC4;SDC1;HSP90B1,2,2,H1
21,KEGG_2021_Human,Gastric cancer,4/149,6.972867537884472e-05,0.0003527187782549319,0,0,21.03448275862069,201.3189081772169,TGFB1;TGFB3;CDH1;ERBB2,2,2,H1
22,KEGG_2021_Human,MAPK signaling pathway,5/294,6.993561982640891e-05,0.0003527187782549319,0,0,13.62006920415225,130.31594304994036,TGFB1;ERBB3;TGFB3;ERBB2;TGFA,2,2,H1
23,KEGG_2021_Human,Phagosome,4/152,7.534183510769726e-05,0.0003641522030205368,0,0,20.604989604989605,195.61295365552743,C3;HLA-B;ITGA5;HLA-E,2,2,H1
24,KEGG_2021_Human,Tuberculosis,4/180,0.0001448137186498904,0.0006658675840200093,0,0,17.302447552447553,152.95471500588434,C3;TGFB1;TGFB3;ITGAX,2,2,H1
25,KEGG_2021_Human,Renal cell carcinoma,3/69,0.0001492461826251745,0.0006658675840200093,0,0,33.50841750841751,295.206255852885,TGFB1;TGFB3;TGFA,2,2,H1
26,KEGG_2021_Human,Adherens junction,3/71,0.00016247922795874684,0.0006980589053042457,0,0,32.51960784313726,283.7322904048699,CDH1;ERBB2;PTPRF,2,2,H1
27,KEGG_2021_Human,Non-small cell lung cancer,3/72,0.0001693722427413636,0.0007016850056427921,0,0,32.04669887278583,278.2746781911583,ALK;ERBB2;TGFA,2,2,H1
28,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,4/193,0.0001892626120058091,0.0007265542809120659,0,0,16.101750101750103,138.0302404443753,C3;CXCL8;HLA-B;HLA-E,2,2,H1
29,KEGG_2021_Human,Pertussis,3/76,0.0001988401004667768,0.0007265542809120659,0,0,30.28462709284627,258.11616658083483,C3;CXCL8;ITGA5,2,2,H1
30,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,3/77,0.000206692166121536,0.0007265542809120659,0,0,29.873873873873872,253.4583103840349,ITGB7;ITGA5;ITGB6,2,2,H1
31,KEGG_2021_Human,Bacterial invasion of epithelial cells,3/77,0.000206692166121536,0.0007265542809120659,0,0,29.873873873873872,253.4583103840349,CDH1;FN1;ITGA5,2,2,H1
32,KEGG_2021_Human,Leishmaniasis,3/77,0.000206692166121536,0.0007265542809120659,0,0,29.873873873873872,253.4583103840349,C3;TGFB1;TGFB3,2,2,H1
33,KEGG_2021_Human,ErbB signaling pathway,3/85,0.0002768365480614746,0.0009445011639744428,0,0,26.94850948509485,220.7644346513235,ERBB3;ERBB2;TGFA,2,2,H1
34,KEGG_2021_Human,Colorectal cancer,3/86,0.0002865529734338402,0.0009497184262378704,0,0,26.62248995983936,217.17528174058037,TGFB1;TGFB3;TGFA,2,2,H1
35,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,4/219,0.0003065427869915118,0.0009877489803059823,0,0,14.135957066189624,114.36205848724674,TGFB1;TGFB3;HLA-B;HLA-E,2,2,H1
36,KEGG_2021_Human,Rheumatoid arthritis,3/93,0.0003607851781524913,0.0011311102882618,0,0,24.54320987654321,194.55961688941923,TGFB1;CXCL8;TGFB3,2,2,H1
37,KEGG_2021_Human,IL-17 signaling pathway,3/94,0.0003723028623192989,0.0011365034744483,0,0,24.27228327228327,191.6491643817023,HSP90AA1;CXCL8;HSP90B1,2,2,H1
38,KEGG_2021_Human,Herpes simplex virus 1 infection,5/498,0.0007988365498237439,0.0023760266610142,0,0,7.901419878296146,56.3557252672223,BST2;C3;HLA-B;ITGA5;HLA-E,2,2,H1
39,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,3/131,0.00097966142379343,0.0028410181290009,0,0,17.223958333333332,119.33281135445452,HLA-B;KLRD1;HLA-E,2,2,H1
40,KEGG_2021_Human,Yersinia infection,3/137,0.0011148983172824,0.0030450137249703,0,0,16.44776119402985,111.82819798488153,CXCL8;FN1;ITGA5,2,2,H1
41,KEGG_2021_Human,Estrogen signaling pathway,3/137,0.0011148983172824,0.0030450137249703,0,0,16.44776119402985,111.82819798488153,HSP90AA1;TGFA;HSP90B1,2,2,H1
42,KEGG_2021_Human,MicroRNAs in cancer,4/310,0.0011287550877045,0.0030450137249703,0,0,9.886375062845651,67.09526792130015,ERBB3;ERBB2;TNC;ITGA5,2,2,H1
43,KEGG_2021_Human,Allograft rejection,2/38,0.0014785875016258,0.0038980943224681,0,0,39.5515873015873,257.74456480935885,HLA-B;HLA-E,2,2,H1
44,KEGG_2021_Human,Hepatitis B,3/162,0.0018036455187457,0.0046289348921123,0,0,13.84416491963662,87.46667771117615,TGFB1;CXCL8;TGFB3,2,2,H1
45,KEGG_2021_Human,Hippo signaling pathway,3/163,0.0018356121123893,0.0046289348921123,0,0,13.756944444444445,86.67394017688295,TGFB1;TGFB3;CDH1,2,2,H1
46,KEGG_2021_Human,Type I diabetes mellitus,2/43,0.001890420419626,0.0046657184824813,0,0,34.71951219512195,217.72453437258287,HLA-B;HLA-E,2,2,H1
47,KEGG_2021_Human,Hepatocellular carcinoma,3/168,0.0020007692016749,0.004835192237381,0,0,13.336700336700336,82.87723759868423,TGFB1;TGFB3;TGFA,2,2,H1
48,KEGG_2021_Human,Intestinal immune network for IgA production,2/48,0.0023504954789734,0.0055644382767535,0,0,30.937888198757765,187.2710323054728,TGFB1;ITGB7,2,2,H1
49,KEGG_2021_Human,Autoimmune thyroid disease,2/53,0.0028581167144899,0.0066308307776167,0,0,27.89775910364145,163.41370065602462,HLA-B;HLA-E,2,2,H1
50,KEGG_2021_Human,Legionellosis,2/57,0.003297983801264,0.0074812389710056,0,0,25.863636363636363,147.79630077100325,C3;CXCL8,2,2,H1
51,KEGG_2021_Human,Endometrial cancer,2/58,0.0034125952701803,0.0074812389710056,0,0,25.400510204081638,144.28206600498726,CDH1;ERBB2,2,2,H1
52,KEGG_2021_Human,Viral carcinogenesis,3/203,0.0034181522884767,0.0074812389710056,0,0,10.983333333333333,62.37056229240534,C3;HLA-B;HLA-E,2,2,H1
53,KEGG_2021_Human,Viral myocarditis,2/60,0.0036473537827288,0.00783505627401,0,0,24.52216748768473,137.66140025976537,HLA-B;HLA-E,2,2,H1
54,KEGG_2021_Human,Human immunodeficiency virus 1 infection,3/212,0.0038605585243045,0.0081422688876241,0,0,10.505582137161085,58.37892543116343,BST2;HLA-B;HLA-E,2,2,H1
55,KEGG_2021_Human,Lipid and atherosclerosis,3/215,0.004015437023104,0.0083176909764298,0,0,10.355345911949684,57.13675073292928,HSP90AA1;CXCL8;HSP90B1,2,2,H1
56,KEGG_2021_Human,Inflammatory bowel disease,2/65,0.0042662887226134,0.0086822717863712,0,0,22.570294784580497,123.16634649030992,TGFB1;TGFB3,2,2,H1
57,KEGG_2021_Human,Human cytomegalovirus infection,3/225,0.0045589569716279,0.0091179139432559,0,0,9.883883883883884,53.28067149220362,CXCL8;HLA-B;HLA-E,2,2,H1
58,KEGG_2021_Human,Chemical carcinogenesis,3/239,0.0053918337584076,0.0106008934911064,0,0,9.2909604519774,48.525476172327096,AR;HSP90AA1;HSP90B1,2,2,H1
59,KEGG_2021_Human,Chronic myeloid leukemia,2/76,0.0057862287304151,0.0111064467138874,0,0,19.204633204633204,98.94754273926414,TGFB1;TGFB3,2,2,H1
60,KEGG_2021_Human,Shigellosis,3/246,0.0058404590478201,0.0111064467138874,0,0,9.020118884316416,46.389983263599625,C3;CXCL8;ITGA5,2,2,H1
61,KEGG_2021_Human,Salmonella infection,3/249,0.0060394012737568,0.011299524963803,0,0,8.908762420957544,45.51887970466737,HSP90AA1;CXCL8;HSP90B1,2,2,H1
62,KEGG_2021_Human,B cell receptor signaling pathway,2/81,0.0065475767330746,0.0120558555720104,0,0,17.984629294755877,90.43859066502284,CD79A;LILRA4,2,2,H1
63,KEGG_2021_Human,Complement and coagulation cascades,2/85,0.0071877384972766,0.013027776026314,0,0,17.1144578313253,84.46633049181104,C3;ITGAX,2,2,H1
64,KEGG_2021_Human,TGF-beta signaling pathway,2/94,0.0087273184884668,0.0155749068409561,0,0,15.433229813664596,73.17352801930804,TGFB1;TGFB3,2,2,H1
65,KEGG_2021_Human,Cytokine-cytokine receptor interaction,3/295,0.0096075402293057,0.0168859797969616,0,0,7.487823439878234,34.78249021899394,TGFB1;CXCL8;TGFB3,2,2,H1
66,KEGG_2021_Human,Th17 cell differentiation,2/107,0.0111874132699015,0.0193692528255012,0,0,13.513605442176871,60.71616908400605,HSP90AA1;TGFB1,2,2,H1
67,KEGG_2021_Human,Toxoplasmosis,2/112,0.0122059337373962,0.0208218869637935,0,0,12.896103896103895,56.818081065593866,TGFB1;TGFB3,2,2,H1
68,KEGG_2021_Human,Cell cycle,2/124,0.0148093553156593,0.0248968871973404,0,0,11.620608899297425,48.95177062069236,TGFB1;TGFB3,2,2,H1
69,KEGG_2021_Human,Osteoclast differentiation,2/127,0.0154945589841582,0.0256766977451765,0,0,11.34,47.25680040858784,TGFB1;LILRA4,2,2,H1
70,KEGG_2021_Human,FoxO signaling pathway,2/131,0.016429116348176,0.026841936568851,0,0,10.986157253599114,45.13882574929996,TGFB1;TGFB3,2,2,H1
71,KEGG_2021_Human,Non-alcoholic fatty liver disease,2/155,0.0225232501267853,0.0362874585375986,0,0,9.251633986928104,35.0933643209813,TGFB1;CXCL8,2,2,H1
72,KEGG_2021_Human,Protein processing in endoplasmic reticulum,2/171,0.0270284247863527,0.0429492777426974,0,0,8.368977176669484,30.219256789750094,HSP90AA1;HSP90B1,2,2,H1
73,KEGG_2021_Human,NOD-like receptor signaling pathway,2/181,0.0300143858308318,0.0470495777888715,0,0,7.897446129289705,27.68906595689205,HSP90AA1;CXCL8,2,2,H1
0,KEGG_2021_Human,Cell adhesion molecules,14/148,6.899731066791374e-17,1.1108567017534111e-14,0,0,38.30458817025981,1425.4081139085874,SELPLG;ITGAM;ITGB2;HLA-B;ICAM2;HLA-C;ICAM3;HLA-A;HLA-F;ITGAL;HLA-G;CD4;PTPRC;SDC1,3,3,H1
1,KEGG_2021_Human,Phagosome,12/152,1.2077064475828338e-13,9.722036903041809e-12,0,0,30.293877551020408,901.087847791572,C3;ITGAM;ITGB2;HLA-B;HLA-C;ITGA5;CALR;HLA-A;CD14;HLA-F;HLA-G;THBS1,3,3,H1
2,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,13/219,4.197738712095976e-13,2.2527864421581737e-11,0,0,22.63353927625772,645.0345990635811,TGFB1;SMAD3;ITGB2;HLA-B;HLA-C;HLA-A;HLA-F;ITGAL;CD3D;HLA-G;TNFRSF1A;CD4;CALR,3,3,H1
3,KEGG_2021_Human,Human papillomavirus infection,13/331,7.648736470375422e-11,3.0786164293261074e-09,0,0,14.578730703259003,339.59543034089484,ITGA3;LAMB2;ITGB4;HLA-B;HLA-C;HLA-A;HLA-F;HLA-G;THBS1;TNFRSF1A;COL1A1;ITGA5;IFNAR1,3,3,H1
4,KEGG_2021_Human,Human immunodeficiency virus 1 infection,11/212,1.3222882603700263e-10,4.257768198391485e-09,0,0,18.9439643885834,430.90864279239423,CD4;HLA-B;HLA-C;TRAF2;CALR;HLA-A;HLA-F;CD3D;HLA-G;TNFRSF1A;GNAI2,3,3,H1
5,KEGG_2021_Human,Human cytomegalovirus infection,11/225,2.497534241040194e-10,6.701716880124522e-09,0,0,17.781439580259057,393.15735536013847,CXCL12;CCL5;HLA-B;HLA-C;TRAF2;CALR;HLA-A;HLA-F;HLA-G;TNFRSF1A;GNAI2,3,3,H1
6,KEGG_2021_Human,Cytokine-cytokine receptor interaction,12/295,2.957995774688657e-10,6.8033902817839106e-09,0,0,14.87809187279152,326.44525736610547,CSF1R;CD4;TGFB1;CXCL12;CSF1;CCL5;CXCR3;CCR7;LTB;CCL19;TNFRSF1A;IFNAR1,3,3,H1
7,KEGG_2021_Human,ECM-receptor interaction,8/88,6.050072931869768e-10,1.2175771775387909e-08,0,0,33.086666666666666,702.2903275550933,COL1A1;ITGA3;LAMB2;ITGB4;SDC1;ITGA5;HSPG2;THBS1,3,3,H1
8,KEGG_2021_Human,Viral myocarditis,7/60,1.2805521421371356e-09,2.2055563563662858e-08,0,0,43.04144757191463,881.3155825373632,ITGB2;HLA-B;HLA-C;HLA-A;ITGAL;HLA-F;HLA-G,3,3,H1
9,KEGG_2021_Human,Epstein-Barr virus infection,10/202,1.5438473695653996e-09,2.2055563563662858e-08,0,0,17.726293103448278,359.6485523880175,HLA-B;HLA-C;TRAF2;CALR;HLA-A;HLA-F;ITGAL;CD3D;HLA-G;IFNAR1,3,3,H1
10,KEGG_2021_Human,Hematopoietic cell lineage,8/99,1.5647554927453443e-09,2.2055563563662858e-08,0,0,29.07106227106227,589.4313771886325,CSF1R;CD4;ITGAM;CSF1;ITGA3;ITGA5;CD14;CD3D,3,3,H1
11,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,8/100,1.696282039964097e-09,2.2055563563662858e-08,0,0,28.7536231884058,580.6744463804018,CSF1R;CXCL12;CSF1;CCL5;CXCR3;CCR7;CCL19;TNFRSF1A,3,3,H1
12,KEGG_2021_Human,Proteoglycans in cancer,10/205,1.7808840144572491e-09,2.2055563563662858e-08,0,0,17.450928381962864,351.56912480521527,COL1A1;TGFB1;GPC1;ERBB2;SDC1;ITGA5;MMP9;HSPG2;THBS1;HBEGF,3,3,H1
13,KEGG_2021_Human,Antigen processing and presentation,7/78,8.348526762469465e-09,9.600805776839885e-08,0,0,32.10043869776033,597.1060623483071,CD4;HLA-B;HLA-C;CALR;HLA-A;HLA-F;HLA-G,3,3,H1
14,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,8/131,1.4514156952643136e-08,1.557852846250363e-07,0,0,21.47317073170732,387.55082000307925,ITGB2;HLA-B;ICAM2;HLA-C;HLA-A;ITGAL;HLA-G;IFNAR1,3,3,H1
15,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,9/193,1.815608838774142e-08,1.8269563940164807e-07,0,0,16.37177597641857,291.81478976836485,C3;HLA-B;HLA-C;TRAF2;HLA-A;HLA-F;HLA-G;TNFRSF1A;IFNAR1,3,3,H1
16,KEGG_2021_Human,Rheumatoid arthritis,7/93,2.8760890757377332e-08,2.723825536433971e-07,0,0,26.48150972169272,459.8315375079864,TGFB1;CXCL12;CSF1;CCL5;ITGB2;LTB;ITGAL,3,3,H1
17,KEGG_2021_Human,Chagas disease,7/102,5.473138553723068e-08,4.8954183730523e-07,0,0,23.9618636755824,400.66221344910457,C3;TGFB1;CCL5;CALR;CD3D;TNFRSF1A;GNAI2,3,3,H1
18,KEGG_2021_Human,Herpes simplex virus 1 infection,12/498,1.0219963065255533e-07,8.660073965821793e-07,0,0,8.574074074074074,138.01119238830896,C3;CCL5;HLA-B;HLA-C;TRAF2;ITGA5;CALR;HLA-A;HLA-F;HLA-G;TNFRSF1A;IFNAR1,3,3,H1
19,KEGG_2021_Human,Allograft rejection,5/38,1.799829380811937e-07,1.4488626515536097e-06,0,0,47.85714285714285,743.2407522800788,HLA-B;HLA-C;HLA-A;HLA-F;HLA-G,3,3,H1
20,KEGG_2021_Human,Pathways in cancer,12/531,2.040806690787528e-07,1.5646184629371048e-06,0,0,8.015276630883568,123.4733365638557,CSF1R;TGFB1;CXCL12;SMAD3;ITGA3;LAMB2;GSTP1;ERBB2;TRAF2;MMP9;IFNAR1;GNAI2,3,3,H1
21,KEGG_2021_Human,Pertussis,6/76,2.2359917959327826e-07,1.6363394506599e-06,0,0,27.458986175115207,420.4907344832443,C3;ITGAM;ITGB2;ITGA5;CD14;GNAI2,3,3,H1
22,KEGG_2021_Human,Graft-versus-host disease,5/42,3.018416348186304e-07,2.0843651045995138e-06,0,0,42.67481767481768,640.6925434391625,HLA-B;HLA-C;HLA-A;HLA-F;HLA-G,3,3,H1
23,KEGG_2021_Human,PI3K-Akt signaling pathway,10/354,3.1071281062353e-07,2.0843651045995138e-06,0,0,9.81756214915798,147.1102467525723,COL1A1;CSF1R;CSF1;ITGA3;LAMB2;ITGB4;ERBB2;ITGA5;THBS1;IFNAR1,3,3,H1
24,KEGG_2021_Human,Type I diabetes mellitus,5/43,3.4066251274515213e-07,2.19386658207878e-06,0,0,41.54970760233918,618.7737664421848,HLA-B;HLA-C;HLA-A;HLA-F;HLA-G,3,3,H1
25,KEGG_2021_Human,Rap1 signaling pathway,8/210,5.567284863934915e-07,3.447434088821236e-06,0,0,13.023102310231025,187.548146965454,CSF1R;ITGAM;CSF1;ITGB2;FPR1;ITGAL;THBS1;GNAI2,3,3,H1
26,KEGG_2021_Human,Malaria,5/50,7.361800479386748e-07,4.389814359930616e-06,0,0,35.07407407407408,495.3087477237293,TGFB1;ITGB2;SDC1;ITGAL;THBS1,3,3,H1
27,KEGG_2021_Human,Staphylococcus aureus infection,6/95,8.451339822718942e-07,4.859520398063391e-06,0,0,21.57629575933309,301.71797166111253,C3;SELPLG;ITGAM;ITGB2;FPR1;ITGAL,3,3,H1
28,KEGG_2021_Human,Autoimmune thyroid disease,5/53,9.8927734839975e-07,5.358191645138634e-06,0,0,32.87698412698413,454.5667534069651,HLA-B;HLA-C;HLA-A;HLA-F;HLA-G,3,3,H1
29,KEGG_2021_Human,Cellular senescence,7/156,9.984208034419816e-07,5.358191645138634e-06,0,0,15.236109583012432,210.5187126366208,TGFB1;SMAD3;HLA-B;HLA-C;HLA-A;HLA-F;HLA-G,3,3,H1
30,KEGG_2021_Human,Amoebiasis,6/102,1.2852728090784564e-06,6.675126524568757e-06,0,0,19.995967741935484,271.23609546327725,COL1A1;TGFB1;ITGAM;LAMB2;ITGB2;CD14,3,3,H1
31,KEGG_2021_Human,NF-kappa B signaling pathway,6/104,1.4406550325398856e-06,7.248295632466299e-06,0,0,19.585911784068465,263.4385958983082,CXCL12;TRAF2;LTB;CCL19;CD14;TNFRSF1A,3,3,H1
32,KEGG_2021_Human,Leukocyte transendothelial migration,6/114,2.465679554147302e-06,1.202952752174896e-05,0,0,17.763440860215052,229.38007756134567,CXCL12;ITGAM;ITGB2;ITGAL;MMP9;GNAI2,3,3,H1
33,KEGG_2021_Human,Osteoclast differentiation,6/127,4.617053095705775e-06,2.18631043649597e-05,0,0,15.84457478005865,194.66254662707524,CSF1R;TGFB1;CSF1;TRAF2;TNFRSF1A;IFNAR1,3,3,H1
34,KEGG_2021_Human,Focal adhesion,7/201,5.382728930378909e-06,2.476055307974298e-05,0,0,11.675342234240324,141.64893060898572,COL1A1;ITGA3;LAMB2;ITGB4;ERBB2;ITGA5;THBS1,3,3,H1
35,KEGG_2021_Human,Viral carcinogenesis,7/203,5.744310330235826e-06,2.568983231022133e-05,0,0,11.55503512880562,139.43808350790636,C3;HLA-B;HLA-C;TRAF2;HLA-A;HLA-F;HLA-G,3,3,H1
36,KEGG_2021_Human,Regulation of actin cytoskeleton,7/218,9.15604544794216e-06,3.984117073293751e-05,0,0,10.72542925957579,124.4267365424707,CXCL12;ITGAM;ITGA3;ITGB4;ITGB2;ITGA5;ITGAL,3,3,H1
37,KEGG_2021_Human,Bladder cancer,4/41,1.1255283437741026e-05,4.768685877569224e-05,0,0,33.60641891891892,382.93415094327565,ERBB2;THBS1;MMP9;HBEGF,3,3,H1
38,KEGG_2021_Human,Tuberculosis,6/180,3.36932666072514e-05,0.00013909271599403782,0,0,10.988876529477198,113.16578612591768,C3;TGFB1;ITGAM;ITGB2;CD14;TNFRSF1A,3,3,H1
39,KEGG_2021_Human,TNF signaling pathway,5/112,3.962024423066749e-05,0.00015947148302843667,0,0,14.704791573950452,149.0502723898783,CSF1;CCL5;TRAF2;MMP9;TNFRSF1A,3,3,H1
40,KEGG_2021_Human,Legionellosis,4/57,4.2143210321859713e-05,0.00016548919175169303,0,0,23.44221698113208,236.16713741807763,C3;ITGAM;ITGB2;CD14,3,3,H1
41,KEGG_2021_Human,Neutrophil extracellular trap formation,6/189,4.426533747397624e-05,0.00016968379365024224,0,0,10.443680592279218,104.70112124368086,C3;SELPLG;ITGAM;ITGB2;FPR1;ITGAL,3,3,H1
42,KEGG_2021_Human,Chemokine signaling pathway,6/192,4.832724022767193e-05,0.00018094617852686468,0,0,10.273673257023932,102.09478390919028,CXCL12;CCL5;CXCR3;CCR7;CCL19;GNAI2,3,3,H1
43,KEGG_2021_Human,Sphingolipid signaling pathway,5/119,5.295945215518625e-05,0.00019378344993147695,0,0,13.796992481203008,135.8449670923655,ADORA1;TRAF2;S1PR4;TNFRSF1A;GNAI2,3,3,H1
44,KEGG_2021_Human,MAPK signaling pathway,7/294,6.21949943245057e-05,0.00022251986858323156,0,0,7.854858056777289,76.07615432923801,CSF1R;TGFB1;CSF1;ERBB2;TRAF2;CD14;TNFRSF1A,3,3,H1
45,KEGG_2021_Human,Fluid shear stress and atherosclerosis,5/139,0.000110643893689971,0.00038725362791489846,0,0,11.725894337834635,106.81344258049624,GPC1;GSTP1;SDC1;MMP9;TNFRSF1A,3,3,H1
46,KEGG_2021_Human,Leishmaniasis,4/77,0.00013719418568415212,0.0004699630615989041,0,0,17.002568493150687,151.22276924231187,C3;TGFB1;ITGAM;ITGB2,3,3,H1
47,KEGG_2021_Human,Shigellosis,6/246,0.00018852602838218937,0.0006323477201985935,0,0,7.940322580645161,68.09838590345795,C3;CCL5;TRAF2;ITGA5;CD14;TNFRSF1A,3,3,H1
48,KEGG_2021_Human,Complement and coagulation cascades,4/85,0.0002011263513315641,0.0006608437258037107,0,0,15.31712962962963,130.3729318428735,C3;ITGAM;F10;ITGB2,3,3,H1
49,KEGG_2021_Human,Endocytosis,6/252,0.0002147320309965884,0.0006914371398090148,0,0,7.744295830055075,65.40924937658649,SMAD3;HLA-B;HLA-C;HLA-A;HLA-F;HLA-G,3,3,H1
50,KEGG_2021_Human,Hepatitis B,5/162,0.0002263782992633049,0.0007146452192429821,0,0,9.996461429582448,83.90333038145732,TGFB1;SMAD3;MMP9;HSPG2;IFNAR1,3,3,H1
51,KEGG_2021_Human,Hypertrophic cardiomyopathy,4/90,0.0002505985293132387,0.0007758916003736813,0,0,14.42296511627907,119.59029963115674,TGFB1;ITGA3;ITGB4;ITGA5,3,3,H1
52,KEGG_2021_Human,Primary immunodeficiency,3/38,0.00029120715321542454,0.0008826526387444739,0,0,26.2378021978022,213.6144284200033,CD4;PTPRC;CD3D,3,3,H1
53,KEGG_2021_Human,IL-17 signaling pathway,4/94,0.0002960449844236124,0.0008826526387444739,0,0,13.779166666666669,111.9557173273732,TRAF2;MMP9;S100A9;S100A8,3,3,H1
54,KEGG_2021_Human,Dilated cardiomyopathy,4/96,0.0003208563224514985,0.0009392339620852956,0,0,13.478260869565217,108.42610042953902,TGFB1;ITGA3;ITGB4;ITGA5,3,3,H1
55,KEGG_2021_Human,Th17 cell differentiation,4/107,0.0004846775712906144,0.0013934480174605,0,0,12.032160194174756,91.8297677350985,CD4;TGFB1;SMAD3;CD3D,3,3,H1
56,KEGG_2021_Human,Toxoplasmosis,4/112,0.0005759367525202112,0.0016267687220307,0,0,11.47222222222222,85.57718745509037,TGFB1;LAMB2;TNFRSF1A;GNAI2,3,3,H1
57,KEGG_2021_Human,Lipid and atherosclerosis,5/215,0.0008242766091280442,0.002288078173614,0,0,7.453514739229025,52.92744091175022,CCL5;TRAF2;CD14;MMP9;TNFRSF1A,3,3,H1
58,KEGG_2021_Human,Relaxin signaling pathway,4/129,0.0009777217473531951,0.0026680203614214,0,0,9.9035,68.63408185820364,COL1A1;TGFB1;MMP9;GNAI2,3,3,H1
59,KEGG_2021_Human,Coronavirus disease,5/232,0.0011576408102789,0.0031063361742484,0,0,6.88937836514929,46.58164397524769,C3;ADAM17;TNFRSF1A;HBEGF;IFNAR1,3,3,H1
60,KEGG_2021_Human,Acute myeloid leukemia,3/67,0.0015413446126464,0.0040681390596078,0,0,14.327884615384615,92.77448736969174,CSF1R;ITGAM;CD14,3,3,H1
61,KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,3/70,0.0017485180389848,0.0045405065205897,0,0,13.684270952927667,86.88125406968709,ADAM17;CCL5;HBEGF,3,3,H1
62,KEGG_2021_Human,Pancreatic cancer,3/76,0.002213182258085,0.0056559102151062,0,0,12.555742887249735,76.75732261509744,TGFB1;SMAD3;ERBB2,3,3,H1
63,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,3/77,0.0022973443046233,0.0057792567663182,0,0,12.385446985446986,75.25399413146187,ITGA3;ITGB4;ITGA5,3,3,H1
64,KEGG_2021_Human,Small cell lung cancer,3/92,0.0038036226138706,0.0094212806282026,0,0,10.290233362143477,57.3351361074206,ITGA3;LAMB2;TRAF2,3,3,H1
65,KEGG_2021_Human,TGF-beta signaling pathway,3/94,0.0040404405499248,0.0098562261899682,0,0,10.06306001690617,55.46156453409548,TGFB1;SMAD3;THBS1,3,3,H1
66,KEGG_2021_Human,Transcriptional misregulation in cancer,4/192,0.0041536798445032,0.0099812306711198,0,0,6.5638297872340425,35.994471356884574,CSF1R;ITGAM;CD14;MMP9,3,3,H1
67,KEGG_2021_Human,Prostate cancer,3/97,0.0044121911590111,0.0104465114205998,0,0,9.740425531914894,52.82606653617872,GSTP1;ERBB2;MMP9,3,3,H1
68,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,3/100,0.0048040547103092,0.0112094609907215,0,0,9.437747819191118,50.38148186551567,COL1A1;TGFB1;SMAD3,3,3,H1
69,KEGG_2021_Human,Diabetic cardiomyopathy,4/203,0.0050568729068937,0.0116308076858555,0,0,6.197550251256281,32.76649149502447,COL1A1;TGFB1;SMAD3;MMP9,3,3,H1
70,KEGG_2021_Human,Protein digestion and absorption,3/103,0.0052163370663076,0.0118177367857045,0,0,9.153230769230769,48.109013282076646,COL1A1;COL18A1;SLC1A5,3,3,H1
71,KEGG_2021_Human,T cell receptor signaling pathway,3/104,0.0053583527040772,0.0118177367857045,0,0,9.062147753236864,47.38686487674727,CD4;PTPRC;CD3D,3,3,H1
72,KEGG_2021_Human,Toll-like receptor signaling pathway,3/104,0.0053583527040772,0.0118177367857045,0,0,9.062147753236864,47.38686487674727,CCL5;CD14;IFNAR1,3,3,H1
73,KEGG_2021_Human,Neuroactive ligand-receptor interaction,5/341,0.0060661801874556,0.013198040678113,0,0,4.628684807256236,23.629557053653247,C3;FPR1;ADORA1;S1PR4;ADRA2A,3,3,H1
74,KEGG_2021_Human,FoxO signaling pathway,3/131,0.0100964492686846,0.0216737110967764,0,0,7.140865384615385,32.81635726479536,TGFB1;SMAD3;S1PR4,3,3,H1
75,KEGG_2021_Human,Salmonella infection,4/249,0.0102498854732357,0.0217135731735652,0,0,5.02219387755102,23.00410254038534,PTPRC;TRAF2;CD14;TNFRSF1A,3,3,H1
76,KEGG_2021_Human,Yersinia infection,3/137,0.0113947838178035,0.0235200024957226,0,0,6.819058553386912,30.512556594459877,CD4;TRAF2;ITGA5,3,3,H1
77,KEGG_2021_Human,Estrogen signaling pathway,3/137,0.0113947838178035,0.0235200024957226,0,0,6.819058553386912,30.512556594459877,MMP9;HBEGF;GNAI2,3,3,H1
78,KEGG_2021_Human,Intestinal immune network for IgA production,2/48,0.0116167597830401,0.0236746623426514,0,0,13.100131752305666,58.36510102971351,TGFB1;CXCL12,3,3,H1
79,KEGG_2021_Human,Measles,3/139,0.0118479892951961,0.0238440784565821,0,0,6.718099547511312,29.798782907593612,RACK1;CD3D;IFNAR1,3,3,H1
80,KEGG_2021_Human,Gastric cancer,3/149,0.0142689212395206,0.0283616829575657,0,0,6.254794520547946,26.58082167920169,TGFB1;SMAD3;ERBB2,3,3,H1
81,KEGG_2021_Human,Regulation of lipolysis in adipocytes,2/55,0.0150621225458357,0.0295731918277995,0,0,11.365923384791309,47.6865513536084,ADORA1;GNAI2,3,3,H1
82,KEGG_2021_Human,Non-alcoholic fatty liver disease,3/155,0.0158465297474571,0.0307384492691639,0,0,6.006072874493927,24.893999355075604,TGFB1;TRAF2;TNFRSF1A,3,3,H1
83,KEGG_2021_Human,Hepatitis C,3/157,0.0163933972403876,0.0314206780440763,0,0,5.927472527472528,24.36710830305253,TRAF2;TNFRSF1A;IFNAR1,3,3,H1
84,KEGG_2021_Human,Necroptosis,3/159,0.0169507988192053,0.0321068071752006,0,0,5.850887573964497,23.8566448918616,TRAF2;TNFRSF1A;IFNAR1,3,3,H1
85,KEGG_2021_Human,Hippo signaling pathway,3/163,0.0180972749850911,0.033879782239531,0,0,5.703461538461538,22.88225293173164,TGFB1;SMAD3;ITGB2,3,3,H1
86,KEGG_2021_Human,cGMP-PKG signaling pathway,3/167,0.0192860810088093,0.0356903338209,0,0,5.563227016885554,21.965687749800672,ADORA1;ADRA2A;GNAI2,3,3,H1
87,KEGG_2021_Human,Hepatocellular carcinoma,3/168,0.0195899081411738,0.0358406273946475,0,0,5.529230769230769,21.745031085472768,TGFB1;SMAD3;GSTP1,3,3,H1
88,KEGG_2021_Human,Inflammatory bowel disease,2/65,0.0206438804303416,0.0372656944345236,0,0,9.556998556998558,37.08436890424736,SMAD3;TGFB1,3,3,H1
89,KEGG_2021_Human,Influenza A,3/172,0.0208317546528392,0.0372656944345236,0,0,5.397269003186163,20.89432222381095,CCL5;TNFRSF1A;IFNAR1,3,3,H1
90,KEGG_2021_Human,MicroRNAs in cancer,4/310,0.021230463399336,0.037561589091133,0,0,4.008578431372549,15.442319550833531,ERBB2;ITGA5;MMP9;THBS1,3,3,H1
91,KEGG_2021_Human,Adipocytokine signaling pathway,2/69,0.0230828770826961,0.0399606796807965,0,0,8.984622342831297,33.86002446746899,TRAF2;TNFRSF1A,3,3,H1
92,KEGG_2021_Human,Renin secretion,2/69,0.0230828770826961,0.0399606796807965,0,0,8.984622342831297,33.86002446746899,ADORA1;GNAI2,3,3,H1
93,KEGG_2021_Human,Central carbon metabolism in cancer,2/70,0.0237103597045097,0.0403031253931091,0,0,8.85204991087344,33.122982836017705,ERBB2;SLC1A5,3,3,H1
94,KEGG_2021_Human,NOD-like receptor signaling pathway,3/181,0.0237813472816482,0.0403031253931091,0,0,5.122039757994815,19.150557470990947,CCL5;TRAF2;IFNAR1,3,3,H1
95,KEGG_2021_Human,Adherens junction,2/71,0.0243448282404302,0.0408283056948881,0,0,8.723320158102768,32.41093639935573,SMAD3;ERBB2,3,3,H1
96,KEGG_2021_Human,Chronic myeloid leukemia,2/76,0.0276201050610613,0.0458436795343389,0,0,8.131859131859132,29.18696090729942,TGFB1;SMAD3,3,3,H1
0,KEGG_2021_Human,PI3K-Akt signaling pathway,29/354,8.314711785013223e-25,1.6878864923576842e-22,0,0,18.96541806020067,1051.5679656088446,LAMA5;ITGB5;TNC;TGFA;THBS2;AREG;EGFR;HSP90B1;RXRA;ERBB3;ERBB2;ITGB8;ITGAV;ITGB7;ITGB6;NGFR;HSP90AA1;INSR;HGF;F2R;FN1;EREG;VEGFA;COL1A1;EFNA1;COL1A2;COL4A1;COL4A5;ITGA5,4,4,H1
1,KEGG_2021_Human,Pathways in cancer,32/531,3.0720468914328145e-23,3.1181275948043068e-21,0,0,13.964107991263424,723.8590447189692,NOTCH2;ALK;NOTCH3;LAMA5;NOTCH1;LRP5;TGFA;CXCR4;EGFR;LRP6;HSP90B1;PLD2;GNAI2;RXRA;CDH1;ERBB2;BDKRB2;ITGAV;JAG2;HSP90AA1;TGFB1;TGFB3;HGF;F2R;FN1;VEGFA;AR;COL4A1;COL4A5;CALM3;CALM1;CALM2,4,4,H1
2,KEGG_2021_Human,ECM-receptor interaction,17/88,2.6051043511485325e-21,1.7627872776105072e-19,0,0,45.603466955579634,2161.459051102014,LAMA5;ITGB5;SDC4;TNC;FN1;THBS2;COL1A1;COL1A2;COL4A1;ITGB8;COL4A5;SDC1;ITGAV;ITGB7;ITGB6;ITGA5;CD44,4,4,H1
3,KEGG_2021_Human,Human papillomavirus infection,24/331,2.461613668520771e-19,1.2492689367742913e-17,0,0,15.773800329090973,675.8805234226818,NOTCH2;NOTCH3;LAMA5;NOTCH1;ITGB5;TNC;HLA-B;FN1;HLA-C;PSEN1;THBS2;TNF;EGFR;VEGFA;COL1A1;COL1A2;PKM;COL4A1;COL4A5;ITGB8;ITGAV;ITGB7;ITGA5;ITGB6,4,4,H1
4,KEGG_2021_Human,Proteoglycans in cancer,19/205,1.903948798191432e-17,7.730032120657215e-16,0,0,19.722064094454986,759.2997937723502,TGFB1;SDC4;ITGB5;HGF;SDC2;FN1;TNF;EGFR;VEGFA;COL1A1;COL1A2;ERBB3;PLAU;ERBB2;SDC1;ITGAV;ITGA5;EZR;CD44,4,4,H1
5,KEGG_2021_Human,Focal adhesion,18/201,2.61367455030609e-16,8.842932228535605e-15,0,0,18.80884927582365,674.8728797655787,LAMA5;ITGB5;HGF;TNC;FN1;THBS2;EGFR;VEGFA;COL1A1;COL1A2;COL4A1;ERBB2;COL4A5;ITGB8;ITGAV;ITGB7;ITGA5;ITGB6,4,4,H1
6,KEGG_2021_Human,Malaria,11/50,7.648334322741177e-15,2.2180169535949414e-13,0,0,50.87179487179487,1653.551497349667,TGFB1;VCAM1;TGFB3;HGF;SDC2;ITGB2;SDC1;ITGAL;THBS2;TNF;ICAM1,4,4,H1
7,KEGG_2021_Human,Fluid shear stress and atherosclerosis,14/139,1.2656917101372506e-13,3.211692714473273e-12,0,0,20.677084112149533,614.0677840465967,ACVR1;HSP90AA1;VCAM1;SDC4;SDC2;TNF;HSP90B1;ICAM1;VEGFA;SDC1;CALM3;ITGAV;CALM1;CALM2,4,4,H1
8,KEGG_2021_Human,Cell adhesion molecules,14/148,3.0381835476295733e-13,6.852791779653369e-12,0,0,19.27953689496443,555.6814906122653,VCAM1;SDC4;SDC2;ITGB2;HLA-B;HLA-C;ITGAL;PTPRF;ICAM1;CDH1;SDC1;ITGB8;ITGAV;ITGB7,4,4,H1
9,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,12/100,9.245525075867533e-13,1.876841590401109e-11,0,0,24.759382819015848,686.0692900230881,COL1A1;TGFB1;VCAM1;COL1A2;COL4A1;TGFB3;FN1;COL4A5;TNF;AGER;ICAM1;VEGFA,4,4,H1
10,KEGG_2021_Human,Regulation of actin cytoskeleton,15/218,4.378050903765351e-12,8.079493940585145e-11,0,0,13.715958732224184,358.7329109543897,ITGB5;F2R;ITGB2;FN1;CXCR4;ITGAL;EGFR;BDKRB2;ITGAX;ITGB8;ITGAV;ITGB7;ITGA5;ITGB6;EZR,4,4,H1
11,KEGG_2021_Human,Axon guidance,14/182,5.230834459548064e-12,8.848828294068808e-11,0,0,15.351246105919005,398.7708814840608,EPHB6;EPHA4;NRP1;SEMA4D;SEMA4C;CXCR4;SEMA3F;GNAI2;EFNA1;EFNB1;PLXNB2;PLXNA1;PLXNB1;EPHB4,4,4,H1
12,KEGG_2021_Human,Rap1 signaling pathway,14/210,3.6128746999151296e-11,5.641642800636701e-10,0,0,13.139519359145527,315.9257132913918,NGFR;INSR;HGF;F2R;ITGB2;ITGAL;EGFR;VEGFA;GNAI2;EFNA1;CDH1;CALM3;CALM1;CALM2,4,4,H1
13,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,14/219,6.330100117755652e-11,9.178645170745695e-10,0,0,12.556918167312514,294.87561578290644,NRP1;TGFB1;TGFB3;ITGB2;HLA-B;HLA-C;CD3G;ITGAL;TNF;ICAM1;CANX;CALR;LTBR;B2M,4,4,H1
14,KEGG_2021_Human,Human cytomegalovirus infection,14/225,9.07095366537586e-11,1.227602396047533e-09,0,0,12.196128803649732,282.01546009408787,HLA-B;HLA-C;CXCR4;TNF;EGFR;VEGFA;GNAI2;CCL5;CALM3;ITGAV;CALR;CALM1;CALM2;B2M,4,4,H1
15,KEGG_2021_Human,Hypertrophic cardiomyopathy,10/90,1.714381924477781e-10,2.175122066681184e-09,0,0,22.29617117117117,501.3695041705728,ACE;TGFB1;ITGB5;TGFB3;ITGB8;ITGAV;ITGB7;ITGB6;ITGA5;TNF,4,4,H1
16,KEGG_2021_Human,Amoebiasis,10/102,6.007477635337867e-10,6.775099777631039e-09,0,0,19.376224050137093,411.41238062262704,COL1A1;LAMA5;TGFB1;COL1A2;COL4A1;TGFB3;ITGB2;FN1;COL4A5;TNF,4,4,H1
17,KEGG_2021_Human,Chagas disease,10/102,6.007477635337867e-10,6.775099777631039e-09,0,0,19.376224050137093,411.41238062262704,ACE;TGFB1;TGFB3;CCL5;BDKRB2;CD3G;CALR;CD247;TNF;GNAI2,4,4,H1
18,KEGG_2021_Human,MAPK signaling pathway,14/294,2.9907856079348504e-09,3.195418307425129e-08,0,0,9.15841121495327,179.75882016505685,NGFR;TGFB1;TGFB3;INSR;HGF;TGFA;TNF;AREG;EGFR;EREG;VEGFA;EFNA1;ERBB3;ERBB2,4,4,H1
19,KEGG_2021_Human,Rheumatoid arthritis,9/93,5.0454425923088435e-09,5.121124231193477e-08,0,0,18.93654336734694,361.7785036682095,TGFB1;TGFB3;CCL5;ITGB2;LTB;ITGAL;TNF;ICAM1;VEGFA,4,4,H1
20,KEGG_2021_Human,Human immunodeficiency virus 1 infection,12/212,6.261044992402861e-09,6.0523434926561e-08,0,0,10.832477064220184,204.61377895475607,HLA-B;HLA-C;CXCR4;CALM3;CD3G;CALR;CD247;CALM1;CALM2;TNF;B2M;GNAI2,4,4,H1
21,KEGG_2021_Human,Dilated cardiomyopathy,9/96,6.698935478060909e-09,6.18129046384711e-08,0,0,18.2807881773399,344.06851308050085,TGFB1;ITGB5;TGFB3;ITGB8;ITGAV;ITGB7;ITGB6;ITGA5;TNF,4,4,H1
22,KEGG_2021_Human,Antigen processing and presentation,8/78,2.3388847127158236e-08,2.0643199855709227e-07,0,0,20.03438685208597,352.0243425371022,HSP90AA1;CANX;HLA-B;HLA-C;KLRD1;CALR;TNF;B2M,4,4,H1
23,KEGG_2021_Human,Cytokine-cytokine receptor interaction,13/295,2.84140737287038e-08,2.403357069552863e-07,0,0,8.364887050170738,145.35146658644135,ACVR1;NGFR;CXCL9;TGFB1;TGFB3;CXCR4;TNF;CXCL10;CCL5;CXCR3;LTBR;LTB;INHA,4,4,H1
24,KEGG_2021_Human,Epstein-Barr virus infection,11/202,4.116911743781731e-08,3.342932335950765e-07,0,0,10.307853403141362,175.29099927096092,CXCL10;HLA-B;HLA-C;CD3G;CALR;CD247;ITGAL;TNF;B2M;CD44;ICAM1,4,4,H1
25,KEGG_2021_Human,MicroRNAs in cancer,13/310,5.0854353513654474e-08,3.970551447412253e-07,0,0,7.936338695597954,133.28525377526842,NOTCH2;NOTCH3;NOTCH1;TNC;EGFR;VEGFA;EFNA1;ERBB3;PLAU;ERBB2;ITGA5;EZR;CD44,4,4,H1
26,KEGG_2021_Human,Lipid and atherosclerosis,11/215,7.78642060232691e-08,5.854234749156899e-07,0,0,9.644607843137257,157.86582950397198,HSP90AA1;VCAM1;RXRA;CCL5;CALM3;CALM1;CALM2;TNF;AGER;HSP90B1;ICAM1,4,4,H1
27,KEGG_2021_Human,Ras signaling pathway,11/232,1.6822730082795725e-07,1.2196479310026898e-06,0,0,8.89502262443439,138.74411628465663,EFNA1;NGFR;INSR;HGF;TGFA;CALM3;CALM1;CALM2;EGFR;VEGFA;PLD2,4,4,H1
28,KEGG_2021_Human,Calcium signaling pathway,11/240,2.3647891543777526e-07,1.6553524080644266e-06,0,0,8.580786026200874,130.92054294083815,ERBB3;HGF;F2R;ERBB2;BDKRB2;CXCR4;CALM3;CALM1;CALM2;EGFR;VEGFA,4,4,H1
29,KEGG_2021_Human,Gastric cancer,9/149,3.082708959441399e-07,2.08596639588868e-06,0,0,11.329783163265306,169.8593597919172,TGFB1;RXRA;TGFB3;CDH1;HGF;ERBB2;LRP5;EGFR;LRP6,4,4,H1
30,KEGG_2021_Human,Phagosome,9/152,3.651105070011568e-07,2.30116371354944e-06,0,0,11.09040959040959,164.3938707779729,ITGB5;CANX;ITGB2;HLA-B;HLA-C;ITGAV;ITGA5;CALR;THBS2,4,4,H1
31,KEGG_2021_Human,Alzheimer disease,13/369,3.786756563161396e-07,2.30116371354944e-06,0,0,6.601097586350395,97.60769574459664,APP;INSR;LRP5;ADAM10;PSEN1;TNF;AGER;RTN4;LRP6;NCSTN;CALM3;CALM1;CALM2,4,4,H1
32,KEGG_2021_Human,Pancreatic cancer,7/76,3.854165825649308e-07,2.30116371354944e-06,0,0,17.629036359013476,260.3621988426834,TGFB1;TGFB3;ERBB2;TGFA;EGFR;PLD2;VEGFA,4,4,H1
33,KEGG_2021_Human,Pertussis,7/76,3.854165825649308e-07,2.30116371354944e-06,0,0,17.629036359013476,260.3621988426834,ITGB2;CALM3;ITGA5;CALM1;TNF;CALM2;GNAI2,4,4,H1
34,KEGG_2021_Human,ErbB signaling pathway,7/85,8.319812795316293e-07,4.82549142128345e-06,0,0,15.587831758884391,218.2211632374428,ERBB3;NRG4;ERBB2;TGFA;AREG;EGFR;EREG,4,4,H1
35,KEGG_2021_Human,Relaxin signaling pathway,8/129,1.176690216700552e-06,6.635225388617002e-06,0,0,11.560301323776786,157.83053927194152,COL1A1;TGFB1;COL1A2;COL4A1;COL4A5;EGFR;VEGFA;GNAI2,4,4,H1
36,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,8/131,1.3220541806166872e-06,7.25343239635642e-06,0,0,11.371177782574286,153.9239448337896,ITGB2;HLA-B;HLA-C;KLRD1;CD247;ITGAL;TNF;ICAM1,4,4,H1
37,KEGG_2021_Human,Notch signaling pathway,6/59,1.5008501141391489e-06,8.017699293953874e-06,0,0,19.516981132075472,261.71254605059124,NOTCH2;JAG2;NOTCH3;NCSTN;NOTCH1;PSEN1,4,4,H1
38,KEGG_2021_Human,Estrogen signaling pathway,8/137,1.8534493891330613e-06,9.64744169215414e-06,0,0,10.838992934074229,143.05803766251975,HSP90AA1;TGFA;CALM3;CALM1;CALM2;EGFR;HSP90B1;GNAI2,4,4,H1
39,KEGG_2021_Human,Prostate cancer,7/97,2.0396264928808616e-06,1.0351104451370374e-05,0,0,13.501267056530214,176.9036440082232,AR;HSP90AA1;PLAU;ERBB2;TGFA;EGFR;HSP90B1,4,4,H1
40,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,7/100,2.50384461715626e-06,1.23970843239688e-05,0,0,13.063761554423694,168.4922574133193,CXCL10;CXCL9;CCL5;CXCR3;CXCR4;LTBR;TNF,4,4,H1
41,KEGG_2021_Human,Breast cancer,8/147,3.1420151562075752e-06,1.5186406588336612e-05,0,0,10.054115999236007,127.39214662374803,JAG2;NOTCH2;NOTCH3;NOTCH1;ERBB2;LRP5;EGFR;LRP6,4,4,H1
42,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",7/106,3.699615609767453e-06,1.7465627180995184e-05,0,0,12.268297005139113,153.44304580011135,RXRA;LRP5;EGFR;PTHLH;PLD2;GNAI2;LRP6,4,4,H1
43,KEGG_2021_Human,Non-small cell lung cancer,6/72,4.8816495825987045e-06,2.2522156028807657e-05,0,0,15.662450592885376,191.5521993695669,ALK;RXRA;HGF;ERBB2;TGFA;EGFR,4,4,H1
44,KEGG_2021_Human,Leukocyte transendothelial migration,7/114,6.002495471221629e-06,2.707792401462201e-05,0,0,11.346450237743891,136.42217525712283,VCAM1;ITGB2;CXCR4;EZR;ITGAL;ICAM1;GNAI2,4,4,H1
45,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,6/77,7.227930265571165e-06,3.189717051980318e-05,0,0,14.555786895284752,172.30496917919604,ITGB5;ITGB8;ITGAV;ITGB7;ITGB6;ITGA5,4,4,H1
46,KEGG_2021_Human,Colorectal cancer,6/86,1.3712390706847563e-05,5.899784770735354e-05,0,0,12.912391304347826,144.58276611081487,TGFB1;TGFB3;TGFA;AREG;EGFR;EREG,4,4,H1
47,KEGG_2021_Human,Tuberculosis,8/180,1.3950229999768324e-05,5.899784770735354e-05,0,0,8.111545585511422,90.68719776954232,TGFB1;TGFB3;ITGB2;ITGAX;CALM3;CALM1;CALM2;TNF,4,4,H1
48,KEGG_2021_Human,Small cell lung cancer,6/92,2.0192733525430435e-05,8.198249811324756e-05,0,0,12.00788675429727,129.80751023150657,LAMA5;RXRA;COL4A1;FN1;COL4A5;ITGAV,4,4,H1
49,KEGG_2021_Human,Th1 and Th2 cell differentiation,6/92,2.0192733525430435e-05,8.198249811324756e-05,0,0,12.00788675429727,129.80751023150657,NOTCH2;JAG2;NOTCH3;NOTCH1;CD3G;CD247,4,4,H1
50,KEGG_2021_Human,TGF-beta signaling pathway,6/94,2.283157028520377e-05,9.08786032920856e-05,0,0,11.733794466403165,125.40335976412126,ACVR1;TGFB1;TGFB3;TNF;LTBP1;FBN1,4,4,H1
51,KEGG_2021_Human,Viral myocarditis,5/60,3.1224041203930185e-05,0.00012189385316149668,0,0,15.536050156739812,161.17599017286304,ITGB2;HLA-B;HLA-C;ITGAL;ICAM1,4,4,H1
52,KEGG_2021_Human,NF-kappa B signaling pathway,6/104,4.0509633891109526e-05,0.00015515954113009875,0,0,10.53114463176575,106.51168864632304,VCAM1;PLAU;LTB;LTBR;TNF;ICAM1,4,4,H1
53,KEGG_2021_Human,Cellular senescence,7/156,4.606762855064902e-05,0.00017318015918114352,0,0,8.13081361120923,81.18942668265055,TGFB1;TGFB3;HLA-B;HLA-C;CALM3;CALM1;CALM2,4,4,H1
54,KEGG_2021_Human,Renal cell carcinoma,5/69,6.152595708749882e-05,0.0002230315944421832,0,0,13.345231681034482,129.39605240073232,TGFB1;TGFB3;HGF;TGFA;VEGFA,4,4,H1
55,KEGG_2021_Human,Renin secretion,5/69,6.152595708749882e-05,0.0002230315944421832,0,0,13.345231681034482,129.39605240073232,ACE;CALM3;CALM1;CALM2;GNAI2,4,4,H1
56,KEGG_2021_Human,Adherens junction,5/71,7.059535902709188e-05,0.0002514185593420992,0,0,12.939524555903866,123.68304264977488,CDH1;INSR;ERBB2;PTPRF;EGFR,4,4,H1
57,KEGG_2021_Human,Hepatocellular carcinoma,7/168,7.363502636629834e-05,0.0002577225922820442,0,0,7.520213577421815,71.56528335875137,TGFB1;TGFB3;HGF;LRP5;TGFA;EGFR;LRP6,4,4,H1
58,KEGG_2021_Human,Glioma,5/75,9.179808816722388e-05,0.000315847659287228,0,0,12.197660098522167,113.38846132195287,TGFA;CALM3;CALM1;CALM2;EGFR,4,4,H1
59,KEGG_2021_Human,Gastric acid secretion,5/76,9.779112244701662e-05,0.0003308599642790729,0,0,12.02525497814473,111.02529214055738,CALM3;EZR;CALM1;CALM2;GNAI2,4,4,H1
60,KEGG_2021_Human,Chemical carcinogenesis,8/239,0.00010429726531438978,0.0003470876206364119,0,0,6.021683331417845,55.20839103186956,NOTCH2;AR;HSP90AA1;RXRA;EGFR;HSP90B1;VEGFA;GNAI2,4,4,H1
61,KEGG_2021_Human,Bladder cancer,4/41,0.00010856460993373834,0.0003554615454282078,0,0,18.334026334026333,167.35601893886937,CDH1;ERBB2;EGFR;VEGFA,4,4,H1
62,KEGG_2021_Human,Graft-versus-host disease,4/42,0.00011943417911837272,0.0003848434660480899,0,0,17.850652271704902,161.24039256551012,HLA-B;HLA-C;KLRD1;TNF,4,4,H1
63,KEGG_2021_Human,Complement and coagulation cascades,5/85,0.0001662714550392117,0.0005273922714524996,0,0,10.667564655172416,92.82796175761754,PLAU;ITGB2;F2R;BDKRB2;ITGAX,4,4,H1
64,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,7/193,0.00017463371162268503,0.0005453945147600779,0,0,6.501179022825882,56.253530923300936,HLA-B;HLA-C;CALM3;CALM1;CALM2;ICAM1;VEGFA,4,4,H1
65,KEGG_2021_Human,Apelin signaling pathway,6/137,0.0001866235069100155,0.0005740086651929264,0,0,7.865117822768005,67.533183760553,NOTCH3;CDH1;CALM3;CALM1;CALM2;GNAI2,4,4,H1
66,KEGG_2021_Human,Intestinal immune network for IgA production,4/48,0.00020189941116588732,0.0006117250815921662,0,0,15.411810411810412,131.11969054053924,TGFB1;CXCR4;ITGB7;LTBR,4,4,H1
67,KEGG_2021_Human,Diabetic cardiomyopathy,7/203,0.00023797934484067845,0.0007104383382743783,0,0,6.166353383458647,51.44790066825028,COL1A1;TGFB1;COL1A2;ACE;TGFB3;INSR;AGER,4,4,H1
68,KEGG_2021_Human,GnRH signaling pathway,5/93,0.000253510511057639,0.0007351804820671531,0,0,9.693867554858937,80.26624384758468,CALM3;CALM1;CALM2;EGFR;PLD2,4,4,H1
69,KEGG_2021_Human,Salivary secretion,5/93,0.000253510511057639,0.0007351804820671531,0,0,9.693867554858937,80.26624384758468,TRPV6;CALM3;LYZ;CALM1;CALM2,4,4,H1
70,KEGG_2021_Human,IL-17 signaling pathway,5/94,0.0002664700761062884,0.0007618792316841768,0,0,9.584463386284384,78.88251641887878,CXCL10;HSP90AA1;TNF;S100A8;HSP90B1,4,4,H1
71,KEGG_2021_Human,cAMP signaling pathway,7/216,0.00034675263180380467,0.0009776497813357272,0,0,5.778980945185931,46.04055698664526,F2R;CALM3;FFAR2;CALM1;CALM2;PLD2;GNAI2,4,4,H1
72,KEGG_2021_Human,Th17 cell differentiation,5/107,0.000484871627679084,0.0013483416495733,0,0,8.357420554428668,63.78071123260579,HSP90AA1;TGFB1;RXRA;CD3G;CD247,4,4,H1
73,KEGG_2021_Human,HIF-1 signaling pathway,5/109,0.0005277673314776009,0.0014477941660804,0,0,8.19587201591512,61.85305796049074,INSR;ERBB2;LTBR;EGFR;VEGFA,4,4,H1
74,KEGG_2021_Human,cGMP-PKG signaling pathway,6/167,0.0005394495058696344,0.0014601099958871,0,0,6.389846070753444,48.083344855167866,INSR;BDKRB2;CALM3;CALM1;CALM2;GNAI2,4,4,H1
75,KEGG_2021_Human,TNF signaling pathway,5/112,0.0005973833245635367,0.0015749196738493,0,0,7.964872703834998,59.12286430931584,CXCL10;VCAM1;CCL5;TNF;ICAM1,4,4,H1
76,KEGG_2021_Human,Toxoplasmosis,5/112,0.0005973833245635367,0.0015749196738493,0,0,7.964872703834998,59.12286430931584,LAMA5;TGFB1;TGFB3;TNF;GNAI2,4,4,H1
77,KEGG_2021_Human,Phototransduction,3/28,0.0006335971067874782,0.0016489770856135,0,0,20.190508474576276,148.68486861580712,CALM3;CALM1;CALM2,4,4,H1
78,KEGG_2021_Human,Neurotrophin signaling pathway,5/119,0.0007864633776092382,0.0020209122234769,0,0,7.473154869933454,53.41784496822658,NGFR;CALM3;PSEN1;CALM1;CALM2,4,4,H1
79,KEGG_2021_Human,Thyroid hormone signaling pathway,5/121,0.0008478735475035528,0.0021514791267902,0,0,7.343564209274673,51.93940710491791,NOTCH2;NOTCH3;NOTCH1;RXRA;ITGAV,4,4,H1
80,KEGG_2021_Human,Chemokine signaling pathway,6/192,0.0011159364350961,0.0027967295842533,0,0,5.5239831697054695,37.55237661905527,CXCL10;CXCL9;CCL5;CXCR3;CXCR4;GNAI2,4,4,H1
81,KEGG_2021_Human,Leishmaniasis,4/77,0.0012271281293637,0.0030378903690345,0,0,9.275728837372672,62.17594033922146,TGFB1;TGFB3;ITGB2;TNF,4,4,H1
82,KEGG_2021_Human,Vascular smooth muscle contraction,5/133,0.0012943473466172,0.0031656929079915,0,0,6.651064116379311,44.227904897108544,RAMP2;RAMP3;CALM3;CALM1;CALM2,4,4,H1
83,KEGG_2021_Human,African trypanosomiasis,3/37,0.0014444001347436,0.0034906336589638,0,0,14.839232303090728,97.04948705631595,VCAM1;TNF;ICAM1,4,4,H1
84,KEGG_2021_Human,Insulin signaling pathway,5/137,0.0014759406733091,0.0035248936080207,0,0,6.448210553814002,42.032400940676496,INSR;CALM3;CALM1;CALM2;PTPRF,4,4,H1
85,KEGG_2021_Human,Allograft rejection,3/38,0.0015613281004726,0.003685460516232,0,0,14.41452784503632,93.14982812630632,HLA-B;HLA-C;TNF,4,4,H1
86,KEGG_2021_Human,Phospholipase D signaling pathway,5/148,0.0020719182311475,0.0048312611501454,0,0,5.948878707499397,36.75978971282513,ARF1;INSR;F2R;EGFR;PLD2,4,4,H1
87,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,4/89,0.00209433980893,0.0048312611501454,0,0,7.961387631975867,49.10995417339319,ALK;CD3G;CD247;EGFR,4,4,H1
88,KEGG_2021_Human,Type I diabetes mellitus,3/43,0.0022344526003817,0.0050965604255899,0,0,12.609533898305084,76.96555604840475,HLA-B;HLA-C;TNF,4,4,H1
89,KEGG_2021_Human,Pathways of neurodegeneration,9/475,0.0024093831055377,0.0054344974491573,0,0,3.3475820049049663,20.180511594883008,APP;LRP5;CALM3;PSEN1;CALM1;CALM2;TNF;AGER;LRP6,4,4,H1
90,KEGG_2021_Human,Oxytocin signaling pathway,5/154,0.0024626675472521,0.005493642990024,0,0,5.707590835454756,34.28270227230309,CALM3;CALM1;CALM2;EGFR;GNAI2,4,4,H1
91,KEGG_2021_Human,Type II diabetes mellitus,3/46,0.0027125431470992,0.0059852854224038,0,0,11.728025226645643,69.31108865414488,PKM;INSR;TNF,4,4,H1
92,KEGG_2021_Human,Circadian entrainment,4/97,0.0028641052168442,0.0062517565485954,0,0,7.273596176821983,42.59053726973836,CALM3;CALM1;CALM2;GNAI2,4,4,H1
93,KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,4/98,0.0029722204953366,0.0064187314952483,0,0,7.195853791598473,41.86868645115037,BDKRB2;CALM3;CALM1;CALM2,4,4,H1
94,KEGG_2021_Human,Hematopoietic cell lineage,4/99,0.0030830942989262,0.0065880857124423,0,0,7.119748088169141,41.16511288263146,CD3G;ITGA5;TNF;CD44,4,4,H1
95,KEGG_2021_Human,Hippo signaling pathway,5/163,0.0031455906745797,0.0066516136139551,0,0,5.380019642077695,30.998347501041145,TGFB1;TGFB3;CDH1;ITGB2;AREG,4,4,H1
96,KEGG_2021_Human,Melanogenesis,4/101,0.0033132536552713,0.0069339225981451,0,0,6.972244250594766,39.81029170422424,CALM3;CALM1;CALM2;GNAI2,4,4,H1
97,KEGG_2021_Human,Protein digestion and absorption,4/103,0.003554853684319,0.0073636254889466,0,0,6.830700164033497,38.52133312042065,COL1A1;COL1A2;COL4A1;COL4A5,4,4,H1
98,KEGG_2021_Human,C-type lectin receptor signaling pathway,4/104,0.0036800275717106,0.0074704559705726,0,0,6.762051282051282,37.90018193083949,CALM3;CALM1;TNF;CALM2,4,4,H1
99,KEGG_2021_Human,Toll-like receptor signaling pathway,4/104,0.0036800275717106,0.0074704559705726,0,0,6.762051282051282,37.90018193083949,CXCL10;CXCL9;CCL5;TNF,4,4,H1
100,KEGG_2021_Human,Shigellosis,6/246,0.0038628955465808,0.0077640375837219,0,0,4.269347826086957,23.7219405651122,ARF1;CCL5;ITGA5;TNF;EGFR;CD44,4,4,H1
101,KEGG_2021_Human,Glucagon signaling pathway,4/107,0.004073441057251,0.0081069464178623,0,0,6.564102564102564,36.12401012921664,PKM;CALM3;CALM1;CALM2,4,4,H1
102,KEGG_2021_Human,Endocytosis,6/252,0.0043421133643166,0.0085577574073424,0,0,4.163944856839873,22.64933708322378,ARF1;HLA-B;HLA-C;CXCR4;EGFR;PLD2,4,4,H1
103,KEGG_2021_Human,Legionellosis,3/57,0.0049826566753176,0.0097257625489373,0,0,9.333804143126176,49.48588870729106,ARF1;ITGB2;TNF,4,4,H1
104,KEGG_2021_Human,Endometrial cancer,3/58,0.0052315184346227,0.010114268973604,0,0,9.163636363636364,48.13707400969599,CDH1;ERBB2;EGFR,4,4,H1
105,KEGG_2021_Human,Sphingolipid signaling pathway,4/119,0.0059308337200341,0.0113581060864804,0,0,5.875585284280937,30.127595181369365,BDKRB2;TNF;PLD2;GNAI2,4,4,H1
106,KEGG_2021_Human,Platelet activation,4/124,0.006847437422278,0.012990932679649,0,0,5.629344729344729,28.055983088607064,COL1A1;COL1A2;F2R;GNAI2,4,4,H1
107,KEGG_2021_Human,Inflammatory bowel disease,3/65,0.0071828377966768,0.0135010747474574,0,0,8.126161837069438,40.11122839216532,TGFB1;TGFB3;TNF,4,4,H1
108,KEGG_2021_Human,Long-term potentiation,3/67,0.0078091955387804,0.014492919434235,0,0,7.871424788135593,38.19572138121446,CALM3;CALM1;CALM2,4,4,H1
109,KEGG_2021_Human,Oocyte meiosis,4/129,0.0078533060973687,0.014492919434235,0,0,5.402803418803419,26.1864193237518,AR;CALM3;CALM1;CALM2,4,4,H1
110,KEGG_2021_Human,FoxO signaling pathway,4/131,0.0082814149244182,0.0151452903572693,0,0,5.317181506157884,25.48919333322111,TGFB1;TGFB3;INSR;EGFR,4,4,H1
111,KEGG_2021_Human,Amphetamine addiction,3/69,0.0084668365349384,0.0152718794219056,0,0,7.632126348228043,36.41744134247907,CALM3;CALM1;CALM2,4,4,H1
112,KEGG_2021_Human,Dopaminergic synapse,4/132,0.0085010954417504,0.0152718794219056,0,0,5.275373931623932,25.15066305127321,CALM3;CALM1;CALM2;GNAI2,4,4,H1
113,KEGG_2021_Human,Central carbon metabolism in cancer,3/70,0.0088074928878119,0.015547139619355,0,0,7.517834556033392,35.57553925260326,PKM;ERBB2;EGFR,4,4,H1
114,KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,3/70,0.0088074928878119,0.015547139619355,0,0,7.517834556033392,35.57553925260326,CCL5;ADAM10;EGFR,4,4,H1
115,KEGG_2021_Human,Melanoma,3/72,0.0095126722736461,0.0166471764788807,0,0,7.299189388356669,33.978678750812335,CDH1;HGF;EGFR,4,4,H1
116,KEGG_2021_Human,Bacterial invasion of epithelial cells,3/77,0.0114164785340787,0.0198080781403246,0,0,6.804283096655978,30.433499872171065,CDH1;FN1;ITGA5,4,4,H1
117,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,4/150,0.0131260304182577,0.02258122182124,0,0,4.62077040159232,20.022528072537224,CALM3;CALM1;CALM2;GNAI2,4,4,H1
118,KEGG_2021_Human,Coronavirus disease,5/232,0.0134953076156563,0.0230214071090607,0,0,3.7315813458909313,16.06599972521498,CXCL10;NRP1;ACE;TNF;EGFR,4,4,H1
119,KEGG_2021_Human,mTOR signaling pathway,4/154,0.0143339718307548,0.024248302347027,0,0,4.496638176638177,19.0887817264157,INSR;LRP5;TNF;LRP6,4,4,H1
120,KEGG_2021_Human,Non-alcoholic fatty liver disease,4/155,0.0146465902008346,0.0245723786014003,0,0,4.466632705043301,18.865036383743146,TGFB1;RXRA;INSR;TNF,4,4,H1
121,KEGG_2021_Human,Hepatitis C,4/157,0.0152847170158226,0.0254327668378032,0,0,4.407798447014133,18.42857262715373,CXCL10;RXRA;TNF;EGFR,4,4,H1
122,KEGG_2021_Human,Salmonella infection,5/249,0.0177924696014442,0.0293648075536031,0,0,3.4685910118711134,13.974883701572418,HSP90AA1;ARF1;TNF;HSP90B1;S100A10,4,4,H1
123,KEGG_2021_Human,Staphylococcus aureus infection,3/95,0.019980420942237,0.0327098826715655,0,0,5.468036109064112,21.39643862476613,ITGB2;ITGAL;ICAM1,4,4,H1
124,KEGG_2021_Human,Protein processing in endoplasmic reticulum,4/171,0.0202435841723689,0.0328755806959272,0,0,4.035416346793593,15.737790292423778,HSP90AA1;CANX;CALR;HSP90B1,4,4,H1
125,KEGG_2021_Human,Influenza A,4/172,0.0206313919536212,0.0332394648141675,0,0,4.011192511192511,15.567203408459838,CXCL10;CCL5;TNF;ICAM1,4,4,H1
126,KEGG_2021_Human,Thyroid cancer,2/37,0.0210599671504756,0.0334632139691069,0,0,9.528931572629052,36.78530955768304,RXRA;CDH1,4,4,H1
127,KEGG_2021_Human,Phosphatidylinositol signaling system,3/97,0.0210999575765797,0.0334632139691069,0,0,5.351153984853949,20.64734336501829,CALM3;CALM1;CALM2,4,4,H1
128,KEGG_2021_Human,Aldosterone synthesis and secretion,3/98,0.0216724135886761,0.034104650841095,0,0,5.294558429973238,20.28723943297898,CALM3;CALM1;CALM2,4,4,H1
129,KEGG_2021_Human,T cell receptor signaling pathway,3/104,0.0252848327012242,0.039483238756527,0,0,4.978519885886894,18.30875859926688,CD3G;CD247;TNF,4,4,H1
130,KEGG_2021_Human,Alcoholism,4/186,0.0265443210554383,0.0411335662156792,0,0,3.7000093923170847,13.42711005059396,CALM3;CALM1;CALM2;GNAI2,4,4,H1
131,KEGG_2021_Human,Insulin resistance,3/108,0.0278621564676528,0.0426306471688699,0,0,4.787893462469734,17.142985080501543,INSR;TNF;PTPRF,4,4,H1
132,KEGG_2021_Human,Neutrophil extracellular trap formation,4/189,0.0279304240071906,0.0426306471688699,0,0,3.63945483945484,13.022110328249989,ITGB2;HMGB1;ITGAL;AGER,4,4,H1
133,KEGG_2021_Human,Transcriptional misregulation in cancer,4/192,0.0293590704758062,0.0444768007954378,0,0,3.5808328787052197,12.633728896418614,NGFR;RXRA;PLAU;ITGB7,4,4,H1
134,KEGG_2021_Human,Herpes simplex virus 1 infection,7/498,0.0318063719941548,0.0475187049947436,0,0,2.4246257190838603,8.360324379056163,CCL5;HLA-B;HLA-C;ITGA5;CALR;TNF;B2M,4,4,H1
135,KEGG_2021_Human,Pathogenic Escherichia coli infection,4/197,0.031835191523572,0.0475187049947436,0,0,3.4871794871794872,12.020945669698852,ARF1;F2R;EZR;TNF,4,4,H1
0,KEGG_2021_Human,ECM-receptor interaction,11/88,2.650949793298434e-20,2.0677408387727786e-18,0,0,203.0408163265306,9152.4269946504,COL1A1;ITGB1;COMP;COL1A2;LAMB2;COL4A1;COL6A2;COL6A1;FN1;SDC1;HSPG2,5,5,H1
1,KEGG_2021_Human,Amoebiasis,9/102,3.1050262753774496e-15,1.2109602473972054e-13,0,0,120.25403225806453,4017.176645249965,COL1A1;COL3A1;TGFB1;COL1A2;LAMB2;COL4A1;ITGB2;FN1;CD14,5,5,H1
2,KEGG_2021_Human,Protein digestion and absorption,8/103,3.77284106739389e-13,9.809386775224111e-12,0,0,98.47678018575851,2817.0049015621003,COL1A1;COL18A1;COL3A1;COL1A2;COL16A1;COL4A1;COL6A2;COL6A1,5,5,H1
3,KEGG_2021_Human,Focal adhesion,9/201,1.5530154696425053e-12,3.0283801658028854e-11,0,0,57.9580078125,1575.9259092979023,COL1A1;ITGB1;COMP;COL1A2;LAMB2;COL4A1;COL6A2;COL6A1;FN1,5,5,H1
4,KEGG_2021_Human,Proteoglycans in cancer,8/205,9.893984602266378e-11,1.5434615979535546e-09,0,0,47.24514780531502,1088.3632757605485,COL1A1;ITGB1;TGFB1;COL1A2;FN1;SDC1;MMP9;HSPG2,5,5,H1
5,KEGG_2021_Human,Human papillomavirus infection,9/331,1.3523391806939534e-10,1.7580409349021394e-09,0,0,34.33171583850932,780.1544294832928,COL1A1;ITGB1;COMP;COL1A2;LAMB2;COL4A1;COL6A2;COL6A1;FN1,5,5,H1
6,KEGG_2021_Human,PI3K-Akt signaling pathway,9/354,2.4518805166668385e-10,2.7320954328573343e-09,0,0,32.005434782608695,708.2481268241023,COL1A1;ITGB1;COMP;COL1A2;LAMB2;COL4A1;COL6A2;COL6A1;FN1,5,5,H1
7,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,6/100,2.2009100328559953e-09,2.1458872820345956e-08,0,0,66.78947368421052,1331.4077443064766,COL1A1;COL3A1;TGFB1;COL1A2;COL4A1;FN1,5,5,H1
8,KEGG_2021_Human,Relaxin signaling pathway,6/129,1.0256516237106472e-08,8.888980738825609e-08,0,0,50.96790757381258,937.5726312524824,COL1A1;COL3A1;TGFB1;COL1A2;COL4A1;MMP9,5,5,H1
9,KEGG_2021_Human,Malaria,4/50,4.205009693617207e-07,3.2799075610214214e-06,0,0,82.52173913043478,1211.569241792194,COMP;TGFB1;ITGB2;SDC1,5,5,H1
10,KEGG_2021_Human,Diabetic cardiomyopathy,5/203,4.618098915203403e-06,3.201198760876645e-05,0,0,24.970959595959595,306.7814090139398,COL1A1;COL3A1;TGFB1;COL1A2;MMP9,5,5,H1
11,KEGG_2021_Human,Small cell lung cancer,4/92,4.924921170579454e-06,3.201198760876645e-05,0,0,43.04545454545455,526.0672076409821,ITGB1;LAMB2;COL4A1;FN1,5,5,H1
12,KEGG_2021_Human,Platelet activation,4/124,1.609632421138831e-05,9.657794526832986e-05,0,0,31.515873015873016,347.838157289951,COL1A1;ITGB1;COL3A1;COL1A2,5,5,H1
13,KEGG_2021_Human,Phagosome,4/152,3.582013252595698e-05,0.0001995693097874746,0,0,25.51737451737452,261.2213747122412,ITGB1;COMP;ITGB2;CD14,5,5,H1
14,KEGG_2021_Human,Pathways in cancer,6/531,3.9221698693452754e-05,0.00020395283320595432,0,0,11.699248120300751,118.70385220444336,ITGB1;TGFB1;LAMB2;COL4A1;FN1;MMP9,5,5,H1
15,KEGG_2021_Human,Pertussis,3/76,0.00011419222790172148,0.0005447325066677066,0,0,37.17683686176837,337.47746996612005,ITGB1;ITGB2;CD14,5,5,H1
16,KEGG_2021_Human,Leishmaniasis,3/77,0.00011872375145321811,0.0005447325066677066,0,0,36.67260442260442,331.47307958978314,ITGB1;TGFB1;ITGB2,5,5,H1
17,KEGG_2021_Human,Toxoplasmosis,3/112,0.0003594018760909219,0.0015540801307857,0,0,24.853211009174316,197.1125404210704,ITGB1;TGFB1;LAMB2,5,5,H1
18,KEGG_2021_Human,Leukocyte transendothelial migration,3/114,0.0003785579805760263,0.0015540801307857,0,0,24.402948402948404,192.274278888393,ITGB1;ITGB2;MMP9,5,5,H1
19,KEGG_2021_Human,Cell adhesion molecules,3/148,0.0008104041674995336,0.0031605762532481,0,0,18.64890282131661,132.74246998288316,ITGB1;ITGB2;SDC1,5,5,H1
20,KEGG_2021_Human,Hepatitis B,3/162,0.0010525068448109,0.0039093111378693,0,0,16.99485420240137,116.52658573835885,TGFB1;MMP9;HSPG2,5,5,H1
21,KEGG_2021_Human,Tuberculosis,3/180,0.0014251986931014,0.0050529771846324,0,0,15.252696456086287,99.95769270276904,TGFB1;ITGB2;CD14,5,5,H1
22,KEGG_2021_Human,Legionellosis,2/57,0.0022953316425005,0.0077841681789149,0,0,31.49407114624506,191.3856261696762,ITGB2;CD14,5,5,H1
23,KEGG_2021_Human,Regulation of actin cytoskeleton,3/218,0.0024610659987552,0.0079984644959544,0,0,12.53276955602537,75.28636061468794,ITGB1;ITGB2;FN1,5,5,H1
24,KEGG_2021_Human,Bacterial invasion of epithelial cells,2/77,0.0041443015963463,0.0129302209806006,0,0,23.07246376811594,126.57602069899022,ITGB1;FN1,5,5,H1
25,KEGG_2021_Human,Hypertrophic cardiomyopathy,2/90,0.0056165618169928,0.0168496854509786,0,0,19.65118577075099,101.83314382617785,ITGB1;TGFB1,5,5,H1
26,KEGG_2021_Human,Rheumatoid arthritis,2/93,0.005985699144896,0.0172920197519218,0,0,19.00047778308648,97.25170595790462,TGFB1;ITGB2,5,5,H1
27,KEGG_2021_Human,Dilated cardiomyopathy,2/96,0.0063656858988136,0.017732982146695,0,0,18.39130434782609,93.00176010517843,ITGB1;TGFB1,5,5,H1
28,KEGG_2021_Human,Yersinia infection,2/137,0.0126051138276089,0.0336894398907851,0,0,12.77938808373591,55.892605043800906,ITGB1;FN1,5,5,H1
29,KEGG_2021_Human,Fluid shear stress and atherosclerosis,2/139,0.0129574768810712,0.0336894398907851,0,0,12.5915582354808,54.72394827734709,SDC1;MMP9,5,5,H1
30,KEGG_2021_Human,Hippo signaling pathway,2/163,0.0175148623564959,0.0440696536711834,0,0,10.70159330272752,43.28479308666137,TGFB1;ITGB2,5,5,H1
0,KEGG_2021_Human,Cell adhesion molecules,20/148,4.334347020102212e-24,7.368389934173762e-22,0,0,42.33518835616438,2277.441408615227,VCAM1;SELPLG;ITGB2;HLA-B;ICAM2;HLA-C;ICAM3;HLA-A;HLA-F;ITGAL;PTPRF;HLA-E;ICAM1;VCAN;CD4;PTPRC;CD40LG;SDC1;ITGAV;JAM3,6,6,H1
1,KEGG_2021_Human,Cytokine-cytokine receptor interaction,19/295,9.709081449632987e-17,8.25271923218804e-15,0,0,18.26228946337642,673.3467728413025,NGFR;CXCL9;TGFB1;CCL21;CXCR4;IL16;TNFRSF1B;IL2RG;CXCL14;TGFBR2;CD4;CXCL12;CD40LG;CCL5;CXCR3;CXCR2;CCR7;CCL19;CCR5,6,6,H1
2,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,13/100,1.017702981121403e-15,5.2642426238888383e-14,0,0,37.020114942528735,1277.9798391207632,CXCL9;CCL21;CXCR4;TNFRSF1B;IL2RG;CXCL14;CXCL12;CCL5;CXCR3;CXCR2;CCR7;CCL19;CCR5,6,6,H1
3,KEGG_2021_Human,Epstein-Barr virus infection,16/202,1.238645323267962e-15,5.2642426238888383e-14,0,0,22.03155983801145,756.2279618671012,SYK;HLA-B;HLA-C;CD3G;HLA-A;HLA-F;ITGAL;CD3D;HLA-E;ICAM1;CD19;VIM;CALR;CD247;B2M;CD44,6,6,H1
4,KEGG_2021_Human,Human immunodeficiency virus 1 infection,16/212,2.6646624419603613e-15,9.059852302665229e-14,0,0,20.896899019348,701.2727444064354,HLA-B;HLA-C;CXCR4;CD3G;HLA-A;TNFRSF1B;HLA-F;CD3D;HLA-E;GNAI2;BST2;CD4;CALR;CD247;CCR5;B2M,6,6,H1
5,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,16/219,4.451611125790247e-15,1.2612898189739033e-13,0,0,20.169151045998337,666.4998889054345,TGFB1;ITGB2;HLA-B;HLA-C;CD3G;HLA-A;IL2RG;HLA-F;ITGAL;CD3D;TGFBR2;HLA-E;ICAM1;CD4;CALR;B2M,6,6,H1
6,KEGG_2021_Human,PI3K-Akt signaling pathway,17/354,5.698288471160364e-13,1.3838700572818023e-11,0,0,12.989614243323444,366.2219143047352,NGFR;SYK;VWF;FN1;IL2RG;EREG;COL1A1;EFNA1;COL1A2;ERBB3;COL4A1;CD19;ERBB2;KDR;SPP1;COL4A5;ITGAV,6,6,H1
7,KEGG_2021_Human,Human cytomegalovirus infection,14/225,2.344953730075132e-12,4.983026676409655e-11,0,0,16.54232407462955,442.98285089531095,HLA-B;HLA-C;CXCR4;HLA-A;HLA-F;HLA-E;GNAI2;CXCL12;CCL5;CXCR2;ITGAV;CALR;CCR5;B2M,6,6,H1
8,KEGG_2021_Human,Viral myocarditis,9/60,8.319033553115015e-12,1.5713730044772806e-10,0,0,41.71428571428572,1064.2346725683656,CD40LG;ITGB2;HLA-B;HLA-C;HLA-A;ITGAL;HLA-F;ICAM1;HLA-E,6,6,H1
9,KEGG_2021_Human,ECM-receptor interaction,10/88,9.63919313928351e-12,1.6386628336781967e-10,0,0,30.628668520234783,776.9018038100885,COL1A1;COL1A2;VWF;COL4A1;SPP1;FN1;COL4A5;SDC1;ITGAV;CD44,6,6,H1
10,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,11/131,2.4032946785847542e-11,3.7141826850855287e-10,0,0,22.119613821138213,540.8598485373293,SYK;ITGB2;HLA-B;ICAM2;HLA-C;KLRD1;CD247;HLA-A;ITGAL;HLA-E;ICAM1,6,6,H1
11,KEGG_2021_Human,Human papillomavirus infection,15/331,3.3995430206784404e-11,4.6195942551990214e-10,0,0,11.92246835443038,287.3886556494057,NOTCH2;VWF;FN1;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E;COL1A1;COL1A2;PKM;COL4A1;SPP1;COL4A5;ITGAV,6,6,H1
12,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,10/100,3.5326309010345455e-11,4.6195942551990214e-10,0,0,26.52878179384204,638.4520919594615,COL1A1;TGFB1;VCAM1;COL1A2;COL4A1;FN1;COL4A5;AGER;TGFBR2;ICAM1,6,6,H1
13,KEGG_2021_Human,Chemokine signaling pathway,12/192,9.169115992530695e-11,1.0864229289769855e-09,0,0,16.236213991769546,375.2610406539647,CXCL9;CXCL12;CCL21;CCL5;CXCR3;CXCR2;CXCR4;CCR7;CCL19;CCR5;CXCL14;GNAI2,6,6,H1
14,KEGG_2021_Human,Antigen processing and presentation,9/78,9.586084667443988e-11,1.0864229289769855e-09,0,0,30.80434782608696,710.598499675852,CD4;HLA-B;HLA-C;KLRD1;HLA-A;CALR;HLA-F;B2M;HLA-E,6,6,H1
15,KEGG_2021_Human,Proteoglycans in cancer,12/205,1.9604985822571178e-10,2.083029743648188e-09,0,0,15.132604106697372,338.25383512057226,COL1A1;TGFB1;COL1A2;ERBB3;ERBB2;FN1;KDR;TIMP3;SDC1;ITGAV;MMP9;CD44,6,6,H1
16,KEGG_2021_Human,Chagas disease,9/102,1.0993246379713936e-09,1.0993246379713938e-08,0,0,22.827188940092167,470.8922606436102,C3;TGFB1;CCL5;CD3G;CALR;CD247;CD3D;TGFBR2;GNAI2,6,6,H1
17,KEGG_2021_Human,Phagosome,10/152,2.247144465901022e-09,2.1223031066842984e-08,0,0,16.769896487357883,333.94910381420493,C3;FCGR2A;ITGB2;HLA-B;HLA-C;ITGAV;CALR;HLA-A;HLA-F;HLA-E,6,6,H1
18,KEGG_2021_Human,Leukocyte transendothelial migration,9/114,2.9727389567139052e-09,2.6598190665334942e-08,0,0,20.206122448979592,396.7226052786087,VCAM1;CXCL12;ITGB2;CXCR4;ITGAL;MMP9;JAM3;ICAM1;GNAI2,6,6,H1
19,KEGG_2021_Human,Malaria,7/50,3.171125741288853e-09,2.695456880095525e-08,0,0,37.60086533261222,735.8180713426998,TGFB1;VCAM1;CD40LG;ITGB2;SDC1;ITGAL;ICAM1,6,6,H1
20,KEGG_2021_Human,Allograft rejection,6/38,2.1019483442462522e-08,1.624232811463013e-07,0,0,42.83405172413793,757.2124869001444,CD40LG;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,6,6,H1
21,KEGG_2021_Human,Primary immunodeficiency,6/38,2.1019483442462522e-08,1.624232811463013e-07,0,0,42.83405172413793,757.2124869001444,CD4;CD40LG;PTPRC;CD19;IL2RG;CD3D,6,6,H1
22,KEGG_2021_Human,Focal adhesion,10/201,3.2890615273235676e-08,2.431045476717419e-07,0,0,12.436762757837633,214.28639822932416,COL1A1;COL1A2;VWF;COL4A1;ERBB2;FN1;KDR;SPP1;COL4A5;ITGAV,6,6,H1
23,KEGG_2021_Human,Graft-versus-host disease,6/42,3.9349326368777415e-08,2.787243951121733e-07,0,0,38.06704980842912,649.0731572859984,HLA-B;HLA-C;KLRD1;HLA-A;HLA-F;HLA-E,6,6,H1
24,KEGG_2021_Human,Relaxin signaling pathway,8/129,1.5483916529409137e-07,1.0529063239998213e-06,0,0,15.390179873602332,241.33154687819535,COL1A1;TGFB1;COL1A2;COL4A1;COL4A5;MMP9;TGFBR2;GNAI2,6,6,H1
25,KEGG_2021_Human,Autoimmune thyroid disease,6/53,1.652858767070304e-07,1.080715347699814e-06,0,0,29.141599413059428,455.0632472840952,CD40LG;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,6,6,H1
26,KEGG_2021_Human,Axon guidance,9/182,1.7503517757807072e-07,1.1020733403063712e-06,0,0,12.221717588769613,190.14889049802903,EFNA1;EPHA4;CXCL12;SEMA4D;PLXNB2;CXCR4;PLXNB1;SLIT2;GNAI2,6,6,H1
27,KEGG_2021_Human,Neutrophil extracellular trap formation,9/189,2.41210199281104e-07,1.4644904956352735e-06,0,0,11.742261904761904,178.92385579961334,C3;FCGR2A;SELPLG;SYK;VWF;ITGB2;HMGB1;ITGAL;AGER,6,6,H1
28,KEGG_2021_Human,Endocytosis,10/252,2.725248144327205e-07,1.597559257019396e-06,0,0,9.790401274519564,147.98716453339983,CXCR2;HLA-B;HLA-C;CXCR4;HLA-A;IL2RG;CCR5;HLA-F;TGFBR2;HLA-E,6,6,H1
29,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,9/193,2.88028878192216e-07,1.6321636430892236e-06,0,0,11.484666149068325,172.9614275990148,C3;SYK;HLA-B;HLA-C;HLA-A;CCR5;HLA-F;HLA-E;ICAM1,6,6,H1
30,KEGG_2021_Human,Viral carcinogenesis,9/203,4.4109000570612484e-07,2.4188806764529424e-06,0,0,10.887150220913108,159.32274019233878,C3;PKM;SYK;HLA-B;HLA-C;HLA-A;CCR5;HLA-F;HLA-E,6,6,H1
31,KEGG_2021_Human,Amoebiasis,7/102,4.820449058181422e-07,2.56086356215888e-06,0,0,16.974785801713587,246.90213927076573,COL1A1;TGFB1;COL1A2;COL4A1;ITGB2;FN1;COL4A5,6,6,H1
32,KEGG_2021_Human,NF-kappa B signaling pathway,7/104,5.503590582675072e-07,2.835183027438673e-06,0,0,16.6231119635579,239.58384165944184,VCAM1;CXCL12;CD40LG;CCL21;SYK;CCL19;ICAM1,6,6,H1
33,KEGG_2021_Human,Th17 cell differentiation,7/107,6.679755036570641e-07,3.3398775182853205e-06,0,0,16.121976744186046,229.2386184382167,CD4;TGFB1;CD3G;CD247;IL2RG;CD3D;TGFBR2,6,6,H1
34,KEGG_2021_Human,Pathways in cancer,13/531,1.0499010796885955e-06,5.099519529916035e-06,0,0,6.082456563706564,83.7360518740849,NOTCH2;TGFB1;FN1;CXCR4;IL2RG;MMP9;TGFBR2;GNAI2;CXCL12;COL4A1;ERBB2;COL4A5;ITGAV,6,6,H1
35,KEGG_2021_Human,Type I diabetes mellitus,5/43,1.6324975395476103e-06,7.709016158974827e-06,0,0,29.708433014354068,395.87673792918434,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,6,6,H1
36,KEGG_2021_Human,ErbB signaling pathway,6/85,2.794789613475791e-06,1.2840925251104983e-05,0,0,17.309471846355304,221.34926310956968,ERBB3;NRG4;ERBB2;NRG1;NRG2;EREG,6,6,H1
37,KEGG_2021_Human,Th1 and Th2 cell differentiation,6/92,4.439406573254844e-06,1.986050309087693e-05,0,0,15.89494787489976,195.9050711469316,NOTCH2;CD4;CD3G;CD247;IL2RG;CD3D,6,6,H1
38,KEGG_2021_Human,Rheumatoid arthritis,6/93,4.727933142737076e-06,2.060893934013597e-05,0,0,15.711454617518829,192.65420874989297,TGFB1;CXCL12;CCL5;ITGB2;ITGAL;ICAM1,6,6,H1
39,KEGG_2021_Human,Staphylococcus aureus infection,6/95,5.350762908389975e-06,2.2740742360657395e-05,0,0,15.356838434715227,186.4054728820644,C3;FCGR2A;SELPLG;ITGB2;ITGAL;ICAM1,6,6,H1
40,KEGG_2021_Human,Cellular senescence,7/156,8.291306122954567e-06,3.437858636347016e-05,0,0,10.79335102231934,126.28547785585448,TGFB1;HLA-B;HLA-C;HLA-A;HLA-F;TGFBR2;HLA-E,6,6,H1
41,KEGG_2021_Human,T cell receptor signaling pathway,6/104,9.034104731145402e-06,3.656661438796949e-05,0,0,13.94018296973962,161.90830706826742,CD4;PTPRC;CD40LG;CD3G;CD247;CD3D,6,6,H1
42,KEGG_2021_Human,Herpes simplex virus 1 infection,11/498,1.976987451419575e-05,7.81599690096111e-05,0,0,5.349326388541093,57.94043316192978,BST2;C3;SYK;CCL5;HLA-B;HLA-C;CALR;HLA-A;HLA-F;B2M;HLA-E,6,6,H1
43,KEGG_2021_Human,Platelet activation,6/124,2.46796646307176e-05,9.535324970959073e-05,0,0,11.565751022793687,122.70719341002508,COL1A1;COL1A2;FCGR2A;SYK;VWF;GNAI2,6,6,H1
44,KEGG_2021_Human,Osteoclast differentiation,6/127,2.8252989542910137e-05,0.00010673351605099384,0,0,11.277286976346538,118.12181420041736,TGFB1;FCGR2A;SYK;SIRPA;LILRA4;TGFBR2,6,6,H1
45,KEGG_2021_Human,Fluid shear stress and atherosclerosis,6/139,4.69363538961655e-05,0.00017254565292595652,0,0,10.253564946849885,102.1943907956652,VCAM1;KDR;SDC1;ITGAV;MMP9;ICAM1,6,6,H1
46,KEGG_2021_Human,Complement and coagulation cascades,5/85,4.7703798161882094e-05,0.00017254565292595652,0,0,14.081676136363637,140.11971187795282,C3;PROC;VWF;ITGB2;ITGAX,6,6,H1
47,KEGG_2021_Human,Rap1 signaling pathway,7/210,5.617965909042475e-05,0.00019896962594525435,0,0,7.90056134723336,77.32244473589861,EFNA1;NGFR;CNR1;ITGB2;KDR;ITGAL;GNAI2,6,6,H1
48,KEGG_2021_Human,MAPK signaling pathway,8/294,6.845944833164347e-05,0.00023751237176284468,0,0,6.456931303990127,61.91725107970157,EFNA1;NGFR;TGFB1;ERBB3;ERBB2;KDR;EREG;TGFBR2,6,6,H1
49,KEGG_2021_Human,Regulation of actin cytoskeleton,7/218,7.109227520615049e-05,0.00024171373570091169,0,0,7.597927917998457,72.57185068471527,CXCL12;ITGB2;FN1;ITGAX;CXCR4;ITGAV;ITGAL,6,6,H1
50,KEGG_2021_Human,Intestinal immune network for IgA production,4/48,7.288549506921119e-05,0.000242951650230704,0,0,20.289070480081715,193.28628305953615,TGFB1;CD40LG;CXCL12;CXCR4,6,6,H1
51,KEGG_2021_Human,Hematopoietic cell lineage,5/99,9.883188015420392e-05,0.00031742883200849544,0,0,11.975942940038683,110.4432275995174,CD4;CD19;CD3G;CD3D;CD44,6,6,H1
52,KEGG_2021_Human,MicroRNAs in cancer,8/310,9.89631064497074e-05,0.00031742883200849544,0,0,6.109855862874952,56.337535560459976,EFNA1;NOTCH2;ERBB3;ERBB2;TIMP3;VIM;MMP9;CD44,6,6,H1
53,KEGG_2021_Human,Protein digestion and absorption,5/103,0.00011921251974140003,0.0003752986732599631,0,0,11.48480983302412,103.7606948160494,COL1A1;COL18A1;COL1A2;COL4A1;COL4A5,6,6,H1
54,KEGG_2021_Human,TNF signaling pathway,5/112,0.0001767870736735288,0.0005464327731727254,0,0,10.514018691588785,90.84705690217164,VCAM1;CCL5;TNFRSF1B;MMP9;ICAM1,6,6,H1
55,KEGG_2021_Human,Tuberculosis,6/180,0.0001949226211819409,0.0005917293857308919,0,0,7.821244550138724,66.81617179736456,C3;TGFB1;FCGR2A;SYK;ITGB2;ITGAX,6,6,H1
56,KEGG_2021_Human,Diabetic cardiomyopathy,6/203,0.0003718304851224791,0.0011089681135231,0,0,6.900052511815159,54.49021488925335,COL1A1;TGFB1;COL1A2;MMP9;AGER;TGFBR2,6,6,H1
57,KEGG_2021_Human,Leishmaniasis,4/77,0.0004574047936431279,0.001340669222747,0,0,12.21117438817916,93.90322030872784,C3;TGFB1;FCGR2A;ITGB2,6,6,H1
58,KEGG_2021_Human,Lipid and atherosclerosis,6/215,0.000504097109538106,0.0014524831969742,0,0,6.499917505362151,49.35219423971517,VCAM1;CD40LG;CCL5;MMP9;AGER;ICAM1,6,6,H1
59,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,4/89,0.0007909892027736086,0.0022411360745252,0,0,10.480898876404494,74.85695097789208,CD4;CD3G;CD247;CD3D,6,6,H1
60,KEGG_2021_Human,Small cell lung cancer,4/92,0.0008956538613494692,0.0024960845316296,0,0,10.122063329928498,71.03620049483177,COL4A1;FN1;COL4A5;ITGAV,6,6,H1
61,KEGG_2021_Human,Toxoplasmosis,4/112,0.001855253841312,0.0050869863390813,0,0,8.239284228048273,51.822904089999696,TGFB1;CD40LG;CCR5;GNAI2,6,6,H1
62,KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,3/70,0.0042542088327827,0.0114796111360803,0,0,9.870646766169154,53.89221592743272,CCL5;CXCR2;JAM3,6,6,H1
63,KEGG_2021_Human,Adherens junction,3/71,0.0044270954976082,0.0117594724155218,0,0,9.725,52.7096123610385,ERBB2;PTPRF;TGFBR2,6,6,H1
64,KEGG_2021_Human,Pancreatic cancer,3/76,0.0053552238291803,0.0137937583478887,0,0,9.05662100456621,47.36325489254818,TGFB1;ERBB2;TGFBR2,6,6,H1
65,KEGG_2021_Human,Pertussis,3/76,0.0053552238291803,0.0137937583478887,0,0,9.05662100456621,47.36325489254818,C3;ITGB2;GNAI2,6,6,H1
66,KEGG_2021_Human,B cell receptor signaling pathway,3/81,0.0063920203479103,0.0162185590917128,0,0,8.473931623931623,42.8162757298944,SYK;CD19;LILRA4,6,6,H1
67,KEGG_2021_Human,Colorectal cancer,3/86,0.007540586362197,0.0188514659054926,0,0,7.96144578313253,38.911210652087526,TGFB1;EREG;TGFBR2,6,6,H1
68,KEGG_2021_Human,Fc gamma R-mediated phagocytosis,3/97,0.0104737112533724,0.0258047958416422,0,0,7.025886524822695,32.03022169777378,FCGR2A;PTPRC;SYK,6,6,H1
69,KEGG_2021_Human,Toll-like receptor signaling pathway,3/104,0.0126392653525305,0.0306890008109542,0,0,6.536633663366336,28.57127938463682,CXCL9;CCL5;SPP1,6,6,H1
70,KEGG_2021_Human,African trypanosomiasis,2/37,0.0128171709269279,0.0306890008109542,0,0,12.478492935635792,54.36841348053223,VCAM1;ICAM1,6,6,H1
71,KEGG_2021_Human,Bladder cancer,2/41,0.0155926996662773,0.0368160964342659,0,0,11.196393350239504,46.58766027879876,ERBB2;MMP9,6,6,H1
